0001414932us-gaap:FairValueInputsLevel3Memberocsl:MeasurementInputAssetMultipleMemberocsl:EquitySecuritiesPreferredCommonMembersrt:MinimumMemberocsl:ValuationEnterpriseValueMember2022-12-310001414932Pluralsight, LLC, First Lien Term Loanocsl:OCSIGlickJVLLCMember2022-12-31


UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Form 10-Q
(Mark One)
þQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 31, 20212022
OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

COMMISSION FILE NUMBER: 1-33901
Oaktree Specialty Lending Corporation


(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
DELAWAREDelaware
(State or jurisdiction of

incorporation or organization)
26-1219283
(I.R.S. Employer

Identification No.)
333 South Grand Avenue, 28th Floor
Los Angeles, CA
(Address of principal executive office)
90071
(Zip Code)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE:
(213) 830-6300




SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:
Title of Each ClassTrading Symbol(s)Name of Each Exchange

on Which Registered
Common Stock, par value $0.01 per shareOCSLThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    YES  Yes  þ     NO       No  ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    YES  Yes  þ   No  ¨   NO  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer  þ
Accelerated filer  ¨
Non-accelerated filer  ¨
Smaller reporting company  ¨
Emerging growth company  ¨


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ¨


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)    YES  Yes  ¨     NO       No  þ
The registrant had 180,468,63377,079,805 shares of common stock outstanding as of February 1, 2022.6, 2023.







OAKTREE SPECIALTY LENDING CORPORATION
FORM 10-Q FOR THE QUARTER ENDED DECEMBER 31, 20212022






TABLE OF CONTENTS


PART I — FINANCIAL INFORMATION
Consolidated Financial Statements:







 





 








 















 
1





PART I — FINANCIAL INFORMATION


Item 1.Consolidated Financial Statements.
Item 1. Consolidated Financial Statements.


Oaktree Specialty Lending Corporation
Consolidated Statements of Assets and Liabilities
(in thousands, except per share amounts)
December 31, 2021 (unaudited)September 30, 2021December 31, 2022 (unaudited)September 30, 2022
ASSETSASSETSASSETS
Investments at fair value:Investments at fair value:Investments at fair value:
Control investments (cost December 31, 2021: $272,970; cost September 30, 2021: $283,599)$259,469 $270,765 
Affiliate investments (cost December 31, 2021: $18,845; cost September 30, 2021: $18,763)18,120 18,289 
Non-control/Non-affiliate investments (cost December 31, 2021: $2,283,055; cost September 30, 2021: $2,236,759)2,311,034 2,267,575 
Total investments at fair value (cost December 31, 2021: $2,574,870; cost September 30, 2021: $2,539,121)2,588,623 2,556,629 
Control investments (cost December 31, 2022: $281,911; cost September 30, 2022: $260,305)Control investments (cost December 31, 2022: $281,911; cost September 30, 2022: $260,305)$232,462 $214,165 
Affiliate investments (cost December 31, 2022: $24,327; cost September 30, 2022: $27,353)Affiliate investments (cost December 31, 2022: $24,327; cost September 30, 2022: $27,353)23,173 26,196 
Non-control/Non-affiliate investments (cost December 31, 2022: $2,471,776; cost September 30, 2022: $2,330,096)Non-control/Non-affiliate investments (cost December 31, 2022: $2,471,776; cost September 30, 2022: $2,330,096)2,387,235 2,253,750 
Total investments at fair value (cost December 31, 2022: $2,778,014; cost September 30, 2022: $2,617,754)Total investments at fair value (cost December 31, 2022: $2,778,014; cost September 30, 2022: $2,617,754)2,642,870 2,494,111 
Cash and cash equivalentsCash and cash equivalents43,765 29,334 Cash and cash equivalents17,382 23,528 
Restricted cashRestricted cash2,292 2,301 Restricted cash1,863 2,836 
Interest, dividends and fees receivableInterest, dividends and fees receivable18,508 22,125 Interest, dividends and fees receivable37,802 35,598 
Due from portfolio companiesDue from portfolio companies2,793 1,990 Due from portfolio companies6,181 22,495 
Receivables from unsettled transactionsReceivables from unsettled transactions25,823 8,150 Receivables from unsettled transactions8,657 4,692 
Due from brokerDue from broker3,450 1,640 Due from broker39,760 45,530 
Deferred financing costsDeferred financing costs9,055 9,274 Deferred financing costs6,781 7,350 
Deferred offering costsDeferred offering costs34 34 Deferred offering costs32 32 
Deferred tax asset, netDeferred tax asset, net1,673 714 Deferred tax asset, net1,722 1,687 
Derivative assets at fair valueDerivative assets at fair value1,075 1,912 Derivative assets at fair value— 6,789 
Other assetsOther assets2,848 2,284 Other assets4,210 1,665 
Total assetsTotal assets$2,699,939 $2,636,387 Total assets$2,767,260 $2,646,313 
LIABILITIES AND NET ASSETSLIABILITIES AND NET ASSETSLIABILITIES AND NET ASSETS
Liabilities:Liabilities:Liabilities:
Accounts payable, accrued expenses and other liabilitiesAccounts payable, accrued expenses and other liabilities$6,169 $3,024 Accounts payable, accrued expenses and other liabilities$3,035 $3,701 
Base management fee and incentive fee payableBase management fee and incentive fee payable26,190 32,649 Base management fee and incentive fee payable16,871 15,940 
Due to affiliateDue to affiliate3,503 4,357 Due to affiliate3,260 3,180 
Interest payableInterest payable6,698 4,597 Interest payable13,368 7,936 
Director fees payable123 — 
Payables from unsettled transactionsPayables from unsettled transactions40,803 8,086 Payables from unsettled transactions20,974 26,981 
Derivative liability at fair valueDerivative liability at fair value5,931 2,108 Derivative liability at fair value44,139 41,969 
Credit facilities payableCredit facilities payable650,000 630,000 Credit facilities payable860,000 700,000 
Unsecured notes payable (net of $6,131 and $6,501 of unamortized financing costs as of December 31, 2021 and September 30, 2021, respectively)635,461 638,743 
Unsecured notes payable (net of $4,650 and $5,020 of unamortized financing costs as of December 31, 2022 and September 30, 2022, respectively)Unsecured notes payable (net of $4,650 and $5,020 of unamortized financing costs as of December 31, 2022 and September 30, 2022, respectively)603,624 601,043 
Total liabilitiesTotal liabilities1,374,878 1,323,564 Total liabilities1,565,271 1,400,750 
Commitments and contingencies (Note 13)Commitments and contingencies (Note 13)Commitments and contingencies (Note 13)
Net assets:Net assets:Net assets:
Common stock, $0.01 par value per share, 250,000 shares authorized; 180,469 and 180,361 shares issued and outstanding as of December 31, 2021 and September 30, 2021, respectively1,805 1,804 
Common stock, $0.01 par value per share, 250,000 shares authorized; 61,220 and 61,125 shares issued and outstanding as of December 31, 2022 and September 30, 2022, respectively (1)Common stock, $0.01 par value per share, 250,000 shares authorized; 61,220 and 61,125 shares issued and outstanding as of December 31, 2022 and September 30, 2022, respectively (1)612 611 
Additional paid-in-capitalAdditional paid-in-capital1,805,139 1,804,354 Additional paid-in-capital1,829,653 1,827,721 
Accumulated overdistributed earningsAccumulated overdistributed earnings(481,883)(493,335)Accumulated overdistributed earnings(628,276)(582,769)
Total net assets (equivalent to $7.34 and $7.28 per common share as of December 31, 2021 and September 30, 2021, respectively) (Note 11)1,325,061 1,312,823 
Total net assets (equivalent to $19.63 and $20.38 per common share as of December 31, 2022 and September 30, 2022, respectively) (Note 11) (1)Total net assets (equivalent to $19.63 and $20.38 per common share as of December 31, 2022 and September 30, 2022, respectively) (Note 11) (1)1,201,989 1,245,563 
Total liabilities and net assetsTotal liabilities and net assets$2,699,939 $2,636,387 Total liabilities and net assets$2,767,260 $2,646,313 

 __________
(1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The issued and outstanding shares and net asset value per share reflect the reverse stock split on a retroactive basis.


See notes to Consolidated Financial Statements.
2



Oaktree Specialty Lending Corporation
Consolidated Statements of Operations
(in thousands, except per share amounts)
(unaudited)
Three months ended
December 31, 2021
Three months ended
December 31, 2020
Interest income:
Control investments$3,480 $2,343 
Affiliate investments334 105 
Non-control/Non-affiliate investments51,635 29,184 
Interest on cash and cash equivalents
Total interest income55,450 31,633 
PIK interest income:
Non-control/Non-affiliate investments4,663 3,089 
Total PIK interest income4,663 3,089 
Fee income:
Control investments13 15 
Affiliate investments
Non-control/Non-affiliate investments894 3,332 
Total fee income912 3,352 
Dividend income:
Control investments3,916 130 
Total dividend income3,916 130 
Total investment income64,941 38,204 
Expenses:
Base management fee9,952 6,541 
Part I incentive fee6,457 4,149 
Part II incentive fee1,751 9,540 
Professional fees1,322 867 
Directors fees123 143 
Interest expense9,400 6,095 
Administrator expense390 333 
General and administrative expenses693 518 
Total expenses30,088 28,186 
Fees waived(750)— 
Net expenses29,338 28,186 
Net investment income before taxes35,603 10,018 
(Provision) benefit for taxes on net investment income(3,308)— 
Net investment income32,295 10,018 
Unrealized appreciation (depreciation):
Control investments(667)8,335 
Affiliate investments(251)(290)
Non-control/Non-affiliate investments(2,831)41,937 
Foreign currency forward contracts(837)(2,426)
Net unrealized appreciation (depreciation)(4,586)47,556 
Realized gains (losses):
Control investments1,868 — 
Non-control/Non-affiliate investments4,481 8,738 
Foreign currency forward contracts2,972 (523)
Net realized gains (losses)9,321 8,215 
(Provision) benefit for taxes on realized and unrealized gains (losses)2,378 (245)
Net realized and unrealized gains (losses), net of taxes7,113 55,526 
Net increase (decrease) in net assets resulting from operations$39,408 $65,544 
Net investment income per common share — basic and diluted$0.18 $0.07 
Earnings (loss) per common share — basic and diluted (Note 5)$0.22 $0.46 
Weighted average common shares outstanding — basic and diluted180,381 140,961 


Three months ended
December 31, 2022
Three months ended
December 31, 2021
Interest income:
Control investments$4,567 $3,480 
Affiliate investments641 334 
Non-control/Non-affiliate investments64,298 51,635 
Interest on cash and cash equivalents472 
Total interest income69,978 55,450 
PIK interest income:
Non-control/Non-affiliate investments6,130 4,663 
Total PIK interest income6,130 4,663 
Fee income:
Control investments13 13 
Affiliate investments
Non-control/Non-affiliate investments2,003 894 
Total fee income2,021 912 
Dividend income:
Control investments1,050 3,916 
Total dividend income1,050 3,916 
Total investment income79,179 64,941 
Expenses:
Base management fee9,917 9,952 
Part I incentive fee7,703 6,457 
Part II incentive fee— 1,751 
Professional fees1,500 1,322 
Directors fees160 123 
Interest expense20,719 9,400 
Administrator expense298 390 
General and administrative expenses746 693 
Total expenses41,043 30,088 
Fees waived(750)(750)
Net expenses40,293 29,338 
Net investment income before taxes38,886 35,603 
(Provision) benefit for taxes on net investment income— (3,308)
Excise tax(78)— 
Net investment income38,808 32,295 
Unrealized appreciation (depreciation):
Control investments(3,309)(667)
Affiliate investments(251)
Non-control/Non-affiliate investments(8,675)(2,831)
Foreign currency forward contracts(11,001)(837)
Net unrealized appreciation (depreciation)(22,982)(4,586)
Realized gains (losses):
Control investments— 1,868 
Non-control/Non-affiliate investments(7,651)4,481 
Foreign currency forward contracts4,448 2,972 
Net realized gains (losses)(3,203)9,321 
(Provision) benefit for taxes on realized and unrealized gains (losses)549 2,378 
Net realized and unrealized gains (losses), net of taxes(25,636)7,113 
Net increase (decrease) in net assets resulting from operations$13,172 $39,408 
Net investment income per common share — basic and diluted (1)$0.63 $0.54 
Earnings (loss) per common share — basic and diluted (Note 5) (1)$0.22 $0.66 
Weighted average common shares outstanding — basic and diluted (1)61,142 60,127 

__________
(1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.



See notes to Consolidated Financial Statements.
3



Oaktree Specialty Lending Corporation
Consolidated Statements of Changes in Net Assets
(in thousands, except per share amounts)
(unaudited)
Three months ended
December 31, 2021
Three months ended
December 31, 2020
Operations:
Net investment income$32,295 $10,018 
Net unrealized appreciation (depreciation)(4,586)47,556 
Net realized gains (losses)9,321 8,215 
(Provision) benefit for taxes on realized and unrealized gains (losses)2,378 (245)
Net increase (decrease) in net assets resulting from operations39,408 65,544 
Stockholder transactions:
Distributions to stockholders(27,956)(15,506)
Net increase (decrease) in net assets from stockholder transactions(27,956)(15,506)
Capital share transactions:
Issuance of common stock under dividend reinvestment plan786 528 
Repurchases of common stock under dividend reinvestment plan— (528)
Net increase (decrease) in net assets from capital share transactions786  
Total increase (decrease) in net assets12,238 50,038 
Net assets at beginning of period1,312,823 914,879 
Net assets at end of period$1,325,061 $964,917 
Net asset value per common share$7.34 $6.85 
Common shares outstanding at end of period180,469 140,961 




Three months ended
December 31, 2022
Three months ended
December 31, 2021
Operations:
Net investment income$38,808 $32,295 
Net unrealized appreciation (depreciation)(22,982)(4,586)
Net realized gains (losses)(3,203)9,321 
(Provision) benefit for taxes on realized and unrealized gains (losses)549 2,378 
Net increase (decrease) in net assets resulting from operations13,172 39,408 
Stockholder transactions:
Distributions to stockholders(58,679)(27,956)
Net increase (decrease) in net assets from stockholder transactions(58,679)(27,956)
Capital share transactions:
Issuance of common stock under dividend reinvestment plan1,933 786 
Net increase (decrease) in net assets from capital share transactions1,933 786 
Total increase (decrease) in net assets(43,574)12,238 
Net assets at beginning of period1,245,563 1,312,823 
Net assets at end of period$1,201,989 $1,325,061 
Net asset value per common share$19.63 $22.03 
Common shares outstanding at end of period61,220 60,156 




See notes to Consolidated Financial Statements.
4

Oaktree Specialty Lending Corporation
Consolidated Statements of Cash Flows
(in thousands)
(unaudited)










Three months ended
December 31, 2021
Three months ended
December 31, 2020
Three months ended
December 31, 2022
Three months ended
December 31, 2021
Operating activities:Operating activities:Operating activities:
Net increase (decrease) in net assets resulting from operationsNet increase (decrease) in net assets resulting from operations$39,408 $65,544 Net increase (decrease) in net assets resulting from operations$13,172 $39,408 
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net unrealized (appreciation) depreciationNet unrealized (appreciation) depreciation4,586 (47,556)Net unrealized (appreciation) depreciation22,982 4,586 
Net realized (gains) lossesNet realized (gains) losses(9,321)(8,215)Net realized (gains) losses3,203 (9,321)
PIK interest incomePIK interest income(4,663)(3,089)PIK interest income(6,130)(4,663)
Accretion of original issue discount on investmentsAccretion of original issue discount on investments(7,076)(3,143)Accretion of original issue discount on investments(5,127)(7,076)
Accretion of original issue discount on unsecured notes payableAccretion of original issue discount on unsecured notes payable170 127 Accretion of original issue discount on unsecured notes payable170 170 
Amortization of deferred financing costsAmortization of deferred financing costs924 636 Amortization of deferred financing costs828 924 
Deferred taxesDeferred taxes(959)(275)Deferred taxes(35)(959)
Purchases of investmentsPurchases of investments(246,623)(243,741)Purchases of investments(261,404)(246,623)
Proceeds from the sales and repayments of investmentsProceeds from the sales and repayments of investments235,020 169,821 Proceeds from the sales and repayments of investments108,831 235,020 
Changes in operating assets and liabilities:Changes in operating assets and liabilities:Changes in operating assets and liabilities:
(Increase) decrease in interest, dividends and fees receivable(Increase) decrease in interest, dividends and fees receivable1,796 (1,848)(Increase) decrease in interest, dividends and fees receivable(1,842)1,796 
(Increase) decrease in due from portfolio companies(Increase) decrease in due from portfolio companies(803)632 (Increase) decrease in due from portfolio companies16,314 (803)
(Increase) decrease in receivables from unsettled transactions(Increase) decrease in receivables from unsettled transactions(17,673)(1,931)(Increase) decrease in receivables from unsettled transactions(3,966)(17,673)
(Increase) decrease in due from broker(Increase) decrease in due from broker(1,810)— (Increase) decrease in due from broker5,770 (1,810)
(Increase) decrease in other assets(Increase) decrease in other assets(564)(26,272)(Increase) decrease in other assets(2,546)(564)
Increase (decrease) in accounts payable, accrued expenses and other liabilitiesIncrease (decrease) in accounts payable, accrued expenses and other liabilities3,145 1,314 Increase (decrease) in accounts payable, accrued expenses and other liabilities(554)3,145 
Increase (decrease) in base management fee and incentive fee payableIncrease (decrease) in base management fee and incentive fee payable(6,459)9,018 Increase (decrease) in base management fee and incentive fee payable931 (6,459)
Increase (decrease) in due to affiliateIncrease (decrease) in due to affiliate(854)225 Increase (decrease) in due to affiliate80 (854)
Increase (decrease) in interest payableIncrease (decrease) in interest payable2,101 2,566 Increase (decrease) in interest payable5,432 2,101 
Increase (decrease) in payables from unsettled transactionsIncrease (decrease) in payables from unsettled transactions32,717 102,259 Increase (decrease) in payables from unsettled transactions(6,007)32,717 
Increase (decrease) in director fees payableIncrease (decrease) in director fees payable123 — Increase (decrease) in director fees payable— 123 
Net cash provided by (used in) operating activitiesNet cash provided by (used in) operating activities23,185 16,072 Net cash provided by (used in) operating activities(109,898)23,185 
Financing activities:Financing activities:Financing activities:
Distributions paid in cashDistributions paid in cash(27,170)(14,978)Distributions paid in cash(56,746)(27,170)
Borrowings under credit facilitiesBorrowings under credit facilities70,000 — Borrowings under credit facilities202,000 70,000 
Repayments of borrowings under credit facilitiesRepayments of borrowings under credit facilities(50,000)(14,800)Repayments of borrowings under credit facilities(42,000)(50,000)
Repurchases of common stock under dividend reinvestment plan— (528)
Deferred financing costs paidDeferred financing costs paid(334)(288)Deferred financing costs paid— (334)
Net cash provided by (used in) financing activitiesNet cash provided by (used in) financing activities(7,504)(30,594)Net cash provided by (used in) financing activities103,254 (7,504)
Effect of exchange rate changes on foreign currencyEffect of exchange rate changes on foreign currency(1,259)(340)Effect of exchange rate changes on foreign currency(475)(1,259)
Net increase (decrease) in cash and cash equivalents and restricted cashNet increase (decrease) in cash and cash equivalents and restricted cash14,422 (14,862)Net increase (decrease) in cash and cash equivalents and restricted cash(7,119)14,422 
Cash and cash equivalents and restricted cash, beginning of periodCash and cash equivalents and restricted cash, beginning of period31,635 39,096 Cash and cash equivalents and restricted cash, beginning of period26,364 31,635 
Cash and cash equivalents and restricted cash, end of periodCash and cash equivalents and restricted cash, end of period$46,057 $24,234 Cash and cash equivalents and restricted cash, end of period$19,245 $46,057 
Supplemental information:Supplemental information:Supplemental information:
Cash paid for interestCash paid for interest$6,205 $2,766 Cash paid for interest$14,289 $6,205 
Non-cash financing activities:Non-cash financing activities:Non-cash financing activities:
Issuance of shares of common stock under dividend reinvestment planIssuance of shares of common stock under dividend reinvestment plan$786 $528 Issuance of shares of common stock under dividend reinvestment plan$1,933 $786 
Deferred financing costs— (57)
Reconciliation to the Consolidated Statements of Assets and LiabilitiesReconciliation to the Consolidated Statements of Assets and LiabilitiesDecember 31, 2021September 30, 2021Reconciliation to the Consolidated Statements of Assets and LiabilitiesDecember 31,
2022
September 30,
2022
Cash and cash equivalentsCash and cash equivalents$43,765 $29,334 Cash and cash equivalents$17,382 $23,528 
Restricted cashRestricted cash2,292 2,301 Restricted cash1,863 2,836 
Total cash and cash equivalents and restricted cashTotal cash and cash equivalents and restricted cash$46,057 $31,635 Total cash and cash equivalents and restricted cash$19,245 $26,364 


See notes to Consolidated Financial Statements.
5

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
December 31, 20212022
(dollar amounts in thousands)
(unaudited)







Portfolio Company/Type of Investment (1)(2)(3)(4)(5)Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotesPortfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Control InvestmentsControl Investments(8)(9)
Control Investments
(8)(9)
C5 Technology Holdings, LLCC5 Technology Holdings, LLCData Processing & Outsourced ServicesC5 Technology Holdings, LLCData Processing & Outsourced Services
829 Common Units829 Common Units$— $— (15)829 Common Units$— $— (15)
34,984,460.37 Preferred Units34,984,460.37 Preferred Units34,984 27,638 (15)34,984,460.37 Preferred Units34,984 27,638 (15)
34,984 27,638 34,984 27,638 
Dominion Diagnostics, LLCDominion Diagnostics, LLCHealth Care ServicesDominion Diagnostics, LLCHealth Care Services
First Lien Term Loan, LIBOR+5.00% cash due 2/28/2024First Lien Term Loan, LIBOR+5.00% cash due 2/28/20246.00 %$23,201 23,201 23,201 (6)(15)First Lien Term Loan, LIBOR+5.00% cash due 2/28/20249.73 %$14,297 14,297 14,297 (6)(15)
First Lien Revolver, LIBOR+5.00% cash due 2/28/2024First Lien Revolver, LIBOR+5.00% cash due 2/28/2024— — — (6)(15)(19)First Lien Revolver, LIBOR+5.00% cash due 2/28/2024— — — (6)(15)(19)
30,030.8 Common Units in DD Healthcare Services Holdings, LLC30,030.8 Common Units in DD Healthcare Services Holdings, LLC18,625 18,065 (12)(15)30,030.8 Common Units in DD Healthcare Services Holdings, LLC15,222 4,227 (15)
41,826 41,266 29,519 18,524 
OCSI Glick JV LLCOCSI Glick JV LLCMulti-Sector Holdings(14)OCSI Glick JV LLCMulti-Sector Holdings(14)
Subordinated Debt, LIBOR+4.50% cash due 10/20/2028Subordinated Debt, LIBOR+4.50% cash due 10/20/20284.58 %61,237 50,588 55,854  (6)(11)(15)(19)Subordinated Debt, LIBOR+4.50% cash due 10/20/20287.67 %59,049 49,961 49,536  (6)(11)(15)(19)
87.5% equity interest87.5% equity interest— —  (11)(16)(19)87.5% equity interest— —  (11)(16)(19)
50,588 55,854 49,961 49,536 
Senior Loan Fund JV I, LLCSenior Loan Fund JV I, LLCMulti-Sector Holdings(14)Senior Loan Fund JV I, LLCMulti-Sector Holdings(14)
Subordinated Debt, LIBOR+7.00% cash due 12/29/2028Subordinated Debt, LIBOR+7.00% cash due 12/29/20288.00 %96,250 96,250 96,250 (6)(11)(15)(19)Subordinated Debt, LIBOR+7.00% cash due 12/29/202810.17 %112,656 112,656 112,656 (6)(11)(15)(19)
87.5% LLC equity interest87.5% LLC equity interest49,322 38,461 (11)(12)(16)(19)87.5% LLC equity interest54,791 24,108 (11)(12)(16)(19)
145,572 134,711 167,447 136,764 
Total Control Investments (19.6% of net assets)$272,970 $259,469 
Total Control Investments (19.3% of net assets) Total Control Investments (19.3% of net assets)$281,911 $232,462 
Affiliate InvestmentsAffiliate Investments(17)Affiliate Investments(17)
Assembled Brands Capital LLCAssembled Brands Capital LLCSpecialized FinanceAssembled Brands Capital LLCSpecialized Finance
First Lien Revolver, LIBOR+6.75% cash due 10/17/2023First Lien Revolver, LIBOR+6.75% cash due 10/17/20237.75 %$15,982 $15,982 $15,724 (6)(15)(19)First Lien Revolver, LIBOR+6.75% cash due 10/17/202311.48 %$21,464 $21,464 $21,252 (6)(15)(19)
1,609,201 Class A Units1,609,201 Class A Units764 386 (15)1,609,201 Class A Units764 354 (15)
1,019,168.80 Preferred Units, 6%1,019,168.80 Preferred Units, 6%1,019 1,172 (15)1,019,168.80 Preferred Units, 6%1,019 1,243 (15)
70,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/202970,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029— — (15)70,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029— — (15)
17,765 17,282 23,247 22,849 
Caregiver Services, Inc.Caregiver Services, Inc.Health Care ServicesCaregiver Services, Inc.Health Care Services
1,080,399 shares of Series A Preferred Stock, 10%1,080,399 shares of Series A Preferred Stock, 10%1,080 838 (15)1,080,399 shares of Series A Preferred Stock, 10%1,080 324 (15)
1,080 838 1,080 324 
Total Affiliate Investments (1.4% of net assets)$18,845 $18,120 
Total Affiliate Investments (1.9% of net assets) Total Affiliate Investments (1.9% of net assets)$24,327 $23,173 
Non-Control/Non-Affiliate InvestmentsNon-Control/Non-Affiliate Investments(18)Non-Control/Non-Affiliate Investments(18)
109 Montgomery Owner LLCReal Estate Operating Companies
First Lien Delayed Draw Term Loan, LIBOR+7.00% cash due 2/2/20237.50 %2,427 2,345 2,696 (6)(15)(19)
107 Fair Street LLC107 Fair Street LLCReal Estate Development
First Lien Delayed Draw Term Loan, 12.50% cash due 5/17/2024First Lien Delayed Draw Term Loan, 12.50% cash due 5/17/2024$1,174 $1,111 $1,108 (10)(15)(19)
1,111 1,108 
112-126 Van Houten Real22 LLC112-126 Van Houten Real22 LLCReal Estate Development
First Lien Delayed Draw Term Loan, 12.00% cash due 5/4/2024First Lien Delayed Draw Term Loan, 12.00% cash due 5/4/20243,239 3,167 3,159 (10)(15)(19)
3,167 3,159 
A.T. Holdings II Ltd.A.T. Holdings II Ltd.Biotechnology
First Lien Revenue Interest Financing Term Loan 14.25% cash due 9/13/2029First Lien Revenue Interest Financing Term Loan 14.25% cash due 9/13/202915,939 15,939 15,939 (11)(15)
2,345 2,696 15,939 15,939 
A.T. Holdings II SÀRLA.T. Holdings II SÀRLBiotechnologyA.T. Holdings II SÀRLBiotechnology
First Lien Term Loan, 9.50% cash due 12/22/202232,454 32,298 32,386 (11)(15)
First Lien Term Loan, 12.50% PIK due 1/20/2023First Lien Term Loan, 12.50% PIK due 1/20/202315,643 15,640 15,722 (11)(15)
32,298 32,386 15,640 15,722 
Access CIG, LLCAccess CIG, LLCDiversified Support ServicesAccess CIG, LLCDiversified Support Services
First Lien Term Loan, LIBOR+3.75% cash due 2/27/20253.84 %3,343 3,152 3,326 (6)
Second Lien Term Loan, LIBOR+7.75% cash due 2/27/2026Second Lien Term Loan, LIBOR+7.75% cash due 2/27/20267.84 %17,000 16,928 17,011 (6)Second Lien Term Loan, LIBOR+7.75% cash due 2/27/202611.82 %20,000 19,932 17,800 (6)(15)
20,080 20,337 19,932 17,800 
Accupac, Inc.Personal Products
First Lien Term Loan, LIBOR+6.00% cash due 1/17/20267.00 %16,099 15,741 16,099 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+6.00% cash due 1/17/2026— (28)— (6)(15)(19)
First Lien Revolver, LIBOR+6.00% cash due 1/17/20267.00 %1,531 1,486 1,531 (6)(15)(19)
17,199 17,630 
Acquia Inc.Application Software
First Lien Term Loan, LIBOR+7.00% cash due 10/31/20258.00 %27,349 26,962 27,319 (6)(15)
First Lien Revolver, LIBOR+7.00% cash due 10/31/2025— (29)(2)(6)(15)(19)
26,933 27,317 
6

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
December 31, 20212022
(dollar amounts in thousands)
(unaudited)







Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
ADB Companies, LLCConstruction & Engineering
First Lien Term Loan, LIBOR+6.25% cash due 12/18/20257.25 %$15,240 $14,641 $15,105 (6)(15)
14,641 15,105 
Aden & Anais Merger Sub, Inc.Apparel, Accessories & Luxury Goods
51,645 Common Units in Aden & Anais Holdings, Inc.5,165 — (15)
5,165  
AI Sirona (Luxembourg) Acquisition S.a.r.l.Pharmaceuticals
Second Lien Term Loan, EURIBOR+7.25% cash due 9/28/20267.25 %24,838 27,732 28,222 (6)(11)(15)
27,732 28,222 
AIP RD Buyer Corp.Distributors
Second Lien Term Loan, SOFR+7.75% cash due 12/23/20298.75 %$14,414 14,127 14,126 (6)(15)
14,410 Common Units in RD Holding LP1,441 1,441 (15)
15,568 15,567 
AirStrip Technologies, Inc.Application Software
5,715 Common Stock Warrants (exercise price $139.99) expiration date 5/11/202590 — (15)
90  
All Web Leads, Inc.Advertising
First Lien Term Loan, LIBOR+6.50% cash due 12/29/20237.50 %23,641 21,550 22,744 (6)(15)
21,550 22,744 
Alvogen Pharma US, Inc.Pharmaceuticals
First Lien Term Loan, LIBOR+5.25% cash due 12/31/20236.25 %13,650 13,216 13,087 (6)
13,216 13,087 
Alvotech Holdings S.A.Biotechnology(13)
Fixed Rate Bond 15% PIK Tranche A due 6/24/202520,967 22,243 22,717 (11)(15)
Fixed Rate Bond 15% PIK Tranche B due 6/24/202520,512 21,798 22,225 (11)(15)
43,889 Common Shares6,323 6,277 (15)
50,364 51,219 
American Tire Distributors, Inc.Distributors
First Lien Term Loan, LIBOR+6.25% cash due 10/20/20287.00 %9,945 9,821 10,027 (6)
9,821 10,027 
Amplify Finco Pty Ltd.Movies & Entertainment
First Lien Term Loan, LIBOR+4.25% cash due 11/26/20265.00 %15,337 13,856 14,902 (6)(11)(15)
Second Lien Term Loan, LIBOR+8.00% cash due 11/26/20278.75 %12,500 12,188 12,062 (6)(11)(15)
26,044 26,964 
Ankura Consulting Group LLCResearch & Consulting Services
Second Lien Term Loan, LIBOR+8.00% cash due 3/19/20298.75 %7,466 7,354 7,541 (6)(15)
7,354 7,541 
Apptio, Inc.Application Software
First Lien Term Loan, LIBOR+7.25% cash due 1/10/20258.25 %34,458 33,502 34,186 (6)(15)
First Lien Revolver, LIBOR+7.25% cash due 1/10/20258.25 %892 853 875 (6)(15)(19)
34,355 35,061 
Ardonagh Midco 3 PLCInsurance Brokers
First Lien Term Loan, EURIBOR+6.75% cash due 7/14/20267.75 %1,964 2,179 2,256 (6)(11)(15)
First Lien Term Loan, UK LIBOR+6.75% cash due 7/14/20267.50 %£18,636 23,268 25,494 (6)(11)(15)
First Lien Term Loan, LIBOR+5.50% cash due 7/14/20266.25 %$10,519 10,325 10,373 (6)(11)(15)
First Lien Delayed Draw Term Loan, SONIA+5.50% cash due 7/14/2026£— (44)— (6)(11)(15)(19)
35,728 38,123 
Associated Asphalt Partners, LLCConstruction Materials
First Lien Term Loan, LIBOR+5.25% cash due 4/5/20246.25 %$2,524 2,267 2,227 (6)
2,267 2,227 
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Accupac, Inc.Personal Products
First Lien Term Loan, SOFR+5.50% cash due 1/16/202610.16 %$15,935 $15,668 $15,903 (6)(15)
First Lien Delayed Draw Term Loan, SOFR+5.50% cash due 1/16/2026— — (6)(6)(15)(19)
First Lien Revolver, SOFR+5.50% cash due 1/16/202610.17 %908 874 904 (6)(15)(19)
16,542 16,801 
Acquia Inc.Application Software
First Lien Term Loan, LIBOR+7.00% cash due 10/31/202510.74 %27,349 27,064 27,240 (6)(15)
First Lien Revolver, LIBOR+7.00% cash due 10/31/202512.18 %1,317 1,296 1,308 (6)(15)(19)
28,360 28,548 
ADB Companies, LLCConstruction & Engineering
First Lien Term Loan, SOFR+6.25% cash due 12/18/202511.34 %14,505 14,079 14,254 (6)(15)
14,079 14,254 
ADC Therapeutics SABiotechnology
First Lien Term Loan, SOFR+7.50% cash due 8/15/202912.23 %6,589 6,269 6,274 (6)(11)(15)
First Lien Delayed Draw Term Loan, SOFR+7.50% cash due 8/15/2029— (38)(35)(6)(11)(15)(19)
28,948 Common Stock Warrants (exercise price $8.297) expiration 8/15/2032174 50 (11)(15)
6,405 6,289 
Aden & Anais Merger Sub, Inc.Apparel, Accessories & Luxury Goods
51,645 Common Units in Aden & Anais Holdings, Inc.5,165 — (15)
5,165  
AI Sirona (Luxembourg) Acquisition S.a.r.l.Pharmaceuticals
Second Lien Term Loan, EURIBOR+7.25% cash due 9/28/20269.15 %24,838 27,775 24,255 (6)(11)(15)
27,775 24,255 
AIP RD Buyer Corp.Distributors
Second Lien Term Loan, SOFR+7.75% cash due 12/23/202912.17 %$14,414 14,163 13,960 (6)(15)
14,410 Common Units in RD Holding LP1,352 1,528 (15)
15,515 15,488 
AirStrip Technologies, Inc.Application Software
5,715 Common Stock Warrants (exercise price $139.99) expiration date 5/11/202590 — (15)
90  
All Web Leads, Inc.Advertising
First Lien Term Loan, LIBOR+1.00% cash 7.50% PIK due 12/29/20235.73 %23,562 22,547 22,354 (6)(15)
22,547 22,354 
Altice France S.A.Integrated Telecommunication Services
Fixed Rate Bond, 5.50% cash due 10/15/20294,050 3,533 3,095 (11)
3,533 3,095 
Alto Pharmacy Holdings, Inc.Health Care Technology
First Lien Term Loan, SOFR+8.00% cash 3.50% PIK due 10/14/202712.68 %8,640 7,904 7,930 (6)(15)
166,414 Common Stock Warrants (exercise price $15.46) expiration date 10/14/2032642 629 (15)
8,546 8,559 
Alvogen Pharma US, Inc.Pharmaceuticals
First Lien Term Loan, SOFR+7.50% cash due 6/30/202512.23 %12,968 12,711 12,903 (6)(15)
12,711 12,903 
7

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
December 31, 20212022
(dollar amounts in thousands)
(unaudited)







Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Astra Acquisition Corp.Application Software
First Lien Term Loan, LIBOR+5.25% cash due 10/25/20285.75 %$5,000 $4,829 $4,921 (6)
4,829 4,921 
Athenex, Inc.Pharmaceuticals
First Lien Term Loan, 11.00% cash due 6/19/202642,145 40,566 41,618 (11)(15)
First Lien Delayed Draw Term Loan, 11.00% cash due 6/19/2026— (274)(263)(11)(15)(19)
328,149 Common Stock Warrants (exercise price $12.63) expiration date 6/19/2027973 33 (11)(15)
41,265 41,388 
Aurora Lux Finco S.À.R.L.Airport Services
First Lien Term Loan, LIBOR+6.00% cash due 12/24/20267.00 %22,598 22,196 21,400 (6)(11)(15)
22,196 21,400 
The AveryReal Estate Operating Companies
First Lien Delayed Draw Term Loan in T8 Urban Condo Owner, LLC, LIBOR+7.30% cash due 2/17/20237.55 %18,550 18,295 18,742 (6)(15)(19)
Subordinated Delayed Draw Debt in T8 Senior Mezz LLC, LIBOR+12.50% cash due 2/17/202312.75 %4,367 4,311 4,368 (6)(15)
22,606 23,110 
BAART Programs, Inc.Health Care Services
First Lien Delayed Draw Term Loan, LIBOR+5.00% cash due 6/11/20276.00 %1,196 1,152 1,173 (6)(15)(19)
Second Lien Term Loan, LIBOR+8.50% cash due 6/11/20289.50 %7,166 7,059 7,130 (6)(15)
Second Lien Delayed Draw Term Loan, LIBOR+8.50% cash due 6/11/2028(163)(55)(6)(15)(19)
8,048 8,248 
Berner Food & Beverage, LLCSoft Drinks
First Lien Term Loan, LIBOR+6.50% cash due 7/30/20277.50 %33,329 32,787 32,762 (6)(15)
First Lien Revolver, LIBOR+6.50% cash due 7/30/20277.50 %1,299 1,249 1,247 (6)(15)(19)
34,036 34,009 
Blackhawk Network Holdings, Inc.Data Processing & Outsourced Services
Second Lien Term Loan, LIBOR+7.00% cash due 6/15/20267.13 %30,625 30,206 30,529 (6)
30,206 30,529 
Blumenthal Temecula, LLCAutomotive Retail
First Lien Term Loan, 9.00% cash due 9/24/20233,979 3,980 3,979 (15)
1,293,324 Preferred Units in Unstoppable Automotive AMV, LLC1,293 1,293 (15)
298,460 Preferred Units in Unstoppable Automotive VMV, LLC298 298 (15)
298,460 Common Units in Unstoppable Automotive AMV, LLC298 298 (15)
99,486 Common Units in Unstoppable Automotive VMV, LLC100 99 (15)
5,969 5,967 
Cadence Aerospace, LLCAerospace & Defense
First Lien Term Loan, LIBOR+6.50% cash 2.00% PIK due 11/14/20237.50 %14,183 12,806 13,026 (6)(15)
12,806 13,026 
Chief Power Finance II, LLCIndependent Power Producers & Energy Traders
First Lien Term Loan, LIBOR+6.50% cash due 12/31/20227.50 %19,733 19,476 19,713 (6)(15)
19,476 19,713 
CircusTrix Holdings, LLCLeisure Facilities
First Lien Term Loan, LIBOR+5.50% cash 2.50% PIK due 7/16/20236.50 %10,736 9,925 8,977 (6)(15)(19)
9,925 8,977 
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Alvotech Holdings S.A.Biotechnology(13)
Tranche A Fixed Rate Bond 8.50% cash 3.50% PIK due 11/16/2026$26,179 $25,798 $25,684 (11)(15)
Tranche B Fixed Rate Bond 8.50% cash 3.50% PIK due 11/16/202625,612 25,264 25,128 (11)(15)
587,930 Common Shares in Alvotech SA5,308 5,879 (11)
124,780 Seller Earn Out Shares in Alvotech SA485 418 (11)(15)
293,082 $10.00 Put Options on Common Shares in Alvotech SA— 580 (11)(15)
408,508 Common Stock Warrants (exercise price $0.01) expiration 12/31/2027— 4,081 (11)(15)
56,855 61,770 
American Auto Auction Group, LLCConsumer Finance
Second Lien Term Loan, SOFR+8.75% cash due 1/2/202913.33 %14,760 14,503 11,439 (6)(15)
14,503 11,439 
American Tire Distributors, Inc.Distributors
First Lien Term Loan, LIBOR+6.25% cash due 10/20/202810.61 %9,870 9,747 9,081 (6)
9,747 9,081 
AMMC CLO 27Multi-Sector Holdings
Class E Notes, SOFR+8.89% cash due 1/20/203613.49 %2,275 2,037 2,087 (6)(11)
2,037 2,087 
Amplify Finco Pty Ltd.Movies & Entertainment
First Lien Term Loan, LIBOR+4.25% cash due 11/26/20268.98 %15,181 14,014 14,637 (6)(11)(15)
Second Lien Term Loan, LIBOR+8.00% cash due 11/26/202712.73 %12,500 12,188 11,833 (6)(11)(15)
26,202 26,470 
Anastasia Parent, LLCPersonal Products
First Lien Term Loan, LIBOR+3.75% cash due 8/11/20258.48 %2,729 2,254 2,043 (6)
2,254 2,043 
Ankura Consulting Group LLCResearch & Consulting Services
Second Lien Term Loan, LIBOR+8.00% cash due 3/19/202912.36 %2,996 2,951 2,558 (6)(15)
2,951 2,558 
Apptio, Inc.Application Software
First Lien Term Loan, LIBOR+6.00% cash due 1/10/20259.94 %34,458 33,818 33,769 (6)(15)
First Lien Revolver, LIBOR+6.00% cash due 1/10/20259.94 %1,338 1,312 1,294 (6)(15)(19)
35,130 35,063 
APX Group Inc.Electrical Components & Equipment
Fixed Rate Bond, 5.75% cash due 7/15/20292,075 1,742 1,721 (11)
1,742 1,721 
Ardonagh Midco 3 PLCInsurance Brokers
First Lien Term Loan, EURIBOR+7.00% cash due 7/14/20268.00 %1,964 2,176 2,103 (6)(11)(15)
First Lien Term Loan, SONIA+7.00% cash due 7/14/202610.43 %£18,636 23,058 22,485 (6)(11)(15)
First Lien Term Loan, LIBOR+5.75% cash due 7/14/20268.81 %$10,519 10,368 10,561 (6)(11)(15)
First Lien Term Loan, SONIA+5.75% cash due 7/14/20267.48 %£3,649 3,666 3,908 (6)(11)(15)
39,268 39,057 
Associated Asphalt Partners, LLCConstruction Materials
First Lien Term Loan, LIBOR+5.25% cash due 4/5/20249.63 %$2,493 2,353 1,928 (6)
2,353 1,928 
Astra Acquisition Corp.Application Software
First Lien Term Loan, LIBOR+5.25% cash due 10/25/20289.63 %5,640 5,489 5,006 (6)
5,489 5,006 
athenahealth Group Inc.Health Care Technology
18,635 Shares of Series A Preferred Stock in Minerva Holdco, Inc., 10.75%18,264 15,606 (15)
18,264 15,606 
Athenex, Inc.Pharmaceuticals
First Lien Term Loan, 11.00% cash due 6/19/202612,556 12,191 12,036 (11)(15)
First Lien Revenue Interest Financing Term Loan due 5/31/20318,649 8,604 8,649 (11)(15)
328,149 Common Stock Warrants (exercise price $0.4955) expiration date 6/19/2027973 (11)(15)
21,768 20,692 
8

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
December 31, 20212022
(dollar amounts in thousands)
(unaudited)







Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
CITGO Holding, Inc.Oil & Gas Refining & Marketing
First Lien Term Loan, LIBOR+7.00% cash due 8/1/20238.00 %$9,111 $9,026 $9,007 (6)
Fixed Rate Bond, 9.25% cash due 8/1/202410,672 10,672 10,737 
19,698 19,744 
CITGO Petroleum Corp.Oil & Gas Refining & Marketing
First Lien Term Loan, LIBOR+6.25% cash due 3/28/20247.25 %8,311 8,073 8,321 (6)
8,073 8,321 
Clear Channel Outdoor Holdings Inc.Advertising
Fixed Rate Bond, 7.50% cash due 6/1/20296,476 6,476 6,924 (11)
6,476 6,924 
Community Brands Parentco, LLCApplication Software
First Lien Revolver, LIBOR+5.00% cash due 12/2/2022— (9)(9)(6)(15)(19)
Second Lien Term Loan, LIBOR+9.25% cash due 6/2/202310.25 %11,000 10,868 10,906 (6)(15)
10,859 10,897 
Continental Intermodal Group LPOil & Gas Storage & Transportation
First Lien Term Loan, LIBOR+8.50% cash due 1/28/20259.50 %38,327 36,319 32,195 (6)(15)
Common Stock Warrants expiration date 7/28/2025648 1,782 (15)
36,967 33,977 
Convergeone Holdings, Inc.IT Consulting & Other Services
First Lien Term Loan, LIBOR+5.00% cash due 1/4/20265.10 %7,006 6,841 6,877 (6)
6,841 6,877 
Conviva Inc.Application Software
517,851 Shares of Series D Preferred Stock605 894 (15)
605 894 
CorEvitas, LLCHealth Care Services
First Lien Term Loan, LIBOR+5.50% cash due 12/13/20256.50 %10,170 10,053 10,096 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 12/13/20256.50 %1,938 1,889 1,911 (6)(15)(19)
First Lien Revolver, PRIME+4.50% cash due 12/13/20257.75 %305 284 292 (6)(15)(19)
1,099 Class A2 Common Units in CorEvitas Holdings, L.P.1,038 2,687 (15)
13,264 14,986 
Coty Inc.Personal Products
First Lien Revolver, LIBOR+1.75% cash due 4/5/2023— (712)(148)(6)(11)(15)(19)
(712)(148)
Coyote Buyer, LLCSpecialty Chemicals
First Lien Term Loan, LIBOR+6.00% cash due 2/6/20267.00 %18,340 17,864 18,179 (6)(15)
First Lien Revolver, LIBOR+6.00% cash due 2/6/2025— (13)(12)(6)(15)(19)
17,851 18,167 
Curium Bidco S.à.r.l.Biotechnology
Second Lien Term Loan, LIBOR+7.75% cash due 10/27/20288.50 %16,787 16,535 16,976 (6)(11)
16,535 16,976 
Delta Topco, Inc.Systems Software
Second Lien Term Loan, LIBOR+7.25% cash due 12/1/20288.00 %6,680 6,647 6,745 (6)
6,647 6,745 
Dialyze Holdings, LLCHealth Care Equipment
First Lien Term Loan, LIBOR+7.00% cash 2.00% PIK due 8/4/20268.00 %24,216 22,650 22,642 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+7.00% cash 2.00% PIK due 8/4/2026— (161)(154)(6)(15)(19)
5,403,823 Class A Warrants (exercise price $1.00) expiration date 8/4/20281,405 1,351 (15)
23,894 23,839 
Digital.AI Software Holdings, Inc.Application Software
First Lien Term Loan, LIBOR+7.00% cash due 2/10/20278.00 %9,978 9,621 9,768 (6)(15)
First Lien Revolver, LIBOR+7.00% cash due 2/10/20278.00 %359 332 336 (6)(15)(19)
9,953 10,104 
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Aurora Lux Finco S.À.R.L.Airport Services
First Lien Term Loan, LIBOR+6.00% cash due 12/24/202610.32 %$22,368 $22,050 $21,274 (6)(11)(15)
22,050 21,274 
Avalara, Inc.Application Software
First Lien Term Loan, SOFR+7.25% cash due 10/19/202811.83 %41,467 40,466 40,430 (6)(15)
First Lien Revolver, SOFR+7.25% cash due 10/19/2028— (100)(104)(6)(15)(19)
40,366 40,326 
The AveryReal Estate Operating Companies
First Lien Term Loan in T8 Urban Condo Owner, LLC, LIBOR+7.30% cash due 2/17/202311.69 %15,301 15,279 15,391 (6)(15)
Subordinated Debt in T8 Senior Mezz LLC, LIBOR+12.50% cash due 2/17/202317.24 %3,706 3,701 3,733 (6)(15)
18,980 19,124 
BAART Programs, Inc.Health Care Services
First Lien Delayed Draw Term Loan, LIBOR+5.00% cash due 6/11/20279.73 %2,541 2,497 2,420 (6)(15)(19)
Second Lien Term Loan, LIBOR+8.50% cash due 6/11/202813.23 %7,166 7,059 6,944 (6)(15)
Second Lien Delayed Draw Term Loan, LIBOR+8.50% cash due 6/11/202813.23 %5,197 5,042 4,854 (6)(15)(19)
14,598 14,218 
Berner Food & Beverage, LLCSoft Drinks
First Lien Term Loan, LIBOR+5.50% cash due 7/30/20279.91 %32,995 32,555 32,533 (6)(15)
First Lien Revolver, PRIME+4.50% cash due 7/30/202612.00 %897 859 857 (6)(15)(19)
33,414 33,390 
BioXcel Therapeutics, Inc.Pharmaceuticals
First Lien Term Loan, 8.00% cash 2.25% PIK due 4/19/20275,383 5,184 5,028 (11)(15)
First Lien Delayed Draw Term Loan, 8.00% cash 2.25% PIK due 4/19/2027— — — (11)(15)(19)
First Lien Revenue Interest Financing Term Loan due 9/30/20322,432 2,432 2,432 (11)(15)
First Lien Revenue Interest Financing Delayed Draw Term Loan due 9/30/2032— — — (11)(15)(19)
21,177 Common Stock Warrants (exercise price $20.04) expiration date 4/19/2029125 275 (11)(15)
7,741 7,735 
Blackhawk Network Holdings, Inc.Data Processing & Outsourced Services
Second Lien Term Loan, LIBOR+7.00% cash due 6/15/202610.94 %30,625 30,300 26,391 (6)
30,300 26,391 
Blumenthal Temecula, LLCAutomotive Retail
First Lien Term Loan, 9.00% cash due 9/24/20233,979 3,980 3,960 (15)
1,293,324 Preferred Units in Unstoppable Automotive AMV, LLC1,293 1,267 (15)
298,460 Preferred Units in Unstoppable Automotive VMV, LLC298 292 (15)
298,460 Common Units in Unstoppable Automotive AMV, LLC298 379 (15)
5,869 5,898 
Cadence Aerospace, LLCAerospace & Defense
First Lien Term Loan, LIBOR+6.50% cash 2.00% PIK due 11/14/202310.92 %14,332 13,700 13,178 (6)(15)
13,700 13,178 
CircusTrix Holdings, LLCLeisure Facilities
First Lien Term Loan, LIBOR+5.50% cash due 7/16/20239.57 %10,668 10,201 10,465 (6)(15)
10,201 10,465 
Clear Channel Outdoor Holdings Inc.Advertising
Fixed Rate Bond, 7.50% cash due 6/1/20294,311 4,311 3,174 (11)
Fixed Rate Bond, 7.75% cash due 4/15/2028676 649 494 (11)
4,960 3,668 
9

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
December 31, 20212022
(dollar amounts in thousands)
(unaudited)







Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
DirecTV Financing, LLCCable & Satellite
First Lien Term Loan, LIBOR+5.00% cash due 8/2/20275.75 %$18,573 $18,387 $18,614 (6)
18,387 18,614 
Eagleview Technology CorporationApplication Software
Second Lien Term Loan, LIBOR+7.50% cash due 8/14/20268.50 %8,974 8,884 8,862 (6)(15)
8,884 8,862 
EHR Canada, LLCFood Retail
First Lien Term Loan, LIBOR+8.00% cash due 2/28/20229.00 %2,500 2,498 2,498 (6)(15)
2,498 2,498 
EOS Fitness Opco Holdings, LLCLeisure Facilities
487.5 Class A Preferred Units, 12%488 320 (15)
12,500 Class B Common Units— — (15)
488 320 
FINThrive Software Intermediate Holdings, Inc.Health Care Technology
Second Lien Term Loan, LIBOR+6.75% cash due 12/17/20297.25 %25,061 24,685 25,053 (6)
24,685 25,053 
Firstlight Holdco, Inc.Alternative Carriers
First Lien Term Loan, LIBOR+3.50% cash due 7/23/20253.60 %4,999 4,710 4,949 (6)
4,710 4,949 
Fortress Biotech, Inc.Biotechnology
First Lien Term Loan, 11.00% cash due 8/27/20259,466 8,970 9,371 (11)(15)
331,200 Common Stock Warrants (exercise price $3.20) expiration date 8/27/2030405 189 (11)(15)
9,375 9,560 
GKD Index Partners, LLCSpecialized Finance
First Lien Term Loan, LIBOR+8.50% cash due 6/29/20239.50 %26,052 25,611 25,557 (6)(15)
First Lien Revolver, LIBOR+8.50% cash due 6/29/20239.50 %1,280 1,255 1,248 (6)(15)(19)
26,866 26,805 
Global Medical Response, Inc.Health Care Services
First Lien Term Loan, LIBOR+4.25% cash due 3/14/20255.25 %5,616 5,435 5,603 (6)
5,435 5,603 
Houghton Mifflin Harcourt Publishers Inc.Education Services
First Lien Term Loan, LIBOR+6.25% cash due 11/22/20247.25 %1,007 983 1,007 (6)(11)
983 1,007 
iCIMs, Inc.Application Software
First Lien Term Loan, LIBOR+6.50% cash due 9/12/20247.50 %25,635 25,077 25,547 (6)(15)
First Lien Revolver, LIBOR+6.50% cash due 9/12/20247.50 %1,176 1,150 1,172 (6)(15)
26,227 26,719 
Immucor, Inc.Health Care Supplies
First Lien Term Loan, LIBOR+5.75% cash due 7/2/20256.75 %8,635 8,419 8,505 (6)(15)
Second Lien Term Loan, LIBOR+8.00% cash 3.50% PIK due 10/2/20259.00 %22,029 21,459 21,809 (6)(15)
29,878 30,314 
Integral Development CorporationOther Diversified Financial Services
1,078,284 Common Stock Warrants (exercise price $0.9274) expiration date 7/10/2024113 — (15)
113  
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Condor Merger Sub Inc.Systems Software
Fixed Rate Bond, 7.375% cash due 2/15/2030$8,420 $8,248 $6,785 
8,248 6,785 
Continental Intermodal Group LPOil & Gas Storage & Transportation
First Lien Term Loan, LIBOR+8.50% cash due 1/28/202512.88 %19,992 19,286 17,893 (6)(15)
Common Stock Warrants expiration date 7/28/2025648 220 (15)
19,934 18,113 
Convergeone Holdings, Inc.IT Consulting & Other Services
First Lien Term Loan, LIBOR+5.00% cash due 1/4/20269.38 %11,882 11,684 6,963 (6)
11,684 6,963 
Conviva Inc.Application Software
517,851 Shares of Series D Preferred Stock605 894 (15)
605 894 
CorEvitas, LLCHealth Care Technology
First Lien Term Loan, SOFR+6.125% cash due 12/13/202510.55 %13,677 13,527 13,344 (6)(15)
First Lien Revolver, PRIME+4.75% cash due 12/13/202512.25 %305 289 261 (6)(15)(19)
1,099 Class A2 Common Units in CorEvitas Holdings, L.P.690 2,340 (15)
14,506 15,945 
Covetrus, Inc.Health Care Distributors
First Lien Term Loan, SOFR+5.00% cash due 9/20/20299.58 %10,336 9,733 9,711 (6)
9,733 9,711 
Coyote Buyer, LLCSpecialty Chemicals
First Lien Term Loan, LIBOR+6.00% cash due 2/6/202610.41 %18,153 17,766 17,798 (6)(15)
First Lien Revolver, LIBOR+6.00% cash due 2/6/2025— (13)(26)(6)(15)(19)
17,753 17,772 
Cuppa Bidco BVSoft Drinks
First Lien Term Loan, EURIBOR+4.75% cash due 7/30/20297.50 %12,340 10,521 10,997 (6)(11)
10,521 10,997 
Delta Leasing SPV II LLCSpecialized Finance
Subordinated Delayed Draw Term Loan, 10.00% cash due 8/31/2029$8,365 8,365 8,365 (11)(15)(19)
419 Series C Preferred Units in Delta Financial Holdings LLC419 419 (11)(15)
2.09 Common Units in Delta Financial Holdings LLC(11)(15)
31.37 Common Warrants (exercise price $1.00)— — (11)(15)
8,786 8,786 
Delta Topco, Inc.Systems Software
Second Lien Term Loan, LIBOR+7.25% cash due 12/1/202811.65 %6,680 6,647 5,319 (6)
6,647 5,319 
Dialyze Holdings, LLCHealth Care Equipment
First Lien Term Loan, LIBOR+9.00% cash due 8/4/202613.73 %20,965 19,913 20,912 (6)(15)
Subordinated Term Loan, 8.00% PIK due 9/30/2027520 520 494 (15)
5,403,823 Class A Warrants (exercise price $1.00) expiration date 8/4/20281,405 1,297 (15)
21,838 22,703 
Digital.AI Software Holdings, Inc.Application Software
First Lien Term Loan, LIBOR+6.50% cash due 2/10/202711.09 %9,877 9,593 9,768 (6)(15)
First Lien Revolver, LIBOR+7.00% cash due 2/10/202711.59 %251 229 239 (6)(15)(19)
9,822 10,007 
DirecTV Financing, LLCCable & Satellite
First Lien Term Loan, LIBOR+5.00% cash due 8/2/20279.38 %8,166 8,012 7,968 (6)
8,012 7,968 
Dryden 66 Euro CLO 2018Multi-Sector Holdings
Class DR Notes, EURIBOR+3.35% cash due 1/18/2032
4.75 %1,500 1,335 1,389 (6)(11)
1,335 1,389 
10

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
December 31, 20212022
(dollar amounts in thousands)
(unaudited)







Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Inventus Power, Inc.Electrical Components & Equipment
First Lien Term Loan, LIBOR+5.00% cash due 3/29/20246.00 %$18,802 $18,662 $18,620 (6)(15)
Second Lien Term Loan, LIBOR+8.50% cash due 9/29/20249.50 %13,674 13,455 13,437 (6)(15)
32,117 32,057 
INW Manufacturing, LLCPersonal Products
First Lien Term Loan, LIBOR+5.75% cash due 5/7/20276.50 %36,797 35,809 36,061 (6)(15)
35,809 36,061 
IPC Corp.Application Software
First Lien Term Loan, LIBOR+6.50% cash due 10/1/20267.50 %34,271 33,390 33,414 (6)(15)
33,390 33,414 
Itafos Inc.Fertilizers & Agricultural Chemicals
First Lien Term Loan, LIBOR+8.25% cash due 8/25/20249.25 %21,662 20,899 20,861 (6)(15)
20,899 20,861 
Ivanti Software, Inc.Application Software
Second Lien Term Loan, LIBOR+7.25% cash due 12/1/20287.75 %10,247 10,196 10,273 (6)
10,196 10,273 
Jazz Acquisition, Inc.Aerospace & Defense
First Lien Term Loan, LIBOR+7.50% cash due 1/29/20278.50 %36,511 35,264 36,920 (6)(15)
35,264 36,920 
LaserShip, Inc.Air Freight & Logistics
Second Lien Term Loan, LIBOR+7.50% cash due 5/7/20298.25 %4,787 4,739 4,829 (6)(15)
4,739 4,829 
Latam Airlines Group S.A.Airlines
First Lien Delayed Draw Term Loan, LIBOR+11.00% PIK due 3/29/202216,776 16,703 16,956 (6)(11)(15)(19)
First Lien Delayed Draw Term Loan, LIBOR+7.50% PIK due 3/29/20224,629 4,585 4,571 (6)(11)(15)(19)
21,288 21,527 
Lift Brands Holdings, Inc.Leisure Facilities
2,000,000 Class A Common Units in Snap Investments, LLC1,399 — (15)
1,399  
Lightbox Intermediate, L.P.Real Estate Services
First Lien Term Loan, LIBOR+5.00% cash due 5/9/20265.22 %41,326 40,396 40,810 (6)(15)
40,396 40,810 
Liquid Environmental Solutions CorporationEnvironmental & Facilities Services
Second Lien Term Loan, LIBOR+8.50% cash due 11/30/20269.50 %4,357 4,272 4,270 (6)(15)
Second Lien Delayed Draw Term Loan, LIBOR+8.50% cash due 11/30/20269.50 %1,162 1,139 1,092 (6)(15)(19)
5,411 5,362 
LTI Holdings, Inc.Electronic Components
Second Lien Term Loan, LIBOR+6.75% cash due 9/6/20266.85 %2,140 2,083 2,135 (6)
2,083 2,135 
Marinus Pharmaceuticals, Inc.Pharmaceuticals
First Lien Term Loan, 11.50% cash due 5/11/20263,441 3,381 3,391 (11)(15)
First Lien Delayed Draw Term Loan, 11.50% cash due 5/11/20266,881 6,762 6,781 (11)(15)(19)
10,143 10,172 
Mayfield Agency Borrower Inc.Property & Casualty Insurance
First Lien Term Loan, LIBOR+4.50% cash due 2/28/20254.60 %6,931 6,878 6,918 (6)
6,878 6,918 
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
DTI Holdco, Inc.Research & Consulting Services
First Lien Term Loan, SOFR+4.75% cash due 4/26/20298.84 %$4,988 $4,897 $4,607 (6)
4,897 4,607 
Eagleview Technology CorporationApplication Software
Second Lien Term Loan, LIBOR+7.50% cash due 8/14/202612.23 %8,974 8,884 7,897 (6)(15)
8,884 7,897 
EOS Fitness Opco Holdings, LLCLeisure Facilities
487.5 Class A Preferred Units, 12%488 1,067 (15)
12,500 Class B Common Units— — (15)
488 1,067 
Establishment Labs Holdings Inc.Health Care Technology
First Lien Term Loan, 3.00% cash 6.00% PIK due 4/21/202710,576 10,441 10,100 (11)(15)
First Lien Delayed Draw Term Loan, 3.00% cash 6.00% PIK due 4/21/20271,694 1,667 1,694 (11)(15)(19)
12,108 11,794 
Fairbridge Strategic Capital Funding LLCReal Estate Operating Companies
First Lien Delayed Draw Term Loan, 9.00% cash due 12/24/202831,000 31,000 31,000 (15)(19)
2,500 Warrant Units (exercise price $0.01) expiration date 11/24/2031— (11)(15)
31,000 31,003 
FINThrive Software Intermediate Holdings, Inc.Health Care Technology
Second Lien Term Loan, LIBOR+6.75% cash due 12/17/202911.13 %25,061 24,685 19,273 (6)
24,685 19,273 
Fortress Biotech, Inc.Biotechnology
First Lien Term Loan, 11.00% cash due 8/27/20259,466 9,106 8,922 (11)(15)
331,200 Common Stock Warrants (exercise price $3.20) expiration date 8/27/2030405 26 (11)(15)
9,511 8,948 
Frontier Communications Holdings, LLCIntegrated Telecommunication Services
Fixed Rate Bond, 6.00% cash due 1/15/20304,881 4,432 3,841 (11)
4,432 3,841 
GKD Index Partners, LLCSpecialized Finance
First Lien Term Loan, LIBOR+7.00% cash due 6/29/202311.73 %24,819 24,682 24,641 (6)(15)
First Lien Revolver, LIBOR+7.00% cash due 6/29/202311.75 %1,280 1,272 1,268 (6)(15)(19)
25,954 25,909 
GoldenTree Loan Management EUR CLO 2Multi-Sector Holdings
Class D Notes, EURIBOR+2.85% cash due 1/20/20324.31 %1,000 865 899 (6)(11)
865 899 
Grove Hotel Parcel Owner, LLCHotels, Resorts & Cruise Lines
First Lien Term Loan, SOFR+8.00% cash due 6/21/202712.33 %$14,275 14,020 13,990 (6)(15)
First Lien Delayed Draw Term Loan, SOFR+8.00% cash due 6/21/2027— (51)(57)(6)(15)(19)
First Lien Revolver, SOFR+8.00% cash due 6/21/2027— (26)(29)(6)(15)(19)
13,943 13,904 
Harbor Purchaser Inc.Education Services
First Lien Term Loan, SOFR+5.25% cash due 4/9/20299.67 %9,369 9,070 8,938 (6)
9,070 8,938 
Hayfin Emerald CLO XIMulti-Sector Holdings
Class E Notes, EURIBOR+8.12% cash due 1/25/203610.11 %2,250 2,041 2,079 (6)(11)
2,041 2,079 
11

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
December 31, 20212022
(dollar amounts in thousands)
(unaudited)







Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Mesoblast, Inc.Biotechnology
First Lien Term Loan, 8.00% cash 1.75% PIK due 11/19/2026$7,121 $6,928 $6,927 (11)(15)
First Lien Delayed Draw Term Loan, 8.00% cash 1.75% PIK due 11/19/2026— (11)(15)(19)
6,929 6,929 
MHE Intermediate Holdings, LLCDiversified Support Services
First Lien Term Loan, LIBOR+5.75% cash due 7/21/20276.75 %16,388 16,085 16,074 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+5.75% cash due 7/21/20276.75 %1,234 1,201 1,212 (6)(15)(19)
First Lien Revolver, LIBOR+5.75% cash due 7/21/2027— (25)(27)(6)(15)(19)
17,261 17,259 
Mindbody, Inc.Internet Services & Infrastructure
First Lien Term Loan, LIBOR+7.00% cash 1.50% PIK due 2/14/20258.00 %45,144 43,863 44,377 (6)(15)
First Lien Revolver, LIBOR+8.00% cash due 2/14/2025— (70)(68)(6)(15)(19)
43,793 44,309 
Mosaic Companies, LLCHome Improvement Retail
First Lien Term Loan, LIBOR+6.75% cash due 7/2/20267.75 %47,092 46,245 46,150 (6)(15)
46,245 46,150 
MRI Software LLCApplication Software
First Lien Term Loan, LIBOR+5.50% cash due 2/10/20266.50 %28,180 27,668 28,158 (6)(15)
First Lien Revolver, LIBOR+5.50% cash due 2/10/2026— (13)(1)(6)(15)(19)
27,655 28,157 
Navisite, LLCData Processing & Outsourced Services
Second Lien Term Loan, LIBOR+8.50% cash due 12/30/20269.50 %22,560 22,185 22,041 (6)(15)
22,185 22,041 
NeuAG, LLCFertilizers & Agricultural Chemicals
First Lien Term Loan, LIBOR+5.50% cash 7.00% PIK due 9/11/20247.00 %47,872 46,273 47,011 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+5.50% cash 7.00% PIK due 9/11/2024— (200)(98)(6)(15)(19)
46,073 46,913 
NN, Inc.Industrial Machinery
First Lien Term Loan, LIBOR+6.88% cash due 9/19/20267.88 %59,160 57,894 57,977 (6)(11)(15)
57,894 57,977 
OEConnection LLCApplication Software
First Lien Term Loan, LIBOR+4.00% cash due 9/25/20264.10 %3,349 3,157 3,344 (6)
Second Lien Term Loan, LIBOR+7.00% cash due 9/25/20277.50 %7,519 7,370 7,369 (6)(15)
10,527 10,713 
Olaplex, Inc.Personal Products
First Lien Term Loan, LIBOR+6.25% cash due 1/8/20267.25 %51,783 50,644 51,912 (6)(15)
First Lien Revolver, LIBOR+6.25% cash due 1/8/2025— (54)(27)(6)(15)(19)
50,590 51,885 
OTG Management, LLCAirport Services
First Lien Term Loan, LIBOR+2.00% cash 8.00% PIK due 9/1/20253.00 %20,296 19,932 19,890 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+2.00% cash 8.00% PIK due 9/1/2025— (36)(38)(6)(15)(19)
19,896 19,852 
P & L Development, LLCPharmaceuticals
Fixed Rate Bond, 7.75% cash due 11/15/20257,776 7,829 7,794 
7,829 7,794 
Park Place Technologies, LLCInternet Services & Infrastructure
First Lien Term Loan, LIBOR+5.00% cash due 11/10/20276.00 %9,925 9,475 9,927 (6)
9,475 9,927 
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Horizon Aircraft Finance ISpecialized Finance
Class A Notes, 4.458% cash due 12/15/2038$7,112 $5,697 $5,838 (6)(11)
5,697 5,838 
iCIMs, Inc.Application Software
First Lien Term Loan, SOFR+3.375% cash 3.875% PIK due 8/18/20287.14 %19,203 18,888 18,420 (6)(15)
First Lien Term Loan, SOFR+7.25% cash due 8/18/202811.52 %2,944 2,895 2,885 (6)(15)
First Lien Delayed Draw Term Loan, SOFR+6.75% cash due 8/18/2028— — — (6)(15)(19)
First Lien Revolver, SOFR+6.75% cash due 8/18/2028— (30)(75)(6)(15)(19)
21,753 21,230 
Immucor, Inc.Health Care Supplies
First Lien Term Loan, LIBOR+5.75% cash due 7/2/202510.48 %8,547 8,395 8,635 (6)(15)
Second Lien Term Loan, LIBOR+8.00% cash 3.50% PIK due 10/2/202512.73 %22,819 22,401 23,275 (6)(15)
30,796 31,910 
Impel Neuropharma, Inc.Health Care Technology
First Lien Revenue Interest Financing Term Loan due 2/15/203113,482 13,482 13,428 (15)
First Lien Term Loan, SOFR+8.75% cash due 3/17/202713.20 %12,161 11,956 11,876 (6)(15)
25,438 25,304 
Innocoll Pharmaceuticals LimitedHealth Care Technology
First Lien Term Loan, 11.00% cash due 1/26/20276,817 6,569 6,336 (11)(15)
First Lien Delayed Draw Term Loan, 11.00% cash due 1/26/2027— — — (11)(15)(19)
56,999 Tranche A Warrant Shares (exercise price $4.23) expiration date 1/26/2029135 662 (11)(15)
6,704 6,998 
Integral Development CorporationOther Diversified Financial Services
1,078,284 Common Stock Warrants (exercise price $0.9274) expiration date 7/10/2024113 — (15)
113  
Inventus Power, Inc.Electrical Components & Equipment
First Lien Term Loan, SOFR+5.00% cash due 3/29/20249.84 %18,612 18,536 18,054 (6)(15)
Second Lien Term Loan, LIBOR+8.50% cash due 9/29/202413.23 %13,674 13,535 13,195 (6)(15)
32,071 31,249 
INW Manufacturing, LLCPersonal Products
First Lien Term Loan, LIBOR+5.75% cash due 3/25/202710.48 %35,156 34,394 30,059 (6)(15)
34,394 30,059 
IPC Corp.Application Software
First Lien Term Loan, LIBOR+6.50% cash due 10/1/20269.44 %34,357 33,660 32,553 (6)(15)
33,660 32,553 
Ivanti Software, Inc.Application Software
Second Lien Term Loan, LIBOR+7.25% cash due 12/1/202812.01 %10,247 10,196 5,994 (6)
10,196 5,994 
Jazz Acquisition, Inc.Aerospace & Defense
First Lien Term Loan, LIBOR+7.50% cash due 1/29/202711.88 %35,912 34,918 36,176 (6)(15)
Second Lien Term Loan, LIBOR+8.00% cash due 6/18/202712.38 %528 480 483 (6)
35,398 36,659 
Kings Buyer, LLCEnvironmental & Facilities Services
First Lien Term Loan, LIBOR+6.50% cash due 10/29/202711.23 %13,589 13,453 13,153 (6)(15)
First Lien Revolver, LIBOR+6.50% cash due 10/29/202711.75 %659 640 599 (6)(15)(19)
14,093 13,752 
12

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
December 31, 20212022
(dollar amounts in thousands)
(unaudited)







Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Performance Health Holdings, Inc.Health Care Distributors
First Lien Term Loan, LIBOR+6.00% cash due 7/12/20277.00 %$20,035 $19,666 $19,677 (6)(15)
19,666 19,677 
PFNY Holdings, LLCLeisure Facilities
First Lien Term Loan, LIBOR+7.00% cash due 12/31/20268.00 %26,286 25,764 25,760 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+7.00% cash due 12/31/2026— (50)(50)(6)(15)(19)
First Lien Revolver, LIBOR+7.00% cash due 12/31/2026— (25)(25)(6)(15)(19)
25,689 25,685 
Pingora MSR Opportunity Fund I-A, LPThrifts & Mortgage Finance
1.86% limited partnership interest752 134 (11)(16)(19)
752 134 
Planview Parent, Inc.Application Software
Second Lien Term Loan, LIBOR+7.25% cash due 12/18/20288.00 %28,627 28,198 28,699 (6)(15)
28,198 28,699 
PLNTF Holdings, LLCLeisure Facilities
First Lien Term Loan, LIBOR+8.00% cash due 3/22/20269.00 %3,950 3,883 3,970 (6)(15)
3,883 3,970 
Pluralsight, LLCApplication Software
First Lien Term Loan, LIBOR+8.00% cash due 4/6/20279.00 %48,689 47,830 47,831 (6)(15)
First Lien Revolver, LIBOR+8.00% cash due 4/6/2027— (62)(62)(6)(15)(19)
47,768 47,769 
PRGX Global, Inc.Data Processing & Outsourced Services
First Lien Term Loan, LIBOR+6.75% cash due 3/3/20267.75 %34,032 32,997 33,498 (6)(15)
First Lien Revolver, LIBOR+6.75% cash due 3/3/2026— (28)(26)(6)(15)(19)
80,515 Class B Common Units79 80 (15)
33,048 33,552 
ProFrac Services, LLCIndustrial Machinery
First Lien Term Loan, LIBOR+8.50% cash due 9/15/20239.75 %30,910 29,378 30,600 (6)(15)
29,378 30,600 
Project Boost Purchaser, LLCApplication Software
Second Lien Term Loan, LIBOR+8.00% cash due 5/31/20278.10 %5,250 5,155 5,237 (6)(15)
5,155 5,237 
Quantum Bidco LimitedFood Distributors
First Lien Term Loan, UK LIBOR+6.00% cash due 1/29/20286.12 %£3,501 4,633 4,680 (6)(11)
4,633 4,680 
QuorumLabs, Inc.Application Software
64,887,669 Junior-2 Preferred Stock375 — (15)
375  
Realfi Strategic Capital Funding LLCReal Estate Operating Companies
First Lien Delayed Draw Term Loan, 9.00% cash due 12/24/2028$— — — (15)(19)
2,500 Warrant Units (exercise price $0.01) expiration date 11/24/2031— — — (15)
  
Relativity ODA LLCApplication Software
First Lien Term Loan, LIBOR+7.50% PIK due 5/12/202723,372 22,877 22,928 (6)(15)
First Lien Revolver, LIBOR+6.50% cash due 5/12/2027— (49)(42)(6)(15)(19)
22,828 22,886 
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Latam Airlines Group S.A.Airlines
First Lien Term Loan, SOFR+9.50% cash due 11/3/202713.99 %$26,205 $24,034 $25,864 (6)(11)
24,034 25,864 
Lift Brands Holdings, Inc.Leisure Facilities
2,000,000 Class A Common Units in Snap Investments, LLC1,399 — (15)
1,399  
Lightbox Intermediate, L.P.Real Estate Services
First Lien Term Loan, LIBOR+5.00% cash due 5/9/20269.73 %36,913 36,233 35,621 (6)(15)
36,233 35,621 
Liquid Environmental Solutions CorporationEnvironmental & Facilities Services
Second Lien Term Loan, LIBOR+8.50% cash due 11/30/202612.88 %4,357 4,289 4,215 (6)(15)
Second Lien Delayed Draw Term Loan, LIBOR+8.50% cash due 11/30/202612.94 %2,370 2,323 2,257 (6)(15)(19)
450.75 Class A2 Units in LES Group Holdings, L.P.451 451 (15)
7,063 6,923 
LSL Holdco, LLCHealth Care Distributors
First Lien Term Loan, LIBOR+6.00% cash due 1/31/202810.38 %21,315 20,839 20,089 (6)(15)
First Lien Revolver, LIBOR+6.00% cash due 1/31/202810.38 %2,137 2,101 2,014 (6)(15)
22,940 22,103 
LTI Holdings, Inc.Electronic Components
Second Lien Term Loan, LIBOR+6.75% cash due 9/6/202611.13 %2,140 2,095 1,712 (6)
2,095 1,712 
Marinus Pharmaceuticals, Inc.Pharmaceuticals
First Lien Term Loan, 11.50% cash due 5/11/202617,203 16,972 16,573 (11)(15)
First Lien Delayed Draw Term Loan, 11.50% cash due 5/11/2026— — — (11)(15)(19)
16,972 16,573 
Mesoblast, Inc.Biotechnology
First Lien Term Loan, 8.00% cash 1.75% PIK due 11/19/20267,247 6,717 6,474 (11)(15)
First Lien Delayed Draw Term Loan, 8.00% cash 1.75% PIK due 11/19/2026— — (11)(15)(19)
209,588 Warrant Shares (exercise price $7.26) expiration date 11/19/2028480 222 (11)(15)
53,887 Warrant Shares (exercise price $3.70) expiration 11/19/2028— 81 (11)(15)
7,198 6,777 
MHE Intermediate Holdings, LLCDiversified Support Services
First Lien Term Loan, SOFR+6.00% cash due 7/21/20279.50 %18,344 18,057 17,678 (6)(15)
First Lien Revolver, SOFR+6.00% cash due 7/21/202710.94 %200 178 148 (6)(15)(19)
18,235 17,826 
Mindbody, Inc.Internet Services & Infrastructure
First Lien Term Loan, LIBOR+7.00% cash due 2/14/202511.72 %45,487 44,616 44,486 (6)(15)
First Lien Revolver, LIBOR+8.00% cash due 2/14/2025— (48)(88)(6)(15)(19)
44,568 44,398 
Mosaic Companies, LLCHome Improvement Retail
First Lien Term Loan, LIBOR+6.75% cash due 7/2/202610.93 %45,907 45,266 45,127 (6)(15)
45,266 45,127 
MRI Software LLCApplication Software
First Lien Term Loan, LIBOR+5.50% cash due 2/10/202610.23 %25,768 25,392 24,833 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 2/10/2026— (11)(95)(6)(15)(19)
First Lien Revolver, LIBOR+5.50% cash due 2/10/2026— (13)(65)(6)(15)(19)
25,368 24,673 
Navisite, LLCData Processing & Outsourced Services
Second Lien Term Loan, LIBOR+8.50% cash due 12/30/202613.23 %22,560 22,260 21,545 (6)(15)
22,260 21,545 
13

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
December 31, 20212022
(dollar amounts in thousands)
(unaudited)







Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Renaissance Holding Corp.Diversified Banks
Second Lien Term Loan, LIBOR+7.00% cash due 5/29/20267.10 %$3,542 $3,515 $3,562 (6)
3,515 3,562 
RumbleOn, Inc.Automotive Retail
First Lien Term Loan, LIBOR+8.25% cash due 8/31/20269.25 %37,941 35,687 36,993 (6)(11)(15)
First Lien Delayed Draw Term Loan, LIBOR+8.25% cash due 8/31/2026— (969)(408)(6)(11)(15)(19)
164,660 Class B Common Stock Warrants (exercise price $33.00) expiration date 2/28/20231,202 1,787 (15)
35,920 38,372 
Sabert CorporationMetal & Glass Containers
First Lien Term Loan, LIBOR+4.50% cash due 12/10/20265.50 %1,771 1,672 1,774 (6)
1,672 1,774 
Scilex Pharmaceuticals Inc.Pharmaceuticals
Fixed Rate Zero Coupon Bond due 8/15/20267,571 6,551 7,154 (15)
6,551 7,154 
ShareThis, Inc.Application Software
345,452 Series C Preferred Stock Warrants (exercise price $3.0395) expiration date 3/4/2024367 — (15)
367  
SiO2 Medical Products, Inc.Metal & Glass Containers
First Lien Term Loan, 11.00% cash due 12/21/202619,302 18,828 18,824 (15)
Common Stock Warrants (exercise price $0.75) expiration date 7/31/2028681 681 (15)
19,509 19,505 
Sirva Worldwide, Inc.Diversified Support Services
First Lien Term Loan, LIBOR+5.50% cash due 8/4/20255.60 %1,727 1,556 1,572 (6)
1,556 1,572 
SM Wellness Holdings, Inc.Health Care Services
Second Lien Term Loan, LIBOR+8.00% cash due 4/16/20298.75 %9,109 8,972 9,177 (6)(15)
8,972 9,177 
SonicWall US Holdings Inc.Technology Distributors
Second Lien Term Loan, LIBOR+7.50% cash due 5/18/20267.67 %3,195 3,163 3,148 (6)(15)
3,163 3,148 
Sorrento Therapeutics, Inc.Biotechnology
50,000 Common Stock Units197 233 (11)
197 233 
Spanx, LLCApparel Retail
First Lien Term Loan, LIBOR+5.50% cash due 11/18/20286.25 %4,568 4,479 4,477 (6)(15)
First Lien Revolver, LIBOR+5.25% cash due 11/18/2027— (61)(62)(6)(15)(19)
4,418 4,415 
SumUp Holdings Luxembourg S.À.R.L.Other Diversified Financial Services
First Lien Delayed Draw Term Loan, EURIBOR+8.50% cash due 3/10/202610.00 %16,911 19,415 18,943 (6)(11)(15)
19,415 18,943 
Sunland Asphalt & Construction, LLCConstruction & Engineering
First Lien Term Loan, LIBOR+6.00% cash due 1/13/20267.00 %$42,944 41,753 42,429 (6)(15)
First Lien Revolver, LIBOR+6.00% cash due 1/13/2022— (5)(7)(6)(15)(19)
41,748 42,422 
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
NeuAG, LLCFertilizers & Agricultural Chemicals
First Lien Term Loan, LIBOR+10.50% cash due 9/11/202415.23 %$50,276 $49,271 $52,292 (6)(15)
49,271 52,292 
NFP Corp.Other Diversified Financial Services
Fixed Rate Bond 6.875% cash due 8/15/202810,191 9,787 8,423 
9,787 8,423 
NN, Inc.Industrial Machinery
First Lien Term Loan, LIBOR+6.88% cash due 9/19/202611.26 %58,564 57,577 55,958 (6)(11)(15)
57,577 55,958 
OCP EURO CLO 2022-6Multi-Sector Holdings
Class D Notes, EURIBOR+6.06% cash due 1/20/20338.05 %2,500 2,503 2,576 (6)(11)
Class E Notes, EURIBOR+6.87% cash due 1/20/20338.86 %3,000 2,677 2,728 (6)(11)
5,180 5,304 
OEConnection LLCApplication Software
First Lien Term Loan, SOFR+4.00% cash due 9/25/20268.42 %$3,315 3,165 3,167 (6)
Second Lien Term Loan, SOFR+7.00% cash due 9/25/202711.42 %7,519 7,396 7,221 (6)(15)
10,561 10,388 
OTG Management, LLCAirport Services
First Lien Term Loan, LIBOR+2.00% cash 8.00% PIK due 9/1/20256.76 %21,993 21,728 21,993 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+2.00% cash 8.00% PIK due 9/1/2025— (30)— (6)(15)(19)
21,698 21,993 
P & L Development, LLCPharmaceuticals
Fixed Rate Bond, 7.75% cash due 11/15/20257,776 7,817 6,318 
7,817 6,318 
Park Place Technologies, LLCInternet Services & Infrastructure
First Lien Term Loan, SOFR+5.00% cash due 11/10/20279.42 %4,838 4,703 4,575 (6)
4,703 4,575 
Performance Health Holdings, Inc.Health Care Distributors
First Lien Term Loan, LIBOR+6.00% cash due 7/12/202710.73 %17,976 17,705 17,537 (6)(15)
17,705 17,537 
PFNY Holdings, LLCLeisure Facilities
First Lien Term Loan, LIBOR+7.00% cash due 12/31/202610.74 %26,088 25,674 25,632 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+7.00% cash due 12/31/202610.74 %2,228 2,188 2,184 (6)(15)(19)
First Lien Revolver, LIBOR+7.00% cash due 12/31/202611.76 %1,252 1,232 1,230 (6)(15)
29,094 29,046 
Planview Parent, Inc.Application Software
Second Lien Term Loan, LIBOR+7.25% cash due 12/18/202811.98 %28,627 28,198 25,693 (6)(15)
28,198 25,693 
Pluralsight, LLCApplication Software
First Lien Term Loan, LIBOR+8.00% cash due 4/6/202711.83 %48,689 47,993 47,471 (6)(15)
First Lien Revolver, LIBOR+8.00% cash due 4/6/202712.36 %1,766 1,716 1,678 (6)(15)(19)
49,709 49,149 
PRGX Global, Inc.Data Processing & Outsourced Services
First Lien Term Loan, LIBOR+6.75% cash due 3/3/202611.50 %31,186 30,466 30,578 (6)(15)
First Lien Revolver, LIBOR+6.75% cash due 3/3/2026— (31)(49)(6)(15)(19)
80,515 Class B Common Units79 121 (15)
30,514 30,650 
Profrac Holdings II, LLCIndustrial Machinery
First Lien Term Loan, SOFR+7.25% cash due 3/4/202511.10 %22,984 22,496 22,432 (6)(15)
22,496 22,432 
14

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
December 31, 20212022
(dollar amounts in thousands)
(unaudited)







Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Supermoose Borrower, LLCApplication Software
First Lien Term Loan, LIBOR+3.75% cash due 8/29/20253.97 %$3,493 $3,082 $3,306 (6)
3,082 3,306 
SVP-Singer Holdings Inc.Home Furnishings
First Lien Term Loan, LIBOR+6.75% cash due 7/28/20287.50 %20,924 19,542 19,738 (6)(15)
19,542 19,738 
Swordfish Merger Sub LLCAuto Parts & Equipment
Second Lien Term Loan, LIBOR+6.75% cash due 2/2/20267.75 %12,500 12,468 12,461 (6)(15)
12,468 12,461 
Tacala, LLCRestaurants
Second Lien Term Loan, LIBOR+7.50% cash due 2/4/20288.25 %9,448 9,323 9,446 (6)
9,323 9,446 
Tahoe Bidco B.V.Application Software
First Lien Term Loan, LIBOR+6.00% cash due 9/29/20286.75 %23,215 22,766 22,750 (6)(11)(15)
First Lien Revolver, LIBOR+6.00% cash due 10/1/2027— (33)(35)(6)(11)(15)(19)
22,733 22,715 
Tecta America Corp.Construction & Engineering
Second Lien Term Loan, LIBOR+8.50% cash due 4/9/20299.25 %5,203 5,125 5,203 (6)(15)
5,125 5,203 
Telestream Holdings CorporationApplication Software
First Lien Term Loan, LIBOR+8.75% cash due 10/15/20259.75 %18,463 18,003 18,241 (6)(15)
First Lien Revolver, LIBOR+8.75% cash due 10/15/20259.75 %703 677 682 (6)(15)(19)
18,680 18,923 
TerSera Therapeutics LLCPharmaceuticals
Second Lien Term Loan, LIBOR+9.50% cash due 3/30/202610.50 %29,663 29,286 29,371 (6)(15)
668,879 Common Units of TerSera Holdings LLC2,192 3,487 (15)
31,478 32,858 
TGNR HoldCo LLCIntegrated Oil & Gas
Subordinated Debt, 11.50% cash due 5/14/20264,984 4,847 4,897 (10)(11)(15)
4,847 4,897 
Thermacell Repellents, Inc.Leisure Products
First Lien Term Loan, LIBOR+5.75% cash due 12/4/20266.75 %6,619 6,586 6,586 (6)(15)
First Lien Revolver, LIBOR+5.75% cash due 12/4/20266.75 %250 246 246 (6)(15)(19)
6,832 6,832 
Thrasio, LLCInternet & Direct Marketing Retail
First Lien Term Loan, LIBOR+7.00% cash due 12/18/20268.00 %37,780 36,683 37,591 (6)(15)
8,434 Shares of Series C-3 Preferred Stock in Thrasio Holdings, Inc.101 171 (15)
284,650.32 Shares of Series C-2 Preferred Stock in Thrasio Holdings, Inc.2,410 5,764 (15)
48,352 Shares of Series D Preferred Stock in Thrasio Holdings, Inc.979 979 (15)
23,201 Shares of Series X Preferred Stock in Thrasio Holdings, Inc.22,986 25,743 (15)(19)
63,159 70,248 
TIBCO Software Inc.Application Software
Second Lien Term Loan, LIBOR+7.25% cash due 3/3/20287.36 %14,788 14,692 14,865 (6)
14,692 14,865 
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Project Boost Purchaser, LLCApplication Software
Second Lien Term Loan, LIBOR+8.00% cash due 5/31/202712.38 %$5,250 $5,173 $4,955 (6)(15)
5,173 4,955 
Quantum Bidco LimitedFood Distributors
First Lien Term Loan, SONIA+6.00% cash due 1/29/20289.63 %£3,501 $4,655 $3,599 (6)(11)(15)
4,655 3,599 
QuorumLabs, Inc.Application Software
64,887,669 Junior-2 Preferred Stock375 — (15)
375  
Radiology Partners Inc.Health Care Distributors
First Lien Term Loan, LIBOR+4.25% cash due 7/9/20258.64 %$3,400 3,221 2,870 (6)
Fixed Rate Bond, 9.25% cash due 2/1/20284,755 4,721 2,677 
7,942 5,547 
Relativity ODA LLCApplication Software
First Lien Term Loan, LIBOR+7.50% PIK due 5/12/202725,405 25,002 24,846 (6)(15)
First Lien Revolver, LIBOR+6.50% cash due 5/12/2027— (40)(47)(6)(15)(19)
24,962 24,799 
Renaissance Holding Corp.Diversified Banks
Second Lien Term Loan, LIBOR+7.00% cash due 5/29/202611.38 %3,542 3,515 3,315 (6)
3,515 3,315 
RumbleOn, Inc.Automotive Retail
First Lien Term Loan, LIBOR+8.25% cash due 8/31/202612.98 %36,092 34,407 34,540 (6)(11)(15)
First Lien Delayed Draw Term Loan, LIBOR+8.25% cash due 8/31/202612.98 %10,920 10,185 10,243 (6)(11)(15)(19)
164,660 Class B Common Stock Warrants (exercise price $31.50) expiration date 7/25/20231,202 — (11)(15)
45,794 44,783 
Salus Workers' Compensation, LLCOther Diversified Financial Services
First Lien Term Loan, SOFR+10.00% cash due 10/7/202614.32 %27,848 26,787 26,804 (6)(15)
First Lien Revolver, SOFR+10.00% cash due 10/7/202614.32 %931 812 814 (6)(15)(19)
991,019 Common Stock Warrants (exercise price $4.83) expiration date 10/7/2032327 307 (15)
27,926 27,925 
SCP Eye Care Services, LLCHealth Care Services
Second Lien Term Loan, SOFR+8.75% cash due 10/7/203012.52 %8,010 7,777 7,778 (6)(15)
Second Lien Delayed Draw Term Loan, SOFR+8.75% cash due 10/7/2030— (35)(68)(6)(15)(19)
1,037 Units in Eyesouth Co-Investor FT Aggregator LLC1,037 1,113 (15)
8,779 8,823 
scPharmaceuticals Inc.Pharmaceuticals
First Lien Term Loan, SOFR+8.75% cash due 10/13/202711.75 %5,212 4,945 4,957 (6)(15)
First Lien Delayed Draw Term Loan, SOFR+8.75% cash due 10/13/2027— — — (6)(15)(19)
53,700 Common Stock Warrants (exercise price $5.40) expiration date 10/12/2029175 262 (15)
5,120 5,219 
ShareThis, Inc.Application Software
345,452 Series C Preferred Stock Warrants (exercise price $3.0395) expiration date 3/4/2024367 — (15)
367  
SiO2 Medical Products, Inc.Metal & Glass Containers
First Lien Term Loan, 5.50% cash 8.50% PIK due 12/21/202647,112 46,447 44,520 (15)
415.34 Common Stock Warrants (exercise price $4,920.75) expiration date 7/31/2028681 243 (15)
47,128 44,763 
SM Wellness Holdings, Inc.Health Care Services
First Lien Term Loan, LIBOR+4.75% cash due 4/17/20289.42 %3,395 2,784 2,767 (6)(15)
Second Lien Term Loan, LIBOR+8.00% cash due 4/16/202912.67 %9,109 8,972 6,604 (6)(15)
11,756 9,371 
15

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
December 31, 20212022
(dollar amounts in thousands)
(unaudited)







Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
TigerConnect, Inc.Application Software
299,110 Series B Preferred Stock Warrants (exercise price $1.3373) expiration date 12/8/2024$60 $525 (15)
60 525 
Touchstone Acquisition, Inc.Health Care Supplies
First Lien Term Loan, LIBOR+6.00% cash due 12/21/20286.75 %$6,046 5,925 5,925 (6)(15)
5,925 5,925 
Velocity Commercial Capital, LLCThrifts & Mortgage Finance
First Lien Term Loan, LIBOR+8.00% cash due 2/5/20269.00 %15,808 15,264 15,729 (6)(15)
15,264 15,729 
Veritas US Inc.Application Software
First Lien Term Loan, LIBOR+5.00% cash due 9/1/20256.00 %5,925 5,607 5,933 (6)
5,607 5,933 
Vitalyst Holdings, Inc.IT Consulting & Other Services
675 Series A Preferred Stock Units675 440 (15)
7,500 Class A Common Stock Units75 — (15)
750 440 
Win Brands Group LLCHousewares & Specialties
First Lien Term Loan, LIBOR+9.00% cash 5.00% PIK due 1/22/202610.00 %1,908 1,889 1,898 (6)(15)
181 Class F Warrants in Brand Value Growth LLC (exercise price $0.01) expiration date 1/25/2027— 111 (15)
1,889 2,009 
Windstream Services II, LLCIntegrated Telecommunication Services
First Lien Term Loan, LIBOR+6.25% cash due 9/21/20277.25 %25,698 24,694 25,818 (6)
18,032 Shares of Common Stock in Windstream Holdings II, LLC216 377 (15)
109,420 Warrants in Windstream Holdings II, LLC1,842 2,286 (15)
26,752 28,481 
WP CPP Holdings, LLCAerospace & Defense
First Lien Term Loan, LIBOR+3.75% cash due 4/30/20254.75 %4,358 4,022 4,189 (6)
Second Lien Term Loan, LIBOR+7.75% cash due 4/30/20268.75 %16,000 15,771 15,688 (6)(15)
19,793 19,877 
WPEngine, Inc.Application Software
First Lien Term Loan, LIBOR+6.50% cash due 3/27/20267.50 %40,536 39,822 40,057 (6)(15)
39,822 40,057 
WWEX Uni Topco Holdings, LLCAir Freight & Logistics
Second Lien Term Loan, LIBOR+7.00% cash due 7/26/20297.75 %5,000 4,925 5,022 (6)
4,925 5,022 
Zep Inc.Specialty Chemicals
Second Lien Term Loan, LIBOR+8.25% cash due 8/11/20259.25 %22,224 22,173 20,646 (6)(15)
22,173 20,646 
Zephyr Bidco LimitedSpecialized Finance
Second Lien Term Loan, UK LIBOR+7.50% cash due 7/23/20267.68 %£18,000 23,802 24,339 (6)(11)
23,802 24,339 
Total Non-Control/Non-Affiliate Investments (174.4% of net assets)$2,283,055 $2,311,034 
Total Portfolio Investments (195.4% of net assets)$2,574,870 $2,588,623 
Cash and Cash Equivalents and Restricted Cash
JP Morgan Prime Money Market Fund, Institutional Shares $32,082 $32,082 
Other cash accounts13,975 13,975 
Total Cash and Cash Equivalents and Restricted Cash (3.5% of net assets)$46,057 $46,057 
Total Portfolio Investments and Cash and Cash Equivalents and Restricted Cash (198.8% of net assets)$2,620,927 $2,634,680 

Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
SonicWall US Holdings Inc.Technology Distributors
Second Lien Term Loan, LIBOR+7.50% cash due 5/18/202612.20 %$3,195 $3,163 $2,971 (6)(15)
3,163 2,971 
Sorrento Therapeutics, Inc.Biotechnology
50,000 Common Stock Units197 44 (11)
197 44 
Spanx, LLCApparel Retail
First Lien Term Loan, LIBOR+5.25% cash due 11/20/20289.64 %4,523 4,447 4,415 (6)(15)
First Lien Revolver, LIBOR+5.25% cash due 11/18/20279.29 %330 280 260 (6)(15)(19)
4,727 4,675 
SPX Flow, Inc.Industrial Machinery
First Lien Term Loan, SOFR+4.50% cash due 4/5/20298.92 %1,496 1,410 1,401 (6)
1,410 1,401 
SumUp Holdings Luxembourg S.À.R.L.Other Diversified Financial Services
First Lien Term Loan, EURIBOR+8.50% cash due 3/10/202610.49 %16,911 19,415 17,732 (6)(11)(15)
19,415 17,732 
Sunland Asphalt & Construction, LLCConstruction & Engineering
First Lien Term Loan, LIBOR+6.00% cash due 1/13/202611.15 %$42,510 41,624 41,702 (6)(15)
41,624 41,702 
Superior Industries International, Inc.Auto Parts & Equipment
First Lien Term Loan, SOFR+8.00% cash due 12/16/202812.32 %39,774 38,591 38,581 (6)(15)
38,591 38,581 
Supermoose Borrower, LLCApplication Software
First Lien Term Loan, LIBOR+3.75% cash due 8/29/20258.48 %3,457 3,162 2,994 (6)
3,162 2,994 
SVP-Singer Holdings Inc.Home Furnishings
First Lien Term Loan, LIBOR+6.75% cash due 7/28/202811.48 %20,714 19,554 17,917 (6)(15)
19,554 17,917 
Swordfish Merger Sub LLCAuto Parts & Equipment
Second Lien Term Loan, LIBOR+6.75% cash due 2/2/202611.14 %12,500 12,476 11,434 (6)(15)
12,476 11,434 
Tacala, LLCRestaurants
Second Lien Term Loan, LIBOR+7.50% cash due 2/4/202811.88 %9,448 9,343 8,610 (6)
9,343 8,610 
Tahoe Bidco B.V.Application Software
First Lien Term Loan, LIBOR+6.00% cash due 9/29/202810.29 %23,215 22,833 22,866 (6)(11)(15)
First Lien Revolver, LIBOR+6.00% cash due 10/1/2027 (28)(26)(6)(11)(15)(19)
22,805 22,840 
Tecta America Corp.Construction & Engineering
Second Lien Term Loan, SOFR+8.50% cash due 4/9/202912.94 %5,203 5,125 4,982 (6)(15)
5,125 4,982 
Telestream Holdings CorporationApplication Software
First Lien Term Loan, SOFR+9.75% cash due 10/15/202513.67 %18,276 17,941 17,765 (6)(15)
First Lien Revolver, SOFR+9.75% cash due 10/15/202513.67 %1,231 1,212 1,182 (6)(15)(19)
19,153 18,947 
TerSera Therapeutics LLCPharmaceuticals
Second Lien Term Loan, LIBOR+9.50% cash due 3/30/202613.88 %29,663 29,375 29,057 (6)(15)
668,879 Common Units of TerSera Holdings LLC2,028 4,662 (15)
31,403 33,719 
TGNR HoldCo LLCIntegrated Oil & Gas
Subordinated Debt, 11.50% cash due 5/14/20264,984 4,873 4,847 (10)(11)(15)
4,873 4,847 
16

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
December 31, 20212022
(dollar amounts in thousands)
(unaudited)








Derivative InstrumentNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateCounterpartyCumulative Unrealized Appreciation /(Depreciation)
Foreign currency forward contract$49,542 42,652 2/10/2022JPMorgan Chase Bank, N.A.$999 
Foreign currency forward contract$54,395 £40,109 2/10/2022JPMorgan Chase Bank, N.A.76 
$1,075 


Derivative InstrumentCompany ReceivesCompany PaysCounterpartyMaturity DateNotional AmountFair Value
Interest rate swapFixed 2.7%Floating 3-month LIBOR +1.658%Royal Bank of Canada1/15/2027$350,000$(5,931)
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Thrasio, LLCInternet & Direct Marketing Retail
First Lien Term Loan, LIBOR+7.00% cash due 12/18/202611.17 %$37,399 $36,532 $34,126 (6)(15)
8,434 Shares of Series C-3 Preferred Stock in Thrasio Holdings, Inc.101 71 (15)
284,650.32 Shares of Series C-2 Preferred Stock in Thrasio Holdings, Inc.2,409 1,882 (15)
48,352 Shares of Series D Preferred Stock in Thrasio Holdings, Inc.979 852 (15)
25,780 Shares of Series X Preferred Stock in Thrasio Holdings, Inc.25,564 29,070 (15)
65,585 66,001 
TIBCO Software Inc.Application Software
First Lien Term Loan, SOFR+4.50% cash due 3/20/20299.18 %12,032 10,986 10,775 (6)
10,986 10,775 
Touchstone Acquisition, Inc.Health Care Supplies
First Lien Term Loan, LIBOR+6.00% cash due 12/29/202810.38 %6,001 5,897 5,866 (6)(15)
5,897 5,866 
Trinitas CLO XVMulti-Sector Holdings
Class E Notes, LIBOR+7.45% cash due 4/22/203411.77 %1,000 810 846 (6)(11)
810 846 
Uniti Group LPSpecialized REITs
Fixed Rate Bond, 6.50% cash due 2/15/20294,500 4,074 2,990 (11)
Fixed Rate Bond, 4.75% cash due 4/15/2028300 260 240 (11)
4,334 3,230 
Win Brands Group LLCHousewares & Specialties
First Lien Term Loan, LIBOR+15.00% cash due 1/22/202620.75 %2,238 2,217 2,137 (6)(15)
3,621 Class F Warrants in Brand Value Growth LLC (exercise price $0.01) expiration date 1/25/2027— 128 (15)
2,217 2,265 
Windstream Services II, LLCIntegrated Telecommunication Services
First Lien Term Loan, SOFR+6.25% cash due 9/21/202710.67 %25,432 24,612 23,131 (6)
18,032 Shares of Common Stock in Windstream Holdings II, LLC216 279 (15)
109,420 Warrants in Windstream Holdings II, LLC1,842 1,695 (15)
26,670 25,105 
WP CPP Holdings, LLCAerospace & Defense
First Lien Term Loan, LIBOR+3.75% cash due 4/30/20258.17 %7,545 7,029 6,598 (6)
Second Lien Term Loan, LIBOR+7.75% cash due 4/30/202612.17 %6,000 5,866 5,055 (6)(15)
12,895 11,653 
WPEngine, Inc.Application Software
First Lien Term Loan, LIBOR+6.00% cash due 3/27/202610.19 %40,536 39,991 40,131 (6)(15)
39,991 40,131 
WWEX Uni Topco Holdings, LLCAir Freight & Logistics
Second Lien Term Loan, LIBOR+7.00% cash due 7/26/202911.73 %5,000 4,925 4,191 (6)(15)
4,925 4,191 
Zayo Group Holdings, Inc.Alternative Carriers
Fixed Rate Bond, 4.00% cash due 3/1/2027250 214 185 
214 185 
17

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
December 31, 20212022
(dollar amounts in thousands)
(unaudited)







Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Zep Inc.Specialty Chemicals
Second Lien Term Loan, LIBOR+8.25% cash due 8/11/202512.98 %$19,578 $19,545 $13,704 (6)(15)
19,545 13,704 
Zephyr Bidco LimitedSpecialized Finance
Second Lien Term Loan, SONIA+7.50% cash due 7/23/202610.96 %£18,000 23,839 16,369 (6)(11)(15)
23,839 16,369 
Total Non-Control/Non-Affiliate Investments (198.6% of net assets)$2,471,776 $2,387,235 
Total Portfolio Investments (219.9% of net assets)$2,778,014 $2,642,870 
Cash and Cash Equivalents and Restricted Cash
JP Morgan Prime Money Market Fund, Institutional Shares $3,421 $3,421 
Other cash accounts15,824 15,824 
Total Cash and Cash Equivalents and Restricted Cash (1.6% of net assets)$19,245 $19,245 
Total Portfolio Investments and Cash and Cash Equivalents and Restricted Cash (221.5% of net assets)
$2,797,259 $2,662,115 


Derivative InstrumentNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateCounterpartyCumulative Unrealized Appreciation /(Depreciation)
Foreign currency forward contract$44,825 44,224 2/9/2023JPMorgan Chase Bank, N.A.$(2,499)
Foreign currency forward contract$46,412 £39,965 2/9/2023JPMorgan Chase Bank, N.A.(1,712)
$(4,211)


Derivative InstrumentCompany ReceivesCompany PaysCounterpartyMaturity DateNotional AmountFair Value
Interest rate swapFixed 2.7%Floating 3-month LIBOR +1.658%Royal Bank of Canada1/15/2027$350,000$(39,928)
18

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
December 31, 2022
(dollar amounts in thousands)
(unaudited)




(1)All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.
(2)See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.
(3)Equity ownership may be held in shares or units of companies related to the portfolio companies.
(4)Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
(5)Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.
(6)The interest rate on the principal balance outstanding for allmost of the floating rate loans is indexed to the London Interbank Offered Rate ("LIBOR") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to the secured overnight financing rate ("SOFR") or the sterling overnight index average ("SONIA"). The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over LIBOR or the alternate basereference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars unless otherwise noted. As of December 31, 2021,2022, the reference rates for the Company's variable rate loans were the 30-day LIBOR at 0.10%, the 60-day LIBOR at 0.16%4.38%, the 90-day LIBOR at 0.22%4.73%, the 180-day LIBOR at 0.35%, the 360-day LIBOR at 0.59%5.15%, the PRIME at 3.25%7.50%, the 30-day UK LIBORSOFR at 0.18%4.32%, the 90-day SOFR at 4.58%, the 180-day UK LIBORSOFR at 0.09%4.79%, the SONIA at 3.43%, the 30-day EURIBOR at (0.64)%1.90%, the 90-day EURIBOR at (0.60)%1.99% and the 180-day EURIBOR at (0.53)%0.38%. Most loans include an interest floor, which generally ranges from 0% to 1%2%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
(7)Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
(8)Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
(9)As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the three months ended December 31, 20212022 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
(10)This investment represents a participation interest in the underlying securities shown.
(11)Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of December 31, 2021,2022, qualifying assets represented 74.9%73.8% of the Company's total assets and non-qualifying assets represented 25.1%26.2% of the Company's total assets.
(12)Income producing through payment of dividends or distributions.
(13)PIK interest income for this investment accrues at an annualized rate of 15%, however, the PIK interest is not contractually capitalized on the investment subsequent to a restructure that occurred during the year ended September 30, 2021. As a result, the principal amountOne half of the investment does not increase overSeller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech SA common share price is at or above a volume weighted average price ("VWAP") of $15.00 per share for accumulated PIK interest. As of December 31, 2021, the accumulated PIK interest balance for the A notesany ten trading days within any twenty trading day period, and the B notes was $1.6 million and $1.6 million, respectively.other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.
(14)See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.
(15)As of December 31, 2021,2022, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820").
(16)This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.
(17)Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.
(18)Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.
(19)Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.



See notes to Consolidated Financial Statements.



1819

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 20212022
(dollar amounts in thousands)


Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Control Investments(8)(9)
C5 Technology Holdings, LLCData Processing & Outsourced Services
829 Common Units$— $— (15)
34,984,460.37 Preferred Units34,984 27,638 (15)
34,984 27,638 
Dominion Diagnostics, LLCHealth Care Services
First Lien Term Loan, LIBOR+5.00% cash due 2/28/20246.00 %$27,381 27,381 27,381 (6)(15)
First Lien Revolver, LIBOR+5.00% cash due 2/28/2024— — — (6)(15)(19)
30,030.8 Common Units in DD Healthcare Services Holdings, LLC18,625 18,065 (12)(15)
46,006 45,446 
First Star Speir Aviation LimitedAirlines(10)
First Lien Term Loan, 9.00% cash due 12/15/20257,500 — 7,500 (11)(15)
100% equity interest6,332 698 (11)(12)(15)
6,332 8,198 
OCSI Glick JV LLCMulti-Sector Holdings(14)
Subordinated Debt, LIBOR+4.50% cash due 10/20/20284.60 %61,709 50,705 55,582  (6)(11)(15)(19)
87.5% equity interest— —  (11)(16)(19)
50,705 55,582 
Senior Loan Fund JV I, LLCMulti-Sector Holdings(14)
Subordinated Debt, LIBOR+7.00% cash due 12/29/20288.00 %96,250 96,250 96,250 (6)(11)(15)(19)
87.5% LLC equity interest49,322 37,651 (11)(12)(16)(19)
145,572 133,901 
 Total Control Investments (20.6% of net assets)$283,599 $270,765 
Affiliate Investments(17)
Assembled Brands Capital LLCSpecialized Finance
First Lien Revolver, LIBOR+6.00% cash due 10/17/20237.00 %$15,899 $15,900 $15,712 (6)(15)(19)
1,609,201 Class A Units764 587 (15)
1,019,168.80 Preferred Units, 6%1,019 1,152 (15)
70,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029— — (15)
17,683 17,451 
Caregiver Services, Inc.Health Care Services
1,080,399 shares of Series A Preferred Stock, 10%1,080 838 (15)
1,080 838 
 Total Affiliate Investments (1.4% of net assets)$18,763 $18,289 
Non-Control/Non-Affiliate Investments(18)
4 Over International, LLCCommercial Printing
First Lien Term Loan, LIBOR+6.00% cash due 6/7/20227.00 %$10,927 $10,524 $10,484 (6)(15)
First Lien Revolver, LIBOR+6.00% cash due 6/7/2022— (24)(93)(6)(15)(19)
10,500 10,391 
109 Montgomery Owner LLCReal Estate Operating Companies
First Lien Delayed Draw Term Loan, LIBOR+7.00% cash due 2/2/20237.50 %3,102 2,984 3,153 (6)(15)(19)
2,984 3,153 
A.T. Holdings II SÀRLBiotechnology
First Lien Term Loan, 9.50% cash due 12/22/202237,158 36,930 36,972 (11)(15)
36,930 36,972 
Access CIG, LLCDiversified Support Services
First Lien Term Loan, LIBOR+3.75% cash due 2/27/20253.83 %5,352 5,021 5,332 (6)
Second Lien Term Loan, LIBOR+7.75% cash due 2/27/20267.83 %17,000 16,923 17,028 (6)
21,944 22,360 
19

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 2021
(dollar amounts in thousands)

Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Accupac, Inc.Personal Products
First Lien Term Loan, LIBOR+6.00% cash due 1/17/20267.00 %$16,140 $15,758 $16,140 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+6.00% cash due 1/17/2026— (29)— (6)(15)(19)
First Lien Revolver, LIBOR+6.00% cash due 1/17/20267.00 %1,838 1,789 1,838 (6)(15)(19)
17,518 17,978 
Acquia Inc.Application Software
First Lien Term Loan, LIBOR+7.00% cash due 10/31/20258.00 %27,349 26,936 27,295 (6)(15)
First Lien Revolver, LIBOR+7.00% cash due 10/31/20258.00 %179 148 175 (6)(15)(19)
27,084 27,470 
ADB Companies, LLCConstruction & Engineering
First Lien Term Loan, LIBOR+6.25% cash due 12/18/20257.25 %15,463 14,817 15,287 (6)(15)
14,817 15,287 
Aden & Anais Merger Sub, Inc.Apparel, Accessories & Luxury Goods
51,645 Common Units in Aden & Anais Holdings, Inc.5,165 — (15)
5,165  
AI Sirona (Luxembourg) Acquisition S.a.r.l.Pharmaceuticals
Second Lien Term Loan, EURIBOR+7.25% cash due 9/28/20267.25 %24,838 27,720 28,738 (6)(11)(15)
27,720 28,738 
AirStrip Technologies, Inc.Application Software
5,715 Common Stock Warrants (exercise price $139.99) expiration date 5/11/202590 — (15)
90  
All Web Leads, Inc.Advertising
First Lien Term Loan, LIBOR+6.50% cash due 12/29/20237.50 %$23,899 21,512 22,992 (6)(15)
21,512 22,992 
Alvogen Pharma US, Inc.Pharmaceuticals
First Lien Term Loan, LIBOR+5.25% cash due 12/31/20236.25 %13,825 13,329 13,383 (6)
13,329 13,383 
Alvotech Holdings S.A.Biotechnology(13)
Fixed Rate Bond 15% PIK Tranche A due 6/24/202520,967 20,576 20,967 (11)(15)
Fixed Rate Bond 15% PIK Tranche B due 6/24/202520,512 20,169 20,512 (11)(15)
27,308 Common Shares6,322 6,322 (15)
47,067 47,801 
Amplify Finco Pty Ltd.Movies & Entertainment
First Lien Term Loan, LIBOR+4.25% cash due 11/26/20265.00 %15,376 13,814 14,985 (6)(11)(15)
Second Lien Term Loan, LIBOR+8.00% cash due 11/26/20278.75 %12,500 12,188 12,063 (6)(11)(15)
26,002 27,048 
Ankura Consulting Group LLCResearch & Consulting Services
Second Lien Term Loan, LIBOR+8.00% cash due 3/19/20298.75 %7,466 7,354 7,606 (6)(15)
7,354 7,606 
Apptio, Inc.Application Software
First Lien Term Loan, LIBOR+7.25% cash due 1/10/20258.25 %34,458 33,420 33,922 (6)(15)
First Lien Revolver, LIBOR+7.25% cash due 1/10/20258.25 %892 849 858 (6)(15)(19)
34,269 34,780 
Ardonagh Midco 3 PLCInsurance Brokers
First Lien Term Loan, EURIBOR+7.25% cash due 7/14/20268.25 %1,964 2,179 2,283 (6)(11)(15)
First Lien Term Loan, UK LIBOR+7.25% cash due 7/14/20268.00 %£18,636 23,336 25,329 (6)(11)(15)
First Lien Delayed Draw Term Loan, LIBOR+6.00% cash due 7/14/2026$— — — (6)(11)(15)(19)
First Lien Delayed Draw Term Loan, SONIA+6.00% cash due 7/14/2026£— — — (6)(11)(15)(19)
25,515 27,612 
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Control Investments(8)(9)
C5 Technology Holdings, LLCData Processing & Outsourced Services
829 Common Units$— $— (15)
34,984,460.37 Preferred Units34,984 27,638 (15)
34,984 27,638 
Dominion Diagnostics, LLCHealth Care Services
First Lien Term Loan, LIBOR+5.00% cash due 2/28/20248.68 %$14,333 14,333 14,333 (6)(15)
First Lien Revolver, LIBOR+5.00% cash due 2/28/2024— — — (6)(15)(19)
30,030.8 Common Units in DD Healthcare Services Holdings, LLC15,222 4,946 (15)
29,555 19,279 
OCSI Glick JV LLCMulti-Sector Holdings(14)
Subordinated Debt, LIBOR+4.50% cash due 10/20/20286.30 %59,662 50,194 50,283  (6)(11)(15)(19)
87.5% equity interest— —  (11)(16)(19)
50,194 50,283 
Senior Loan Fund JV I, LLCMulti-Sector Holdings(14)
Subordinated Debt, LIBOR+7.00% cash due 12/29/20288.80 %96,250 96,250 96,250 (6)(11)(15)(19)
87.5% LLC equity interest49,322 20,715 (11)(12)(16)(19)
145,572 116,965 
 Total Control Investments (17.2% of net assets)$260,305 $214,165 
Affiliate Investments(17)
Assembled Brands Capital LLCSpecialized Finance
First Lien Revolver, LIBOR+6.75% cash due 10/17/202310.42 %$24,490 $24,490 $24,225 (6)(15)(19)
1,609,201 Class A Units764 370 (15)
1,019,168.80 Preferred Units, 6%1,019 1,223 (15)
70,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029— — (15)
26,273 25,818 
Caregiver Services, Inc.Health Care Services
1,080,399 shares of Series A Preferred Stock, 10%1,080 378 (15)
1,080 378 
 Total Affiliate Investments (2.1% of net assets)$27,353 $26,196 
Non-Control/Non-Affiliate Investments(18)
109 Montgomery Owner LLCReal Estate Operating Companies
First Lien Term Loan, LIBOR+7.00% cash due 2/2/20239.80 %$389 $387 $727 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+7.00% cash due 2/2/2023— (31)— (6)(15)(19)
356 727 
A.T. Holdings II SÀRLBiotechnology
First Lien Term Loan, 10.50% PIK due 12/22/202233,997 33,960 34,891 (11)(15)
33,960 34,891 
Access CIG, LLCDiversified Support Services
Second Lien Term Loan, LIBOR+7.75% cash due 2/27/202610.82 %20,000 19,927 19,075 (6)
19,927 19,075 
Accupac, Inc.Personal Products
First Lien Term Loan, SOFR+5.50% cash due 1/16/20269.12 %15,976 15,686 15,944 (6)(15)
First Lien Delayed Draw Term Loan, SOFR+5.50% cash due 1/16/2026— — (6)(6)(15)(19)
First Lien Revolver, SOFR+5.50% cash due 1/16/20269.14 %500 462 495 (6)(15)(19)
16,148 16,433 
20

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 20212022
(dollar amounts in thousands)


Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Associated Asphalt Partners, LLCConstruction Materials
First Lien Term Loan, LIBOR+5.25% cash due 4/5/20246.25 %$2,531 $2,245 $2,350 (6)
2,245 2,350 
Athenex, Inc.Pharmaceuticals
First Lien Term Loan, 11.00% cash due 6/19/202642,145 40,475 41,845 (11)(15)
First Lien Delayed Draw Term Loan, 11.00% cash due 6/19/2026— (274)(150)(11)(15)(19)
328,149 Common Stock Warrants (exercise price $12.63) expiration date 6/19/2027973 95 (11)(15)
41,174 41,790 
Aurora Lux Finco S.À.R.L.Airport Services
First Lien Term Loan, LIBOR+6.00% cash due 12/24/20267.00 %22,655 22,232 21,318 (6)(11)(15)
22,232 21,318 
The AveryReal Estate Operating Companies
First Lien Delayed Draw Term Loan in T8 Urban Condo Owner, LLC, LIBOR+7.30% cash due 2/17/20237.55 %20,287 19,933 20,490 (6)(15)(19)
Subordinated Delayed Draw Debt in T8 Senior Mezz LLC, LIBOR+12.50% cash due 2/17/202312.75 %4,692 4,614 4,698 (6)(15)(19)
24,547 25,188 
BAART Programs, Inc.Health Care Services
Second Lien Term Loan, LIBOR+8.50% cash due 6/11/20289.50 %7,166 7,059 7,130 (6)(15)
Second Lien Delayed Draw Term Loan, LIBOR+8.50% cash due 6/11/2028— (52)(18)(6)(15)(19)
7,007 7,112 
Berner Food & Beverage, LLCSoft Drinks
First Lien Term Loan, LIBOR+6.50% cash due 7/30/20277.50 %33,412 32,844 32,844 (6)(15)
First Lien Revolver, LIBOR+6.50% cash due 7/30/20277.50 %619 566 566 (6)(15)(19)
33,410 33,410 
Blackhawk Network Holdings, Inc.Data Processing & Outsourced Services
Second Lien Term Loan, LIBOR+7.00% cash due 6/15/20267.13 %30,625 30,181 30,523 (6)
30,181 30,523 
Blumenthal Temecula, LLCAutomotive Retail
First Lien Term Loan, 9.00% cash due 9/24/20233,979 3,980 3,979 (15)
1,293,324 Preferred Units in Unstoppable Automotive AMV, LLC1,293 1,293 (15)
298,460 Preferred Units in Unstoppable Automotive VMV, LLC298 298 (15)
298,460 Common Units in Unstoppable Automotive AMV, LLC298 298 (15)
99,486 Common Units in Unstoppable Automotive VMV, LLC100 99 (15)
5,969 5,967 
Cadence Aerospace, LLCAerospace & Defense
First Lien Term Loan, LIBOR+6.50% cash 2.00% PIK due 11/14/20237.50 %14,146 12,574 12,992 (6)(15)
12,574 12,992 
Chief Power Finance II, LLCIndependent Power Producers & Energy Traders
First Lien Term Loan, LIBOR+6.50% cash due 12/31/20227.50 %23,850 23,458 23,552 (6)(15)
23,458 23,552 
CircusTrix Holdings, LLCLeisure Facilities
First Lien Term Loan, LIBOR+5.50% cash 2.50% PIK due 7/16/20236.50 %10,686 9,793 8,816 (6)(15)(19)
9,793 8,816 
CITGO Holding, Inc.Oil & Gas Refining & Marketing
First Lien Term Loan, LIBOR+7.00% cash due 8/1/20238.00 %11,635 11,517 11,512 (6)
Fixed Rate Bond, 9.25% cash due 8/1/202410,672 10,672 10,765 
22,189 22,277 
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Acquia Inc.Application Software
First Lien Term Loan, LIBOR+7.00% cash due 10/31/20259.63 %$27,349 $27,038 $27,158 (6)(15)
First Lien Revolver, LIBOR+7.00% cash due 10/31/202510.64 %914 890 898 (6)(15)(19)
27,928 28,056 
ADB Companies, LLCConstruction & Engineering
First Lien Term Loan, SOFR+6.25% cash due 12/18/20259.80 %14,685 14,217 14,431 (6)(15)
14,217 14,431 
ADC Therapeutics SABiotechnology
First Lien Term Loan, SOFR+7.50% cash due 8/15/202911.20 %6,589 6,256 6,262 (6)(11)(15)
First Lien Delayed Draw Term Loan, SOFR+7.50% cash due 8/15/2029— (38)(37)(6)(11)(15)(19)
28,948 Common Stock Warrants (exercise price $8.297) expiration 8/15/2032174 73 (11)(15)
6,392 6,298 
Aden & Anais Merger Sub, Inc.Apparel, Accessories & Luxury Goods
51,645 Common Units in Aden & Anais Holdings, Inc.5,165 — (15)
5,165  
AI Sirona (Luxembourg) Acquisition S.a.r.l.Pharmaceuticals
Second Lien Term Loan, EURIBOR+7.25% cash due 9/28/20267.94 %24,838 27,752 22,143 (6)(11)(15)
27,752 22,143 
AIP RD Buyer Corp.Distributors
Second Lien Term Loan, SOFR+7.75% cash due 12/23/202910.88 %$14,414 14,154 13,910 (6)(15)
14,410 Common Units in RD Holding LP1,352 1,291 (15)
15,506 15,201 
AirStrip Technologies, Inc.Application Software
5,715 Common Stock Warrants (exercise price $139.99) expiration date 5/11/202590 — (15)
90  
All Web Leads, Inc.Advertising
First Lien Term Loan, LIBOR+8.50% PIK due 12/29/202323,338 22,057 22,141 (6)(15)
22,057 22,141 
Altice France S.A.Integrated Telecommunication Services
Fixed Rate Bond, 5.50% cash due 10/15/20294,050 3,518 3,057 (11)
3,518 3,057 
Alvogen Pharma US, Inc.Pharmaceuticals
First Lien Term Loan, SOFR+7.50% cash due 6/30/202511.20 %13,134 12,847 13,068 (6)(15)
12,847 13,068 
Alvotech Holdings S.A.Biotechnology(13)
Tranche A Fixed Rate Bond 10.00% cash due 6/24/202524,043 23,747 23,923 (11)(15)
Tranche B Fixed Rate Bond 10.00% cash due 6/24/202523,522 23,264 23,404 (11)(15)
587,930 Common Shares in Alvotech SA5,308 3,974 (11)
124,780 Seller Earn Out Shares in Alvotech SA485 212 (11)(15)
52,804 51,513 
American Auto Auction Group, LLCConsumer Finance
Second Lien Term Loan, SOFR+8.75% cash due 1/2/202912.30 %14,760 14,492 13,284 (6)(15)
14,492 13,284 
American Tire Distributors, Inc.Distributors
First Lien Term Loan, LIBOR+6.25% cash due 10/20/20289.03 %9,895 9,772 9,293 (6)
9,772 9,293 
Amplify Finco Pty Ltd.Movies & Entertainment
First Lien Term Loan, LIBOR+4.25% cash due 11/26/20267.92 %15,220 13,973 14,687 (6)(11)(15)
Second Lien Term Loan, LIBOR+8.00% cash due 11/26/202711.67 %12,500 12,188 11,958 (6)(11)(15)
26,161 26,645 
21

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 20212022
(dollar amounts in thousands)


Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
CITGO Petroleum Corp.Oil & Gas Refining & Marketing
First Lien Term Loan, LIBOR+6.25% cash due 3/28/20247.25 %$14,221 $13,855 $14,269 (6)
13,855 14,269 
Clear Channel Outdoor Holdings Inc.Advertising
Fixed Rate Bond, 7.50% cash due 6/1/20297,137 7,137 7,431 (11)
7,137 7,431 
Continental Intermodal Group LPOil & Gas Storage & Transportation
First Lien Term Loan, LIBOR+9.50% PIK due 1/28/202538,876 36,668 32,628 (6)(15)
Common Stock Warrants expiration date 7/28/2025648 1,909 (15)
37,316 34,537 
Convergeone Holdings, Inc.IT Consulting & Other Services
First Lien Term Loan, LIBOR+5.00% cash due 1/4/20265.08 %7,024 6,848 7,003 (6)
6,848 7,003 
Conviva Inc.Application Software
517,851 Shares of Series D Preferred Stock605 894 (15)
605 894 
CorEvitas, LLCHealth Care Services
First Lien Term Loan, LIBOR+5.50% cash due 12/13/20256.50 %10,196 10,071 10,109 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 12/13/20256.50 %1,943 1,894 1,912 (6)(15)(19)
First Lien Revolver, PRIME+4.50% cash due 12/13/20257.75 %305 283 290 (6)(15)(19)
1,099 Class A2 Common Units in CorEvitas Holdings, L.P.1,038 1,177 (15)
13,286 13,488 
Coty Inc.Personal Products
First Lien Revolver, LIBOR+1.75% cash due 4/5/2023— (712)(395)(6)(11)(15)(19)
(712)(395)
Coyote Buyer, LLCSpecialty Chemicals
First Lien Term Loan, LIBOR+6.00% cash due 2/6/20267.00 %18,387 17,887 18,225 (6)(15)
First Lien Revolver, LIBOR+6.00% cash due 2/6/2025— (13)(12)(6)(15)(19)
17,874 18,213 
Curium Bidco S.à.r.l.Biotechnology
Second Lien Term Loan, LIBOR+7.75% cash due 10/27/20288.50 %16,787 16,535 17,070 (6)(11)(15)
16,535 17,070 
Delta Topco, Inc.Systems Software
Second Lien Term Loan, LIBOR+7.25% cash due 12/1/20288.00 %6,680 6,647 6,769 (6)
6,647 6,769 
Dialyze Holdings, LLCHealth Care Equipment
First Lien Term Loan, LIBOR+7.00% cash 2.00% PIK due 8/4/20268.00 %24,093 22,439 22,467 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+7.00% cash 2.00% PIK due 8/4/2026— (170)(163)(6)(15)(19)
5,403,823 Class A Warrants (exercise price $1.00) expiration date 8/4/20281,405 1,459 (15)
23,674 23,763 
Digital.AI Software Holdings, Inc.Application Software
First Lien Term Loan, LIBOR+7.00% cash due 2/10/20278.00 %10,003 9,627 9,783 (6)(15)
First Lien Revolver, LIBOR+7.00% cash due 2/10/20278.00 %180 151 156 (6)(15)(19)
9,778 9,939 
DirecTV Financing, LLCCable & Satellite
First Lien Term Loan, LIBOR+5.00% cash due 8/2/20275.75 %27,000 26,730 27,048 (6)
26,730 27,048 
Eagleview Technology CorporationApplication Software
Second Lien Term Loan, LIBOR+7.50% cash due 8/14/20268.50 %8,974 8,884 8,918 (6)(15)
8,884 8,918 
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Anastasia Parent, LLCPersonal Products
First Lien Term Loan, LIBOR+3.75% cash due 8/11/20257.42 %$2,736 $2,260 $2,189 (6)
2,260 2,189 
Ankura Consulting Group LLCResearch & Consulting Services
Second Lien Term Loan, LIBOR+8.00% cash due 3/19/202910.78 %4,346 4,281 3,813 (6)(15)
4,281 3,813 
Apptio, Inc.Application Software
First Lien Term Loan, LIBOR+6.00% cash due 1/10/20258.46 %34,458 33,737 33,738 (6)(15)
First Lien Revolver, LIBOR+6.00% cash due 1/10/20258.46 %892 863 846 (6)(15)(19)
34,600 34,584 
APX Group Inc.Electrical Components & Equipment
Fixed Rate Bond, 5.75% cash due 7/15/20292,075 1,733 1,645 (11)
1,733 1,645 
Ardonagh Midco 3 PLCInsurance Brokers
First Lien Term Loan, EURIBOR+7.00% cash due 7/14/20268.00 %1,964 2,176 1,927 (6)(11)(15)
First Lien Term Loan, SONIA+7.00% cash due 7/14/20269.19 %£18,636 23,139 20,826 (6)(11)(15)
First Lien Term Loan, LIBOR+5.75% cash due 7/14/20268.81 %$10,519 10,357 10,328 (6)(11)(15)
First Lien Delayed Draw Term Loan, SONIA+5.75% cash due 7/14/2026£— (44)— (6)(11)(15)(19)
35,628 33,081 
ASP Unifrax Holdings, Inc.Trading Companies & Distributors
Fixed Rate Bond, 7.50% cash due 9/30/2029$5,500 5,408 3,641 
Fixed Rate Bond, 5.25% cash due 9/30/20282,500 2,220 1,926 
7,628 5,567 
Associated Asphalt Partners, LLCConstruction Materials
First Lien Term Loan, LIBOR+5.25% cash due 4/5/20248.06 %2,501 2,331 1,934 (6)
2,331 1,934 
Astra Acquisition Corp.Application Software
First Lien Term Loan, LIBOR+5.25% cash due 10/25/20288.37 %5,640 5,482 4,822 (6)
5,482 4,822 
athenahealth Group Inc.Health Care Technology
18,635 Shares of Series A Preferred Stock in Minerva Holdco, Inc., 10.75%18,264 16,575 (15)
18,264 16,575 
Athenex, Inc.Pharmaceuticals
First Lien Term Loan, 11.00% cash due 6/19/202613,346 12,929 12,812 (11)(15)
First Lien Revenue Interest Financing Term Loan due 5/31/20318,309 8,264 8,309 (11)(15)
328,149 Common Stock Warrants (exercise price $0.4955 expiration date 6/19/2027973 16 (11)(15)
22,166 21,137 
Aurora Lux Finco S.À.R.L.Airport Services
First Lien Term Loan, LIBOR+6.00% cash due 12/24/20268.78 %22,425 22,086 21,326 (6)(11)(15)
22,086 21,326 
The AveryReal Estate Operating Companies
First Lien Term Loan in T8 Urban Condo Owner, LLC, LIBOR+7.30% cash due 2/17/202310.44 %15,674 15,605 15,682 (6)(15)
Subordinated Debt in T8 Senior Mezz LLC, LIBOR+12.50% cash due 2/17/202316.17 %3,789 3,774 3,800 (6)(15)
19,379 19,482 
BAART Programs, Inc.Health Care Services
First Lien Delayed Draw Term Loan, LIBOR+5.00% cash due 6/11/20278.12 %2,546 2,503 2,395 (6)(15)(19)
Second Lien Term Loan, LIBOR+8.50% cash due 6/11/202811.62 %7,166 7,059 6,915 (6)(15)
Second Lien Delayed Draw Term Loan, LIBOR+8.50% cash due 6/11/202811.62 %4,227 4,070 3,839 (6)(15)(19)
13,632 13,149 
22

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 20212022
(dollar amounts in thousands)


Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
EHR Canada, LLCFood Retail
First Lien Term Loan, LIBOR+8.00% cash due 12/31/20219.00 %$3,750 $3,745 $3,750 (6)(15)
3,745 3,750 
EOS Fitness Opco Holdings, LLCLeisure Facilities
487.5 Class A Preferred Units, 12%488 274 (15)
12,500 Class B Common Units— — (15)
488 274 
Firstlight Holdco, Inc.Alternative Carriers
First Lien Term Loan, LIBOR+3.50% cash due 7/23/20253.58 %7,012 6,578 6,939 (6)
6,578 6,939 
Fortress Biotech, Inc.Biotechnology
First Lien Term Loan, 11.00% cash due 8/27/202511,359 10,722 11,075 (11)(15)
331,200 Common Stock Warrants (exercise price $3.20) expiration date 8/27/2030405 341 (11)(15)
11,127 11,416 
GI Chill Acquisition LLCManaged Health Care
First Lien Term Loan, LIBOR+3.75% cash due 8/6/20253.90 %12,653 12,442 12,621 (6)(15)
Second Lien Term Loan, LIBOR+7.50% cash due 8/6/20267.63 %6,250 6,212 6,219 (6)(15)
18,654 18,840 
GKD Index Partners, LLCSpecialized Finance
First Lien Term Loan, LIBOR+8.50% cash due 6/29/20239.50 %26,360 25,837 25,931 (6)(15)
First Lien Revolver, LIBOR+8.50% cash due 6/29/20239.50 %1,280 1,251 1,252 (6)(15)(19)
27,088 27,183 
Global Medical Response, Inc.Health Care Services
First Lien Term Loan, LIBOR+4.25% cash due 3/14/20255.25 %8,630 8,399 8,674 (6)
8,399 8,674 
Gulf Operating, LLCOil & Gas Storage & Transportation
First Lien Revolver, LIBOR+4.00% cash due 12/27/2021— (704)(75)(6)(15)(19)
(704)(75)
Houghton Mifflin Harcourt Publishers Inc.Education Services
First Lien Term Loan, LIBOR+6.25% cash due 11/22/20247.25 %1,007 981 1,009 (6)(11)
981 1,009 
iCIMs, Inc.Application Software
First Lien Term Loan, LIBOR+6.50% cash due 9/12/20247.50 %25,635 25,024 25,525 (6)(15)
First Lien Revolver, LIBOR+6.50% cash due 9/12/20247.50 %1,176 1,147 1,171 (6)(15)
26,171 26,696 
Immucor, Inc.Health Care Supplies
First Lien Term Loan, LIBOR+5.75% cash due 7/2/20256.75 %8,657 8,425 8,570 (6)(15)
Second Lien Term Loan, LIBOR+8.00% cash 3.50% PIK due 10/2/20259.00 %21,834 21,225 21,616 (6)(15)
29,650 30,186 
Integral Development CorporationOther Diversified Financial Services
1,078,284 Common Stock Warrants (exercise price $0.9274) expiration date 7/10/2024113 — (15)
113  
Inventus Power, Inc.Electrical Components & Equipment
First Lien Term Loan, LIBOR+5.00% cash due 3/29/20246.00 %18,849 18,693 18,708 (6)(15)
Second Lien Term Loan, LIBOR+8.50% cash due 9/29/20249.50 %13,674 13,434 13,434 (6)(15)
32,127 32,142 
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Berner Food & Beverage, LLCSoft Drinks
First Lien Term Loan, LIBOR+5.50% cash due 7/30/20278.31 %$33,078 $32,612 $32,053 (6)(15)
First Lien Revolver, PRIME+4.50% cash due 7/30/202610.75 %1,702 1,660 1,617 (6)(15)(19)
34,272 33,670 
BioXcel Therapeutics, Inc.Pharmaceuticals
First Lien Term Loan, 10.25% cash due 4/19/20275,322 5,111 5,114 (11)(15)
First Lien Delayed Draw Term Loan, 10.25% cash due 4/19/2027— — — (11)(15)(19)
First Lien Revenue Interest Financing Term Loan due 9/30/20322,353 2,353 2,353 (11)(15)
First Lien Revenue Interest Financing Delayed Draw Term Loan due 9/30/2032— — — (11)(15)(19)
21,177 Common Stock Warrants (exercise price $20.04) expiration date 4/19/2029125 98 (11)(15)
7,589 7,565 
Blackhawk Network Holdings, Inc.Data Processing & Outsourced Services
Second Lien Term Loan, LIBOR+7.00% cash due 6/15/20269.50 %30,625 30,276 29,017 (6)
30,276 29,017 
Blumenthal Temecula, LLCAutomotive Retail
First Lien Term Loan, 9.00% cash due 9/24/20233,979 3,980 3,960 (15)
1,293,324 Preferred Units in Unstoppable Automotive AMV, LLC1,293 1,280 (15)
298,460 Preferred Units in Unstoppable Automotive VMV, LLC298 295 (15)
298,460 Common Units in Unstoppable Automotive AMV, LLC298 349 (15)
5,869 5,884 
Cadence Aerospace, LLCAerospace & Defense
First Lien Term Loan, LIBOR+6.50% cash 2.00% PIK due 11/14/20239.31 %14,294 13,471 13,143 (6)(15)
13,471 13,143 
Carvana Co.Automotive Retail
Fixed Rate Bond, 5.625% cash due 10/1/20256,700 5,825 4,724 (11)
5,825 4,724 
CCO Holdings LLCCable & Satellite
Fixed Rate Bond, 4.50% cash due 5/1/20322,097 1,746 1,603 (11)
1,746 1,603 
CircusTrix Holdings, LLCLeisure Facilities
First Lien Term Loan, LIBOR+5.50% cash due 7/16/20238.62 %10,692 10,004 10,209 (6)(15)
10,004 10,209 
CITGO Holding, Inc.Oil & Gas Refining & Marketing
Fixed Rate Bond, 9.25% cash due 8/1/20247,857 7,857 7,807 
7,857 7,807 
CITGO Petroleum Corp.Oil & Gas Refining & Marketing
First Lien Term Loan, LIBOR+6.25% cash due 3/28/20249.37 %795 770 797 (6)
770 797 
Clear Channel Outdoor Holdings Inc.Advertising
Fixed Rate Bond, 7.50% cash due 6/1/20294,311 4,311 3,132 (11)
Fixed Rate Bond, 5.125% cash due 8/15/20271,374 1,229 1,163 (11)
Fixed Rate Bond, 7.75% cash due 4/15/2028676 648 512 (11)
6,188 4,807 
Condor Merger Sub Inc.Systems Software
Fixed Rate Bond, 7.375% cash due 2/15/20308,420 8,243 6,900 
8,243 6,900 
Continental Intermodal Group LPOil & Gas Storage & Transportation
First Lien Term Loan, LIBOR+8.50% cash due 1/28/202511.62 %22,537 21,642 20,396 (6)(15)
Common Stock Warrants expiration date 7/28/2025648 457 (15)
22,290 20,853 
23

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 20212022
(dollar amounts in thousands)


Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
INW Manufacturing, LLCPersonal Products
First Lien Term Loan, LIBOR+5.75% cash due 5/7/20276.50 %$37,031 $35,988 $36,291 (6)(15)
35,988 36,291 
Itafos Inc.Fertilizers & Agricultural Chemicals
First Lien Term Loan, LIBOR+8.25% cash due 8/25/20249.25 %22,506 21,636 21,651 (6)(15)
21,636 21,651 
Ivanti Software, Inc.Application Software
Second Lien Term Loan, LIBOR+8.50% cash due 12/1/20289.50 %17,346 16,864 17,368 (6)(15)
16,864 17,368 
Jazz Acquisition, Inc.Aerospace & Defense
First Lien Term Loan, LIBOR+7.50% cash due 1/29/20278.50 %36,603 35,292 36,531 (6)(15)
35,292 36,531 
Latam Airlines Group S.A.Airlines
First Lien Delayed Draw Term Loan, LIBOR+11.00% PIK due 3/29/202216,239 16,085 16,356 (6)(11)(15)(19)
16,085 16,356 
Lift Brands Holdings, Inc.Leisure Facilities
2,000,000 Class A Common Units in Snap Investments, LLC1,399 — (15)
1,399  
Lightbox Intermediate, L.P.Real Estate Services
First Lien Term Loan, LIBOR+5.00% cash due 5/9/20265.13 %41,432 40,445 41,225 (6)(15)
40,445 41,225 
LogMeIn, Inc.Application Software
First Lien Term Loan, LIBOR+4.75% cash due 8/31/20274.83 %3,970 3,720 3,973 (6)
3,720 3,973 
LTI Holdings, Inc.Electronic Components
Second Lien Term Loan, LIBOR+6.75% cash due 9/6/20266.83 %10,140 10,080 10,127 (6)
10,080 10,127 
Marinus Pharmaceuticals, Inc.Pharmaceuticals
First Lien Term Loan, 11.50% cash due 5/11/20263,441 3,377 3,389 (11)(15)
First Lien Delayed Draw Term Loan, 11.50% cash due 5/11/20266,881 6,755 6,778 (11)(15)(19)
10,132 10,167 
Mayfield Agency Borrower Inc.Property & Casualty Insurance
First Lien Term Loan, LIBOR+4.50% cash due 2/28/20254.58 %9,949 9,884 9,949 (6)
9,884 9,949 
MedAssets Software Intermediate Holdings, Inc.Health Care Technology
Second Lien Term Loan, LIBOR+7.75% cash due 1/29/20298.50 %14,137 13,877 13,960 (6)(15)
13,877 13,960 
MHE Intermediate Holdings, LLCDiversified Support Services
First Lien Term Loan, LIBOR+5.75% cash due 7/21/20276.75 %16,429 16,111 16,100 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+5.75% cash due 7/21/20276.75 %106 84 83 (6)(15)(19)
First Lien Revolver, LIBOR+5.75% cash due 7/21/2027— (27)(28)(6)(15)(19)
16,168 16,155 
Mindbody, Inc.Internet Services & Infrastructure
First Lien Term Loan, LIBOR+7.00% cash 1.50% PIK due 2/14/20258.00 %38,774 37,513 38,038 (6)(15)
First Lien Revolver, LIBOR+8.00% cash due 2/14/2025— (75)(76)(6)(15)(19)
37,438 37,962 
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Convergeone Holdings, Inc.IT Consulting & Other Services
First Lien Term Loan, LIBOR+5.00% cash due 1/4/20268.12 %$11,913 $11,697 $8,596 (6)
11,697 8,596 
Conviva Inc.Application Software
517,851 Shares of Series D Preferred Stock605 894 (15)
605 894 
CorEvitas, LLCHealth Care Technology
First Lien Term Loan, SOFR+5.75% cash due 12/13/20258.88 %13,712 13,554 13,583 (6)(15)
First Lien Revolver, PRIME+4.75% cash due 12/13/202511.00 %916 898 898 (6)(15)(19)
1,099 Class A2 Common Units in CorEvitas Holdings, L.P.690 2,340 (15)
15,142 16,821 
Covetrus, Inc.Health Care Distributors
First Lien Term Loan, SOFR+5.00% cash due 9/20/20297.65 %10,336 9,716 9,681 (6)
9,716 9,681 
Coyote Buyer, LLCSpecialty Chemicals
First Lien Term Loan, LIBOR+6.00% cash due 2/6/20268.81 %18,200 17,790 17,843 (6)(15)
First Lien Revolver, LIBOR+6.00% cash due 2/6/2025— (13)(26)(6)(15)(19)
17,777 17,817 
Delivery Hero FinCo LLCInternet & Direct Marketing Retail
First Lien Term Loan, SOFR+5.75% cash due 8/12/20278.49 %4,988 4,882 4,757 (6)(11)
4,882 4,757 
Delta Leasing SPV II LLCSpecialized Finance
Subordinated Delayed Draw Term Loan, 10.00% cash due 8/31/20294,183 4,183 4,183 (11)(15)(19)
419 Series C Preferred Units in Delta Financial Holdings LLC419 419 (11)(15)
2.09 Common Units in Delta Financial Holdings LLC(11)(15)
31.37 Common Warrants (exercise price $1.00)— — (11)(15)
4,604 4,604 
Delta Topco, Inc.Systems Software
Second Lien Term Loan, LIBOR+7.25% cash due 12/1/20289.34 %6,680 6,647 5,934 (6)
6,647 5,934 
Dialyze Holdings, LLCHealth Care Equipment
First Lien Term Loan, LIBOR+9.00% cash 2.00% PIK due 8/4/202612.67 %24,396 23,083 22,993 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+9.00% cash 2.00% PIK due 8/4/2026— (135)(129)(6)(15)(19)
5,403,823 Class A Warrants (exercise price $1.00) expiration date 8/4/20281,405 1,297 (15)
24,353 24,161 
Digital.AI Software Holdings, Inc.Application Software
First Lien Term Loan, LIBOR+7.00% cash due 2/10/20279.91 %9,902 9,599 9,793 (6)(15)
First Lien Revolver, LIBOR+6.50% cash due 2/10/20279.41 %251 228 239 (6)(15)(19)
9,827 10,032 
DirecTV Financing, LLCCable & Satellite
First Lien Term Loan, LIBOR+5.00% cash due 8/2/20278.12 %19,242 18,970 17,973 (6)
18,970 17,973 
DTI Holdco, Inc.Research & Consulting Services
First Lien Term Loan, SOFR+4.75% cash due 4/26/20297.33 %5,000 4,906 4,760 (6)
4,906 4,760 
Eagleview Technology CorporationApplication Software
Second Lien Term Loan, LIBOR+7.50% cash due 8/14/202611.17 %8,974 8,884 8,503 (6)(15)
8,884 8,503 
24

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 20212022
(dollar amounts in thousands)


Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Ministry Brands, LLCApplication Software
First Lien Revolver, LIBOR+5.00% cash due 12/2/2022$— $(9)$(9)(6)(15)(19)
Second Lien Term Loan, LIBOR+9.25% cash due 6/2/202310.25 %11,000 10,844 10,906 (6)(15)
10,835 10,897 
Mosaic Companies, LLCHome Improvement Retail
First Lien Term Loan, LIBOR+6.75% cash due 7/2/20267.75 %47,388 46,487 46,488 (6)(15)
46,487 46,488 
MRI Software LLCApplication Software
First Lien Term Loan, LIBOR+5.50% cash due 2/10/20266.50 %27,352 26,815 27,335 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 2/10/2026— (25)— (6)(15)(19)
First Lien Revolver, LIBOR+5.50% cash due 2/10/2026— (13)(1)(6)(15)(19)
26,777 27,334 
Navisite, LLCData Processing & Outsourced Services
Second Lien Term Loan, LIBOR+8.50% cash due 12/30/20269.50 %22,560 22,165 22,176 (6)(15)
22,165 22,176 
NeuAG, LLCFertilizers & Agricultural Chemicals
First Lien Term Loan, LIBOR+5.50% cash 7.00% PIK due 9/11/20247.00 %47,031 45,279 45,996 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+5.50% cash 7.00% PIK due 9/11/2024— (202)(120)(6)(15)(19)
45,077 45,876 
NN, Inc.Industrial Machinery
First Lien Term Loan, LIBOR+6.88% cash due 9/19/20267.88 %59,309 57,971 58,419 (6)(11)(15)
57,971 58,419 
OEConnection LLCApplication Software
First Lien Term Loan, LIBOR+4.00% cash due 9/25/20264.08 %3,355 3,152 3,351 (6)
3,152 3,351 
Olaplex, Inc.Personal Products
First Lien Term Loan, LIBOR+6.25% cash due 1/8/20267.25 %52,122 50,906 51,731 (6)(15)
First Lien Revolver, LIBOR+6.25% cash due 1/8/2025— (58)(75)(6)(15)(19)
50,848 51,656 
OmniSYS Acquisition CorporationDiversified Support Services
100,000 Common Units in OSYS Holdings, LLC1,000 729 (15)
1,000 729 
Onvoy, LLCIntegrated Telecommunication Services
First Lien Term Loan, LIBOR+4.50% cash due 2/10/20245.50 %3,601 3,410 3,603 (6)
Second Lien Term Loan, LIBOR+10.50% cash due 2/10/202511.50 %9,277 9,277 9,277 (6)(15)
19,666.67 Class A Units in GTCR Onvoy Holdings, LLC1,967 2,372 (15)
13,664.73 Series 3 Class B Units in GTCR Onvoy Holdings, LLC— — (15)
14,654 15,252 
OTG Management, LLCAirport Services
First Lien Term Loan, LIBOR+10.00% cash due 9/1/202511.00 %19,894 19,504 19,496 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+10.00% cash due 9/1/2025— (37)(38)(6)(15)(19)
19,467 19,458 
P & L Development, LLCPharmaceuticals
Fixed Rate Bond, 7.75% cash due 11/15/20257,776 7,832 8,089 
7,832 8,089 
Park Place Technologies, LLCInternet Services & Infrastructure
First Lien Term Loan, LIBOR+5.00% cash due 11/10/20276.00 %9,950 9,479 9,961 (6)
9,479 9,961 
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
EOS Fitness Opco Holdings, LLCLeisure Facilities
487.5 Class A Preferred Units, 12%$488 $966 (15)
12,500 Class B Common Units— — (15)
488 966 
Establishment Labs Holdings Inc.Health Care Technology
First Lien Term Loan, 3.00% cash 6.00% PIK due 4/21/2027$10,418 10,275 10,231 (11)(15)
First Lien Delayed Draw Term Loan, 3.00% cash 6.00% PIK due 4/21/2027— (11)(15)(19)
10,278 10,231 
Fairbridge Strategic Capital Funding LLCReal Estate Operating Companies(20)
First Lien Delayed Draw Term Loan, 9.00% cash due 12/24/202827,850 27,850 27,850 (15)(19)
2,500 Warrant Units (exercise price $0.01) expiration date 11/24/2031— (11)(15)
27,850 27,853 
FINThrive Software Intermediate Holdings, Inc.Health Care Technology
Second Lien Term Loan, LIBOR+6.75% cash due 12/17/20299.87 %25,061 24,685 21,646 (6)
24,685 21,646 
Fortress Biotech, Inc.Biotechnology
First Lien Term Loan, 11.00% cash due 8/27/20259,466 9,071 9,008 (11)(15)
331,200 Common Stock Warrants (exercise price $3.20) expiration date 8/27/2030405 66 (11)(15)
9,476 9,074 
Frontier Communications Holdings, LLCIntegrated Telecommunication Services
Fixed Rate Bond, 6.00% cash due 1/15/20304,881 4,420 3,845 (11)
4,420 3,845 
GKD Index Partners, LLCSpecialized Finance
First Lien Term Loan, LIBOR+7.00% cash due 6/29/202310.67 %25,128 24,915 24,851 (6)(15)
First Lien Revolver, LIBOR+7.00% cash due 6/29/202310.60 %1,280 1,268 1,262 (6)(15)(19)
26,183 26,113 
Global Medical Response, Inc.Health Care Services
First Lien Term Loan, LIBOR+4.25% cash due 3/14/20257.37 %5,572 5,435 4,848 (6)
5,435 4,848 
Grove Hotel Parcel Owner, LLCHotels, Resorts & Cruise Lines
First Lien Term Loan, SOFR+8.00% cash due 6/21/202711.04 %14,311 14,041 14,060 (6)(15)
First Lien Delayed Draw Term Loan, SOFR+8.00% cash due 6/21/2027— (54)(50)(6)(15)(19)
First Lien Revolver, SOFR+8.00% cash due 6/21/2027— (27)(25)(6)(15)(19)
13,960 13,985 
Harbor Purchaser Inc.Education Services
First Lien Term Loan, SOFR+5.25% cash due 4/9/20298.38 %9,392 9,080 8,582 (6)
9,080 8,582 
iCIMs, Inc.Application Software
First Lien Term Loan, SOFR+6.75% cash due 8/18/20289.49 %19,203 18,874 18,867 (6)(15)
First Lien Delayed Draw Term Loan, SOFR+6.75% cash due 8/18/2028— — — (6)(15)(19)
First Lien Revolver, SOFR+6.75% cash due 8/18/2028— (31)(32)(6)(15)(19)
18,843 18,835 
Immucor, Inc.Health Care Supplies
First Lien Term Loan, LIBOR+5.75% cash due 7/2/20259.42 %8,569 8,401 8,407 (6)(15)
Second Lien Term Loan, LIBOR+8.00% cash 3.50% PIK due 10/2/202511.67 %22,619 22,162 22,275 (6)(15)
30,563 30,682 
25

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 20212022
(dollar amounts in thousands)


Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Performance Health Holdings, Inc.Health Care Distributors
First Lien Term Loan, LIBOR+6.00% cash due 7/12/20277.00 %$20,085 $19,698 $19,683 (6)(15)
19,698 19,683 
Pingora MSR Opportunity Fund I-A, LPThrifts & Mortgage Finance
1.86% limited partnership interest752 112 (11)(16)(19)
752 112 
Planview Parent, Inc.Application Software
Second Lien Term Loan, LIBOR+7.25% cash due 12/18/20288.00 %28,627 28,198 28,699 (6)(15)
28,198 28,699 
PLNTF Holdings, LLCLeisure Facilities
First Lien Term Loan, LIBOR+8.00% cash due 3/22/20269.00 %13,729 13,482 13,798 (6)(15)
13,482 13,798 
Pluralsight, LLCApplication Software
First Lien Term Loan, LIBOR+8.00% cash due 4/6/20279.00 %48,689 47,788 47,763 (6)(15)
First Lien Revolver, LIBOR+8.00% cash due 4/6/2027— (65)(67)(6)(15)(19)
47,723 47,696 
PRGX Global, Inc.Data Processing & Outsourced Services
First Lien Term Loan, LIBOR+6.75% cash due 3/3/20267.75 %34,118 33,016 33,547 (6)(15)
First Lien Revolver, LIBOR+6.75% cash due 3/3/2026— (44)(42)(6)(15)(19)
80,515 Class B Common Units79 81 (15)
33,051 33,586 
ProFrac Services, LLCIndustrial Machinery
First Lien Term Loan, LIBOR+8.50% cash due 9/15/20239.75 %30,910 29,146 30,600 (6)(15)
29,146 30,600 
Project Boost Purchaser, LLCApplication Software
Second Lien Term Loan, LIBOR+8.00% cash due 5/31/20278.08 %5,250 5,151 5,224 (6)(15)
5,151 5,224 
Quantum Bidco LimitedFood Distributors
First Lien Term Loan, UK LIBOR+6.00% cash due 1/29/20286.11 %£3,501 4,625 4,673 (6)(11)
4,625 4,673 
QuorumLabs, Inc.Application Software
64,887,669 Junior-2 Preferred Stock375 — (15)
375  
Relativity ODA LLCApplication Software
First Lien Term Loan, LIBOR+7.50% PIK due 5/12/2027$22,856 22,337 22,376 (6)(15)
First Lien Revolver, LIBOR+6.50% cash due 5/12/2027— (52)(47)(6)(15)(19)
22,285 22,329 
Renaissance Holding Corp.Diversified Banks
Second Lien Term Loan, LIBOR+7.00% cash due 5/29/20267.08 %3,542 3,515 3,562 (6)
3,515 3,562 
RevSpring, Inc.Commercial Printing
First Lien Term Loan, LIBOR+4.25% cash due 10/11/20254.38 %9,725 9,185 9,709 (6)
9,185 9,709 
RumbleOn, Inc.Automotive Retail
First Lien Term Loan, LIBOR+8.25% cash due 8/31/20269.25 %38,036 35,651 35,640 (6)(11)(15)
First Lien Delayed Draw Term Loan, LIBOR+8.25% cash due 8/31/2026— (1,022)(1,027)(6)(11)(15)(19)
164,660 Class B Common Stock Warrants (exercise price $33.00) expiration date 2/28/20231,202 1,553 (15)
35,831 36,166 
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Impel Neuropharma, Inc.Health Care Technology
First Lien Revenue Interest Financing Term Loan due 2/15/2031$13,083 $13,083 $13,083 (15)
First Lien Term Loan, SOFR+8.75% cash due 3/17/202712.45 %12,161 11,944 11,942 (6)(15)
25,027 25,025 
Innocoll Pharmaceuticals LimitedHealth Care Technology
First Lien Term Loan, 11.00% cash due 1/26/20276,817 6,553 6,408 (11)(15)
First Lien Delayed Draw Term Loan, 11.00% cash due 1/26/2027— — — (11)(15)(19)
56,999 Tranche A Warrant Shares (exercise price $4.23) expiration date 1/26/2029135 609 (11)(15)
6,688 7,017 
Integral Development CorporationOther Diversified Financial Services
1,078,284 Common Stock Warrants (exercise price $0.9274) expiration date 7/10/2024113 — (15)
113  
Inventus Power, Inc.Electrical Components & Equipment
First Lien Term Loan, SOFR+5.00% cash due 3/29/20248.55 %18,660 18,567 18,134 (6)(15)
Second Lien Term Loan, LIBOR+8.50% cash due 9/29/202412.17 %13,674 13,514 13,154 (6)(15)
32,081 31,288 
INW Manufacturing, LLCPersonal Products
First Lien Term Loan, LIBOR+5.75% cash due 3/25/20279.42 %35,625 34,806 31,528 (6)(15)
34,806 31,528 
IPC Corp.Application Software
First Lien Term Loan, LIBOR+6.50% cash due 10/1/20269.44 %34,357 33,612 32,639 (6)(15)
33,612 32,639 
Ivanti Software, Inc.Application Software
Second Lien Term Loan, LIBOR+7.25% cash due 12/1/202810.33 %10,247 10,196 7,702 (6)
10,196 7,702 
Jazz Acquisition, Inc.Aerospace & Defense
First Lien Term Loan, LIBOR+7.50% cash due 1/29/202710.62 %36,234 35,170 36,392 (6)(15)
Second Lien Term Loan, LIBOR+8.00% cash due 6/18/202711.12 %528 478 481 (6)
35,648 36,873 
Kings Buyer, LLCEnvironmental & Facilities Services
First Lien Term Loan, LIBOR+6.50% cash due 10/29/202710.17 %13,623 13,487 13,351 (6)(15)
First Lien Revolver, LIBOR+6.50% cash due 10/29/202710.17 %329 311 292 (6)(15)(19)
13,798 13,643 
LaserShip, Inc.Air Freight & Logistics
Second Lien Term Loan, LIBOR+7.50% cash due 5/7/202910.38 %2,394 2,370 1,867 (6)(15)
2,370 1,867 
Lift Brands Holdings, Inc.Leisure Facilities
2,000,000 Class A Common Units in Snap Investments, LLC1,399 — (15)
1,399  
Lightbox Intermediate, L.P.Real Estate Services
First Lien Term Loan, LIBOR+5.00% cash due 5/9/20268.67 %41,008 40,243 39,573 (6)(15)
40,243 39,573 
Liquid Environmental Solutions CorporationEnvironmental & Facilities Services
Second Lien Term Loan, LIBOR+8.50% cash due 11/30/202611.38 %4,357 4,285 4,226 (6)(15)
Second Lien Delayed Draw Term Loan, LIBOR+8.50% cash due 11/30/202611.38 %2,370 2,323 2,265 (6)(15)(19)
450.75 Class A2 Units in LES Group Holdings, L.P.451 451 (15)
7,059 6,942 
26

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 20212022
(dollar amounts in thousands)


Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Sabert CorporationMetal & Glass Containers
First Lien Term Loan, LIBOR+4.50% cash due 12/10/20265.50 %$1,818 $1,711 $1,825 (6)
1,711 1,825 
Scilex Pharmaceuticals Inc.Pharmaceuticals
Fixed Rate Zero Coupon Bond due 8/15/20267,692 6,512 7,169 (15)
6,512 7,169 
ShareThis, Inc.Application Software
345,452 Series C Preferred Stock Warrants (exercise price $3.0395) expiration date 3/4/2024367 — (15)
367  
SIO2 Medical Products, Inc.Metal & Glass Containers
Subordinated Debt, 11.25% cash due 2/28/202215,896 15,161 15,022 (15)
Subordinated Delayed Draw Debt, 11.25% cash due 2/28/2022— (110)(119)(15)(19)
Common Stock Warrants (exercise price $0.75) expiration date 7/31/2028681 685 (15)
15,732 15,588 
Sirva Worldwide, Inc.Diversified Support Services
First Lien Term Loan, LIBOR+5.50% cash due 8/4/20255.58 %1,739 1,554 1,644 (6)
1,554 1,644 
SM Wellness Holdings, Inc.Health Care Services
Second Lien Term Loan, LIBOR+8.00% cash due 4/16/20298.75 %9,109 8,972 9,177 (6)(15)
8,972 9,177 
SonicWall US Holdings Inc.Technology Distributors
Second Lien Term Loan, LIBOR+7.50% cash due 5/18/20267.63 %3,195 3,163 3,178 (6)
3,163 3,178 
Sorrento Therapeutics, Inc.Biotechnology
50,000 Common Stock Units197 382 (11)
197 382 
Star US Bidco LLCIndustrial Machinery
First Lien Term Loan, LIBOR+4.25% cash due 3/17/20275.25 %1,194 1,114 1,199 (6)
1,114 1,199 
SumUp Holdings Luxembourg S.À.R.L.Other Diversified Financial Services
First Lien Delayed Draw Term Loan, EURIBOR+8.50% cash due 3/10/202610.00 %13,980 15,991 15,908 (6)(11)(15)(19)
15,991 15,908 
Sunland Asphalt & Construction, LLCConstruction & Engineering
First Lien Term Loan, LIBOR+6.00% cash due 1/13/20267.00 %$43,052 41,782 42,450 (6)(15)
First Lien Revolver, LIBOR+6.00% cash due 1/13/20227.00 %203 150 169 (6)(15)(19)
41,932 42,619 
Supermoose Borrower, LLCApplication Software
First Lien Term Loan, LIBOR+3.75% cash due 8/29/20253.88 %8,576 7,581 7,996 (6)
7,581 7,996 
SVP-Singer Holdings Inc.Home Furnishings
First Lien Term Loan, LIBOR+6.75% cash due 7/28/20287.50 %20,976 19,537 19,735 (6)(15)
19,537 19,735 
Swordfish Merger Sub LLCAuto Parts & Equipment
Second Lien Term Loan, LIBOR+6.75% cash due 2/2/20267.75 %12,500 12,466 12,365 (6)(15)
12,466 12,365 
Tacala, LLCRestaurants
Second Lien Term Loan, LIBOR+7.50% cash due 2/4/20288.25 %9,448 9,317 9,451 (6)
9,317 9,451 
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
LSL Holdco, LLCHealth Care Distributors
First Lien Term Loan, LIBOR+6.00% cash due 1/31/20289.12 %$19,236 $18,894 $18,707 (6)(15)
First Lien Revolver, LIBOR+6.00% cash due 1/31/20289.12 %1,710 1,672 1,651 (6)(15)(19)
20,566 20,358 
LTI Holdings, Inc.Electronic Components
Second Lien Term Loan, LIBOR+6.75% cash due 9/6/20269.87 %2,140 2,092 1,890 (6)
2,092 1,890 
Marinus Pharmaceuticals, Inc.Pharmaceuticals
First Lien Term Loan, 11.50% cash due 5/11/202617,203 16,954 16,644 (11)(15)
First Lien Delayed Draw Term Loan, 11.50% cash due 5/11/2026— — — (11)(15)(19)
16,954 16,644 
Mesoblast, Inc.Biotechnology
First Lien Term Loan, 8.00% cash 1.75% PIK due 11/19/20267,215 6,650 6,440 (11)(15)
First Lien Delayed Draw Term Loan, 8.00% cash 1.75% PIK due 11/19/2026— — (11)(15)(19)
209,588 Warrant Shares (exercise price $7.26) expiration date 11/19/2028480 170 (11)(15)
7,131 6,610 
MHE Intermediate Holdings, LLCDiversified Support Services
First Lien Term Loan, SOFR+6.00% cash due 7/21/20279.50 %18,390 18,088 17,691 (6)(15)
First Lien Revolver, SOFR+6.00% cash due 7/21/2027— (23)(54)(6)(15)(19)
18,065 17,637 
Mindbody, Inc.Internet Services & Infrastructure
First Lien Term Loan, LIBOR+7.00% cash 1.50% PIK due 2/14/202510.64 %45,665 44,689 44,523 (6)(15)
First Lien Revolver, LIBOR+8.00% cash due 2/14/2025— (54)(100)(6)(15)(19)
44,635 44,423 
Mosaic Companies, LLCHome Improvement Retail
First Lien Term Loan, LIBOR+6.75% cash due 7/2/20269.89 %46,499 45,802 45,421 (6)(15)
45,802 45,421 
MRI Software LLCApplication Software
First Lien Term Loan, LIBOR+5.50% cash due 2/10/20269.17 %29,565 29,128 28,734 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 2/10/2026— (12)(96)(6)(15)(19)
First Lien Revolver, LIBOR+5.50% cash due 2/10/2026— (13)(51)(6)(15)(19)
29,103 28,587 
Navisite, LLCData Processing & Outsourced Services
Second Lien Term Loan, LIBOR+8.50% cash due 12/30/202612.17 %22,560 22,241 21,524 (6)(15)
22,241 21,524 
NeuAG, LLCFertilizers & Agricultural Chemicals
First Lien Term Loan, LIBOR+10.50% cash due 9/11/202414.17 %50,459 49,301 51,972 (6)(15)
49,301 51,972 
NFP Corp.Other Diversified Financial Services
Fixed Rate Bond 6.875% cash due 8/15/202810,191 9,773 7,966 
9,773 7,966 
NN, Inc.Industrial Machinery
First Lien Term Loan, LIBOR+6.88% cash due 9/19/20269.99 %58,713 57,655 56,805 (6)(11)(15)
57,655 56,805 
OEConnection LLCApplication Software
First Lien Term Loan, LIBOR+4.00% cash due 9/25/20267.12 %3,323 3,162 3,207 (6)
Second Lien Term Loan, LIBOR+7.00% cash due 9/25/202710.05 %7,519 7,389 7,237 (6)(15)
10,551 10,444 
27

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 20212022
(dollar amounts in thousands)


Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Tecta America Corp.Construction & Engineering
Second Lien Term Loan, LIBOR+8.50% cash due 4/9/20299.25 %$5,203 $5,125 $5,203 (6)(15)
5,125 5,203 
Telestream Holdings CorporationApplication Software
First Lien Term Loan, LIBOR+8.75% cash due 10/15/20259.75 %18,510 18,017 18,250 (6)(15)
First Lien Revolver, LIBOR+8.75% cash due 10/15/20259.75 %492 464 468 (6)(15)(19)
18,481 18,718 
TerSera Therapeutics LLCPharmaceuticals
Second Lien Term Loan, LIBOR+9.50% cash due 3/30/202610.50 %29,663 29,359 29,371 (6)(15)
668,879 Common Units of TerSera Holdings LLC2,192 3,487 (15)
31,551 32,858 
TGNR HoldCo LLCIntegrated Oil & Gas
Subordinated Debt, 11.50% cash due 5/14/20264,984 4,842 4,884 (11)(15)(20)
4,842 4,884 
Thermacell Repellents, Inc.Leisure Products
First Lien Term Loan, LIBOR+5.75% cash due 12/4/20266.75 %6,636 6,603 6,603 (6)(15)
First Lien Revolver, LIBOR+5.75% cash due 12/4/2026— (4)(4)(6)(15)(19)
6,599 6,599 
Thrasio, LLCInternet & Direct Marketing Retail
First Lien Term Loan, LIBOR+7.00% cash due 12/18/20268.00 %37,876 36,736 37,686 (6)(15)
8,434 Shares of Series C-3 Preferred Stock in Thrasio Holdings, Inc.101 171 (15)
284,650.32 Shares of Series C-2 Preferred Stock in Thrasio Holdings, Inc.2,410 5,764 (15)
23,201 Shares of Series X Preferred Stock in Thrasio Holdings, Inc.22,986 24,803 (15)(19)
62,233 68,424 
TIBCO Software Inc.Application Software
Second Lien Term Loan, LIBOR+7.25% cash due 3/3/20287.34 %16,788 16,681 17,002 (6)
16,681 17,002 
TigerConnect, Inc.Application Software
299,110 Series B Preferred Stock Warrants (exercise price $1.3373) expiration date 12/8/202460 525 (15)
60 525 
Transact Holdings Inc.Application Software
First Lien Term Loan, LIBOR+4.75% cash due 4/30/20264.83 %6,860 6,757 6,809 (6)(15)
6,757 6,809 
Velocity Commercial Capital, LLCThrifts & Mortgage Finance
First Lien Term Loan, LIBOR+8.00% cash due 2/5/20269.00 %15,909 15,327 15,830 (6)(15)
15,327 15,830 
Veritas US Inc.Application Software
First Lien Term Loan, LIBOR+5.00% cash due 9/1/20256.00 %5,940 5,599 5,975 (6)
5,599 5,975 
Vitalyst Holdings, Inc.IT Consulting & Other Services
675 Series A Preferred Stock Units675 440 (15)
7,500 Class A Common Stock Units75 — (15)
750 440 
Win Brands Group LLCHousewares & Specialties
First Lien Term Loan, LIBOR+9.00% cash 5.00% PIK due 1/22/202610.00 %1,894 1,875 1,884 (6)(15)
181 Class F Warrants in Brand Value Growth LLC (exercise price $0.01) expiration date 1/25/2027— 119 (15)
1,875 2,003 
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
OTG Management, LLCAirport Services
First Lien Term Loan, LIBOR+2.00% cash 8.00% PIK due 9/1/20255.08 %$21,557 $21,267 $21,557 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+2.00% cash 8.00% PIK due 9/1/2025— (31)— (6)(15)(19)
21,236 21,557 
P & L Development, LLCPharmaceuticals
Fixed Rate Bond, 7.75% cash due 11/15/20257,776 7,820 5,846 
7,820 5,846 
Park Place Technologies, LLCInternet Services & Infrastructure
First Lien Term Loan, SOFR+5.00% cash due 11/10/20278.13 %9,850 9,460 9,374 (6)
9,460 9,374 
Performance Health Holdings, Inc.Health Care Distributors
First Lien Term Loan, LIBOR+6.00% cash due 7/12/20278.88 %17,976 17,690 17,537 (6)(15)
17,690 17,537 
PFNY Holdings, LLCLeisure Facilities
First Lien Term Loan, LIBOR+7.00% cash due 12/31/20269.28 %26,154 25,712 25,893 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+7.00% cash due 12/31/20269.25 %2,228 2,186 2,203 (6)(15)(19)
First Lien Revolver, LIBOR+7.00% cash due 12/31/2026— (21)(13)(6)(15)(19)
27,877 28,083 
Planview Parent, Inc.Application Software
Second Lien Term Loan, LIBOR+7.25% cash due 12/18/202810.92 %28,627 28,198 27,482 (6)(15)
28,198 27,482 
Pluralsight, LLCApplication Software
First Lien Term Loan, LIBOR+8.00% cash due 4/6/202710.68 %48,689 47,951 47,155 (6)(15)
First Lien Revolver, LIBOR+8.00% cash due 4/6/2027— (53)(111)(6)(15)(19)
47,898 47,044 
PRGX Global, Inc.Data Processing & Outsourced Services
First Lien Term Loan, LIBOR+6.75% cash due 3/3/202610.42 %33,775 32,931 33,116 (6)(15)
First Lien Revolver, LIBOR+6.75% cash due 3/3/2026— (34)(49)(6)(15)(19)
80,515 Class B Common Units79 89 (15)
32,976 33,156 
Profrac Holdings II, LLCIndustrial Machinery
First Lien Term Loan, SOFR+8.50% cash due 3/4/202510.01 %23,275 22,722 22,810 (6)(15)
22,722 22,810 
Project Boost Purchaser, LLCApplication Software
Second Lien Term Loan, LIBOR+8.00% cash due 5/31/202711.12 %5,250 5,168 5,047 (6)(15)
5,168 5,047 
Quantum Bidco LimitedFood Distributors
First Lien Term Loan, SONIA+6.00% cash due 1/29/20288.39 %£3,501 4,646 3,367 (6)(11)(15)
4,646 3,367 
QuorumLabs, Inc.Application Software
64,887,669 Junior-2 Preferred Stock375 — (15)
375  
Radiology Partners Inc.Health Care Distributors
First Lien Term Loan, LIBOR+4.25%cash due 7/9/20257.33 %$3,400 3,202 2,880 (6)
Fixed Rate Bond, 9.25% cash due 2/1/20284,755 4,720 3,109 
7,922 5,989 
Relativity ODA LLCApplication Software
First Lien Term Loan, LIBOR+7.50% PIK due 5/12/202724,692 24,265 24,101 (6)(15)
First Lien Revolver, LIBOR+6.50% cash due 5/12/2027— (43)(64)(6)(15)(19)
24,222 24,037 
Renaissance Holding Corp.Diversified Banks
Second Lien Term Loan, LIBOR+7.00% cash due 5/29/202610.12 %3,542 3,515 3,402 (6)
3,515 3,402 
28

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 20212022
(dollar amounts in thousands)


Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Windstream Services II, LLCIntegrated Telecommunication Services
First Lien Term Loan, LIBOR+6.25% cash due 9/21/20277.25 %$31,598 $30,347 $31,793 (6)
18,032 Shares of Common Stock in Windstream Holdings II, LLC216 363 (15)
109,420 Warrants in Windstream Holdings II, LLC1,842 2,199 (15)
32,405 34,355 
WP CPP Holdings, LLCAerospace & Defense
First Lien Term Loan, LIBOR+3.75% cash due 4/30/20254.75 %4,369 4,005 4,264 (6)
Second Lien Term Loan, LIBOR+7.75% cash due 4/30/20268.75 %16,000 15,758 15,815 (6)(15)
19,763 20,079 
WPEngine, Inc.Application Software
First Lien Term Loan, LIBOR+6.50% cash due 3/27/20267.50 %40,536 39,778 40,013 (6)(15)
39,778 40,013 
WWEX Uni Topco Holdings, LLCAir Freight & Logistics
Second Lien Term Loan, LIBOR+7.00% cash due 7/26/20297.75 %5,000 4,925 4,981 (6)
4,925 4,981 
Zep Inc.Specialty Chemicals
First Lien Term Loan, LIBOR+4.00% cash due 8/12/20245.00 %6,495 6,165 6,353 (6)
Second Lien Term Loan, LIBOR+8.25% cash due 8/11/20259.25 %22,748 22,692 21,993 (6)(15)
28,857 28,346 
Zephyr Bidco LimitedSpecialized Finance
Second Lien Term Loan, UK LIBOR+7.50% cash due 7/23/20267.55 %£18,000 23,783 24,210 (6)(11)
23,783 24,210 
Total Non-Control/Non-Affiliate Investments (172.7% of net assets)$2,236,759 $2,267,575 
Total Portfolio Investments (194.7% of net assets)$2,539,121 $2,556,629 
Cash and Cash Equivalents and Restricted Cash
JP Morgan Prime Money Market Fund, Institutional Shares $23,600 $23,600 
Other cash accounts8,035 8,035 
Total Cash and Cash Equivalents and Restricted Cash (2.4% of net assets)$31,635 $31,635 
Total Portfolio Investments and Cash and Cash Equivalents and Restricted Cash (197.2% of net assets)$2,570,756 $2,588,264 

Derivative InstrumentNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateCounterpartyCumulative Unrealized Appreciation /(Depreciation)
Foreign currency forward contract$52,186 £37,709 11/12/2021JPMorgan Chase Bank, N.A.$1,339 
Foreign currency forward contract$46,663 39,736 11/12/2021JPMorgan Chase Bank, N.A.573 
$1,912 

Derivative InstrumentCompany ReceivesCompany PaysCounterpartyMaturity DateNotional AmountFair Value
Interest rate swapFixed 2.7%Floating 3-month LIBOR +1.658%Royal Bank of Canada1/15/2027$350,000$(2,108)
Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
RP Escrow Issuer LLCHealth Care Distributors
Fixed Rate Bond, 5.25% cash due 12/15/2025$1,325 $1,218 $1,097 
1,218 1,097 
RumbleOn, Inc.Automotive Retail
First Lien Term Loan, LIBOR+8.25% cash due 8/31/202611.92 %37,656 35,775 36,187 (6)(11)(15)
First Lien Delayed Draw Term Loan, LIBOR+8.25% cash due 8/31/202611.92 %11,393 10,583 10,760 (6)(11)(15)(19)
164,660 Class B Common Stock Warrants (exercise price $33.00) expiration date 2/28/20231,202 74 (11)(15)
47,560 47,021 
Sabert CorporationMetal & Glass Containers
First Lien Term Loan, LIBOR+4.50% cash due 12/10/20267.63 %1,691 1,610 1,623 (6)
1,610 1,623 
ShareThis, Inc.Application Software
345,452 Series C Preferred Stock Warrants (exercise price $3.0395) expiration date 3/4/2024367 — (15)
367  
SiO2 Medical Products, Inc.Metal & Glass Containers
First Lien Term Loan, 5.50% cash 8.50% PIK due 12/21/202646,121 45,413 45,295 (15)
415.34 Common Stock Warrants (exercise price $4,920.75) expiration date 7/31/2028681 681 (15)
46,094 45,976 
SM Wellness Holdings, Inc.Health Care Services
Second Lien Term Loan, LIBOR+8.00% cash due 4/16/202910.74 %9,109 8,972 8,289 (6)(15)
8,972 8,289 
SonicWall US Holdings Inc.Technology Distributors
Second Lien Term Loan, LIBOR+7.50% cash due 5/18/202610.48 %3,195 3,163 2,997 (6)(15)
3,163 2,997 
Sorrento Therapeutics, Inc.Biotechnology
50,000 Common Stock Units197 79 (11)
197 79 
Spanx, LLCApparel Retail
First Lien Term Loan, LIBOR+5.25% cash due 11/20/20288.30 %4,534 4,455 4,427 (6)(15)
First Lien Revolver, LIBOR+5.25% cash due 11/18/20278.03 %866 813 796 (6)(15)(19)
5,268 5,223 
SPX Flow, Inc.Industrial Machinery
First Lien Term Loan, SOFR+4.50% cash due 4/5/20297.63 %1,500 1,410 1,393 (6)
1,410 1,393 
SumUp Holdings Luxembourg S.À.R.L.Other Diversified Financial Services
First Lien Term Loan, EURIBOR+8.50% cash due 3/10/202610.00 %16,911 19,414 16,360 (6)(11)(15)
19,414 16,360 
Sunland Asphalt & Construction, LLCConstruction & Engineering
First Lien Term Loan, LIBOR+6.00% cash due 1/13/20268.88 %$42,618 41,654 41,723 (6)(15)
41,654 41,723 
Supermoose Borrower, LLCApplication Software
First Lien Term Loan, LIBOR+3.75% cash due 8/29/20257.42 %3,466 3,141 3,056 (6)
3,141 3,056 
SVP-Singer Holdings Inc.Home Furnishings
First Lien Term Loan, LIBOR+6.75% cash due 7/28/202810.42 %20,766 19,550 18,188 (6)(15)
19,550 18,188 
Swordfish Merger Sub LLCAuto Parts & Equipment
Second Lien Term Loan, LIBOR+6.75% cash due 2/2/20269.81 %12,500 12,474 11,469 (6)(15)
12,474 11,469 
29

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 20212022
(dollar amounts in thousands)


Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Tacala, LLCRestaurants
Second Lien Term Loan, LIBOR+7.50% cash due 2/4/202810.62 %$9,448 $9,338 $8,692 (6)
9,338 8,692 
Tahoe Bidco B.V.Application Software
First Lien Term Loan, LIBOR+6.00% cash due 9/29/20288.68 %23,215 22,815 22,843 (6)(11)(15)
First Lien Revolver, LIBOR+6.00% cash due 10/1/2027— (29)(28)(6)(11)(15)(19)
22,786 22,815 
Tecta America Corp.Construction & Engineering
Second Lien Term Loan, LIBOR+8.50% cash due 4/9/202911.62 %5,203 5,125 5,034 (6)(15)
5,125 5,034 
Telestream Holdings CorporationApplication Software
First Lien Term Loan, SOFR+9.25% cash due 10/15/202512.11 %18,323 17,956 17,865 (6)(15)
First Lien Revolver, SOFR+9.25% cash due 10/15/202512.20 %1,231 1,210 1,187 (6)(15)(19)
19,166 19,052 
TerSera Therapeutics LLCPharmaceuticals
Second Lien Term Loan, LIBOR+9.50% cash due 3/30/202613.17 %29,663 29,352 29,031 (6)(15)
668,879 Common Units of TerSera Holdings LLC2,028 4,077 (15)
31,380 33,108 
TGNR HoldCo LLCIntegrated Oil & Gas
Subordinated Debt, 11.50% cash due 5/14/20264,984 4,866 4,872 (10)(11)(15)
4,866 4,872 
Thrasio, LLCInternet & Direct Marketing Retail
First Lien Term Loan, LIBOR+7.00% cash due 12/18/202611.17 %37,494 36,569 35,807 (6)(15)
8,434 Shares of Series C-3 Preferred Stock in Thrasio Holdings, Inc.101 69 (15)
284,650.32 Shares of Series C-2 Preferred Stock in Thrasio Holdings, Inc.2,409 2,320 (15)
48,352 Shares of Series D Preferred Stock in Thrasio Holdings, Inc.979 979 (15)
23,201 Shares of Series X Preferred Stock in Thrasio Holdings, Inc.22,986 26,487 (15)(19)
63,044 65,662 
TIBCO Software Inc.Application Software
First Lien Term Loan, SOFR+4.50% cash due 3/20/20298.15 %12,032 10,949 10,827 (6)
10,949 10,827 
Touchstone Acquisition, Inc.Health Care Supplies
First Lien Term Loan, LIBOR+6.00% cash due 12/29/20289.12 %6,016 5,908 5,895 (6)(15)
5,908 5,895 
Uniti Group LPSpecialized REITs
Fixed Rate Bond, 6.50% cash due 2/15/20294,500 4,060 3,026 (11)
Fixed Rate Bond, 4.75% cash due 4/15/2028300 258 238 (11)
4,318 3,264 
Win Brands Group LLCHousewares & Specialties
First Lien Term Loan, LIBOR+15.00% cash due 1/22/202619.64 %2,316 2,293 2,264 (6)(15)
3,621 Class F Warrants in Brand Value Growth LLC (exercise price $0.01) expiration date 1/25/2027— 192 (15)
2,293 2,456 
30

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 2022
(dollar amounts in thousands)

Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Windstream Services II, LLCIntegrated Telecommunication Services
First Lien Term Loan, LIBOR+6.25% cash due 9/21/20279.37 %$25,499 $24,632 $23,204 (6)
18,032 Shares of Common Stock in Windstream Holdings II, LLC216 296 (15)
109,420 Warrants in Windstream Holdings II, LLC1,842 1,799 (15)
26,690 25,299 
WP CPP Holdings, LLCAerospace & Defense
First Lien Term Loan, LIBOR+3.75% cash due 4/30/20256.56 %7,564 6,989 6,795 (6)
Second Lien Term Loan, LIBOR+7.75% cash due 4/30/202610.56 %6,000 5,855 5,070 (6)(15)
12,844 11,865 
WPEngine, Inc.Application Software
First Lien Term Loan, LIBOR+6.00% cash due 3/27/202610.19 %40,536 39,947 40,131 (6)(15)
39,947 40,131 
WWEX Uni Topco Holdings, LLCAir Freight & Logistics
Second Lien Term Loan, LIBOR+7.00% cash due 7/26/202910.67 %5,000 4,925 4,538 (6)(15)
4,925 4,538 
Zayo Group Holdings, Inc.Alternative Carriers
Fixed Rate Bond, 4.00% cash due 3/1/2027250 212 201 
212 201 
Zep Inc.Specialty Chemicals
Second Lien Term Loan, LIBOR+8.25% cash due 8/11/202511.92 %19,578 19,542 16,152 (6)(15)
19,542 16,152 
Zephyr Bidco LimitedSpecialized Finance
Second Lien Term Loan, SONIA+7.50% cash due 7/23/20269.72 %£18,000 23,804 16,552 (6)(11)(15)
23,804 16,552 
Total Non-Control/Non-Affiliate Investments (180.9% of net assets)$2,330,096 $2,253,750 
Total Portfolio Investments (200.2% of net assets)$2,617,754 $2,494,111 
Cash and Cash Equivalents and Restricted Cash
JP Morgan Prime Money Market Fund, Institutional Shares $5,261 $5,261 
Other cash accounts21,103 21,103 
Total Cash and Cash Equivalents and Restricted Cash (2.1% of net assets)$26,364 $26,364 
Total Portfolio Investments and Cash and Cash Equivalents and Restricted Cash (202.4% of net assets)$2,644,118 $2,520,475 

Derivative InstrumentNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateCounterpartyCumulative Unrealized Appreciation /(Depreciation)
Foreign currency forward contract$43,179 41,444 11/10/2022JPMorgan Chase Bank, N.A.$2,466 
Foreign currency forward contract$45,692 £37,033 11/10/2022JPMorgan Chase Bank, N.A.4,323 
$6,789 

Derivative InstrumentCompany ReceivesCompany PaysCounterpartyMaturity DateNotional AmountFair Value
Interest rate swapFixed 2.7%Floating 3-month LIBOR +1.658%Royal Bank of Canada1/15/2027$350,000$(41,969)

31

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 2022
(dollar amounts in thousands)

(1)All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.
(2)See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.
(3)Equity ownership may be held in shares or units of companies related to the portfolio companies.
(4)Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
(5)Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.
(6)The interest rate on the principal balance outstanding for allmost of the floating rate loans is indexed to LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to SOFR or SONIA. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over LIBOR or the alternate basereference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2021,2022, the reference rates for the Company's variable rate loans were the 30-day LIBOR at 0.08%, the 60-day LIBOR at 0.11%3.12%, the 90-day LIBOR at 0.13%3.67%, the 180-day LIBOR at 0.16%4.17%, the 360-day LIBOR at 0.24%4.78%, the PRIME at 3.25%6.25%, the 30-day UK LIBORSOFR at 0.05%3.03%, the 180-day UK LIBOR90-day SOFR at 0.09%3.55%, the SONIA at 1.69%, the 30-day EURIBOR at (0.57)%0.69%, the 90-day EURIBOR at (0.56)%0.99% and the 180-day EURIBOR at (0.53)%0.38%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
(7)Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
(8)Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
(9)As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the Company's annual report on Form 10-K foraccompanying notes to the year ended September 30, 2021Consolidated Financial Statements for transactions during the year ended September 30, 20212022 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
(10)First Star Speir Aviation 1 Limited isThis investment represents a wholly-owned holding company formed by the Company in order to facilitate its investment strategy. In accordance with ASU 2013-08, the Company has deemed the holding company to be an investment company under GAAP and therefore deemed it appropriate to consolidate the financial results and financial position of the holding company and to recognize dividend income versus a combination ofparticipation interest income and dividend income. Accordingly, the debt and equity investments in the wholly-owned holding company are disregarded for accounting purposes since the economic substance of these instruments are equity investments in the operating entities.underlying securities shown.
(11)Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2021,2022, qualifying assets represented 75.7% of the Company's total assets and non-qualifying assets represented 24.3% of the Company's total assets.
(12)Income producing through payment of dividends or distributions.
(13)PIK interest income for this investment accrues at an annualized rate of 15%, however, the PIK interest is not contractually capitalized on the investment subsequent to a restructure that occurred during the year ended September 30, 2021. As a result, the principal amountOne half of the investment does not increase overSeller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech SA common share price is at or above a VWAP of $15.00 per share for accumulated PIK interest. As of September 30, 2021, the accumulated PIK interest balance for the A notesany ten trading days within any twenty trading day period, and the B notes was $0.9 million and $0.8 million, respectively.other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.
(14)See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.
(15)As of September 30, 2021,2022, these investments were categorized as Level 3 within the fair value hierarchy established by FASB guidance under ASC 820.
(16)This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.
(17)Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.
(18)Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.
(19)Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
(20)This investment represents a participation interest inwas renamed during the underlying securities shown.three months ended March 31, 2022. For periods prior to March 31, 2022, this investment was referenced as Realfi Strategic Capital Funding LLC.

See notes to Consolidated Financial Statements.


3032

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








Note 1. Organization
Oaktree Specialty Lending Corporation (together with its consolidated subsidiaries, the "Company") is a specialty finance company that looks to provide customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The Company was formed in late 2007 and operates as a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a Business Development Company under the Investment Company Act. The Company has qualified and elected to be treated as a regulated investment company ("RIC") under the Internal Revenue Code of 1986, as amended (the "Code"), for U.S. federal income tax purposes.
The Company's investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. The Company may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions.
The Company is externally managed by Oaktree Fund Advisors, LLC ("Oaktree"), a subsidiary of Oaktree Capital Group, LLC (“OCG”), pursuant to an investment advisory agreement between the Company and Oaktree (as amended and restated, the "Investment Advisory Agreement"). Oaktree is an affiliate of Oaktree Capital Management, L.P. ("OCM"), the Company's external investment adviser from October 17, 2017 through May 3, 2020 and also a subsidiary of OCG.2020. Oaktree Fund Administration, LLC ("Oaktree Administrator"), a subsidiary of OCM, provides certain administrative and other services necessary for the Company to operate pursuant to an administration agreement between the Company and Oaktree Administrator (the "Administration Agreement"). See Note 10. In 2019, Brookfield Corporation (f/k/a Brookfield Asset Management Inc.) ("Brookfield") acquired a majority economic interest in OCG. OCG operatesOaktree Capital Group, LLC. Oaktree and its affiliates operate as an independent business within Brookfield, with itstheir own product offerings and investment, marketing and support teams.
On March 19, 2021, the Company acquired Oaktree Strategic Income Corporation (“OCSI”), pursuant to that certain Agreement and Plan of Merger (the “Merger“OCSI Merger Agreement”), dated as of October 28, 2020, by and among OCSI, the Company, Lion Merger Sub, Inc., a wholly-owned subsidiary of the Company, (“Merger Sub”), and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OCSI Merger Agreement, Merger Sub was first merged with and into OCSI, with OCSI as the surviving corporation (the “Merger”), and, immediately following the Merger, OCSI was then merged with and into the Company in a two-step transaction, with the Company as the surviving company (together(the "OCSI Merger”).
On January 23, 2023, the Company acquired Oaktree Strategic Income II, Inc. (“OSI2”) pursuant to that certain Agreement and Plan of Merger (the “OSI2 Merger Agreement”), dated as of September 14, 2022, by and among OSI2, the Company, Project Superior Merger Sub, Inc., a wholly-owned subsidiary of the Company, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OSI2 Merger Agreement, OSI2 was merged with and into the Company in a two-step transaction with the Merger,Company as the “Mergers”surviving company (the “OSI2 Merger”). In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of OCSI’s common stock was converted into the right to receive 1.3371 shares of the Company’s common stock (with OCSI’s stockholders receiving cash in lieu of fractional shares of the Company’s common stock). As a result of the Mergers, the Company issued an aggregate of 39,400,011 shares of its common stock to former OCSI stockholders.See Note 14.


Note 2. Significant Accounting Policies
Basis of Presentation:
The Consolidated Financial Statements of the Company have been prepared in accordance with GAAP and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments of a normal recurring nature considered necessary for the fair presentation of the Consolidated Financial Statements have been made. All intercompany balances and transactions have been eliminated. The Company is an investment company following the accounting and reporting guidance in ASC Topic 946, Financial Services - Investment Companies ("ASC 946").
Certain prior period amounts have been reclassified to conform to the current period presentation. All per share amounts and common shares outstanding as of and for the three months ended December 31, 2022 and all prior periods reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
Use of Estimates:
The preparation of the financial statements in conformity with GAAPaccounting principles generally accepted in the United States ("GAAP") requires management to make certain estimates and assumptions affecting amounts reported in the financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition.
33

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Consolidation:
The accompanying Consolidated Financial Statements include the accounts of Oaktree Specialty Lending Corporation and its consolidated subsidiaries. Each consolidated subsidiary is wholly-owned and, as such, consolidated into the Consolidated Financial Statements. Certain subsidiaries that hold investments are treated as pass through entities for U.S. federal income tax purposes. The assets of certain of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of Oaktree Specialty Lending Corporation or any of its other subsidiaries.
31

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




As an investment company, portfolio investments held by the Company are not consolidated into the Consolidated Financial Statements but rather are included on the Statements of Assets and Liabilities as investments at fair value.


Fair Value Measurements:
The Company values its investments in accordance with ASC 820, which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments' complexity.
Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows:
 
Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date.
Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities.
Level 3 — Unobservable inputs that reflect management'sOaktree's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.
If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. The Company'sOaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions.
Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company's investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations.
The CompanyOaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If the CompanyOaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within the Company'sOaktree's set threshold, the CompanyOaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, the CompanyOaktree does not adjust any of the prices received from these sources.
If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, the CompanyOaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value ("EV") of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of
34

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that the Company is deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its
32

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company's assets and (vii) offers from third parties to buy the portfolio company. The CompanyOaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and the CompanyOaktree considers the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, the CompanyOaktree depends on primary market data, including newly funded transactions and industry specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable.
In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable.
The CompanyOaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk free rate. Changes in the subjective input assumptions can materially affect the fair value estimates.
Rule 2a-5 under the Investment Company Act permits boards of directors of registered investment companies and Business Development Companies to either (i) choose to determine fair value in good faith or (ii) designate a valuation designee tasked with determining fair value in good faith, subject to the board’s oversight. The Company's Board of Directors has designated Oaktree to serve as its valuation designee effective September 8, 2022.
Oaktree undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company's investments:
The quarterly valuation process begins with each portfolio company or investment being initially valued by Oaktree's valuation team in conjunction with Oaktree's portfolio management team and investment professionals responsible for each portfolio investment;team;
Preliminary valuations are then reviewed and discussed with management of Oaktree;
Separately, independent valuation firms engaged by the Board of Directors prepare valuations of the Company's investments, on a selected basis, for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment, and submit the reports to the Company and provide such reports to Oaktree and the Audit Committee of the Board of Directors;Oaktree;
Oaktree compares and contrasts its preliminary valuations to the valuations of the independent valuation firms and prepares a valuation report for the Audit Committee;
The Audit Committee reviews the preliminary valuationsvaluation report with Oaktree, and Oaktree responds and supplements the preliminary valuationsvaluation report to reflect any discussions between Oaktree and the Audit Committee; and
The Audit Committee makes a recommendation to the full Board of Directors regarding the fair value of the investments in the Company's portfolio; and
The Board of Directors discusses valuations andOaktree, as valuation designee, determines the fair value of each investment in the Company's portfolio.
The fair value of the Company's investments as of December 31, 20212022 and September 30, 20212022 was determined in good faith by Oaktree, as the Board of Directors.Company's valuation designee. The Board of DirectorsCompany has and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of the Company'sits portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter, and the Board of Directors may reasonably rely on that assistance. However, the Board of Directors is responsible for the ultimate valuation of the portfolio investments at fair value as determined in good faith pursuant to the Company's valuation policy and a consistently applied valuation process.quarter.
Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.
35

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




With the exception of the line items entitled "deferred financing costs," "deferred offering costs," "other assets," "deferred tax asset, net," "credit facilities payable" and "unsecured notes payable," which are reported at amortized cost, all assets and liabilities approximate fair value on the Consolidated Statements of Assets and Liabilities. The carrying value of the line items titled "interest, dividends and fees receivable," "due from portfolio companies," "receivables from unsettled transactions," "due
33

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




from broker," "accounts payable, accrued expenses and other liabilities," "base management fee and incentive fee payable," "due to affiliate," "interest payable," "director fees payable" and "payables from unsettled transactions" approximate fair value due to their short maturities.
Foreign Currency Translation:
The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company.
Derivative Instruments:
Foreign Currency Forward Contracts
The Company uses foreign currency forward contracts to reduce the Company's exposure to fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. Foreign currency forward contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts areis recorded within derivative assets or derivative liabilities on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting with respect to foreign currency forward contracts and as such, the Company recognizes its foreign currency forward contracts at fair value with changes included in the net unrealized appreciation (depreciation) on the Consolidated Statements of Operations.
Interest Rate Swaps
The Company uses an interest rate swap to hedge some of the Company's fixed rate debt. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship, and therefore the periodic payments are recognized as components of interest expense in the Consolidated Statements of Operations. Depending on the nature of the balance at period end, the fair value of the interest rate swap is either included as a derivative asset or derivative liability on the Company's Consolidated Statements of Assets and Liabilities. The change in fair value of the interest rate swap is offset by a change in the carrying value of the fixed rate debt. Any amounts paid to the counterparty to cover collateral obligations under the terms of the interest rate swap agreement are included in due from broker on the Company's Consolidated Statements of Assets and Liabilities.
Investment Income:
Interest Income
Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash and the portfolio
36

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of each of December 31, 20212022 and September 30, 2021,2022, there were no investments on non-accrual status.
In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan.
34

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




PIK Interest Income
The Company's investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost bases of these investments in the Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by the Company to Oaktree. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s stockholders, even though the Company has not yet collected the cash and may never do so.
Fee Income
Oaktree or its affiliates may provide financial advisory services to portfolio companies and, in return, the Company may receive fees for capital structuring services. These fees are generally non-recurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered.
The Company has also structured exit fees across certain of its portfolio investments to be received upon the future exit of those investments. These fees are typically paid to the Company upon the earliest to occur of (i) a sale of the borrower or substantially all of the assets of the borrower, (ii) the maturity date of the loan or (iii) the date when full prepayment of the loan occurs. The receipt of such fees is contingent upon the occurrence of one of the events listed above for each of the investments. These fees are included in net investment income over the life of the loan.
Dividend Income
The Company generally recognizes dividend income on the ex-dividend date for public securities and the record date for private equity investments. Distributions received from private equity investments are evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from private equity investments as dividend income unless there are sufficient earnings at the portfolio company prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment.
Cash and Cash Equivalents and Restricted Cash:
Cash and cash equivalents consist of demand deposits and highly liquid investments with maturities of three months or less when acquired. The Company places its cash and cash equivalents and restricted cash with financial institutions and, at times, cash held in bank accounts may exceed the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets.
37

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




As of each of December 31, 20212022 and September 30, 2021,2022, included in restricted cash was $2.3$1.9 million and $2.8 million, respectively, that was held at Wells Fargo Bank, N.A. in connection with the Citibank Facility (as defined in Note 6. Borrowings). Pursuant to the terms of the Citibank Facility, the Company was restricted in terms of access to $2.3$1.9 million and $2.8 million as of December 31, 2022 and September 30, 2022, respectively, until the occurrence of the periodic distribution dates and, in connection therewith, the Company’s submission of its required periodic reporting schedules and verifications of the Company’s compliance with the terms of the Citibank Facility.
35

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Due from Portfolio Companies:
Due from portfolio companies consists of amounts payable to the Company from its portfolio companies, including proceeds from the sale of portfolio companies not yet received or being held in escrow and excluding those amounts attributable to interest, dividends or fees receivable. These amounts are recognized as they become payable to the Company (e.g., principal payments on the scheduled amortization payment date).
Receivables/Payables from Unsettled Transactions:
Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date.
Deferred Financing Costs:
Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities and debt offerings. Deferred financing costs in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Company's Consolidated Statements of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense. For extinguishments of the Company’s unsecured notes payable, any unamortized deferred financing costs are deducted from the carrying amount of the debt in determining the gain or loss from the extinguishment.


Deferred Offering Costs:
Legal fees and other costs incurred in connection with the Company’s shelf registration statement are capitalized as deferred offering costs in the Consolidated Statements of Assets and Liabilities. To the extent any such costs relate to equity offerings, these costs are charged as a reduction of capital upon utilization. To the extent any such costs relate to debt offerings, these costs are treated as deferred financing costs and are amortized over the term of the respective debt arrangement. Any deferred offering costs that remain at the expiration of the shelf registration statement or when it becomes probable that an offering will not be completed are expensed.
Income Taxes:
The Company has elected to be subject to tax as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to be subject to tax as a RIC, among other things, the Company is required to meet certain source of income and asset diversification requirements and timely distribute dividends to its stockholders of an amount generally at least equal to 90% of investment company taxable income, as defined by the Code and determined without regard to any deduction for dividends paid, for each taxable year. As a RIC, the Company is not subject to U.S. federal income tax on the portion of its taxable income and gains distributed currently to stockholders as a dividend. Depending on the level of taxable income earned during a taxable year, the Company may choose to retain taxable income in excess of current year dividend distributions and would distribute such taxable income in the next taxable year. The Company would then incur a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income, determined on a calendar year basis, could exceed estimated current calendar year dividend distributions, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. The Company anticipates timely distribution of its taxable income within the tax rules under Subchapter M of the Code. The Company did not incur a U.S. federal excise tax for calendar years 2020 and 2021 andyear 2021. For the calendar year 2022, the Company incurred $0.1 million of excise tax. The Company does not expect to incur a U.S. federal excise tax for calendar year 2022.2023.
The Company holds certain portfolio investments through taxable subsidiaries. The purpose of the Company's taxable subsidiaries is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiaries are consolidated for financial reporting purposes, and portfolio investments held by them are included in the Company’s Consolidated Financial
38

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Statements as portfolio investments and recorded at fair value. The taxable subsidiaries are not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statements of Operations. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to
36

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences.
FASB ASC Topic 740, Accounting for Uncertainty in Income Taxes ("ASC 740"), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the Company's Consolidated Financial Statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Management's determinations regarding ASC 740 may be subject to review and adjustment at a later date based upon factors including an ongoing analysis of tax laws, regulations and interpretations thereof. The Company recognizes the tax benefits of uncertain tax positions only where the position is "more-likely-than-not" to be sustained assuming examination by tax authorities. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax years 2018, 2019, 2020 and 2020.2021. The Company identifies its major tax jurisdictions as U.S. Federal and California, and the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially in the next 12 months.
Recently Adopted Accounting Pronouncements
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting if certain criteria are met. The guidance is effective from March 12, 2020 through December 31, 2022. As of December 31, 2022, the adoption of this guidance did not have an impact on the Company's Consolidated Financial Statements.
Note 3. Portfolio Investments
As of December 31, 2021, 195.4%2022, 219.9%of net assets at fair value, or $2.6 billion, was invested in 140156 portfolio companies, including (i) $134.7$136.8 million in subordinated notes and limited liability company ("LLC") equity interests of Senior Loan Fund JV I, LLC ("SLF JV I"), a joint venture through which the Company and Trinity Universal Insurance Company, a subsidiary of Kemper Corporation ("Kemper"), co-invest in senior secured loans of middle-market companies and other corporate debt securities and (ii) $55.9$49.5 million in subordinated notes and LLC equity interests of OCSI Glick JV LLC ("Glick JV" and, together with SLF JV I, the "JVs"), a joint venture through which the Company and GF Equity Funding 2014 LLC ("GF Equity Funding") co-invest primarily in senior secured loans of middle-market companies. As of December 31, 2021, 3.5%2022, 1.6% of net assets at fair value, or $46.1$19.2 million, was invested in cash and cash equivalents (including $2.3$1.9 million of restricted cash). In comparison, as of September 30, 2021, 194.7%2022, 200.2% of net assets at fair value, or $2.6$2.5 billion, was invested in 138149 portfolio investments, including (i) $133.9$117.0 million in subordinated notes and LLC equity interests of SLF JV I and (ii) $55.6$50.3 million in subordinated notes and LLC equity interests of Glick JV. As of September 30, 2021, 2.4%2022, 2.1% of net assets at fair value, or $31.6$26.4 million, was invested in cash and cash equivalents (including $2.3$2.8 million of restricted cash). As of December 31, 2021, 87.4%2022, 86.3% of the Company's portfolio at fair value consisted of senior secured debt investments and 6.9%8.5% consisted of subordinated debt investments, including the debt investments in the JVs. As of September 30, 2021, 86.7%2022, 86.9% of the Company's portfolio at fair value consisted of senior secured debt investments and 7.6%8.1% consisted of subordinated debt investments, including the debt investments in the JVs.
The Company also held equity investments in certain of its portfolio companies consisting of common stock, preferred stock, warrants, limited partnership interests or LLC equity interests. These instruments generally do not produce a current return but are held for potential investment appreciation and capital gain.
During the three months ended December 31, 20212022 and 2020,2021, the Company recorded net realized gains (losses) of $9.3$(3.2) million and $8.2$9.3 million, respectively. During the three monthmonths ended December 31, 20212022 and 2020,2021, the Company recorded net unrealized appreciation (depreciation)depreciation of $(4.6)$23.0 million and $47.6$4.6 million, respectively.
The composition of the Company's investments as of December 31, 2021 and September 30, 2021 at cost and fair value was as follows:
 December 31, 2021September 30, 2021
 CostFair ValueCostFair Value
Investments in debt securities$2,264,967 $2,290,199 $2,222,223 $2,259,924 
Investments in equity securities113,743 107,859 120,621 107,222 
Debt investments in the JVs146,838 152,104 146,955 151,832 
Equity investments in the JVs49,322 38,461 49,322 37,651 
Total$2,574,870 $2,588,623 $2,539,121 $2,556,629 
3739

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)









The composition of the Company's investments as of December 31, 2022 and September 30, 2022 at cost and fair value was as follows:
 December 31, 2022September 30, 2022
 CostFair ValueCostFair Value
Investments in debt securities$2,428,251 $2,343,380 $2,294,392 $2,223,329 
Investments in equity securities132,355 113,190 127,596 103,534 
Debt investments in the JVs162,617 162,192 146,444 146,533 
Equity investments in the JVs54,791 24,108 49,322 20,715 
Total$2,778,014 $2,642,870 $2,617,754 $2,494,111 

The following table presents the composition of the Company's debt investments as of December 31, 20212022 and September 30, 20212022 at fixed rates and floating rates:
 December 31, 2022September 30, 2022
 Fair Value% of Debt
Portfolio
Fair Value% of Debt
Portfolio
Floating rate debt securities, including the debt investments in the JVs$2,188,193 87.33 %$2,049,644 86.49 %
Fixed rate debt securities317,379 12.67 320,218 13.51 
Total$2,505,572 100.00 %$2,369,862 100.00 %
 December 31, 2021September 30, 2021
 Fair Value% of Debt
Portfolio
Fair Value% of Debt
Portfolio
Floating rate debt securities, including the debt investments in the JVs$2,236,839 91.59 %$2,205,648 91.45 %
Fixed rate debt securities205,464 8.41 206,108 8.55 
Total$2,442,303 100.00 %$2,411,756 100.00 %


The following table presents the financial instruments carried at fair value as of December 31, 20212022 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:
Level 1Level 2Level 3Measured at Net Asset Value (a)TotalLevel 1Level 2Level 3Measured at Net Asset Value (a)Total
Investments in debt securities (senior secured)Investments in debt securities (senior secured)$— $329,177 $1,934,096 $— $2,263,273 Investments in debt securities (senior secured)$— $233,393 $2,047,842 $— $2,281,235 
Investments in debt securities (subordinated, including the debt investments in the JVs)Investments in debt securities (subordinated, including the debt investments in the JVs)— 17,661 161,369 — 179,030 Investments in debt securities (subordinated, including the debt investments in the JVs)— 44,706 179,631 — 224,337 
Investments in equity securities (preferred)Investments in equity securities (preferred)— — 65,550 — 65,550 Investments in equity securities (preferred)— — 80,625 — 80,625 
Investments in equity securities (common and warrants, including LLC equity interests of the JVs)Investments in equity securities (common and warrants, including LLC equity interests of the JVs)233 — 41,942 38,595 80,770 Investments in equity securities (common and warrants, including LLC equity interests of the JVs)5,923 — 26,642 24,108 56,673 
Total investments at fair valueTotal investments at fair value233 346,838 2,202,957 38,595 2,588,623 Total investments at fair value5,923 278,099 2,334,740 24,108 2,642,870 
Cash equivalentsCash equivalents32,082 — — — 32,082 Cash equivalents3,421 — — — 3,421 
Derivative asset— 1,075 — — 1,075 
Total assets at fair valueTotal assets at fair value$32,315 $347,913 $2,202,957 $38,595 $2,621,780 Total assets at fair value$9,344 $278,099 $2,334,740 $24,108 $2,646,291 
Derivative liabilityDerivative liability$— $5,931 $— $— $5,931 Derivative liability$— $44,139 $— $— $44,139 
Total liabilities at fair valueTotal liabilities at fair value$ $5,931 $ $ $5,931 Total liabilities at fair value$ $44,139 $ $ $44,139 
__________ 
(a)In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities.
3840

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








The following table presents the financial instruments carried at fair value as of September 30, 20212022 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:
Level 1Level 2Level 3Measured at Net Asset Value (a)Total
Investments in debt securities (senior secured)$— $338,707 $1,878,536 $— $2,217,243 
Investments in debt securities (subordinated, including the debt investments in the JVs)— 18,196 176,317 — 194,513 
Investments in equity securities (preferred)— — 63,565 — 63,565 
Investments in equity securities (common and warrants, including LLC equity interests of the JVs)382 — 43,163 37,763 81,308 
Total investments at fair value382 356,903 2,161,581 37,763 2,556,629 
Cash equivalents23,600 — — — 23,600 
Derivative asset— 1,912 — — 1,912 
Total assets at fair value$23,982 $358,815 $2,161,581 $37,763 $2,582,141 
Derivative liability$— $2,108 $— $— $2,108 
Total liabilities at fair value$ $2,108 $ $ $2,108 
Level 1Level 2Level 3Measured at Net Asset Value (a)Total
Investments in debt securities (senior secured)$— $255,803 $1,910,606 $— $2,166,409 
Investments in debt securities (subordinated, including the debt investments in the JVs)— 44,065 159,388 — 203,453 
Investments in equity securities (preferred)— — 79,523 — 79,523 
Investments in equity securities (common and warrants, including LLC equity interests of the JVs)4,053 — 19,958 20,715 44,726 
Total investments at fair value4,053 299,868 2,169,475 20,715 2,494,111 
Cash equivalents5,261 — — — 5,261 
Derivative assets— 6,789 — — 6,789 
Total assets at fair value$9,314 $306,657 $2,169,475 $20,715 $2,506,161 
Derivative liability$— $41,969 $— $— $41,969 
Total liabilities at fair value$ $41,969 $ $ $41,969 
__________ 
(a)In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities.


When a determination is made to classify a financial instrument within Level 3 of the valuation hierarchy, the determination is based upon the fact that the unobservable factors are significant to the overall fair value measurement. However, Level 3 financial instruments typically have both unobservable or Level 3 components and observable components (i.e. components that are actively quoted and can be validated by external sources). Accordingly, the appreciation (depreciation) in the tables below includes changes in fair value due in part to observable factors that are part of the valuation methodology. Transfers between levels are recognized at the beginning of the reporting period.
The following table provides a roll-forward in the changes in fair value from September 30, 2022 to December 31, 2022 for all investments for which the Company determined fair value using unobservable (Level 3) factors:
Investments
Senior Secured DebtSubordinated
Debt (including debt investments in the JVs)
Preferred
Equity
Common
Equity and Warrants
Total
Fair value as of September 30, 2022$1,910,606 $159,388 $79,523 $19,958 $2,169,475 
Purchases 177,599 21,104 2,579 2,181 203,463 
Sales and repayments(55,885)(699)— (48)(56,632)
Transfers in (a)19,075 — — — 19,075 
Capitalized PIK interest income5,763 — — 5,769 
Accretion of OID4,114 398 — — 4,512 
Net unrealized appreciation (depreciation)(12,271)(566)(1,477)4,505 (9,809)
Net realized gains (losses)(1,159)— — 46 (1,113)
Fair value as of December 31, 2022$2,047,842 $179,631 $80,625 $26,642 $2,334,740 
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2022$(12,398)$(566)$(1,477)$4,505 $(9,936)
__________
(a) There was a transfer into Level 3 from Level 2 for an investment during the three months ended December 31, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity.

41

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




The following table provides a roll-forward in the changes in fair value from September 30, 2021 to December 31, 2021 for all investments for which the Company determined fair value using unobservable (Level 3) factors:
Investments
Senior Secured DebtSubordinated
Debt (including debt investments in the JVs)
Preferred
Equity
Common
Equity and Warrants
Total
Fair value as of September 30, 2021$1,878,536 $176,317 $63,565 $43,163 $2,161,581 
Purchases 191,087 3,589 979 1,441 197,096 
Sales and repayments(131,946)(20,185)— (6,503)(158,634)
Transfers in (a)3,178 — — — 3,178 
Transfers out (a)(17,070)— — — (17,070)
Capitalized PIK interest income6,172 313 — — 6,485 
Accretion of OID5,378 819 — — 6,197 
Net unrealized appreciation (depreciation)(9,877)516 1,006 6,636 (1,719)
Net realized gains (losses)8,638 — — (2,795)5,843 
Fair value as of December 31, 2021$1,934,096 $161,369 $65,550 $41,942 $2,202,957 
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2021 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2021$(717)$368 $1,006 $1,139 $1,796 
__________
(a) There were transfers into/out of Level 3 from/to Level 2 for certain investments during the three months ended December 31, 2021 as a result of a change in the number of market quotes available and/or a change in market liquidity.


39

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




The following table provides a roll-forward in the changes in fair value from September 30, 2020 to December 31, 2020 for all investments for which the Company determined fair value using unobservable (Level 3) factors:
Investments
Senior Secured DebtSubordinated
Debt (including debt investment in SLF JV I)
Preferred
Equity
Common
Equity and Warrants
Total
Fair value as of September 30, 2020$904,237 $126,152 $29,959 $35,080 $1,095,428 
Purchases 209,177 — — — 209,177 
Sales and repayments(68,895)(34,905)(31)(5,147)(108,978)
Transfers in (a)(b)18,458 — — 437 18,895 
Capitalized PIK interest income2,873 — — — 2,873 
Accretion of OID1,379 992 — — 2,371 
Net unrealized appreciation (depreciation)12,751 14,648 (228)2,467 29,638 
Net realized gains (losses)(1,564)7,285 31 2,635 8,387 
Fair value as of December 31, 2020$1,078,416 $114,172 $29,731 $35,472 $1,257,791 
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of December 31, 2020 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended December 31, 2020$15,672 $(56)$(228)$2,209 $17,597 
__________
(a) There were transfers into Level 3 from Level 2 for certain investments during the three months ended December 31, 2020 as a result of a change in the number of market quotes available and/or a change in market liquidity.
(b) There was a transfer into Level 3 from Level 2 as a result of an investment restructuring in which Level 2 senior secured debt was exchanged for Level 3 senior secured debt and common equity.

Significant Unobservable Inputs for Level 3 Investments
The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of December 31, 2021:2022:
AssetAssetFair ValueValuation TechniqueUnobservable InputRangeWeighted
Average (a)
AssetFair ValueValuation TechniqueUnobservable InputRangeWeighted
Average (a)
Senior Secured DebtSenior Secured Debt$1,458,164 Market YieldMarket Yield(b)7.0%-30.0%10.4%Senior Secured Debt$1,692,264 Market YieldMarket Yield(b)9.0%-33.0%14.0%
32,178 Enterprise ValueEBITDA Multiple(c)4.0x-9.0x5.4x14,297 Enterprise ValueEBITDA Multiple(c)5.0x-7.0x6.0x
83,273 Transaction PrecedentTransaction Price(d)N/A-N/AN/A38,581 Transaction PrecedentTransaction Price(d)N/A-N/AN/A
360,481 Broker QuotationsBroker Quoted Price(e)N/A-N/AN/A302,700 Broker QuotationsBroker Quoted Price(e)N/A-N/AN/A
Subordinated DebtSubordinated Debt9,265 Market YieldMarket Yield(b)13.0%-15.0%13.9%Subordinated Debt13,706 Market YieldMarket Yield(b)10.0%-20.0%11.4%
3,733 Broker QuotationsBroker Quoted Price(e)N/A-N/AN/A
Debt Investments in the JVsDebt Investments in the JVs152,104 Enterprise ValueN/A(f)N/A-N/AN/ADebt Investments in the JVs162,192 Enterprise ValueN/A(f)N/A-N/AN/A
Preferred & Common EquityPreferred & Common Equity31,329 Enterprise ValueRevenue Multiple(c)0.5x-6.1x0.7xPreferred & Common Equity30,226 Enterprise ValueRevenue Multiple(c)0.1x-4.3x0.5x
68,256 Enterprise ValueEBITDA Multiple(c)3.0x-20.5x11.0x73,822 Enterprise ValueEBITDA Multiple(c)3.0x-20.0x14.6x
189 Enterprise ValueAsset Multiple(c)0.9x-1.1x1.0x1,600 Enterprise ValueAsset Multiple(c)0.9x-1.1x1.0x
7,718 Transaction PrecedentTransaction Price(d)N/A-N/AN/A1,619 Transaction PrecedentTransaction Price(d)N/A-N/AN/A
TotalTotal$2,202,957 Total$2,334,740 
__________
(a)Weighted averages are calculated based on fair value of investments.
(b)Used when market participants would take into account market yield when pricing the investment.
(c)Used when market participants would use such multiples when pricing the investment.
(d)Used when there is an observable transaction or pending event for the investment.
(e)The CompanyOaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. The CompanyOaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Each quoted price is evaluated by the Audit Committee of the Company's Board of Directors in conjunction with additional information compiled by Oaktree.
(f)The CompanyOaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique.
4042

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of September 30, 2021:2022:
AssetAssetFair ValueValuation TechniqueUnobservable InputRangeWeighted
Average (a)
AssetFair ValueValuation TechniqueUnobservable InputRangeWeighted
Average (a)
Senior Secured DebtSenior Secured Debt$1,413,373 Market YieldMarket Yield(b)4.0%-30.0%10.4%Senior Secured Debt$1,599,148 Market YieldMarket Yield(b)9.0%-30.0%13.7%
36,197 Enterprise ValueEBITDA Multiple(c)3.0x-9.0x4.5x
7,500 Enterprise ValueAsset Multiple(c)0.9x-1.1x1.0x14,333 Enterprise ValueEBITDA Multiple(c)5.0x-7.0x6.0x
421,466 Broker QuotationsBroker Quoted Price(e)N/A-N/AN/A297,125 Broker QuotationsBroker Quoted Price(e)N/A-N/AN/A
Subordinated DebtSubordinated Debt24,485 Market YieldMarket Yield(b)12.0%-14.0%12.6%Subordinated Debt12,855 Market YieldMarket Yield(b)10.0%-19.0%13.8%
Debt Investments in the JVsDebt Investments in the JVs151,832 Enterprise ValueN/A(f)N/A-N/AN/ADebt Investments in the JVs146,533 Enterprise ValueN/A(f)N/A-N/AN/A
Preferred & Common EquityPreferred & Common Equity6,188 Enterprise ValueRevenue Multiple(c)0.9x-11.2x2.5xPreferred & Common Equity61,693 Enterprise ValueRevenue Multiple(c)0.4x-10.1x4.3x
93,520 Enterprise ValueEBITDA Multiple(c)3.0x-35.0x15.9x36,913 Enterprise ValueEBITDA Multiple(c)3.0x-20.0x11.4x
698 Enterprise ValueAsset Multiple(c)0.9x-1.1x1.0xEnterprise ValueAsset Multiple(c)0.9x-1.1x1.0x
6,322 Transactions PrecedentTransaction Price(d)N/A-N/AN/A872 Transaction PrecedentTransaction Price(d)N/A-N/AN/A
TotalTotal$2,161,581 Total$2,169,475 
__________
__________
(a)Weighted averages are calculated based on fair value of investments.
(b)Used when market participants would take into account market yield when pricing the investment.
(c)Used when market participants would use such multiples when pricing the investment.
(d)Used when there is an observable transaction or pending event for the investment.
(e)The CompanyOaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. The CompanyOaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Each quoted price is evaluated by the Audit Committee of the Company's Board of Directors in conjunction with additional information compiled by Oaktree.
(f)The CompanyOaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique.
Under the market yield technique, the significant unobservable input used in the fair value measurement of the Company's investments in debt securities is the market yield. Increases or decreases in the market yield may result in a lower or higher fair value measurement, respectively.
Under the EV technique, the significant unobservable input used in the fair value measurement of the Company's investments in debt or equity securities is the earnings before interest, taxes, depreciation and amortization ("EBITDA"), revenue or asset multiple, as applicable. Increases or decreases in the valuation multiples in isolation may result in a higher or lower fair value measurement, respectively.
 
Financial Instruments Disclosed, But Not Carried, At Fair Value
The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of December 31, 20212022 and the level of each financial liability within the fair value hierarchy:
 
Carrying
Value
Fair ValueLevel 1Level 2Level 3Carrying
Value
Fair ValueLevel 1Level 2Level 3
Syndicated Facility payableSyndicated Facility payable$495,000 $495,000 $— $— $495,000 Syndicated Facility payable$695,000 $695,000 $— $— $695,000 
Citibank Facility payableCitibank Facility payable155,000 155,000 — — 155,000 Citibank Facility payable165,000 165,000 — — 165,000 
2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)296,053 312,750 — 312,750 — 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)297,303 286,734 — 286,734 — 
2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)339,408 347,372 — 347,372 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)306,321 296,835 — 296,835 — 
TotalTotal$1,285,461 $1,310,122 $ $660,122 $650,000 Total$1,463,624 $1,443,569 $ $583,569 $860,000 
4143

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)










The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of September 30, 20212022 and the level of each financial liability within the fair value hierarchy:
Carrying
Value
Fair ValueLevel 1Level 2Level 3Carrying
Value
Fair ValueLevel 1Level 2Level 3
Syndicated Facility payableSyndicated Facility payable$495,000 $495,000 $— $— $495,000 Syndicated Facility payable$540,000 $540,000 $— $— $540,000 
Citibank Facility payableCitibank Facility payable135,000 135,000 — — 135,000 Citibank Facility payable160,000 160,000 — — 160,000 
2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)295,740 314,541 — 314,541 — 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)296,991 283,077 — 283,077 — 
2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)343,003 351,134 — 351,134 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)304,052 294,028 — 294,028 — 
TotalTotal$1,268,743 $1,295,675 $ $665,675 $630,000 Total$1,301,043 $1,277,105 $ $577,105 $700,000 
 
The principal values of the credit facilities payable approximate fair value due to their variable interest rates and are included in Level 3 of the hierarchy. The CompanyOaktree used market quotes as of the valuation date to estimate the fair value of itsthe Company's 3.500% notes due 2025 (the "2025 Notes") and 2.700% notes due 2027 (the "2027 Notes"), which are included in Level 2 of the hierarchy.


Portfolio Composition
Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables:
December 31, 2021September 30, 2021 December 31, 2022September 30, 2022
Cost:Cost: % of Total Investments% of Total InvestmentsCost: % of Total Investments% of Total Investments
Senior secured debtSenior secured debt$2,238,661 86.94 %$2,179,907 85.85 %Senior secured debt$2,359,295 84.94 %$2,227,245 85.08 %
Debt investments in the JVsDebt investments in the JVs146,838 5.70 %146,955 5.79 %Debt investments in the JVs162,617 5.85 %146,444 5.59 %
Preferred equityPreferred equity66,918 2.60 %65,939 2.60 %Preferred equity87,878 3.16 %85,300 3.26 %
Subordinated debtSubordinated debt68,956 2.48 %67,147 2.57 %
LLC equity interests of the JVsLLC equity interests of the JVs49,322 1.92 %49,322 1.94 %LLC equity interests of the JVs54,791 1.97 %49,322 1.88 %
Common equity and warrantsCommon equity and warrants46,825 1.82 %54,682 2.15 %Common equity and warrants44,477 1.60 %42,296 1.62 %
Subordinated debt26,306 1.02 %42,316 1.67 %
TotalTotal$2,574,870 100.00 %$2,539,121 100.00 %Total$2,778,014 100.00 %$2,617,754 100.00 %


December 31, 2021September 30, 2021 December 31, 2022September 30, 2022
Fair Value:Fair Value: % of Total Investments% of Net Assets% of Total Investments% of Net AssetsFair Value: % of Total Investments% of Net Assets% of Total Investments% of Net Assets
Senior secured debtSenior secured debt$2,263,273 87.43 %170.81 %$2,217,243 86.72 %168.89 %Senior secured debt$2,281,235 86.32 %189.78 %$2,166,409 86.86 %173.93 %
Debt investments in the JVsDebt investments in the JVs152,104 5.88 %11.48 %151,832 5.94 %11.56 %Debt investments in the JVs162,192 6.14 %13.49 %146,533 5.88 %11.77 %
Preferred equityPreferred equity65,550 2.53 %4.95 %63,565 2.49 %4.84 %Preferred equity80,625 3.05 %6.71 %79,523 3.19 %6.38 %
Subordinated debtSubordinated debt62,145 2.35 %5.17 %56,920 2.28 %4.57 %
Common equity and warrantsCommon equity and warrants42,309 1.63 %3.19 %43,657 1.71 %3.33 %Common equity and warrants32,565 1.23 %2.71 %24,011 0.96 %1.93 %
LLC equity interests of the JVsLLC equity interests of the JVs38,461 1.49 %2.90 %37,651 1.47 %2.87 %LLC equity interests of the JVs24,108 0.91 %2.01 %20,715 0.83 %1.66 %
Subordinated debt26,926 1.04 %2.03 %42,681 1.67 %3.25 %
TotalTotal$2,588,623 100.00 %195.36 %$2,556,629 100.00 %194.74 %Total$2,642,870 100.00 %219.87 %$2,494,111 100.00 %200.24 %


4244

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets:
December 31, 2021September 30, 2021 December 31, 2022September 30, 2022
Cost:Cost: % of Total Investments % of Total InvestmentsCost: % of Total Investments % of Total Investments
NortheastNortheast$746,398 28.99 %$720,781 28.39 %Northeast$772,197 27.78 %$747,420 28.55 %
MidwestMidwest374,014 14.53 %385,846 15.20 %Midwest403,393 14.52 %373,236 14.26 %
SoutheastSoutheast397,717 14.32 %356,041 13.60 %
WestWest332,784 12.92 %365,471 14.39 %West351,871 12.67 %358,306 13.69 %
Southeast323,392 12.56 %294,339 11.59 %
InternationalInternational309,697 12.03 %268,817 10.59 %International350,510 12.62 %301,242 11.51 %
SouthwestSouthwest236,060 9.17 %256,227 10.09 %Southwest204,143 7.35 %221,308 8.45 %
SouthSouth161,518 6.27 %156,764 6.17 %South164,094 5.91 %168,819 6.45 %
NorthwestNorthwest91,007 3.53 %90,876 3.58 %Northwest134,089 4.83 %91,382 3.49 %
TotalTotal$2,574,870 100.00 %$2,539,121 100.00 %Total$2,778,014 100.00 %$2,617,754 100.00 %


December 31, 2021September 30, 2021 December 31, 2022September 30, 2022
Fair Value:Fair Value: % of Total Investments% of Net Assets % of Total Investments% of Net AssetsFair Value: % of Total Investments% of Net Assets % of Total Investments% of Net Assets
NortheastNortheast$749,297 28.94 %56.54 %$721,647 28.24 %54.97 %Northeast$716,827 27.12 %59.63 %$696,368 27.93 %55.90 %
MidwestMidwest368,848 14.25 %27.84 %382,475 14.96 %29.13 %Midwest384,219 14.54 %31.97 %356,934 14.31 %28.66 %
West336,910 13.02 %25.43 %371,257 14.52 %28.28 %
SoutheastSoutheast327,294 12.64 %24.70 %299,486 11.71 %22.81 %Southeast380,276 14.39 %31.64 %344,567 13.82 %27.66 %
InternationalInternational314,423 12.15 %23.73 %275,904 10.79 %21.02 %International342,447 12.96 %28.49 %279,646 11.21 %22.45 %
WestWest330,698 12.51 %27.51 %345,251 13.84 %27.72 %
SouthwestSouthwest237,831 9.19 %17.95 %258,940 10.13 %19.72 %Southwest195,818 7.41 %16.29 %214,984 8.62 %17.26 %
SouthSouth162,328 6.27 %12.25 %155,526 6.08 %11.85 %South160,150 6.06 %13.32 %166,230 6.66 %13.35 %
NorthwestNorthwest91,692 3.54 %6.92 %91,394 3.57 %6.96 %Northwest132,435 5.01 %11.02 %90,131 3.61 %7.24 %
TotalTotal$2,588,623 100.00 %195.36 %$2,556,629 100.00 %194.74 %Total$2,642,870 100.00 %219.87 %$2,494,111 100.00 %200.24 %
4345

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








The following tables show the composition of the Company's portfolio by industry at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets as of December 31, 20212022 and September 30, 2021:2022:
December 31, 2021September 30, 2021December 31, 2022September 30, 2022
Cost:Cost: % of Total Investments % of Total InvestmentsCost: % of Total Investments % of Total Investments
Application SoftwareApplication Software$413,870 16.04 %$367,265 14.49 %Application Software$435,165 15.66 %$391,938 14.98 %
Multi-Sector Holdings (1)Multi-Sector Holdings (1)196,160 7.62 196,277 7.73 Multi-Sector Holdings (1)229,676 8.27 195,766 7.48 
PharmaceuticalsPharmaceuticals138,214 5.37 138,250 5.44 Pharmaceuticals131,307 4.73 126,508 4.83 
Data Processing & Outsourced ServicesData Processing & Outsourced Services120,423 4.68 120,381 4.74 Data Processing & Outsourced Services118,058 4.25 120,477 4.60 
BiotechnologyBiotechnology115,698 4.49 111,856 4.41 Biotechnology111,745 4.02 109,960 4.20 
Personal Products102,886 4.00 103,642 4.08 
Health Care TechnologyHealth Care Technology110,251 3.97 100,084 3.82 
Specialized FinanceSpecialized Finance87,523 3.15 80,864 3.09 
Industrial MachineryIndustrial Machinery87,272 3.39 88,231 3.47 Industrial Machinery81,483 2.93 81,787 3.12 
Health Care ServicesHealth Care Services78,625 3.05 84,750 3.34 Health Care Services65,732 2.37 58,674 2.24 
Specialized Finance68,433 2.66 68,554 2.70 
Internet & Direct Marketing RetailInternet & Direct Marketing Retail65,585 2.36 67,926 2.59 
Aerospace & DefenseAerospace & Defense67,863 2.64 67,629 2.66 Aerospace & Defense61,993 2.23 61,963 2.37 
Construction & EngineeringConstruction & Engineering60,828 2.19 60,996 2.33 
Health Care DistributorsHealth Care Distributors58,320 2.10 57,112 2.18 
Other Diversified Financial ServicesOther Diversified Financial Services57,241 2.06 29,300 1.12 
Personal ProductsPersonal Products53,190 1.91 53,214 2.03 
Automotive RetailAutomotive Retail51,663 1.86 59,254 2.26 
Auto Parts & EquipmentAuto Parts & Equipment51,067 1.84 12,474 0.48 
Real Estate Operating CompaniesReal Estate Operating Companies49,980 1.80 47,585 1.82 
Fertilizers & Agricultural ChemicalsFertilizers & Agricultural Chemicals66,972 2.60 66,713 2.63 Fertilizers & Agricultural Chemicals49,271 1.77 49,301 1.88 
Internet & Direct Marketing Retail63,159 2.45 62,233 2.45 
Construction & Engineering61,514 2.39 61,874 2.44 
Internet Services & InfrastructureInternet Services & Infrastructure53,268 2.07 46,917 1.85 Internet Services & Infrastructure49,271 1.77 54,095 2.07 
Metal & Glass ContainersMetal & Glass Containers47,128 1.70 47,704 1.82 
Home Improvement RetailHome Improvement Retail46,245 1.80 46,487 1.83 Home Improvement Retail45,266 1.63 45,802 1.75 
Soft DrinksSoft Drinks43,935 1.58 34,272 1.31 
Airport ServicesAirport Services42,092 1.63 41,699 1.64 Airport Services43,748 1.57 43,322 1.65 
Automotive Retail41,889 1.63 41,800 1.65 
Leisure FacilitiesLeisure Facilities41,384 1.61 25,162 0.99 Leisure Facilities41,182 1.48 39,768 1.52 
Insurance BrokersInsurance Brokers39,268 1.41 35,628 1.36 
Diversified Support ServicesDiversified Support Services38,167 1.37 37,992 1.45 
Specialty ChemicalsSpecialty Chemicals37,298 1.34 37,319 1.43 
Health Care SuppliesHealth Care Supplies36,693 1.32 36,471 1.39 
Real Estate ServicesReal Estate Services40,396 1.57 40,445 1.59 Real Estate Services36,233 1.30 40,243 1.54 
Specialty Chemicals40,024 1.55 46,731 1.84 
Diversified Support Services38,897 1.51 40,666 1.60 
Oil & Gas Storage & Transportation36,967 1.44 36,612 1.44 
Health Care Supplies35,803 1.39 29,650 1.17 
Insurance Brokers35,728 1.39 25,515 1.00 
Soft Drinks34,036 1.32 33,410 1.32 
Integrated Telecommunication ServicesIntegrated Telecommunication Services34,635 1.25 34,628 1.32 
Electrical Components & EquipmentElectrical Components & Equipment32,117 1.25 32,127 1.27 Electrical Components & Equipment33,813 1.22 33,814 1.29 
AdvertisingAdvertising28,026 1.09 28,649 1.13 Advertising27,507 0.99 28,245 1.08 
Oil & Gas Refining & Marketing27,771 1.08 36,044 1.42 
Integrated Telecommunication Services26,752 1.04 47,059 1.85 
Movies & EntertainmentMovies & Entertainment26,044 1.01 26,002 1.02 Movies & Entertainment26,202 0.94 26,161 1.00 
DistributorsDistributors25,389 0.99 — — Distributors25,262 0.91 25,278 0.97 
Real Estate Operating Companies24,951 0.97 27,531 1.08 
Health Care Technology24,685 0.96 13,877 0.55 
AirlinesAirlines24,034 0.87 — — 
Health Care EquipmentHealth Care Equipment23,894 0.93 23,674 0.93 Health Care Equipment21,838 0.79 24,353 0.93 
Airlines21,288 0.83 22,417 0.88 
Metal & Glass Containers21,181 0.82 17,443 0.69 
Health Care Distributors19,666 0.76 19,698 0.78 
Environmental & Facilities ServicesEnvironmental & Facilities Services21,156 0.76 20,857 0.80 
Oil & Gas Storage & TransportationOil & Gas Storage & Transportation19,934 0.72 22,290 0.85 
Home FurnishingsHome Furnishings19,542 0.76 19,537 0.77 Home Furnishings19,554 0.70 19,550 0.75 
Other Diversified Financial Services19,528 0.76 16,104 0.63 
Independent Power Producers & Energy Traders19,476 0.76 23,458 0.92 
Systems SoftwareSystems Software14,895 0.54 14,890 0.57 
Consumer FinanceConsumer Finance14,503 0.52 14,492 0.55 
Hotels, Resorts & Cruise LinesHotels, Resorts & Cruise Lines13,943 0.50 13,960 0.53 
IT Consulting & Other ServicesIT Consulting & Other Services11,684 0.42 11,697 0.45 
RestaurantsRestaurants9,343 0.34 9,338 0.36 
Education ServicesEducation Services9,070 0.33 9,080 0.35 
Cable & SatelliteCable & Satellite18,387 0.71 26,730 1.05 Cable & Satellite8,012 0.29 20,716 0.79 
Thrifts & Mortgage Finance16,016 0.62 16,079 0.63 
Auto Parts & Equipment12,468 0.48 12,466 0.49 
Research & Consulting ServicesResearch & Consulting Services7,848 0.28 9,187 0.35 
Apparel, Accessories & Luxury GoodsApparel, Accessories & Luxury Goods5,165 0.19 5,165 0.20 
Air Freight & LogisticsAir Freight & Logistics9,664 0.38 4,925 0.19 Air Freight & Logistics4,925 0.18 7,295 0.28 
Restaurants9,323 0.36 9,317 0.37 
IT Consulting & Other Services7,591 0.29 7,598 0.30 
Research & Consulting Services7,354 0.29 7,354 0.29 
Property & Casualty Insurance6,878 0.27 9,884 0.39 
Leisure Products6,832 0.27 6,599 0.26 
Systems Software6,647 0.26 6,647 0.26 
Environmental & Facilities Services5,411 0.21 — — 
Apparel, Accessories & Luxury Goods5,165 0.20 5,165 0.20 
Integrated Oil & GasIntegrated Oil & Gas4,847 0.19 4,842 0.19 Integrated Oil & Gas4,873 0.18 4,866 0.19 
Alternative Carriers4,710 0.18 6,578 0.26 
Apparel RetailApparel Retail4,727 0.17 5,268 0.20 
Food DistributorsFood Distributors4,633 0.18 4,625 0.18 Food Distributors4,655 0.17 4,646 0.18 
Apparel Retail4,418 0.17 — — 
Specialized REITsSpecialized REITs4,334 0.16 4,318 0.16 
Real Estate DevelopmentReal Estate Development4,278 0.15 — — 
Diversified BanksDiversified Banks3,515 0.14 3,515 0.14 Diversified Banks3,515 0.13 3,515 0.13 
Technology DistributorsTechnology Distributors3,163 0.12 3,163 0.12 Technology Distributors3,163 0.11 3,163 0.12 
Food Retail2,498 0.10 3,745 0.15 
Construction MaterialsConstruction Materials2,267 0.09 2,245 0.09 Construction Materials2,353 0.08 2,331 0.09 
Housewares & SpecialtiesHousewares & Specialties2,217 0.08 2,293 0.09 
Electronic ComponentsElectronic Components2,083 0.08 10,080 0.40 Electronic Components2,095 0.08 2,092 0.08 
Housewares & Specialties1,889 0.07 1,875 0.07 
Education Services983 0.04 981 0.04 
Commercial Printing— — 19,685 0.78 
Managed Health Care— — 18,654 0.73 
Total$2,574,870 100.00 %$2,539,121 100.00 %
Alternative CarriersAlternative Carriers214 0.01 212 0.01 
Oil & Gas Refining & MarketingOil & Gas Refining & Marketing— — 8,627 0.33 
Trading Companies & DistributorsTrading Companies & Distributors— — 7,628 0.29 
$2,778,014 100.00 %$2,617,754 100.00 %
4446

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








December 31, 2021September 30, 2021December 31, 2022September 30, 2022
Fair Value:Fair Value: % of Total Investments% of Net Assets % of Total Investments% of Net AssetsFair Value: % of Total Investments% of Net Assets % of Total Investments% of Net Assets
Application SoftwareApplication Software$418,247 16.20 %31.59 %$372,606 14.58 %28.39 %Application Software$422,862 15.95 %35.18 %$384,589 15.43 %30.87 %
Multi-Sector Holdings (1)Multi-Sector Holdings (1)190,565 7.36 14.38 189,483 7.41 14.43 Multi-Sector Holdings (1)198,904 7.53 16.55 167,248 6.71 13.43 
PharmaceuticalsPharmaceuticals140,675 5.43 10.62 142,194 5.56 10.83 Pharmaceuticals127,414 4.82 10.60 119,511 4.79 9.59 
BiotechnologyBiotechnology117,303 4.53 8.85 113,641 4.44 8.66 Biotechnology115,489 4.37 9.61 108,465 4.35 8.71 
Data Processing & Outsourced ServicesData Processing & Outsourced Services113,760 4.39 8.59 113,923 4.46 8.68 Data Processing & Outsourced Services106,224 4.02 8.84 111,335 4.46 8.94 
Personal Products105,428 4.07 7.96 105,530 4.13 8.04 
Health Care TechnologyHealth Care Technology103,479 3.92 8.61 97,315 3.90 7.81 
Industrial MachineryIndustrial Machinery88,577 3.42 6.68 90,218 3.53 6.87 Industrial Machinery79,791 3.02 6.64 81,008 3.25 6.50 
Health Care Services80,118 3.10 6.05 84,735 3.31 6.45 
Specialized FinanceSpecialized Finance79,751 3.02 6.63 73,087 2.93 5.87 
Internet & Direct Marketing RetailInternet & Direct Marketing Retail70,248 2.71 5.30 68,424 2.68 5.21 Internet & Direct Marketing Retail66,001 2.50 5.49 70,419 2.82 5.65 
Aerospace & DefenseAerospace & Defense69,823 2.70 5.27 69,602 2.72 5.30 Aerospace & Defense61,490 2.33 5.12 61,881 2.48 4.97 
Specialized Finance68,426 2.64 5.16 68,844 2.69 5.24 
Construction & EngineeringConstruction & Engineering60,938 2.31 5.07 61,188 2.45 4.91 
Health Care DistributorsHealth Care Distributors54,898 2.08 4.57 54,662 2.19 4.39 
Other Diversified Financial ServicesOther Diversified Financial Services54,080 2.05 4.50 24,326 0.98 1.95 
Fertilizers & Agricultural ChemicalsFertilizers & Agricultural Chemicals67,774 2.62 5.11 67,527 2.64 5.14 Fertilizers & Agricultural Chemicals52,292 1.98 4.35 51,972 2.08 4.17 
Construction & Engineering62,730 2.42 4.73 63,109 2.47 4.81 
Health Care ServicesHealth Care Services51,260 1.94 4.26 45,943 1.84 3.69 
Automotive RetailAutomotive Retail50,681 1.92 4.22 57,629 2.31 4.63 
Real Estate Operating CompaniesReal Estate Operating Companies50,127 1.90 4.17 48,062 1.93 3.86 
Auto Parts & EquipmentAuto Parts & Equipment50,015 1.89 4.16 11,469 0.46 0.92 
Internet Services & InfrastructureInternet Services & Infrastructure54,236 2.10 4.09 47,923 1.87 3.65 Internet Services & Infrastructure48,973 1.85 4.07 53,797 2.16 4.32 
Personal ProductsPersonal Products48,903 1.85 4.07 50,150 2.01 4.03 
Home Improvement RetailHome Improvement Retail46,150 1.78 3.48 46,488 1.82 3.54 Home Improvement Retail45,127 1.71 3.75 45,421 1.82 3.65 
Automotive Retail44,339 1.71 3.35 42,133 1.65 3.21 
Metal & Glass ContainersMetal & Glass Containers44,763 1.69 3.72 47,599 1.91 3.82 
Soft DrinksSoft Drinks44,387 1.68 3.69 33,670 1.35 2.70 
Airport ServicesAirport Services41,252 1.59 3.11 40,776 1.59 3.11 Airport Services43,267 1.64 3.60 42,883 1.72 3.44 
Real Estate Services40,810 1.58 3.08 41,225 1.61 3.14 
Diversified Support Services39,168 1.51 2.96 40,888 1.60 3.11 
Leisure FacilitiesLeisure Facilities38,952 1.50 2.94 22,888 0.90 1.74 Leisure Facilities40,578 1.54 3.38 39,258 1.57 3.15 
Specialty Chemicals38,813 1.50 2.93 46,559 1.82 3.55 
Insurance BrokersInsurance Brokers38,123 1.47 2.88 27,612 1.08 2.10 Insurance Brokers39,057 1.48 3.25 33,081 1.33 2.66 
Health Care SuppliesHealth Care Supplies36,239 1.40 2.73 30,186 1.18 2.30 Health Care Supplies37,776 1.43 3.14 36,577 1.47 2.94 
Soft Drinks34,009 1.31 2.57 33,410 1.31 2.54 
Diversified Support ServicesDiversified Support Services35,626 1.35 2.96 36,712 1.47 2.95 
Real Estate ServicesReal Estate Services35,621 1.35 2.96 39,573 1.59 3.18 
Electrical Components & EquipmentElectrical Components & Equipment32,970 1.25 2.74 32,933 1.32 2.64 
Integrated Telecommunication ServicesIntegrated Telecommunication Services32,041 1.21 2.67 32,201 1.29 2.59 
Specialty ChemicalsSpecialty Chemicals31,476 1.19 2.62 33,969 1.36 2.73 
Movies & EntertainmentMovies & Entertainment26,470 1.00 2.20 26,645 1.07 2.14 
AdvertisingAdvertising26,022 0.98 2.16 26,948 1.08 2.16 
AirlinesAirlines25,864 0.98 2.15 — — — 
DistributorsDistributors24,569 0.93 2.04 24,494 0.98 1.97 
Health Care EquipmentHealth Care Equipment22,703 0.86 1.89 24,161 0.97 1.94 
Environmental & Facilities ServicesEnvironmental & Facilities Services20,675 0.78 1.72 20,585 0.83 1.65 
Oil & Gas Storage & TransportationOil & Gas Storage & Transportation33,977 1.31 2.56 34,462 1.35 2.63 Oil & Gas Storage & Transportation18,113 0.69 1.51 20,853 0.84 1.67 
Electrical Components & Equipment32,057 1.24 2.42 32,142 1.26 2.45 
Advertising29,668 1.15 2.24 30,423 1.19 2.32 
Integrated Telecommunication Services28,481 1.10 2.15 49,607 1.94 3.78 
Oil & Gas Refining & Marketing28,065 1.08 2.12 36,546 1.43 2.78 
Movies & Entertainment26,964 1.04 2.03 27,048 1.06 2.06 
Real Estate Operating Companies25,806 1.00 1.95 28,341 1.11 2.16 
Distributors25,594 0.99 1.93 — — — 
Health Care Technology25,053 0.97 1.89 13,960 0.55 1.06 
Health Care Equipment23,839 0.92 1.80 23,763 0.93 1.81 
Airlines21,527 0.83 1.62 24,554 0.96 1.87 
Metal & Glass Containers21,279 0.82 1.61 17,413 0.68 1.33 
Home FurnishingsHome Furnishings19,738 0.76 1.49 19,735 0.77 1.50 Home Furnishings17,917 0.68 1.49 18,188 0.73 1.46 
Independent Power Producers & Energy Traders19,713 0.76 1.49 23,552 0.92 1.79 
Health Care Distributors19,677 0.76 1.48 19,683 0.77 1.50 
Other Diversified Financial Services18,943 0.73 1.43 15,908 0.62 1.21 
Hotels, Resorts & Cruise LinesHotels, Resorts & Cruise Lines13,904 0.53 1.16 13,985 0.56 1.12 
Systems SoftwareSystems Software12,104 0.46 1.01 12,834 0.51 1.03 
Consumer FinanceConsumer Finance11,439 0.43 0.95 13,284 0.53 1.07 
Education ServicesEducation Services8,938 0.34 0.74 8,582 0.34 0.69 
RestaurantsRestaurants8,610 0.33 0.72 8,692 0.35 0.70 
Cable & SatelliteCable & Satellite18,614 0.72 1.40 27,048 1.06 2.06 Cable & Satellite7,968 0.30 0.66 19,576 0.78 1.57 
Thrifts & Mortgage Finance15,863 0.61 1.20 15,942 0.62 1.21 
Auto Parts & Equipment12,461 0.48 0.94 12,365 0.48 0.94 
Air Freight & Logistics9,851 0.38 0.74 4,981 0.19 0.38 
Restaurants9,446 0.36 0.71 9,451 0.37 0.72 
Research & Consulting ServicesResearch & Consulting Services7,541 0.29 0.57 7,606 0.30 0.58 Research & Consulting Services7,165 0.27 0.60 8,573 0.34 0.69 
IT Consulting & Other ServicesIT Consulting & Other Services7,317 0.28 0.55 7,443 0.29 0.57 IT Consulting & Other Services6,963 0.26 0.58 8,596 0.34 0.69 
Property & Casualty Insurance6,918 0.27 0.52 9,949 0.39 0.76 
Leisure Products6,832 0.26 0.52 6,599 0.26 0.50 
Systems Software6,745 0.26 0.51 6,769 0.26 0.52 
Environmental & Facilities Services5,362 0.21 0.40 — — — 
Alternative Carriers4,949 0.19 0.37 6,939 0.27 0.53 
Integrated Oil & GasIntegrated Oil & Gas4,897 0.19 0.37 4,884 0.19 0.37 Integrated Oil & Gas4,847 0.18 0.40 4,872 0.20 0.39 
Apparel RetailApparel Retail4,675 0.18 0.39 5,223 0.21 0.42 
Real Estate DevelopmentReal Estate Development4,267 0.16 0.35 — — — 
Air Freight & LogisticsAir Freight & Logistics4,191 0.16 0.35 6,405 0.26 0.51 
Food DistributorsFood Distributors4,680 0.18 0.35 4,673 0.18 0.36 Food Distributors3,599 0.14 0.30 3,367 0.13 0.27 
Apparel Retail4,415 0.17 0.33 — — — 
Diversified BanksDiversified Banks3,562 0.14 0.27 3,562 0.14 0.27 Diversified Banks3,315 0.13 0.28 3,402 0.14 0.27 
Specialized REITsSpecialized REITs3,230 0.12 0.27 3,264 0.13 0.26 
Technology DistributorsTechnology Distributors3,148 0.12 0.24 3,178 0.12 0.24 Technology Distributors2,971 0.11 0.25 2,997 0.12 0.24 
Food Retail2,498 0.10 0.19 3,750 0.15 0.29 
Housewares & SpecialtiesHousewares & Specialties2,265 0.09 0.19 2,456 0.10 0.20 
Construction MaterialsConstruction Materials2,227 0.09 0.17 2,350 0.09 0.18 Construction Materials1,928 0.07 0.16 1,934 0.08 0.16 
Electronic ComponentsElectronic Components2,135 0.08 0.16 10,127 0.40 0.77 Electronic Components1,712 0.06 0.14 1,890 0.08 0.15 
Housewares & Specialties2,009 0.08 0.15 2,003 0.08 0.15 
Education Services1,007 0.04 0.08 1,009 0.04 0.08 
Commercial Printing— — — 20,100 0.79 1.53 
Managed Health Care— — — 18,840 0.74 1.44 
Alternative CarriersAlternative Carriers185 0.01 0.02 201 0.01 0.02 
Oil & Gas Refining & MarketingOil & Gas Refining & Marketing— — — 8,604 0.34 0.69 
Trading Companies & DistributorsTrading Companies & Distributors— — — 5,567 0.22 0.45 
TotalTotal$2,588,623 100.00 %195.36 %$2,556,629 100.00 %194.74 %Total$2,642,870 100.00 %219.87 %$2,494,111 100.00 %200.24 %
___________________
(1)This industry includes the Company's investments in the JVs and certain limited partnership interests.JVs.


As of December 31, 20212022 and September 30, 2021,2022, the Company had no single investment that represented greater than 10%of the total investment portfolio at fair value. Income, consisting of interest, dividends, fees, other investment income and realization of gains or losses, may fluctuate and in any given period can be highly concentrated among several investments.
4547

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)










Senior Loan Fund JV I, LLC
In May 2014, the Company entered into an LLC agreement with Kemper to form SLF JV I. The Company co-invests in senior secured loans of middle-market companies and other corporate debt securities with Kemper through its investment in SLF JV I. SLF JV I is managed by a four person Board of Directors, two of whom are selected by the Company and two of whom are selected by Kemper. All portfolio decisions and investment decisions in respect of SLF JV I must be approved by the SLF JV I investment committee, which consists of one representative selected by the Company and one representative selected by Kemper (with approval from a representative of each required). Since the Company does not have a controlling financial interest in SLF JV I, the Company does not consolidate SLF JV I.
SLF JV I is capitalized pro rata with LLC equity interests as transactions are completed and may be capitalized with additional subordinated notes issued to the Company and Kemper by SLF JV I. The subordinated notes issued by SLF JV I (the "SLF JV I Notes") are senior in right of payment to SLF JV I LLC equity interests and subordinated in right of payment to SLF JV I’s secured debt. As of December 31, 20212022 and September 30, 2021,2022, the Company and Kemper owned, in the aggregate, 87.5% and 12.5%, respectively, of the LLC equity interests of SLF JV I and the outstanding SLF JV I Notes. SLF JV I is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act.
SLF JV I has a senior revolving credit facility with Deutsche Bank AG, New York Branch (as amended, the "SLF JV I Deutsche Bank Facility"), which permitted up to $260.0 million of borrowings (subject to borrowing base and other limitations) as of each of December 31, 20212022 and September 30, 2021.2022. Borrowings under the SLF JV I Deutsche Bank Facility are secured by all of the assets of SLF JV I Funding LLC, a special purpose financing subsidiary of SLF JV I. As of December 31, 2021,2022, the reinvestment period of the SLF JV I Deutsche Bank Facility was scheduled to expire May 3, 2023 and the maturity date was May 3, 2028. As of December 31, 2021,2022, borrowings under the SLF JV I Deutsche Bank Facility accrued interest at a rate equal to 3-month LIBOR plus 2.00% per annum during the reinvestment period, 3-month LIBOR plus 2.15% per annum for the first year after the reinvestment period, 3-month LIBOR plus 2.25% for the following year and 3-month LIBOR plus 2.50% thereafter, in each case with a 0.125% LIBOR floor. $220.0$226.0 million and $215.6$230.0 million of borrowings were outstanding under the SLF JV I Deutsche Bank Facility as of December 31, 20212022 and September 30, 2021,2022, respectively.
As of December 31, 20212022 and September 30, 2021,2022, SLF JV I had total assets of $393.3$409.4 million and $379.2$385.2 million, respectively. SLF JV I's portfolio primarily consisted of senior secured loans to 6159 and 5560 portfolio companies as of December 31, 20212022 and September 30, 2021,2022, respectively. The portfolio companies in SLF JV I are in industries similar to those in which the Company may invest directly. As of December 31, 2021,2022, the Company's investment in SLF JV I consisted of LLC equity interests and SLF JV I Notes of $134.7$136.8 million in aggregate, at fair value. As of September 30, 2021,2022, the Company's investment in SLF JV I consisted of LLC equity interests and SLF JV I Notes of $133.9$117.0 million in aggregate, at fair value.
As of each of December 31, 20212022, the Company and Kemper had funded approximately $190.5 million to SLF JV I, of which $166.7 million was from the Company. As of September 30, 2021,2022, the Company and Kemper had funded approximately $165.5 million to SLF JV I, of which $144.8 million was from the Company. As of each of December 31, 20212022, the Company had aggregate commitments to fund SLF JV I of $13.1 million, of which approximately $9.8 million was to fund additional SLF JV I Notes and approximately $3.3 million was to fund LLC equity interests in SLF JV I. During the three months ended December 31, 2022, the Company contributed $16.4 million to fund additional SLF JV I Notes and approximately $5.5 million to fund additional LLC equity interests in SLF JV I. As of September 30, 2021,2022, the Company had aggregate commitments to fund SLF JV I of $35.0 million, of which approximately $26.2 million was to fund additional SLF JV I Notes and approximately $8.8 million was to fund LLC equity interests in SLF JV I.
Below is a summary of SLF JV I's portfolio, followed by a listing of the individual loans in SLF JV I's portfolio as of December 31, 2021 and September 30, 2021:
December 31, 2021September 30, 2021
Senior secured loans (1)$362,106$344,196
Weighted average interest rate on senior secured loans (2)5.76%5.60%
Number of borrowers in SLF JV I6155
Largest exposure to a single borrower (1)$9,813$9,875
Total of five largest loan exposures to borrowers (1)$47,882$46,984
__________
(1) At principal amount.
(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.

46

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




SLF JV I Portfolio as of December 31, 2021
Portfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
Access CIG, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 2/27/20253.84 %Diversified Support Services$9,087 $9,062 $9,042 (4)
ADB Companies, LLCFirst Lien Term Loan, LIBOR+6.25% cash due 12/18/20257.25 %Construction & Engineering8,839 8,674 8,761 (4)
Alvogen Pharma US, Inc.First Lien Term Loan, LIBOR+5.25% cash due 12/31/20236.25 %Pharmaceuticals9,632 9,479 9,234 (4)
American Tire Distributors, Inc.First Lien Term Loan, LIBOR+6.25% cash due 10/20/20287.00 %Distributors4,897 4,836 4,937 (4)
Amplify Finco Pty Ltd.First Lien Term Loan, LIBOR+4.25% cash due 11/26/20265.00 %Movies & Entertainment7,860 7,781 7,637 (4)
Anastasia Parent, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/11/20253.97 %Personal Products1,966 1,544 1,772 
Apptio, Inc.First Lien Term Loan, LIBOR+7.25% cash due 1/10/20258.25 %Application Software4,615 4,569 4,579 (4)
Apptio, Inc.First Lien Revolver, LIBOR+7.25% cash due 1/10/20258.25 %Application Software154 150 151 (4)(5)
Total Apptio, Inc.4,769 4,719 4,730 
ASP-R-PAC Acquisition Co LLCFirst Lien Term Loan, LIBOR+6.00% cash due 12/29/20276.75 %Paper Packaging4,197 4,114 4,113 
ASP-R-PAC Acquisition Co LLCFirst Lien Revolver, LIBOR+6.00% cash due 12/29/20276.75 %Paper Packaging100 90 90 (5)
Total ASP-R-PAC Acquisition Co LLC4,297 4,204 4,203 
Astra Acquisition Corp.First Lien Term Loan, LIBOR+5.25% cash due 10/25/20285.75 %Application Software4,900 4,732 4,822 (4)
Asurion, LLCSecond Lien Term Loan, LIBOR+5.25% cash due 1/20/20295.35 %Property & Casualty Insurance1,846 1,828 1,841 
Aurora Lux Finco S.À.R.L.First Lien Term Loan, LIBOR+6.00% cash due 12/24/20267.00 %Airport Services6,386 6,273 6,048 (4)
BAART Programs, Inc.First Lien Term Loan, LIBOR+5.00% cash due 6/11/20276.00 %Health Care Services5,970 5,910 5,940 
BAART Programs, Inc.First Lien Delayed Draw Term Loan, LIBOR+5.00% cash due 6/11/20276.00 %Health Care Services992 958 974 (4)(5)
Total BAART Programs, Inc.6,962 6,868 6,914 
Blackhawk Network Holdings, Inc.First Lien Term Loan, LIBOR+3.00% cash due 6/15/20253.10 %Data Processing & Outsourced Services9,650 9,638 9,602 
Boxer Parent Company Inc.First Lien Term Loan, LIBOR+3.75% cash due 10/2/20253.97 %Systems Software3,134 3,101 3,118 
Brazos Delaware II, LLCFirst Lien Term Loan, LIBOR+4.00% cash due 5/21/20254.10 %Oil & Gas Equipment & Services7,234 7,216 7,061 
BYJU's Alpha, Inc.First Lien Term Loan, LIBOR+5.50% cash due 11/24/20266.25 %Application Software7,500 7,388 7,609 
C5 Technology Holdings, LLC171 Common UnitsData Processing & Outsourced Services— — (4)
C5 Technology Holdings, LLC7,193,539.63 Preferred UnitsData Processing & Outsourced Services7,194 5,683 (4)
Total C5 Technology Holdings, LLC7,194 5,683 
Centerline Communications, LLCFirst Lien Term Loan, LIBOR+5.50% cash due 8/10/20276.50 %Wireless Telecommunication Services1,995 1,957 1,955 
Centerline Communications, LLCFirst Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 8/10/20236.50 %Wireless Telecommunication Services1,915 1,881 1,872 (5)
Centerline Communications, LLCFirst Lien Revolver, LIBOR+5.50% cash due 8/10/20276.50 %Wireless Telecommunication Services400 389 388 (5)
Total Centerline Communications, LLC4,310 4,227 4,215 
CITGO Petroleum Corp.First Lien Term Loan, LIBOR+6.25% cash due 3/28/20247.25 %Oil & Gas Refining & Marketing7,092 7,021 7,101 (4)
City Football Group LimitedFirst Lien Term Loan, LIBOR+3.50% cash due 7/21/20284.00 %Movies & Entertainment6,500 6,468 6,476 
Connect U.S. Finco LLCFirst Lien Term Loan, LIBOR+3.50% cash due 12/11/20264.50 %Alternative Carriers4,351 4,245 4,357 
47

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Portfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
Convergeone Holdings, Inc.First Lien Term Loan, LIBOR+5.00% cash due 1/4/20265.10 %IT Consulting & Other Services$7,430 $7,223 $7,293 (4)
Curium Bidco S.à.r.l.First Lien Term Loan, LIBOR+4.00% cash due 7/9/20264.22 %Biotechnology5,865 5,821 5,872 
Dcert Buyer, Inc.First Lien Term Loan, LIBOR+4.00% cash due 10/16/20264.10 %Internet Services & Infrastructure2,878 2,871 2,876 
DirecTV Financing, LLCFirst Lien Term Loan, LIBOR+5.00% cash due 8/2/20275.75 %Cable & Satellite5,865 5,806 5,878 (4)
Domtar CorporationFirst Lien Term Loan, LIBOR+5.50% cash due 11/30/20286.25 %Paper Products2,371 2,347 2,348 
Domtar CorporationFirst Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 11/30/2028Paper Products— (11)(11)(5)
Total Domtar Corporation2,371 2,336 2,337 
eResearch Technology, Inc.First Lien Term Loan, LIBOR+4.50% cash due 2/4/20275.50 %Application Software7,388 7,314 7,422 
Gibson Brands, Inc.First Lien Term Loan, LIBOR+5.00% cash due 8/11/20285.75 %Leisure Products7,500 7,425 7,444 
Global Medical Response, Inc.First Lien Term Loan, LIBOR+4.25% cash due 3/14/20255.25 %Health Care Services1,995 1,995 1,990 (4)
Global Medical Response, Inc.First Lien Term Loan, LIBOR+4.25% cash due 10/2/20255.25 %Health Care Services2,209 2,175 2,203 
Total Global Medical Response, Inc.4,204 4,170 4,193 
Grab Holdings Inc.First Lien Term Loan, LIBOR+4.50% cash due 1/29/20265.50 %Interactive Media & Services2,978 2,905 2,994 
Indivior Finance S.À.R.L.First Lien Term Loan, LIBOR+5.25% cash due 6/30/20266.00 %Pharmaceuticals7,463 7,326 7,419 
Intelsat Jackson Holdings S.A.First Lien Term Loan, PRIME+4.75% cash due 11/27/20238.00 %Alternative Carriers3,568 3,552 3,569 
Intelsat Jackson Holdings S.A.First Lien Term Loan, LIBOR+4.75% cash due 7/13/20225.75 %Alternative Carriers5,000 4,955 5,008 
Intelsat Jackson Holdings S.A.First Lien Delayed Draw Term Loan, LIBOR+4.75% cash due 7/13/2022Alternative Carriers— (9)(5)
Total Intelsat Jackson Holdings S.A.8,568 8,498 8,579 
INW Manufacturing, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 5/7/20276.50 %Personal Products9,813 9,549 9,616 (4)
LaserAway Intermediate Holdings II, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 10/14/20276.50 %Health Care Services7,500 7,355 7,472 
Lightbox Intermediate, L.P.First Lien Term Loan, LIBOR+5.00% cash due 5/9/20265.22 %Real Estate Services7,424 7,361 7,331 (4)
LogMeIn, Inc.First Lien Term Loan, LIBOR+4.75% cash due 8/31/20274.86 %Application Software7,920 7,797 7,887 
LTI Holdings, Inc.First Lien Term Loan, LIBOR+3.50% cash due 9/6/20253.60 %Electronic Components7,423 7,318 7,347 
Maravai Intermediate Holdings, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 10/19/20274.75 %Biotechnology3,808 3,770 3,830 
Mindbody, Inc.First Lien Term Loan, LIBOR+7.00% cash 1.50% PIK due 2/14/20258.00 %Internet Services & Infrastructure4,633 4,586 4,555 (4)
Mindbody, Inc.First Lien Revolver, LIBOR+8.00% cash due 2/14/2025Internet Services & Infrastructure— (5)(8)(4)(5)
Total Mindbody, Inc.4,633 4,581 4,547 
MRI Software LLCFirst Lien Term Loan, LIBOR+5.50% cash due 2/10/20266.50 %Application Software4,009 3,975 4,006 (4)
MRI Software LLCFirst Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 2/10/2026Application Software— (5)(2)(5)
MRI Software LLCFirst Lien Revolver, LIBOR+5.50% cash due 2/10/2026Application Software— (3)— (4)(5)
Total MRI Software LLC4,009 3,967 4,004 
Northern Star Industries Inc.First Lien Term Loan, LIBOR+4.75% cash due 3/31/20255.75 %Electrical Components & Equipment6,738 6,722 6,754 
OEConnection LLCFirst Lien Term Loan, LIBOR+4.00% cash due 9/25/20264.10 %Application Software7,836 7,800 7,827 (4)
Olaplex, Inc.First Lien Term Loan, LIBOR+6.25% cash due 1/8/20267.25 %Personal Products6,232 6,153 6,247 (4)
Olaplex, Inc.First Lien Revolver, LIBOR+6.25% cash due 1/8/2025Personal Products— (7)(3)(4)(5)
Total Olaplex, Inc.6,232 6,146 6,244 
48

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








Portfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
Park Place Technologies, LLCFirst Lien Term Loan, LIBOR+5.00% cash due 11/10/20276.00 %Internet Services & Infrastructure$4,963 $4,796 $4,964 (4)
Planview Parent, Inc.Second Lien Term Loan, LIBOR+7.25% cash due 12/18/20288.00 %Application Software4,503 4,435 4,514 (4)
Pluralsight, LLCFirst Lien Term Loan, LIBOR+8.00% cash due 4/6/20279.00 %Application Software6,795 6,675 6,676 (4)
Pluralsight, LLCFirst Lien Revolver, LIBOR+8.00% cash due 4/6/2027Application Software— (7)(7)(4)(5)
Total Pluralsight, LLC6,795 6,668 6,669 
RevSpring, Inc.First Lien Term Loan, LIBOR+4.25% cash due 10/11/20254.47 %Commercial Printing9,700 9,677 9,736 
Sabert CorporationFirst Lien Term Loan, LIBOR+4.50% cash due 12/10/20265.50 %Metal & Glass Containers2,657 2,631 2,661 (4)
SHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.23% cash due 4/27/20246.23 %Footwear138 138 131 
SHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.25% cash due 4/27/20246.25 %Footwear8,266 8,256 7,853 
Total SHO Holding I Corporation8,404 8,394 7,984 
Sirva Worldwide, Inc.First Lien Term Loan, LIBOR+5.50% cash due 8/4/20255.60 %Diversified Support Services1,079 1,063 982 (4)
Sorenson Communications, LLCFirst Lien Term Loan, LIBOR+5.50% cash due 3/17/20266.25 %Communications Equipment2,766 2,739 2,779 
Spanx, LLCFirst Lien Term Loan, LIBOR+5.50% cash due 11/18/20286.25 %Apparel Retail9,000 8,823 8,820 (4)
Star US Bidco LLCFirst Lien Term Loan, LIBOR+4.25% cash due 3/17/20275.25 %Industrial Machinery5,428 5,281 5,424 
Supermoose Borrower, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/29/20253.97 %Application Software7,803 7,469 7,387 (4)
Surgery Center Holdings, Inc.First Lien Term Loan, LIBOR+3.75% cash due 8/31/20264.50 %Health Care Facilities3,403 3,391 3,406 
Touchstone Acquisition, Inc.First Lien Term Loan, LIBOR+6.00% cash due 12/21/20286.75 %Health Care Supplies7,322 7,176 7,176 (4)
Trench Plate Rental, Co.First Lien Term Loan, LIBOR+4.75% cash due 12/3/20265.75 %Construction Materials3,930 3,872 3,872 
Trench Plate Rental, Co.First Lien Delayed Draw Term Loan, LIBOR+4.75% cash due 12/3/2026Construction Materials— (11)(11)(5)
Trench Plate Rental, Co.First Lien Revolver, LIBOR+4.75% cash due 12/3/20265.75 %Construction Materials24 16 15 (5)
Total Trench Plate Rental, Co.3,954 3,877 3,876 
Veritas US Inc.First Lien Term Loan, LIBOR+5.00% cash due 9/1/20256.00 %Application Software6,419 6,324 6,427 (4)
Verscend Holding Corp.First Lien Term Loan, LIBOR+4.00% cash due 8/27/20254.10 %Health Care Technology1,078 1,065 1,079 
Waystar Technologies, Inc.First Lien Term Loan, LIBOR+4.00% cash due 10/22/20264.10 %Health Care Technology5,895 5,866 5,897 
Windstream Services II, LLCFirst Lien Term Loan, LIBOR+6.25% cash due 9/21/20277.25 %Integrated Telecommunication Services7,879 7,621 7,916 (4)
WP CPP Holdings, LLCSecond Lien Term Loan, LIBOR+7.75% cash due 4/30/20268.75 %Aerospace & Defense6,000 5,966 5,883 (4)
Total Portfolio Investments$362,106 $363,821 $363,909 
Below is a summary of SLF JV I's portfolio, followed by a listing of the individual loans in SLF JV I's portfolio as of December 31, 2022 and September 30, 2022:
December 31, 2022September 30, 2022
Senior secured loans (1)$382,148$383,194
Weighted average interest rate on senior secured loans (2)9.55%8.33%
Number of borrowers in SLF JV I5960
Largest exposure to a single borrower (1)$11,337$10,093
Total of five largest loan exposures to borrowers (1)$51,990$48,139
__________
(1) At principal amount.
(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.

49

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




SLF JV I Portfolio as of December 31, 2022
Portfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
Access CIG, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 2/27/20257.82 %Diversified Support Services$10,067 $10,008 $9,883 
ADB Companies, LLCFirst Lien Term Loan, SOFR+6.25% cash due 12/18/202511.34 %Construction & Engineering8,413 8,296 8,267 (4)
Altice France S.A.First Lien Term Loan, LIBOR+4.00% cash due 8/14/20268.65 %Integrated Telecommunication Services2,992 2,844 2,791 
Alvogen Pharma US, Inc.First Lien Term Loan, SOFR+7.50% cash due 6/30/202512.23 %Pharmaceuticals9,150 9,060 9,104 (4)
American Rock Salt Company LLCFirst Lien Term Loan, LIBOR+4.00% cash due 6/9/20288.38 %Diversified Metals & Mining1,995 1,836 1,883 
American Tire Distributors, Inc.First Lien Term Loan, LIBOR+6.25% cash due 10/20/202810.61 %Distributors4,860 4,800 4,471 (4)
Amplify Finco Pty Ltd.First Lien Term Loan, LIBOR+4.25% cash due 11/26/20268.98 %Movies & Entertainment7,780 7,702 7,501 (4)
Anastasia Parent, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/11/20258.48 %Personal Products1,535 1,200 1,149 (4)
Apptio, Inc.First Lien Term Loan, LIBOR+6.00% cash due 1/10/20259.94 %Application Software4,615 4,584 4,523 (4)
Apptio, Inc.First Lien Revolver, LIBOR+6.00% cash due 1/10/20259.94 %Application Software231 228 223 (4)(5)
Total Apptio, Inc.4,846 4,812 4,746 
ASP-R-PAC Acquisition Co LLCFirst Lien Term Loan, LIBOR+6.00% cash due 12/29/202710.38 %Paper Packaging4,166 4,097 4,012 
ASP-R-PAC Acquisition Co LLCFirst Lien Revolver, LIBOR+6.00% cash due 12/29/2027Paper Packaging— (8)(18)(5)
Total ASP-R-PAC Acquisition Co LLC4,166 4,089 3,994 
Astra Acquisition Corp.First Lien Term Loan, LIBOR+5.25% cash due 10/25/20289.63 %Application Software5,052 4,866 4,484 (4)
Asurion, LLCFirst Lien Term Loan, SOFR+4.00% cash due 8/19/20288.68 %Property & Casualty Insurance4,988 4,752 4,463 
Asurion, LLCSecond Lien Term Loan, LIBOR+5.25% cash due 1/20/20299.63 %Property & Casualty Insurance4,346 3,995 3,404 
Total Asurion, LLC9,334 8,747 7,867 
athenahealth Group Inc.First Lien Term Loan, SOFR+3.50% cash due 2/15/20297.82 %Health Care Technology2,558 2,353 2,316 
athenahealth Group Inc.First Lien Delayed Draw Term Loan, SOFR+3.50% cash due 2/15/20297.82 %Health Care Technology109 74 68 (5)
Total athenahealth Group Inc.2,667 2,427 2,384 
Aurora Lux Finco S.À.R.L.First Lien Term Loan, LIBOR+6.00% cash due 12/24/202610.32 %Airport Services6,321 6,232 6,012 (4)
BAART Programs, Inc.First Lien Term Loan, LIBOR+5.00% cash due 6/11/20279.07 %Health Care Services6,354 6,295 6,176 
BAART Programs, Inc.First Lien Delayed Draw Term Loan, LIBOR+5.00% cash due 6/11/20279.73 %Health Care Services1,767 1,747 1,682 (4)(5)
Total BAART Programs, Inc.8,121 8,042 7,858 
Blackhawk Network Holdings, Inc.First Lien Term Loan, LIBOR+3.00% cash due 6/15/20257.08 %Data Processing & Outsourced Services9,550 9,542 9,331 
Boxer Parent Company Inc.First Lien Term Loan, LIBOR+3.75% cash due 10/2/20258.13 %Systems Software1,994 1,917 1,914 
BYJU's Alpha, Inc.First Lien Term Loan, LIBOR+6.00% cash due 11/24/202610.70 %Application Software7,425 7,335 5,988 
C5 Technology Holdings, LLC171 Common UnitsData Processing & Outsourced Services— — (4)
C5 Technology Holdings, LLC7,193,539.63 Preferred UnitsData Processing & Outsourced Services7,194 5,683 (4)
Total C5 Technology Holdings, LLC7,194 5,683 
Cengage Learning, Inc.First Lien Term Loan, LIBOR+4.75% cash due 7/14/20267.81 %Education Services2,992 2,734 2,698 
50

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Portfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
Centerline Communications, LLCFirst Lien Term Loan, SOFR+5.50% cash due 8/10/202310.43 %Wireless Telecommunication Services$6,345 $6,242 $6,231 
Centerline Communications, LLCFirst Lien Revolver, SOFR+5.50% cash due 8/10/2027Wireless Telecommunication Services— (10)(10)(5)
Total Centerline Communications, LLC6,345 6,232 6,221 
Convergeone Holdings, Inc.First Lien Term Loan, LIBOR+5.00% cash due 1/4/20269.38 %IT Consulting & Other Services7,354 7,200 4,309 (4)
Covetrus, Inc.First Lien Term Loan, SOFR+5.00% cash due 9/20/20299.58 %Health Care Distributors5,375 5,053 5,050 (4)
Curium Bidco S.à.r.l.First Lien Term Loan, LIBOR+4.00% cash due 7/9/20268.73 %Biotechnology7,800 7,726 7,644 
Curium Bidco S.à.r.l.First Lien Term Loan, LIBOR+4.25% cash due 12/2/20278.98 %Biotechnology997 978 975 
Total Curium Bidco S.à.r.l.8,797 8,704 8,619 
DirecTV Financing, LLCFirst Lien Term Loan, LIBOR+5.00% cash due 8/2/20279.38 %Cable & Satellite6,277 6,178 6,124 (4)
Domtar CorporationFirst Lien Term Loan, LIBOR+5.50% cash due 11/30/20289.79 %Paper Products4,090 4,055 3,926 
DTI Holdco, Inc.First Lien Term Loan, SOFR+4.75% cash due 4/26/20298.84 %Research & Consulting Services7,980 7,835 7,372 (4)
eResearch Technology, Inc.First Lien Term Loan, LIBOR+4.50% cash due 2/4/20278.88 %Application Software7,811 7,681 6,915 
Gibson Brands, Inc.First Lien Term Loan, LIBOR+5.00% cash due 8/11/20289.13 %Leisure Products7,425 7,351 5,495 
Global Medical Response, Inc.First Lien Term Loan, LIBOR+4.25% cash due 10/2/20258.42 %Health Care Services1,260 1,246 891 
Harbor Purchaser Inc.First Lien Term Loan, SOFR+5.25% cash due 4/9/20299.67 %Education Services7,980 7,764 7,613 (4)
Indivior Finance S.À.R.L.First Lien Term Loan, SOFR+5.25% cash due 6/30/202610.09 %Pharmaceuticals7,388 7,282 7,277 
INW Manufacturing, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 3/25/202710.48 %Personal Products9,375 9,172 8,016 (4)
Iris Holding, Inc.First Lien Term Loan, SOFR+4.75% cash due 6/28/20288.94 %Metal & Glass Containers4,988 4,630 4,548 
LABL, Inc.First Lien Term Loan, LIBOR+5.00% cash due 10/29/20289.38 %Office Services & Supplies2,992 2,858 2,848 
LaserAway Intermediate Holdings II, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 10/14/20279.76 %Health Care Services7,425 7,306 7,295 
Lightbox Intermediate, L.P.First Lien Term Loan, LIBOR+5.00% cash due 5/9/20269.73 %Real Estate Services11,337 11,152 10,941 (4)
LogMeIn, Inc.First Lien Term Loan, LIBOR+4.75% cash due 8/31/20279.14 %Application Software7,840 7,736 5,080 
LTI Holdings, Inc.First Lien Term Loan, LIBOR+3.50% cash due 9/6/20257.88 %Electronic Components7,347 7,270 7,050 
McAfee Corp.First Lien Term Loan, SOFR+3.75% cash due 3/1/20297.97 %Systems Software1,995 1,876 1,862 
Mindbody, Inc.First Lien Term Loan, LIBOR+7.00% cash due 2/14/202511.72 %Internet Services & Infrastructure4,668 4,636 4,566 (4)
Mindbody, Inc.First Lien Revolver, LIBOR+8.00% cash due 2/14/2025Internet Services & Infrastructure— (3)(10)(4)(5)
Total Mindbody, Inc.4,668 4,633 4,556 
MRI Software LLCFirst Lien Term Loan, LIBOR+5.50% cash due 2/10/202610.23 %Application Software10,611 10,416 10,227 (4)
MRI Software LLCFirst Lien Revolver, LIBOR+5.50% cash due 2/10/2026Application Software— (3)(12)(4)(5)
Total MRI Software LLC10,611 10,413 10,215 
Northern Star Industries Inc.First Lien Term Loan, LIBOR+4.50% cash due 3/31/20259.23 %Electrical Components & Equipment6,668 6,657 6,467 
OEConnection LLCFirst Lien Term Loan, SOFR+4.00% cash due 9/25/20268.42 %Application Software7,757 7,721 7,411 (4)
51

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Portfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
Park Place Technologies, LLCFirst Lien Term Loan, SOFR+5.00% cash due 11/10/20279.42 %Internet Services & Infrastructure$9,900 $9,504 $9,362 (4)
Planview Parent, Inc.First Lien Term Loan, LIBOR+4.00% cash due 12/17/20278.73 %Application Software2,435 2,294 2,274 
Planview Parent, Inc.Second Lien Term Loan, LIBOR+7.25% cash due 12/18/202811.98 %Application Software4,503 4,435 4,041 (4)
Total Planview Parent, Inc.6,938 6,729 6,315 
Pluralsight, LLCFirst Lien Term Loan, LIBOR+8.00% cash due 4/6/202711.83 %Application Software6,796 6,698 6,626 (4)
Pluralsight, LLCFirst Lien Revolver, LIBOR+8.00% cash due 4/6/2027Application Software212 206 201 (4)(5)
Total Pluralsight, LLC7,008 6,904 6,827 
RevSpring, Inc.First Lien Term Loan, LIBOR+4.00% cash due 10/11/20258.73 %Commercial Printing9,600 9,583 9,288 
SHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.25% cash due 4/27/20249.66 %Footwear8,179 8,173 6,339 
SHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.23% cash due 4/27/20249.64 %Footwear138 138 120 
Total SHO Holding I Corporation8,317 8,311 6,459 
Sorenson Communications, LLCFirst Lien Term Loan, LIBOR+5.50% cash due 3/17/202610.23 %Communications Equipment2,478 2,454 2,374 
Spanx, LLCFirst Lien Term Loan, LIBOR+5.25% cash due 11/20/20289.64 %Apparel Retail8,910 8,760 8,699 (4)
SPX Flow, Inc.First Lien Term Loan, SOFR+4.50% cash due 4/5/20298.92 %Industrial Machinery10,075 9,610 9,436 (4)
Supermoose Borrower, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/29/20258.48 %Application Software7,723 7,482 6,688 (4)
Surgery Center Holdings, Inc.First Lien Term Loan, LIBOR+3.75% cash due 8/31/20268.05 %Health Care Facilities3,044 3,034 3,014 
TIBCO Software Inc.First Lien Term Loan, SOFR+4.50% cash due 3/20/20299.18 %Application Software6,256 5,712 5,602 (4)
Touchstone Acquisition, Inc.First Lien Term Loan, LIBOR+6.00% cash due 12/29/202810.38 %Health Care Supplies7,267 7,142 7,104 (4)
Veritas US Inc.First Lien Term Loan, LIBOR+5.00% cash due 9/1/20259.73 %Application Software6,354 6,286 4,515 
Windstream Services II, LLCFirst Lien Term Loan, SOFR+6.25% cash due 9/21/202710.67 %Integrated Telecommunication Services7,798 7,587 7,092 (4)
WP CPP Holdings, LLCSecond Lien Term Loan, LIBOR+7.75% cash due 4/30/202612.17 %Aerospace & Defense6,000 5,974 5,055 (4)
WP CPP Holdings, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 4/30/20258.17 %Aerospace & Defense1,980 1,913 1,732 (4)
Total WP CPP Holdings, LLC7,980 7,887 6,787 
Zayo Group Holdings, Inc.First Lien Term Loan, LIBOR+3.00% cash due 3/9/20277.38 %Alternative Carriers2,155 2,009 1,756 
Total Portfolio Investments$382,148 $380,682 $355,427 
_________
(1) Represents the interest rate as of December 31, 2021.2022. All interest rates are payable in cash, unless otherwise noted.
(2) The interest rate on the principal balance outstanding for allmost of the floating rate loans is indexed to LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to SOFR. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over LIBOR or the alternate base ratereference rates based on each respective credit agreement and the cash interest rate as of period end. All the LIBOR shown above is in U.S. dollars. As of December 31, 2021,2022, the reference rates for SLF JV I's variable rate loans were the 30-day LIBOR at 0.10%, the 60-day LIBOR at 0.16%4.38%, the 90-day LIBOR at 0.22%4.73%, the 180-day LIBOR30-day SOFR at 0.35%4.32%, the 360-day LIBOR90-day SOFR at 0.59%4.58% and the PRIME180-day SOFR at 3.25%4.79%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
(3) Represents the current determination of fair value as of December 31, 20212022 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the Company's Board of Directors' valuation process described elsewhere herein.
(4) This investment was held by both the Company and SLF JV I as of December 31, 2021.2022.
(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
4952

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








SLF JV I Portfolio as of September 30, 20212022


Portfolio CompanyPortfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)NotesPortfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
Access CIG, LLCAccess CIG, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 2/27/20253.83 %Diversified Support Services$9,111 $9,084 $9,078 (4)Access CIG, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 2/27/20256.82 %Diversified Support Services$10,093 $10,028 $9,692 
ADB Companies, LLCADB Companies, LLCFirst Lien Term Loan, LIBOR+6.25% cash due 12/18/20257.25 %Construction & Engineering7,732 7,566 7,644 (4)ADB Companies, LLCFirst Lien Term Loan, SOFR+6.25% cash due 12/18/20259.80 %Construction & Engineering8,518 8,389 8,371 (4)
Altice France S.A.Altice France S.A.First Lien Term Loan, LIBOR+4.00% cash due 8/14/20264.12 %Integrated Telecommunication Services2,596 2,468 2,591 Altice France S.A.First Lien Term Loan, LIBOR+4.00% cash due 8/14/20266.91 %Integrated Telecommunication Services3,000 2,841 2,730 
Alvogen Pharma US, Inc.Alvogen Pharma US, Inc.First Lien Term Loan, LIBOR+5.25% cash due 12/31/20236.25 %Pharmaceuticals9,755 9,580 9,443 (4)Alvogen Pharma US, Inc.First Lien Term Loan, SOFR+7.50% cash due 6/30/202511.20 %Pharmaceuticals9,267 9,166 9,221 (4)
American Tire Distributors, Inc.American Tire Distributors, Inc.First Lien Term Loan, LIBOR+6.25% cash due 10/20/20289.03 %Distributors4,873 4,812 4,576 (4)
Amplify Finco Pty Ltd.Amplify Finco Pty Ltd.First Lien Term Loan, LIBOR+4.25% cash due 11/26/20265.00 %Movies & Entertainment7,880 7,801 7,680 (4)Amplify Finco Pty Ltd.First Lien Term Loan, LIBOR+4.25% cash due 11/26/20267.92 %Movies & Entertainment7,800 7,722 7,527 (4)
Anastasia Parent, LLCAnastasia Parent, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/11/20253.88 %Personal Products2,799 2,211 2,378 Anastasia Parent, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/11/20257.42 %Personal Products1,539 1,203 1,232 (4)
Apptio, Inc.Apptio, Inc.First Lien Term Loan, LIBOR+7.25% cash due 1/10/20258.25 %Application Software4,615 4,565 4,544 (4)Apptio, Inc.First Lien Term Loan, LIBOR+6.00% cash due 1/10/20258.46 %Application Software4,615 4,580 4,519 (4)
Apptio, Inc.Apptio, Inc.First Lien Revolver, LIBOR+7.25% cash due 1/10/20258.25 %Application Software154 150 148 (4)(5)Apptio, Inc.First Lien Revolver, LIBOR+6.00% cash due 1/10/20258.46 %Application Software154 151 146 (4)(5)
Total Apptio, Inc.Total Apptio, Inc.4,769 4,715 4,692 Total Apptio, Inc.4,769 4,731 4,665 
ASP-R-PAC Acquisition Co LLCASP-R-PAC Acquisition Co LLCFirst Lien Term Loan, LIBOR+6.00% cash due 12/29/20279.67 %Paper Packaging4,176 4,103 4,080 
ASP-R-PAC Acquisition Co LLCASP-R-PAC Acquisition Co LLCFirst Lien Revolver, LIBOR+6.00% cash due 12/29/2027Paper Packaging— (9)(11)(5)
Total ASP-R-PAC Acquisition Co LLCTotal ASP-R-PAC Acquisition Co LLC4,176 4,094 4,069 
Astra Acquisition Corp.Astra Acquisition Corp.First Lien Term Loan, LIBOR+5.25% cash due 10/25/20288.37 %Application Software5,052 4,858 4,319 (4)
Asurion, LLCAsurion, LLCSecond Lien Term Loan, LIBOR+5.25% cash due 1/20/20295.33 %Property & Casualty Insurance6,000 5,940 5,980 Asurion, LLCFirst Lien Term Loan, SOFR+4.00% cash due 8/19/20287.70 %Property & Casualty Insurance5,000 4,753 4,276 
Asurion, LLCAsurion, LLCSecond Lien Term Loan, LIBOR+5.25% cash due 1/20/20298.37 %Property & Casualty Insurance4,346 3,981 3,347 
Total Asurion, LLCTotal Asurion, LLC9,346 8,734 7,623 
Aurora Lux Finco S.À.R.L.Aurora Lux Finco S.À.R.L.First Lien Term Loan, LIBOR+6.00% cash due 12/24/20267.00 %Airport Services6,403 6,283 6,025 (4)Aurora Lux Finco S.À.R.L.First Lien Term Loan, LIBOR+6.00% cash due 12/24/20268.78 %Airport Services6,338 6,242 6,027 (4)
BAART Programs, Inc.BAART Programs, Inc.First Lien Term Loan, LIBOR+5.00% cash due 6/11/20276.00 %Health Care Services5,985 5,925 5,970 BAART Programs, Inc.First Lien Term Loan, LIBOR+5.00% cash due 6/11/20278.12 %Health Care Services6,371 6,311 6,148 
BAART Programs, Inc.BAART Programs, Inc.First Lien Delayed Draw Term Loan, LIBOR+5.00% cash due 6/11/20276.00 %Health Care Services450 436 446 (5)BAART Programs, Inc.First Lien Delayed Draw Term Loan, LIBOR+5.00% cash due 6/11/20278.12 %Health Care Services1,771 1,751 1,664 (4)(5)
Total BAART Programs, Inc.Total BAART Programs, Inc.6,435 6,361 6,416 Total BAART Programs, Inc.8,142 8,062 7,812 
Blackhawk Network Holdings, Inc.Blackhawk Network Holdings, Inc.First Lien Term Loan, LIBOR+3.00% cash due 6/15/20253.08 %Data Processing & Outsourced Services9,675 9,662 9,615 Blackhawk Network Holdings, Inc.First Lien Term Loan, LIBOR+3.00% cash due 6/15/20256.03 %Data Processing & Outsourced Services9,575 9,566 8,977 
Boxer Parent Company Inc.First Lien Term Loan, LIBOR+3.75% cash due 10/2/20253.88 %Systems Software6,643 6,570 6,615 
Brazos Delaware II, LLCFirst Lien Term Loan, LIBOR+4.00% cash due 5/21/20254.08 %Oil & Gas Equipment & Services7,253 7,234 7,158 
BYJU's Alpha, Inc.BYJU's Alpha, Inc.First Lien Term Loan, LIBOR+6.00% cash due 11/24/20268.98 %Application Software7,444 7,347 5,455 
C5 Technology Holdings, LLCC5 Technology Holdings, LLC171 Common UnitsData Processing & Outsourced Services— — (4)C5 Technology Holdings, LLC171 Common UnitsData Processing & Outsourced Services— — (4)
C5 Technology Holdings, LLCC5 Technology Holdings, LLC7,193,539.63 Preferred UnitsData Processing & Outsourced Services7,194 5,683 (4)C5 Technology Holdings, LLC7,193,539.63 Preferred UnitsData Processing & Outsourced Services7,194 5,683 (4)
Total C5 Technology Holdings, LLCTotal C5 Technology Holdings, LLC7,194 5,683 Total C5 Technology Holdings, LLC7,194 5,683 
Centerline Communications, LLCCenterline Communications, LLCFirst Lien Term Loan, LIBOR+5.50% cash due 8/10/20276.50 %Wireless Telecommunication Services2,000 1,961 1,960 Centerline Communications, LLCFirst Lien Term Loan, SOFR+5.50% cash due 8/10/20279.12 %Wireless Telecommunication Services4,358 4,286 4,280 
Centerline Communications, LLCCenterline Communications, LLCFirst Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 8/10/20236.50 %Wireless Telecommunication Services1,920 1,890 1,889 (5)Centerline Communications, LLCFirst Lien Delayed Draw Term Loan, SOFR+5.50% cash due 8/10/20279.12 %Wireless Telecommunication Services449 432 413 (5)
Centerline Communications, LLCCenterline Communications, LLCFirst Lien Revolver, LIBOR+5.50% cash due 8/10/2027Wireless Telecommunication Services— (12)(12)(5)Centerline Communications, LLCFirst Lien Revolver, SOFR+5.50% cash due 8/10/2027Wireless Telecommunication Services— (10)(11)(5)
Total Centerline Communications, LLCTotal Centerline Communications, LLC3,920 3,839 3,837 Total Centerline Communications, LLC4,807 4,708 4,682 
CITGO Petroleum Corp.First Lien Term Loan, LIBOR+6.25% cash due 3/28/20247.25 %Oil & Gas Refining & Marketing7,111 7,040 7,134 (4)
City Football Group LimitedFirst Lien Term Loan, LIBOR+3.50% cash due 7/21/20284.00 %Movies & Entertainment6,500 6,468 6,492 
Connect U.S. Finco LLCFirst Lien Term Loan, LIBOR+3.50% cash due 12/11/20264.50 %Alternative Carriers7,362 7,204 7,376 
Convergeone Holdings, Inc.First Lien Term Loan, LIBOR+5.00% cash due 1/4/20265.08 %IT Consulting & Other Services7,449 7,229 7,427 (4)
Curium Bidco S.à.r.l.First Lien Term Loan, LIBOR+4.00% cash due 7/9/20264.13 %Biotechnology5,880 5,836 5,884 
Dcert Buyer, Inc.First Lien Term Loan, LIBOR+4.00% cash due 10/16/20264.08 %Internet Services & Infrastructure5,885 5,870 5,893 
DirecTV Financing, LLCFirst Lien Term Loan, LIBOR+5.00% cash due 8/2/20275.75 %Cable & Satellite6,000 5,940 6,011 (4)
Enviva Holdings, LPFirst Lien Term Loan, LIBOR+5.50% cash due 2/17/20266.50 %Forest Products5,878 5,819 5,893 
5053

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








Portfolio CompanyPortfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)NotesPortfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
CITGO Petroleum Corp.CITGO Petroleum Corp.First Lien Term Loan, LIBOR+6.25% cash due 3/28/20249.37 %Oil & Gas Refining & Marketing$7,038 $6,967 $7,057 (4)
City Football Group LimitedCity Football Group LimitedFirst Lien Term Loan, LIBOR+3.50% cash due 7/21/20286.48 %Movies & Entertainment6,451 6,419 6,166 
Convergeone Holdings, Inc.Convergeone Holdings, Inc.First Lien Term Loan, LIBOR+5.00% cash due 1/4/20268.12 %IT Consulting & Other Services7,373 7,206 5,320 (4)
Covetrus, Inc.Covetrus, Inc.First Lien Term Loan, SOFR+5.00% cash due 9/20/20297.65 %Health Care Distributors5,375 5,053 5,035 (4)
Curium Bidco S.à.r.l.Curium Bidco S.à.r.l.First Lien Term Loan, LIBOR+4.00% cash due 7/9/20267.67 %Biotechnology5,820 5,776 5,587 
Dealer Tire, LLCDealer Tire, LLCFirst Lien Term Loan, LIBOR+4.25% cash due 12/12/20257.37 %Distributors2,992 2,935 2,924 
Delivery Hero FinCo LLCDelivery Hero FinCo LLCFirst Lien Term Loan, SOFR+5.75% cash due 8/12/20278.49 %Internet & Direct Marketing Retail6,035 5,876 5,756 (4)
DirecTV Financing, LLCDirecTV Financing, LLCFirst Lien Term Loan, LIBOR+5.00% cash due 8/2/20278.12 %Cable & Satellite6,436 6,332 6,012 (4)
Domtar CorporationDomtar CorporationFirst Lien Term Loan, LIBOR+5.50% cash due 11/30/20288.26 %Paper Products4,100 4,065 3,921 
DTI Holdco, Inc.DTI Holdco, Inc.First Lien Term Loan, SOFR+4.75% cash due 4/26/20297.33 %Research & Consulting Services8,000 7,849 7,616 (4)
Eagle Parent Corp.Eagle Parent Corp.First Lien Term Loan, SOFR+4.25% cash due 4/1/20297.80 %Industrial Machinery4,478 4,373 4,367 
eResearch Technology, Inc.eResearch Technology, Inc.First Lien Term Loan, LIBOR+4.50% cash due 2/4/20275.50 %Application Software$7,406 $7,332 $7,451 eResearch Technology, Inc.First Lien Term Loan, LIBOR+4.50% cash due 2/4/20277.62 %Application Software7,331 7,258 6,859 
GI Chill Acquisition LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/6/20253.90 %Managed Health Care3,721 3,737 3,712 (4)
GI Chill Acquisition LLCSecond Lien Term Loan, LIBOR+7.50% cash due 8/6/20267.63 %Managed Health Care3,750 3,674 3,731 (4)
Total GI Chill Acquisition LLC7,471 7,411 7,443 
Gibson Brands, Inc.Gibson Brands, Inc.First Lien Term Loan, LIBOR+5.00% cash due 8/11/20285.75 %Leisure Products7,500 7,425 7,463 Gibson Brands, Inc.First Lien Term Loan, LIBOR+5.00% cash due 8/11/20287.94 %Leisure Products7,444 7,369 6,029 
Global Medical Response, Inc.Global Medical Response, Inc.First Lien Term Loan, LIBOR+4.75% cash due 10/2/20255.75 %Health Care Services2,214 2,178 2,226 Global Medical Response, Inc.First Lien Term Loan, LIBOR+4.25% cash due 3/14/20257.37 %Health Care Services1,979 1,979 1,722 (4)
Global Medical Response, Inc.Global Medical Response, Inc.First Lien Term Loan, LIBOR+4.25% cash due 3/14/20255.25 %Health Care Services1,995 1,995 2,004 (4)Global Medical Response, Inc.First Lien Term Loan, LIBOR+4.25% cash due 10/2/20256.81 %Health Care Services2,192 2,165 1,912 
Total Global Medical Response, Inc.Total Global Medical Response, Inc.4,209 4,173 4,230 Total Global Medical Response, Inc.4,171 4,144 3,634 
Grab Holdings Inc.First Lien Term Loan, LIBOR+4.50% cash due 1/29/20265.50 %Interactive Media & Services2,985 2,907 3,025 
Harbor Purchaser Inc.Harbor Purchaser Inc.First Lien Term Loan, SOFR+5.25% cash due 4/9/20298.38 %Education Services8,000 7,774 7,310 (4)
Indivior Finance S.À.R.L.Indivior Finance S.À.R.L.First Lien Term Loan, LIBOR+5.25% cash due 6/30/20266.00 %Pharmaceuticals7,481 7,336 7,456 Indivior Finance S.À.R.L.First Lien Term Loan, SOFR+5.25% cash due 6/30/20268.80 %Pharmaceuticals7,406 7,293 7,286 
Intelsat Jackson Holdings S.A.First Lien Term Loan, PRIME+4.75% cash due 11/27/20238.00 %Alternative Carriers3,568 3,550 3,622 
Intelsat Jackson Holdings S.A.First Lien Term Loan, LIBOR+4.75% cash due 7/13/20225.75 %Alternative Carriers5,000 4,935 5,044 
Intelsat Jackson Holdings S.A.First Lien Delayed Draw Term Loan, LIBOR+4.75% cash due 7/13/2022Alternative Carriers— (13)(5)
Total Intelsat Jackson Holdings S.A.8,568 8,472 8,675 
INW Manufacturing, LLCINW Manufacturing, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 5/7/20276.50 %Personal Products9,875 9,597 9,678 (4)INW Manufacturing, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 3/25/20279.42 %Personal Products9,500 9,282 8,408 (4)
Iris Holding, Inc.Iris Holding, Inc.First Lien Term Loan, SOFR+4.75% cash due 6/28/20287.89 %Metal & Glass Containers5,000 4,624 4,610 
LaserAway Intermediate Holdings II, LLCLaserAway Intermediate Holdings II, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 10/14/20278.23 %Health Care Services7,444 7,318 7,323 
Lightbox Intermediate, L.P.Lightbox Intermediate, L.P.First Lien Term Loan, LIBOR+5.00% cash due 5/9/20265.13 %Real Estate Services7,443 7,377 7,405 (4)Lightbox Intermediate, L.P.First Lien Term Loan, LIBOR+5.00% cash due 5/9/20268.67 %Real Estate Services7,367 7,315 7,109 (4)
LogMeIn, Inc.LogMeIn, Inc.First Lien Term Loan, LIBOR+4.75% cash due 8/31/20274.83 %Application Software7,940 7,812 7,946 (4)LogMeIn, Inc.First Lien Term Loan, LIBOR+4.75% cash due 8/31/20277.80 %Application Software7,860 7,751 5,494 
LTI Holdings, Inc.LTI Holdings, Inc.First Lien Term Loan, LIBOR+3.50% cash due 9/6/20253.58 %Electronic Components7,442 7,329 7,354 LTI Holdings, Inc.First Lien Term Loan, LIBOR+3.25% cash due 9/6/20256.37 %Electronic Components7,366 7,282 6,835 
Maravai Intermediate Holdings, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 10/19/20274.75 %Biotechnology6,819 6,751 6,846 
Mindbody, Inc.Mindbody, Inc.First Lien Term Loan, LIBOR+7.00% cash 1.50% PIK due 2/14/20258.00 %Internet Services & Infrastructure4,616 4,565 4,528 (4)Mindbody, Inc.First Lien Term Loan, LIBOR+7.00% cash 1.50% PIK due 2/14/202510.64 %Internet Services & Infrastructure4,687 4,651 4,570 (4)
Mindbody, Inc.Mindbody, Inc.First Lien Revolver, LIBOR+8.00% cash due 2/14/2025Internet Services & Infrastructure— (6)(9)(4)(5)Mindbody, Inc.First Lien Revolver, LIBOR+8.00% cash due 2/14/2025Internet Services & Infrastructure— (4)(12)(4)(5)
Total Mindbody, Inc.Total Mindbody, Inc.4,616 4,559 4,519 Total Mindbody, Inc.4,687 4,647 4,558 
MRI Software LLCMRI Software LLCFirst Lien Term Loan, LIBOR+5.50% cash due 2/10/20266.50 %Application Software3,877 3,843 3,875 (4)MRI Software LLCFirst Lien Term Loan, LIBOR+5.50% cash due 2/10/20269.17 %Application Software6,139 6,104 5,966 (4)
MRI Software LLCMRI Software LLCFirst Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 2/10/2026Application Software— (6)(1)(4)(5)MRI Software LLCFirst Lien Revolver, LIBOR+5.50% cash due 2/10/2026Application Software— (3)(10)(4)(5)
MRI Software LLCFirst Lien Revolver, LIBOR+5.50% cash due 2/10/2026Application Software— (3)— (4)(5)
Total MRI Software LLCTotal MRI Software LLC3,877 3,834 3,874 Total MRI Software LLC6,139 6,101 5,956 
Northern Star Industries Inc.Northern Star Industries Inc.First Lien Term Loan, LIBOR+4.50% cash due 3/31/20255.50 %Electrical Components & Equipment6,755 6,738 6,738 Northern Star Industries Inc.First Lien Term Loan, LIBOR+4.75% cash due 3/31/20257.87 %Electrical Components & Equipment6,685 6,673 6,484 
OEConnection LLCOEConnection LLCFirst Lien Term Loan, LIBOR+4.00% cash due 9/25/20264.08 %Application Software7,852 7,816 7,842 (4)OEConnection LLCFirst Lien Term Loan, LIBOR+4.00% cash due 9/25/20267.12 %Application Software7,777 7,741 7,505 (4)
Olaplex, Inc.First Lien Term Loan, LIBOR+6.25% cash due 1/8/20267.25 %Personal Products6,273 6,189 6,226 (4)
Olaplex, Inc.First Lien Revolver, LIBOR+6.25% cash due 1/8/2025Personal Products— (7)(8)(4)(5)
Total Olaplex, Inc.6,273 6,182 6,218 
Park Place Technologies, LLCPark Place Technologies, LLCFirst Lien Term Loan, LIBOR+5.00% cash due 11/10/20276.00 %Internet Services & Infrastructure4,975 4,801 4,981 (4)Park Place Technologies, LLCFirst Lien Term Loan, SOFR+5.00% cash due 11/10/20278.13 %Internet Services & Infrastructure4,925 4,781 4,687 (4)
Planview Parent, Inc.Second Lien Term Loan, LIBOR+7.25% cash due 12/18/20288.00 %Application Software4,503 4,435 4,514 (4)
Peloton Interactive, Inc.Peloton Interactive, Inc.First Lien Term Loan, SOFR+6.50% cash due 5/25/20278.35 %Leisure Products5,486 5,251 5,371 
5154

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








Portfolio CompanyPortfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)NotesPortfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
Planview Parent, Inc.Planview Parent, Inc.Second Lien Term Loan, LIBOR+7.25% cash due 12/18/202810.92 %Application Software$4,503 $4,435 $4,323 (4)
Pluralsight, LLCPluralsight, LLCFirst Lien Term Loan, LIBOR+8.00% cash due 4/6/20279.00 %Application Software$6,796 $6,669 $6,667 (4)Pluralsight, LLCFirst Lien Term Loan, LIBOR+8.00% cash due 4/6/202710.68 %Application Software6,796 6,694 6,582 (4)
Pluralsight, LLCPluralsight, LLCFirst Lien Revolver, LIBOR+8.00% cash due 4/6/2027Application Software— (8)(8)(4)(5)Pluralsight, LLCFirst Lien Revolver, LIBOR+8.00% cash due 4/6/2027Application Software— (6)(13)(4)(5)
Total Pluralsight, LLCTotal Pluralsight, LLC6,796 6,661 6,659 Total Pluralsight, LLC6,796 6,688 6,569 
RevSpring, Inc.RevSpring, Inc.First Lien Term Loan, LIBOR+4.00% cash due 10/11/20257.67 %Commercial Printing9,625 9,607 9,304 
Sabert CorporationSabert CorporationFirst Lien Term Loan, LIBOR+4.50% cash due 12/10/20265.50 %Metal & Glass Containers2,728 2,700 2,738 (4)Sabert CorporationFirst Lien Term Loan, LIBOR+4.50% cash due 12/10/20267.63 %Metal & Glass Containers2,536 2,511 2,435 (4)
SHO Holding I CorporationSHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.25% cash due 4/27/20246.25 %Footwear8,288 8,277 7,874 SHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.25% cash due 4/27/20248.06 %Footwear8,201 8,194 7,176 
SHO Holding I CorporationSHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.23% cash due 4/27/20246.23 %Footwear138 138 131 SHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.23% cash due 4/27/20248.04 %Footwear138 138 121 
Total SHO Holding I CorporationTotal SHO Holding I Corporation8,426 8,415 8,005 Total SHO Holding I Corporation8,339 8,332 7,297 
Sirva Worldwide, Inc.First Lien Term Loan, LIBOR+5.50% cash due 8/4/20255.58 %Diversified Support Services1,087 1,071 1,027 (4)
Sorenson Communications, LLCSorenson Communications, LLCFirst Lien Term Loan, LIBOR+5.50% cash due 3/17/20266.25 %Communications Equipment2,854 2,825 2,877 Sorenson Communications, LLCFirst Lien Term Loan, LIBOR+5.50% cash due 3/17/20269.17 %Communications Equipment2,553 2,528 2,454 
Star US Bidco LLCFirst Lien Term Loan, LIBOR+4.25% cash due 3/17/20275.25 %Industrial Machinery8,255 8,075 8,289 (4)
Spanx, LLCSpanx, LLCFirst Lien Term Loan, LIBOR+5.25% cash due 11/20/20288.30 %Apparel Retail8,933 8,776 8,721 (4)
SPX Flow, Inc.SPX Flow, Inc.First Lien Term Loan, SOFR+4.50% cash due 4/5/20297.63 %Industrial Machinery7,500 7,184 6,966 (4)
Supermoose Borrower, LLCSupermoose Borrower, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/29/20253.88 %Application Software7,823 7,465 7,294 (4)Supermoose Borrower, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/29/20257.42 %Application Software7,743 7,479 6,827 (4)
Surgery Center Holdings, Inc.Surgery Center Holdings, Inc.First Lien Term Loan, LIBOR+3.75% cash due 8/31/20264.50 %Health Care Facilities4,911 4,895 4,925 Surgery Center Holdings, Inc.First Lien Term Loan, LIBOR+3.75% cash due 8/31/20266.51 %Health Care Facilities3,377 3,365 3,213 
Trench Plate Rental, Co.First Lien Term Loan, LIBOR+4.75% cash due 12/3/20265.75 %Construction Materials3,942 3,882 3,881 
Trench Plate Rental, Co.First Lien Delayed Draw Term Loan, LIBOR+4.75% cash due 12/3/2026Construction Materials— (11)(12)(5)
Trench Plate Rental, Co.First Lien Revolver, LIBOR+4.75% cash due 12/3/20265.75 %Construction Materials24 15 15 (5)
Total Trench Plate Rental, Co.3,966 3,886 3,884 
TIBCO Software Inc.TIBCO Software Inc.First Lien Term Loan, SOFR+4.50% cash due 3/20/20298.15 %Application Software6,256 5,693 5,629 (4)
Touchstone Acquisition, Inc.Touchstone Acquisition, Inc.First Lien Term Loan, LIBOR+6.00% cash due 12/29/20289.12 %Health Care Supplies7,285 7,155 7,140 (4)
Veritas US Inc.Veritas US Inc.First Lien Term Loan, LIBOR+5.00% cash due 9/1/20256.00 %Application Software6,435 6,333 6,473 (4)Veritas US Inc.First Lien Term Loan, LIBOR+5.00% cash due 9/1/20258.67 %Application Software6,365 6,290 5,087 
Verscend Holding Corp.First Lien Term Loan, LIBOR+4.00% cash due 8/27/20254.08 %Health Care Technology4,080 4,052 4,091 
Waystar Technologies, Inc.First Lien Term Loan, LIBOR+4.00% cash due 10/22/20264.08 %Health Care Technology5,910 5,880 5,921 
Windstream Services II, LLCWindstream Services II, LLCFirst Lien Term Loan, LIBOR+6.25% cash due 9/21/20277.25 %Integrated Telecommunication Services7,899 7,629 7,948 (4)Windstream Services II, LLCFirst Lien Term Loan, LIBOR+6.25% cash due 9/21/20279.37 %Integrated Telecommunication Services7,818 7,596 7,115 (4)
WP CPP Holdings, LLCWP CPP Holdings, LLCSecond Lien Term Loan, LIBOR+7.75% cash due 4/30/20268.75 %Aerospace & Defense6,000 5,964 5,931 (4)WP CPP Holdings, LLCSecond Lien Term Loan, LIBOR+7.75% cash due 4/30/202610.56 %Aerospace & Defense6,000 5,972 5,070 (4)
WP CPP Holdings, LLCWP CPP Holdings, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 4/30/20256.56 %Aerospace & Defense1,985 1,910 1,783 (4)
Total WP CPP Holdings, LLCTotal WP CPP Holdings, LLC7,985 7,882 6,853 
Zayo Group Holdings, Inc.Zayo Group Holdings, Inc.First Lien Term Loan, LIBOR+3.00% cash due 3/9/20276.12 %Alternative Carriers2,155 2,000 1,812 
Total Portfolio InvestmentsTotal Portfolio Investments$344,196 $346,052 $346,665 Total Portfolio Investments$383,194 $382,673 $359,625 
___________________
(1) Represents the interest rate as of September 30, 2021.2022. All interest rates are payable in cash, unless otherwise noted.
(2) The interest rate on the principal balance outstanding for allmost of the floating rate loans is indexed to LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to SOFR. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over LIBOR or the alternate base ratereference rates based on each respective credit agreement and the cash interest rate as of period end. All the LIBOR shown above is in U.S. dollars. As of September 30, 2021,2022, the reference rates for SLF JV I's variable rate loans were the 30-day LIBOR at 0.08%, the 60-day LIBOR at 0.11%3.12%, the 90-day LIBOR at 0.13%3.67%, the 180-day LIBOR30-day SOFR at 0.16%3.03%, the 360-day LIBOR90-day SOFR at 0.24%3.55% and the PRIME180-day SOFR at 3.25%3.98%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
(3) Represents the current determination of fair value as of September 30, 20212022 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the Company's Board of Directors' valuation process described elsewhere herein.
(4) This investment was held by both the Company and SLF JV I as of September 30, 2021.2022.
(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.


5255

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








Both the cost and fair value of the Company's SLF JV I Notes were $112.7 million as of December 31, 2022. Both the cost and fair value of the Company's SLF JV I Notes were $96.3 million as of each of December 31, 2021 and September 30, 2021.2022. The Company earned interest income of $2.0$2.6 million and $1.8$2.0 million on the SLF JV I Notes for the three months ended December 31, 20212022 and 2020,2021, respectively. As of December 31, 2021,2022, the SLF JV I Notes bore interest at a rate of one-month LIBOR plus 7.00% per annum with a LIBOR floor of 1.00% and will mature on December 29, 2028.
The cost and fair value of the LLC equity interests in SLF JV I held by the Company were $49.3$54.8 million and $38.5$24.1 million, respectively, as of December 31, 2021,2022, and $49.3 million and $37.7$20.7 million, respectively, as of September 30, 2021.2022. The Company earned $1.1 million and $0.5 million in dividend income for the three months ended December 31, 2021 with respect to its investment in the LLC equity interests of SLF JV I. The Company did not earn dividend income for the three months ended2022 and December 31, 20202021, respectively, with respect to its investment in the LLC equity interests of SLF JV I. The LLC equity interests of SLF JV I are generally dividend producing to the extent SLF JV I has residual cash to be distributed on a quarterly basis.
Below is certain summarized financial information for SLF JV I as of December 31, 20212022 and September 30, 20212022 and for the three months ended December 31, 20212022 and 2020:2021:
December 31, 2021September 30, 2021December 31, 2022September 30, 2022
Selected Balance Sheet Information:Selected Balance Sheet Information:Selected Balance Sheet Information:
Investments at fair value (cost December 31, 2021: $363,821; cost September 30, 2021: $346,052)$363,909 $346,665 
Investments at fair value (cost December 31, 2022: $380,682; cost September 30, 2022: $382,673)Investments at fair value (cost December 31, 2022: $380,682; cost September 30, 2022: $382,673)$355,427 $359,625 
Cash and cash equivalentsCash and cash equivalents20,191 23,446 Cash and cash equivalents39,259 14,274 
Restricted cashRestricted cash4,328 4,517 Restricted cash6,612 5,642 
Other assetsOther assets4,919 4,529 Other assets8,106 5,686 
Total assetsTotal assets$393,347 $379,157 Total assets$409,404 $385,227 
Senior credit facility payableSenior credit facility payable$220,000 $215,620 Senior credit facility payable$226,000 $230,000 
SLF JV I Notes payable at fair value (proceeds December 31, 2021: $110,000; proceeds September 30, 2021: $110,000)110,000 110,000 
SLF JV I Notes payable at fair value (proceeds December 31, 2022: $128,750; proceeds September 30, 2022: $110,000)SLF JV I Notes payable at fair value (proceeds December 31, 2022: $128,750; proceeds September 30, 2022: $110,000)128,750 110,000 
Other liabilitiesOther liabilities19,392 10,507 Other liabilities27,094 21,539 
Total liabilitiesTotal liabilities$349,392 $336,127 Total liabilities$381,844 $361,539 
Members' equityMembers' equity43,955 43,030 Members' equity27,560 23,688 
Total liabilities and members' equityTotal liabilities and members' equity$393,347 $379,157 Total liabilities and members' equity$409,404 $385,227 
Three months ended December 31, 2021Three months ended December 31, 2020Three months ended December 31, 2022Three months ended December 31, 2021
Selected Statements of Operations Information:Selected Statements of Operations Information:Selected Statements of Operations Information:
Interest incomeInterest income$5,423 $4,475 Interest income$8,781 $5,423 
Other incomeOther income11 54 Other income— 11 
Total investment incomeTotal investment income5,434 4,529 Total investment income8,781 5,434 
Senior credit facility interest expenseSenior credit facility interest expense1,514 1,574 Senior credit facility interest expense3,709 1,514 
SLF JV I Notes interest expenseSLF JV I Notes interest expense2,249 2,007 SLF JV I Notes interest expense2,982 2,249 
Other expensesOther expenses79 62 Other expenses69 79 
Total expenses (1)Total expenses (1)3,842 3,643 Total expenses (1)6,760 3,842 
Net investment incomeNet investment income2,021 1,592 
Net unrealized appreciation (depreciation)Net unrealized appreciation (depreciation)(525)8,486 Net unrealized appreciation (depreciation)(2,207)(525)
Net realized gains (losses)Net realized gains (losses)374 (144)Net realized gains (losses)(992)374 
Net income (loss)Net income (loss)$1,441 $9,228 Net income (loss)$(1,178)$1,441 
 __________
(1) There are no management fees or incentive fees charged at SLF JV I.


SLF JV I has elected to fair value the SLF JV I Notes issued to the Company and Kemper under FASB ASC Topic 825, Financial Instruments - Fair Value Option ("ASC 825"). The SLF JV I Notes are valued based on the total assets less the total liabilities senior to the SLF JV I Notes in an amount not exceeding par under the EV technique.
During the three months ended December 31, 2022, the Company sold $13.5 million of senior secured debt investments to SLF JV I for $12.9 million cash consideration, which represented the fair value at the time of sale. A loss of $0.1 million was recognized by the Company on these transactions. During the three months ended December 31, 2021, the Company sold $9.7 million of senior secured debt investments to SLF JV I for $9.7 million cash consideration, which represented the fair value at the time of sale. A gain of $0.5 million was recognized by the Company on these transactions. During the three months ended December 31, 2020, the Company did not sell any debt investments to SLF JV I.
5356

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)









OCSI Glick JV LLC
On March 19, 2021, as a result of the consummation of the Mergers, the Company became party to the LLC agreement of Glick JV. The Glick JV investsCompany co-invests primarily in senior secured loans of middle-market companies. The Company co-invests in these securitiescompanies with GF Equity Funding through the Glick JV. The Glick JV is managed by a four person Board of Directors, two of whom are selected by the Company and two of whom are selected by GF Equity Funding. The Glick JV is capitalized as transactions are completed, and portfolio decisions and investment decisions in respect of the Glick JV must be approved by the Glick JV investment committee, which consists of one representative selected by the Company and one representative selected by GF Equity Funding (with approval from a representative of each required). Since the Company does not have a controlling financial interest in the Glick JV, the Company does not consolidate the Glick JV.
The members provide capital to the Glick JV in exchange for LLC equity interests, and the Company and GF Debt Funding 2014 LLC ("GF Debt Funding"), an entity advised by affiliates of GF Equity Funding, provide capital to the Glick JV in exchange for subordinated notes issued by the Glick JV (the "Glick JV Notes"). As of December 31, 20212022 and September 30, 2021,2022, the Company and GF Equity Funding owned 87.5% and 12.5%, respectively, of the outstanding LLC equity interests, and the Company and GF Debt Funding owned 87.5% and 12.5%, respectively, of the Glick JV Notes. The Glick JV is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act.
The Glick JV has a senior revolving credit facility with Deutsche Bank AG, New York Branch (the "Glick JV Deutsche Bank Facility"), which, as of December 31, 2021,2022, had a reinvestment period end date and maturity date of May 3, 2023 and May 3, 2028, respectively, and permitted borrowings of up to $90.0 million (subject to borrowing base and other limitations). Borrowings under the Glick JV Deutsche Bank Facility are secured by all of the assets of the Glick JV and all of the equity interests in the Glick JV and, as of December 31, 2021,2022, bore interest at a rate equal to 3-month LIBOR plus 2.25% per annum during the reinvestment period, 3-month LIBOR plus 2.40% for the first year after the end of the reinvestment period, 3-month LIBOR plus 2.50% for the following year and 3-month LIBOR plus 2.75% thereafter, in each case with a 0.125% LIBOR floor. $71.9$76.1 million and $82.1 million of borrowings were outstanding under the Glick JV Deutsche Bank Facility as of each of December 31, 20212022 and September 30, 2021.2022, respectively.
As of December 31, 20212022 and September 30, 2021,2022, the Glick JV had total assets of $145.1$137.5 million and $141.0$146.8 million, respectively. The Glick JV's portfolio consisted of middle-market and other corporate debt securities of 4440 and 3743 portfolio companies as of December 31, 20212022 and September 30, 2021,2022, respectively. The portfolio companies in the Glick JV are in industries similar to those in which the Company may invest directly.The Company's investment in the Glick JV consisted of LLC equity interests and Glick JV Notes of $55.9$49.5 million and $55.6$50.3 million in the aggregate at fair value as of December 31, 20212022 and September 30, 2021,2022, respectively. The Glick JV Notes are junior in right of payment to the repayment of temporary contributions made by the Company to fund investments of the Glick JV that are repaid when GF Equity Funding and GF Debt Funding make their capital contributions and fund their Glick JV Notes, respectively.
As of each of December 31, 20212022 and September 30, 2021,2022, the Glick JV had total capital commitments of $100.0 million, $87.5 million of which was from the Company and the remaining $12.5 million of which was from GF Equity Funding and GF Debt Funding. Approximately $84.0 million in aggregate commitments were funded as of each of December 31, 20212022 and September 30, 2021,2022, of which $73.5 million was from the Company. As of each of December 31, 20212022 and September 30, 2021,2022, the Company had commitments to fund Glick JV Notes of $78.8 million, of which $12.4 million were unfunded. As of each of December 31, 20212022 and September 30, 2021,2022, the Company had commitments to fund LLC equity interests in the Glick JV of $8.7 million, of which $1.6 million were unfunded.


5457

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








Below is a summary of the Glick JV's portfolio, followed by a listing of the individual loans in the Glick JV's portfolio as of December 31, 20212022 and September 30, 2021:2022:
December 31, 2021September 30, 2021December 31, 2022September 30, 2022
Senior secured loans (1)Senior secured loans (1)$140,078$126,512Senior secured loans (1)$134,080$143,225
Weighted average current interest rate on senior secured loans (2)Weighted average current interest rate on senior secured loans (2)6.05%5.86%Weighted average current interest rate on senior secured loans (2)9.86%8.52%
Number of borrowers in the Glick JVNumber of borrowers in the Glick JV4437Number of borrowers in the Glick JV4043
Largest loan exposure to a single borrower (1)Largest loan exposure to a single borrower (1)$6,820$6,907Largest loan exposure to a single borrower (1)$7,476$6,562
Total of five largest loan exposures to borrowers (1)Total of five largest loan exposures to borrowers (1)$28,283$28,324Total of five largest loan exposures to borrowers (1)$29,830$28,973
__________
(1) At principal amount.
(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.


Glick JV Portfolio as of December 31, 20212022
Portfolio CompanyPortfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)NotesPortfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
ADB Companies, LLCADB Companies, LLCFirst Lien Term Loan, LIBOR+6.25% cash due 12/18/20257.25%Construction & Engineering$4,822 $4,736 $4,779 (4)ADB Companies, LLCFirst Lien Term Loan, SOFR+6.25% cash due 12/18/202511.34%Construction & Engineering$4,589 $4,528 $4,510 (4)
Alvogen Pharma US, Inc.First Lien Term Loan, LIBOR+5.25% cash due 12/31/20236.25%Pharmaceuticals6,820 6,709 6,539 (4)
Alvogen Pharma IncAlvogen Pharma IncFirst Lien Term Loan, SOFR+7.50% cash due 6/30/202512.23%Pharmaceuticals6,479 6,413 6,447 (4)
Alvogen Pharma IncAlvogen Pharma IncFirst Lien Term Loan, LIBOR+4.00% cash due 6/9/20288.38%Diversified Metals & Mining997 918 941 
Total Alvogen Pharma IncTotal Alvogen Pharma Inc7,476 7,331 7,388 
American Tire Distributors, Inc.American Tire Distributors, Inc.First Lien Term Loan, LIBOR+6.25% cash due 10/20/20287.00%Distributors2,904 2,868 2,928 (4)American Tire Distributors, Inc.First Lien Term Loan, LIBOR+6.25% cash due 10/20/202810.61%Distributors2,882 2,846 2,652 (4)
Amplify Finco Pty Ltd.Amplify Finco Pty Ltd.First Lien Term Loan, LIBOR+4.25% cash due 11/26/20265.00%Movies & Entertainment2,948 2,918 2,864 (4)Amplify Finco Pty Ltd.First Lien Term Loan, LIBOR+4.25% cash due 11/26/20268.98%Movies & Entertainment2,918 2,888 2,813 (4)
Anastasia Parent, LLCAnastasia Parent, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/11/20253.97%Personal Products1,171 913 1,056 Anastasia Parent, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/11/20258.48%Personal Products914 711 685 (4)
ASP-R-PAC Acquisition Co LLCASP-R-PAC Acquisition Co LLCFirst Lien Term Loan, LIBOR+6.00% cash due 12/29/20276.75%Paper Packaging1,743 1,708 1,708 ASP-R-PAC Acquisition Co LLCFirst Lien Revolver, LIBOR+6.00% cash due 12/29/2027Paper Packaging— (3)(8)(5)
ASP-R-PAC Acquisition Co LLCASP-R-PAC Acquisition Co LLCFirst Lien Revolver, LIBOR+6.00% cash due 12/29/20276.75%Paper Packaging41 37 37 (5)ASP-R-PAC Acquisition Co LLCFirst Lien Term Loan, LIBOR+6.00% cash due 12/29/202710.38%Paper Packaging1,729 1,701 1,666 
Total ASP-R-PAC Acquisition Co LLCTotal ASP-R-PAC Acquisition Co LLC1,784 1,745 1,745 Total ASP-R-PAC Acquisition Co LLC1,729 1,698 1,658 
Astra Acquisition Corp.Astra Acquisition Corp.First Lien Term Loan, LIBOR+5.25% cash due 10/25/20285.75%Application Software2,000 1,931 1,968 (4)Astra Acquisition Corp.First Lien Term Loan, LIBOR+5.25% cash due 10/25/20289.63%Application Software2,078 2,034 1,844 (4)
Asurion, LLCAsurion, LLCSecond Lien Term Loan, LIBOR+5.25% cash due 1/20/20295.35%Property & Casualty Insurance923 914 920 Asurion, LLCFirst Lien Term Loan, SOFR+4.00% cash due 8/19/20288.68%Property & Casualty Insurance1,995 1,901 1,785 
Asurion, LLCAsurion, LLCSecond Lien Term Loan, LIBOR+5.25% cash due 1/20/20299.63%Property & Casualty Insurance2,423 2,220 1,898 
Total Asurion, LLCTotal Asurion, LLC4,418 4,121 3,683 
Aurora Lux Finco S.À.R.L.Aurora Lux Finco S.À.R.L.First Lien Term Loan, LIBOR+6.00% cash due 12/24/20267.00%Airport Services3,684 3,619 3,489 (4)Aurora Lux Finco S.À.R.L.First Lien Term Loan, LIBOR+6.00% cash due 12/24/202610.32%Airport Services3,647 3,595 3,468 (4)
BAART Programs, Inc.BAART Programs, Inc.First Lien Term Loan, LIBOR+5.00% cash due 6/11/20276.00%Health Care Services3,184 3,152 3,168 BAART Programs, Inc.First Lien Term Loan, LIBOR+5.00% cash due 6/11/20279.07%Health Care Services3,389 3,357 3,294 
BAART Programs, Inc.BAART Programs, Inc.First Lien Delayed Draw Term Loan, LIBOR+5.00% cash due 6/11/20276.00%Health Care Services465 449 457 (4)(5)BAART Programs, Inc.First Lien Term Loan, LIBOR+5.00% cash due 6/11/20279.73%Health Care Services806 798 768 (4)(5)
Total BAART Programs, Inc.Total BAART Programs, Inc.3,649 3,601 3,625 Total BAART Programs, Inc.4,195 4,155 4,062 
Brazos Delaware II, LLCFirst Lien Term Loan, LIBOR+4.00% cash due 5/21/20254.10%Oil & Gas Equipment & Services4,822 4,811 4,707 
BYJU's Alpha, Inc.BYJU's Alpha, Inc.First Lien Term Loan, LIBOR+5.50% cash due 11/24/20266.25%Application Software4,000 3,940 4,058 BYJU's Alpha, Inc.First Lien Term Loan, LIBOR+6.00% cash due 11/24/202610.70%Application Software3,960 3,912 3,193 
CITGO Petroleum Corp.First Lien Term Loan, LIBOR+6.25% cash due 3/28/20247.25%Oil & Gas Refining & Marketing3,546 3,511 3,551 (4)
City Football Group LimitedFirst Lien Term Loan, LIBOR+3.50% cash due 7/21/20284.00%Movies & Entertainment2,500 2,488 2,491 
Covetrus, Inc.Covetrus, Inc.First Lien Term Loan, SOFR+5.00% cash due 9/20/20299.58%Health Care Distributors2,280 2,143 2,142 (4)
Curium Bidco S.à.r.l.Curium Bidco S.à.r.l.First Lien Term Loan, LIBOR+4.00% cash due 7/9/20264.22%Biotechnology2,893 2,871 2,896 Curium Bidco S.à.r.l.First Lien Term Loan, LIBOR+4.00% cash due 7/9/20268.73%Biotechnology2,863 2,842 2,806 
DirecTV Financing, LLCDirecTV Financing, LLCFirst Lien Term Loan, LIBOR+5.00% cash due 8/2/20275.75%Cable & Satellite2,933 2,903 2,939 (4)DirecTV Financing, LLCFirst Lien Term Loan, LIBOR+5.00% cash due 8/2/20279.38%Cable & Satellite2,663 2,636 2,598 (4)
Domtar CorporationDomtar CorporationFirst Lien Term Loan, LIBOR+5.50% cash due 11/30/20286.25%Paper Products2,032 2,012 2,012 Domtar CorporationFirst Lien Term Loan, LIBOR+5.50% cash due 11/30/20289.79%Paper Products2,497 2,472 2,397 
Domtar CorporationFirst Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 11/30/2028Paper Products— (10)(9)(5)
Total Domtar Corporation2,032 2,002 2,003 
eResearch Technology, Inc.First Lien Term Loan, LIBOR+4.50% cash due 2/4/20275.50%Application Software2,463 2,438 2,474 
DTI Holdco, Inc.DTI Holdco, Inc.First Lien Term Loan, SOFR+4.75% cash due 4/26/20298.84%Research & Consulting Services2,993 2,938 2,764 (4)
5558

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








Portfolio CompanyPortfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)NotesPortfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
eResearch Technology, Inc.eResearch Technology, Inc.First Lien Term Loan, LIBOR+4.50% cash due 2/4/20278.88%Application Software$2,438 $2,413 $2,158 
Gibson Brands, Inc.Gibson Brands, Inc.First Lien Term Loan, LIBOR+5.00% cash due 8/11/20285.75%Leisure Products$4,000 $3,960 $3,970 Gibson Brands, Inc.First Lien Term Loan, LIBOR+5.00% cash due 8/11/20289.13%Leisure Products3,960 3,920 2,930 
Houghton Mifflin Harcourt Publishers Inc.First Lien Term Loan, LIBOR+6.25% cash due 11/22/20247.25%Education Services431 421 432 (4)
Harbor Purchaser Inc.Harbor Purchaser Inc.First Lien Term Loan, SOFR+5.25% cash due 4/9/20299.67%Education Services3,990 3,882 3,807 (4)
Indivior Finance S.À.R.L.Indivior Finance S.À.R.L.First Lien Term Loan, LIBOR+5.25% cash due 6/30/20266.00%Pharmaceuticals3,980 3,907 3,957 Indivior Finance S.À.R.L.First Lien Term Loan, SOFR+5.25% cash due 6/30/202610.09%Pharmaceuticals3,940 3,884 3,881 
Integro Parent, Inc.First Lien Term Loan, LIBOR+5.75% cash due 10/31/20226.75%Insurance Brokers3,217 3,213 3,081 
Intelsat Jackson Holdings S.A.First Lien Term Loan, LIBOR+4.75% cash due 7/13/20225.75%Alternative Carriers4,167 4,130 4,173 
Intelsat Jackson Holdings S.A.First Lien Delayed Draw Term Loan, LIBOR+4.75% cash due 7/13/2022Alternative Carriers— (7)(5)
Total Intelsat Jackson Holdings S.A.4,167 4,123 4,174 
INW Manufacturing, LLCINW Manufacturing, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 5/7/20276.50%Personal Products2,453 2,387 2,404 (4)INW Manufacturing, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 3/25/202710.48%Personal Products2,344 2,293 2,004 (4)
Iris Holding, Inc.Iris Holding, Inc.First Lien Term Loan, SOFR+4.75% cash due 6/28/20288.94%Metal & Glass Containers1,995 1,849 1,819 
LaserAway Intermediate Holdings II, LLCLaserAway Intermediate Holdings II, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 10/14/20276.50%Health Care Services4,000 3,922 3,985 LaserAway Intermediate Holdings II, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 10/14/20279.76%Health Care Services3,960 3,897 3,891 
Lightstone Holdco LLCFirst Lien Term Loan, LIBOR+3.75% cash due 1/30/20244.75%Electric Utilities3,439 3,150 2,922 
LTI Holdings, Inc.LTI Holdings, Inc.First Lien Term Loan, LIBOR+3.50% cash due 9/6/20253.60%Electronic Components1,369 1,159 1,355 LTI Holdings, Inc.First Lien Term Loan, LIBOR+3.50% cash due 9/6/20257.88%Electronic Components1,355 1,203 1,300 
MRI Software LLCMRI Software LLCFirst Lien Term Loan, LIBOR+5.50% cash due 2/10/20266.50%Application Software1,659 1,646 1,658 (4)MRI Software LLCFirst Lien Revolver, LIBOR+5.50% cash due 2/10/2026Application Software— (1)(6)(4)(5)
MRI Software LLCMRI Software LLCFirst Lien Revolver, LIBOR+5.50% cash due 2/10/2026Application Software— (1)— (4)(5)MRI Software LLCFirst Lien Term Loan, LIBOR+5.50% cash due 2/10/202610.23%Application Software1,642 1,629 1,583 (4)
Total MRI Software LLC Total MRI Software LLC1,659 1,645 1,658  Total MRI Software LLC1,642 1,628 1,577 
Northern Star Industries Inc.Northern Star Industries Inc.First Lien Term Loan, LIBOR+4.75% cash due 3/31/20255.75%Electrical Components & Equipment5,294 5,281 5,307 Northern Star Industries Inc.First Lien Term Loan, LIBOR+4.50% cash due 3/31/20259.23%Electrical Components & Equipment5,239 5,230 5,082 
OEConnection LLCOEConnection LLCFirst Lien Term Loan, LIBOR+4.00% cash due 9/25/20264.10%Application Software3,918 3,900 3,913 (4)OEConnection LLCFirst Lien Term Loan, SOFR+4.00% cash due 9/25/20268.42%Application Software3,878 3,861 3,705 (4)
Olaplex, Inc.First Lien Term Loan, LIBOR+6.25% cash due 1/8/20267.25%Personal Products3,479 3,434 3,488 (4)
Olaplex, Inc.First Lien Revolver, LIBOR+6.25% cash due 1/8/2025Personal Products— (4)(2)(4)(5)
Total Olaplex, Inc.3,479 3,430 3,486 
Planview Parent, Inc.Planview Parent, Inc.Second Lien Term Loan, LIBOR+7.25% cash due 12/18/20288.00%Application Software2,842 2,799 2,849 (4)Planview Parent, Inc.First Lien Term Loan, LIBOR+4.00% cash due 12/17/20278.73%Application Software688 649 643 
Planview Parent, Inc.Planview Parent, Inc.Second Lien Term Loan, LIBOR+7.25% cash due 12/18/202811.98%Application Software2,842 2,799 2,551 (4)
Total Planview Parent, Inc.Total Planview Parent, Inc.3,530 3,448 3,194 
Pluralsight, LLCPluralsight, LLCFirst Lien Term Loan, LIBOR+8.00% cash due 4/6/20279.00%Application Software4,465 4,386 4,387 (4)Pluralsight, LLCFirst Lien Term Loan, LIBOR+8.00% cash due 4/6/202711.83%Application Software4,465 4,401 4,354 (4)
Pluralsight, LLCPluralsight, LLCFirst Lien Revolver, LIBOR+8.00% cash due 4/6/2027Application Software— (5)(6)(4)(5)Pluralsight, LLCFirst Lien Revolver, LIBOR+8.00% cash due 4/6/202712.36%Application Software158 153 150 (4)(5)
Total Pluralsight, LLCTotal Pluralsight, LLC4,465 4,381 4,381 Total Pluralsight, LLC4,623 4,554 4,504 
Sabert CorporationFirst Lien Term Loan, LIBOR+4.50% cash due 12/10/20265.50%Metal & Glass Containers1,772 1,754 1,774 (4)
SHO Holding I CorporationSHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.25% cash due 4/27/20246.25%Footwear6,143 6,125 5,835 SHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.25% cash due 4/27/20249.66%Footwear6,078 6,068 4,710 
SHO Holding I CorporationSHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.23% cash due 4/27/20246.23%Footwear102 102 97 SHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.23% cash due 4/27/20249.64%Footwear102 102 89 
Total SHO Holding I CorporationTotal SHO Holding I Corporation6,245 6,227 5,932 Total SHO Holding I Corporation6,180 6,170 4,799 
Spanx, LLCSpanx, LLCFirst Lien Term Loan, LIBOR+5.50% cash due 11/18/20286.25%Apparel Retail5,000 4,902 4,900 (4)Spanx, LLCFirst Lien Term Loan, LIBOR+5.25% cash due 11/20/20289.64%Apparel Retail4,950 4,867 4,833 (4)
SPX Flow, Inc.SPX Flow, Inc.First Lien Term Loan, SOFR+4.50% cash due 4/5/20298.92%Industrial Machinery5,985 5,730 5,605 (4)
Supermoose Borrower, LLCSupermoose Borrower, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/29/20253.97%Application Software2,842 2,705 2,690 (4)Supermoose Borrower, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/29/20258.48%Application Software2,813 2,714 2,436 (4)
Surgery Center Holdings, Inc.Surgery Center Holdings, Inc.First Lien Term Loan, LIBOR+3.75% cash due 8/31/20264.50%Health Care Facilities3,403 3,391 3,406 Surgery Center Holdings, Inc.First Lien Term Loan, LIBOR+3.75% cash due 8/31/20268.05%Health Care Facilities3,044 3,034 3,014 
TIBCO Software Inc.TIBCO Software Inc.First Lien Term Loan, SOFR+4.50% cash due 3/20/20299.18%Application Software2,654 2,423 2,377 (4)
Touchstone Acquisition, Inc.Touchstone Acquisition, Inc.First Lien Term Loan, LIBOR+6.00% cash due 12/21/20286.75%Health Care Supplies3,039 2,978 2,978 (4)Touchstone Acquisition, Inc.First Lien Term Loan, LIBOR+6.00% cash due 12/29/202810.38%Health Care Supplies3,016 2,964 2,948 (4)
Tribe Buyer LLCTribe Buyer LLCFirst Lien Term Loan, LIBOR+4.50% cash due 2/16/20245.50%Human Resource & Employment Services1,595 1,594 1,361 Tribe Buyer LLCFirst Lien Term Loan, LIBOR+4.50% cash due 2/16/20248.88%Human Resource & Employment Services1,578 1,578 987 
Verscend Holding Corp.First Lien Term Loan, LIBOR+4.00% cash due 8/27/20254.10%Health Care Technology1,716 1,705 1,718 
Waystar Technologies, Inc.First Lien Term Loan, LIBOR+4.00% cash due 10/22/20264.10%Health Care Technology1,935 1,925 1,936 
Windstream Services II, LLCWindstream Services II, LLCFirst Lien Term Loan, SOFR+6.25% cash due 9/21/202710.67%Integrated Telecommunication Services4,874 4,742 4,433 (4)
WP CPP Holdings, LLCWP CPP Holdings, LLCSecond Lien Term Loan, LIBOR+7.75% cash due 4/30/202612.17%Aerospace & Defense3,000 2,987 2,528 (4)
WP CPP Holdings, LLCWP CPP Holdings, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 4/30/20258.17%Aerospace & Defense990 956 864 (4)
Total WP CPP Holdings, LLCTotal WP CPP Holdings, LLC3,990 3,943 3,392 
Total Portfolio InvestmentsTotal Portfolio Investments$134,080 $131,077 $123,339 


5659

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








Portfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
Windstream Services II, LLCFirst Lien Term Loan, LIBOR+6.25% cash due 9/21/20277.25%Integrated Telecommunication Services$4,924 $4,763 $4,948 (4)
WP CPP Holdings, LLCSecond Lien Term Loan, LIBOR+7.75% cash due 4/30/20268.75%Aerospace & Defense3,000 2,983 2,942 (4)
Total Portfolio Investments$140,078 $137,523 $137,491 
__________
(1) Represents the interest rate as of December 31, 2021.2022. All interest rates are payable in cash, unless otherwise noted.
(2) The interest rate on the principal balance outstanding for allmost of the floating rate loans is indexed to LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to SOFR. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over LIBOR or the alternate base ratereference rates based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars. As of December 31, 2021,2022, the reference rates for the Glick JV's variable rate loans were the 30-day LIBOR at 0.10%, the 60-day LIBOR at 0.16%4.38%, the 90-day LIBOR at 0.22%4.73%, the 180-day LIBOR30-day SOFR at 0.35%4.32% and the 360-day LIBOR90-day SOFR at 0.59%4.58%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
(3) Represents the current determination of fair value as of December 31, 20212022 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the Company's Board of Directors' valuation process described elsewhere herein.
(4) This investment was held by both the Company and the Glick JV as of December 31, 2021.2022.
(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

Glick JV Portfolio as of September 30, 2022

Portfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
ADB Companies, LLCFirst Lien Term Loan, SOFR+6.25% cash due 12/18/20259.80%Construction & Engineering$4,647 $4,579 $4,567 (4)
Alvogen Pharma IncFirst Lien Term Loan, SOFR+7.50% cash due 6/30/202511.20%Pharmaceuticals6,562 6,489 6,529 (4)
American Tire Distributors, Inc.First Lien Term Loan, LIBOR+6.25% cash due 10/20/20289.03%Distributors2,889 2,853 2,714 (4)
Amplify Finco Pty Ltd.First Lien Term Loan, LIBOR+4.25% cash due 11/26/20267.92%Movies & Entertainment2,925 2,896 2,823 (4)
Anastasia Parent, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/11/20257.42%Personal Products917 712 734 (4)
ASP-R-PAC Acquisition Co LLCFirst Lien Term Loan, LIBOR+6.00% cash due 12/29/20279.67%Paper Packaging1,734 1,704 1,694 
ASP-R-PAC Acquisition Co LLCFirst Lien Revolver, LIBOR+6.00% cash due 12/29/2027Paper Packaging— (4)(5)(5)
Total ASP-R-PAC Acquisition Co LLC1,734 1,700 1,689 
Astra Acquisition Corp.First Lien Term Loan, LIBOR+5.25% cash due 10/25/20288.37%Application Software2,078 2,033 1,777 (4)
Asurion, LLCFirst Lien Term Loan, SOFR+4.00% cash due 8/19/20287.70%Property & Casualty Insurance2,000 1,901 1,711 
Asurion, LLCSecond Lien Term Loan, LIBOR+5.25% cash due 1/20/20298.37%Property & Casualty Insurance2,423 2,212 1,866 
Total Asurion, LLC4,423 4,113 3,577 
Aurora Lux Finco S.À.R.L.First Lien Term Loan, LIBOR+6.00% cash due 12/24/20268.78%Airport Services3,656 3,601 3,476 (4)
BAART Programs, Inc.First Lien Term Loan, LIBOR+5.00% cash due 6/11/20278.12%Health Care Services3,398 3,366 3,279 
BAART Programs, Inc.First Lien Delayed Draw Term Loan, LIBOR+5.00% cash due 6/11/20278.12%Health Care Services808 800 760 (4)(5)
Total BAART Programs, Inc.4,206 4,166 4,039 
BYJU's Alpha, Inc.First Lien Term Loan, LIBOR+6.00% cash due 11/24/20268.98%Application Software3,970 3,919 2,909 
CITGO Petroleum Corp.First Lien Term Loan, LIBOR+6.25% cash due 3/28/20249.37%Oil & Gas Refining & Marketing3,519 3,484 3,529 (4)
City Football Group LimitedFirst Lien Term Loan, LIBOR+3.50% cash due 7/21/20286.48%Movies & Entertainment2,481 2,469 2,372 
Covetrus, Inc.First Lien Term Loan, SOFR+5.00% cash due 9/20/20297.65%Health Care Distributors2,280 2,143 2,136 (4)
Curium Bidco S.à.r.l.First Lien Term Loan, LIBOR+4.00% cash due 7/9/20267.67%Biotechnology2,870 2,849 2,756 
DirecTV Financing, LLCFirst Lien Term Loan, LIBOR+5.00% cash due 8/2/20278.12%Cable & Satellite2,730 2,703 2,549 (4)
Domtar CorporationFirst Lien Term Loan, LIBOR+5.50% cash due 11/30/20288.26%Paper Products2,503 2,478 2,394 
DTI Holdco, Inc.First Lien Term Loan, SOFR+4.75% cash due 4/26/20297.33%Research & Consulting Services3,000 2,943 2,856 (4)
57
60

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








Glick JV Portfolio as of September 30, 2021
Portfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
ADB Companies, LLCFirst Lien Term Loan, LIBOR+6.25% cash due 12/18/20257.25%Construction & Engineering$3,866 $3,783 $3,822 (4)
Alvogen Pharma US, Inc.First Lien Term Loan, LIBOR+5.25% cash due 12/31/20236.25%Pharmaceuticals6,907 6,780 6,687 (4)
Amplify Finco Pty Ltd.First Lien Term Loan, LIBOR+4.25% cash due 11/26/20265.00%Movies & Entertainment2,955 2,925 2,880 (4)
Anastasia Parent, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/11/20253.88%Personal Products1,667 1,310 1,416 
Asurion, LLCSecond Lien Term Loan, LIBOR+5.25% cash due 1/20/20295.33%Property & Casualty Insurance3,000 2,970 2,990 
Aurora Lux Finco S.À.R.L.First Lien Term Loan, LIBOR+6.00% cash due 12/24/20267.00%Airport Services3,694 3,625 3,476 (4)
BAART Programs, Inc.First Lien Term Loan, LIBOR+5.00% cash due 6/11/20276.00%Health Care Services3,192 3,160 3,184 
BAART Programs, Inc.First Lien Delayed Draw Term Loan, LIBOR+5.00% cash due 6/11/20276.00%Health Care Services240 232 238 (5)
Total BAART Programs, Inc.3,432 3,392 3,422 
Brazos Delaware II, LLCFirst Lien Term Loan, LIBOR+4.00% cash due 5/21/20254.08%Oil & Gas Equipment & Services4,835 4,823 4,772 
CITGO Petroleum Corp.First Lien Term Loan, LIBOR+6.25% cash due 3/28/20247.25%Oil & Gas Refining & Marketing3,555 3,520 3,567 (4)
City Football Group LimitedFirst Lien Term Loan, LIBOR+3.50% cash due 7/21/20284.00%Movies & Entertainment2,500 2,488 2,497 
Curium Bidco S.à.r.l.First Lien Term Loan, LIBOR+4.00% cash due 7/9/20264.13%Biotechnology4,900 4,863 4,903 
DirecTV Financing, LLCFirst Lien Term Loan, LIBOR+5.00% cash due 8/2/20275.75%Cable & Satellite3,000 2,970 3,005 (4)
Enviva Holdings, LPFirst Lien Term Loan, LIBOR+5.50% cash due 2/17/20266.50%Forest Products3,919 3,879 3,928 
eResearch Technology, Inc.First Lien Term Loan, LIBOR+4.50% cash due 2/4/20275.50%Application Software2,469 2,444 2,484 
Gibson Brands, Inc.First Lien Term Loan, LIBOR+5.00% cash due 8/11/20285.75%Leisure Products4,000 3,960 3,981 
Houghton Mifflin Harcourt Publishers Inc.First Lien Term Loan, LIBOR+6.25% cash due 11/22/20247.25%Education Services431 420 433 (4)
Indivior Finance S.À.R.L.First Lien Term Loan, LIBOR+5.25% cash due 6/30/20266.00%Pharmaceuticals3,990 3,913 3,977 
Integro Parent, Inc.First Lien Term Loan, LIBOR+5.75% cash due 10/31/20226.75%Insurance Brokers3,229 3,221 3,173 
Intelsat Jackson Holdings S.A.First Lien Term Loan, LIBOR+4.75% cash due 7/13/20225.75%Alternative Carriers4,167 4,112 4,203 
Intelsat Jackson Holdings S.A.First Lien Delayed Draw Term Loan, LIBOR+4.75% cash due 7/13/2022Alternative Carriers— (11)(5)
Total Intelsat Jackson Holdings S.A.4,167 4,101 4,210 
INW Manufacturing, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 5/7/20276.50%Personal Products2,469 2,399 2,419 (4)
Lightstone Holdco LLCFirst Lien Term Loan, LIBOR+3.75% cash due 1/30/20244.75%Electric Utilities3,439 3,115 2,855 
LTI Holdings, Inc.First Lien Term Loan, LIBOR+3.50% cash due 9/6/20253.58%Electronic Components1,372 1,147 1,356 
MRI Software LLCFirst Lien Term Loan, LIBOR+5.50% cash due 2/10/20266.50%Application Software1,635 1,621 1,634 (4)
MRI Software LLCFirst Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 2/10/2026Application Software— (1)— (4)(5)
MRI Software LLCFirst Lien Revolver, LIBOR+5.50% cash due 2/10/2026Application Software— (1)— (4)(5)
   Total MRI Software LLC1,635 1,619 1,634 
Portfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
Eagle Parent Corp.First Lien Term Loan, SOFR+4.25% cash due 4/1/20297.80%Industrial Machinery$2,488 $2,429 $2,426 
eResearch Technology, Inc.First Lien Term Loan, LIBOR+4.50% cash due 2/4/20277.62%Application Software2,444 2,419 2,286 
Gibson Brands, Inc.First Lien Term Loan, LIBOR+5.00% cash due 8/11/20287.94%Leisure Products3,970 3,930 3,216 
Harbor Purchaser Inc.First Lien Term Loan, SOFR+5.25% cash due 4/9/20298.38%Education Services4,000 3,887 3,655 (4)
Indivior Finance S.À.R.L.First Lien Term Loan, LIBOR+5.25% cash due 6/30/20268.80%Pharmaceuticals3,950 3,890 3,886 
INW Manufacturing, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 3/25/20279.42%Personal Products2,375 2,320 2,102 (4)
Iris Holding, Inc.First Lien Term Loan, SOFR+4.75% cash due 6/28/20287.89%Metal & Glass Containers2,000 1,846 1,844 
LaserAway Intermediate Holdings II, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 10/14/20278.23%Health Care Services3,970 3,903 3,905 
LTI Holdings, Inc.First Lien Term Loan, LIBOR+3.25% cash due 9/6/20256.37%Electronic Components1,358 1,192 1,260 
MRI Software LLCFirst Lien Term Loan, LIBOR+5.50% cash due 2/10/20269.17%Application Software1,647 1,632 1,600 (4)
MRI Software LLCFirst Lien Revolver, LIBOR+5.50% cash due 2/10/2026Application Software— (1)(4)(4)(5)
   Total MRI Software LLC1,647 1,631 1,596 
Northern Star Industries Inc.First Lien Term Loan, LIBOR+4.75% cash due 3/31/20257.87%Electrical Components & Equipment5,252 5,243 5,095 
OEConnection LLCFirst Lien Term Loan, LIBOR+4.00% cash due 9/25/20267.12%Application Software3,888 3,871 3,752 (4)
Planview Parent, Inc.Second Lien Term Loan, LIBOR+7.25% cash due 12/18/202810.92%Application Software2,842 2,799 2,728 (4)
Pluralsight, LLCFirst Lien Term Loan, LIBOR+8.00% cash due 4/6/202710.68%Application Software4,465 4,398 4,325 (4)
Pluralsight, LLCFirst Lien Revolver, LIBOR+8.00% cash due 4/6/2027Application Software— (5)(10)(4)(5)
Total Pluralsight, LLC4,465 4,393 4,315 
Sabert CorporationFirst Lien Term Loan, LIBOR+4.50% cash due 12/10/20267.63%Metal & Glass Containers1,691 1,674 1,623 (4)
SHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.25% cash due 4/27/20248.06%Footwear6,094 6,082 5,332 
SHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.23% cash due 4/27/20248.04%Footwear102 102 90 
Total SHO Holding I Corporation6,196 6,184 5,422 
Spanx, LLCFirst Lien Term Loan, LIBOR+5.25% cash due 11/20/20288.30%Apparel Retail4,962 4,876 4,845 (4)
SPX Flow, Inc.First Lien Term Loan, SOFR+4.50% cash due 4/5/20297.63%Industrial Machinery6,000 5,734 5,572 (4)
Supermoose Borrower, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/29/20257.42%Application Software2,820 2,712 2,487 (4)
Surgery Center Holdings, Inc.First Lien Term Loan, LIBOR+3.75% cash due 8/31/20266.51%Health Care Facilities3,377 3,365 3,213 
TIBCO Software Inc.First Lien Term Loan, SOFR+4.50% cash due 3/20/20298.15%Application Software2,654 2,415 2,388 (4)
Touchstone Acquisition, Inc.First Lien Term Loan, LIBOR+6.00% cash due 12/29/20289.12%Health Care Supplies3,024 2,970 2,963 (4)
Tribe Buyer LLCFirst Lien Term Loan, LIBOR+4.50% cash due 2/16/20247.62%Human Resource & Employment Services1,583 1,582 1,266 
Windstream Services II, LLCFirst Lien Term Loan, LIBOR+6.25% cash due 9/21/20279.37%Integrated Telecommunication Services4,886 4,747 4,447 (4)
WP CPP Holdings, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 4/30/20256.56%Aerospace & Defense993 955 892 (4)
WP CPP Holdings, LLCSecond Lien Term Loan, LIBOR+7.75% cash due 4/30/202610.56%Aerospace & Defense3,000 2,986 2,534 (4)
Total WP CPP Holdings, LLC3,993 3,941 3,426 
Total Portfolio Investments$143,225 $140,083 $133,144 
5861

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








Portfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
Northern Star Industries Inc.First Lien Term Loan, LIBOR+4.50% cash due 3/31/20255.50%Electrical Components & Equipment$5,308 $5,294 $5,294 
OEConnection LLCFirst Lien Term Loan, LIBOR+4.00% cash due 9/25/20264.08%Application Software3,926 3,908 3,921 (4)
Olaplex, Inc.First Lien Term Loan, LIBOR+6.25% cash due 1/8/20267.25%Personal Products3,502 3,454 3,475 (4)
Olaplex, Inc.First Lien Revolver, LIBOR+6.25% cash due 1/8/2025Personal Products— (4)(5)(4)(5)
Total Olaplex, Inc.3,502 3,450 3,470 
Planview Parent, Inc.Second Lien Term Loan, LIBOR+7.25% cash due 12/18/20288.00%Application Software2,842 2,799 2,849 (4)
Pluralsight, LLCFirst Lien Term Loan, LIBOR+8.00% cash due 4/6/20279.00%Application Software4,465 4,383 4,380 (4)
Pluralsight, LLCFirst Lien Revolver, LIBOR+8.00% cash due 4/6/2027Application Software— (6)(6)(4)(5)
Total Pluralsight, LLC4,465 4,377 4,374 
Sabert CorporationFirst Lien Term Loan, LIBOR+4.50% cash due 12/10/20265.50%Metal & Glass Containers1,819 1,800 1,825 (4)
SHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.25% cash due 4/27/20246.25%Footwear6,159 6,140 5,851 
SHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.23% cash due 4/27/20246.23%Footwear102 102 97 
Total SHO Holding I Corporation6,261 6,242 5,948 
Supermoose Borrower, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/29/20253.88%Application Software2,850 2,703 2,657 (4)
Surgery Center Holdings, Inc.First Lien Term Loan, LIBOR+3.75% cash due 8/31/20264.50%Health Care Facilities4,911 4,895 4,925 
Tribe Buyer LLCFirst Lien Term Loan, LIBOR+4.50% cash due 2/16/20245.50%Human Resource & Employment Services1,599 1,598 1,354 
Verscend Holding Corp.First Lien Term Loan, LIBOR+4.00% cash due 8/27/20254.08%Health Care Technology1,721 1,709 1,725 
Waystar Technologies, Inc.First Lien Term Loan, LIBOR+4.00% cash due 10/22/20264.08%Health Care Technology3,940 3,920 3,947 
Windstream Services II, LLCFirst Lien Term Loan, LIBOR+6.25% cash due 9/21/20277.25%Integrated Telecommunication Services4,937 4,768 4,967 (4)
WP CPP Holdings, LLCSecond Lien Term Loan, LIBOR+7.75% cash due 4/30/20268.75%Aerospace & Defense3,000 2,982 2,965 (4)
Total Portfolio Investments$126,512 $124,112 $124,108 
__________
(1) Represents the interest rate as of September 30, 2021.2022. All interest rates are payable in cash, unless otherwise noted.
(2) The interest rate on the principal balance outstanding for allmost of the floating rate loans is indexed to LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to SOFR. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over LIBOR or the alternate base ratereference rates based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars. As of September 30, 2021,2022, the reference rates for the Glick JV's variable rate loans were the 30-day LIBOR at 0.08%, the 60-day LIBOR at 0.11%3.12%, the 90-day LIBOR at 0.13%3.67%, the 180-day LIBOR30-day SOFR at 0.16%3.03% and the 360-day LIBOR90-day SOFR at 0.24%3.55%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
(3) Represents the current determination of fair value as of September 30, 20212022 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the Company's Board of Directors' valuation process described elsewhere herein.
(4) This investment was held by both the Company and the Glick JV as of September 30, 2021.2022.
(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

The cost and fair value of the Company's aggregate investment in the Glick JV was $50.6$50.0 million and $55.9$49.5 million, respectively, as of December 31, 2021.2022. The cost and fair value of the Company's aggregate investment in the Glick JV was $50.7$50.2 million and $55.6$50.3 million, respectively, as of September 30, 2021.2022. For the three months ended December 31, 2022 and December 31, 2021, the Company's investment in the Glick JV Notes earned interest income of $1.6 million and $1.1 million.million, respectively. The Company did not earn dividend income for the three months ended December 31, 2022 and December 31, 2021 with respect to its investment in the LLC equity interest of the Glick JV. The LLC equity interests of the Glick JV are income producing to the extent there is residual cash to be distributed on a quarterly basis. As of December 31, 2021,2022, the Glick JV Notes bore interest at a rate of one-month LIBOR plus 4.50% per annum and will mature on October 20, 2028.
59


Below is certain summarized financial information for the Glick JV as of December 31, 20212022 and September 30, 20212022 and for the three months ended December 31, 2022 and December 31, 2021:
December 31, 2021September 30, 2021December 31, 2022September 30, 2022
Selected Balance Sheet Information:Selected Balance Sheet Information:Selected Balance Sheet Information:
Investments at fair value (cost December 31, 2021: $137,523; September 30, 2021: $124,112)$137,491 $124,108 
Investments at fair value (cost December 31, 2022: $131,077; September 30, 2022: $140,083)Investments at fair value (cost December 31, 2022: $131,077; September 30, 2022: $140,083)$123,339 $133,144 
Cash and cash equivalentsCash and cash equivalents4,678 14,087 Cash and cash equivalents9,777 7,021 
Restricted cashRestricted cash1,048 1,055 Restricted cash1,747 1,788 
Other assetsOther assets1,906 1,750 Other assets2,592 4,855 
Total assetsTotal assets$145,123 $141,000 Total assets$137,455 $146,808 
Senior credit facility payableSenior credit facility payable$71,882 $71,882 Senior credit facility payable$76,082 $82,082 
Glick JV Notes payable at fair value (proceeds December 31, 2021: $69,985; September 30, 2021: $70,525)63,835 63,522 
Glick JV Notes payable at fair value (proceeds December 31, 2022: $67,485; September 30, 2022: $68,185)Glick JV Notes payable at fair value (proceeds December 31, 2022: $67,485; September 30, 2022: $68,185)56,614 57,463 
Other liabilitiesOther liabilities9,406 5,596 Other liabilities4,759 7,263 
Total liabilitiesTotal liabilities$145,123 $141,000 Total liabilities$137,455 $146,808 
Members' equityMembers' equity— — Members' equity— — 
Total liabilities and members' equityTotal liabilities and members' equity$145,123 $141,000 Total liabilities and members' equity$137,455 $146,808 
For the three months ended December 31, 2021
Selected Statements of Operations Information:
Interest income$2,160 
Total investment income2,160
Senior credit facility interest expense510 
Glick JV Notes interest expense818 
Other expenses39 
Total expenses (1)1,367
Net unrealized appreciation (depreciation)(882)
Realized gain (loss)89 
Net income (loss)$
For the three months ended December 31, 2022For the three months ended December 31, 2021
Selected Statements of Operations Information:
Interest income$3,403 $2,160 
Fee income— — 
Total investment income3,403 2,160 
Senior credit facility interest expense1,285 510 
Glick JV Notes interest expense1,324 818 
Other expenses53 39 
Total expenses (1)2,662 1,367 
Net investment income741 793 
Net unrealized appreciation (depreciation)(651)(882)
Realized gain (loss)(90)89 
Net income (loss)$ $ 
__________
(1) There are no management fees or incentive fees charged at the Glick JV.
62

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




The Glick JV has elected to fair value the Glick JV Notes issued to the Company and GF Debt Funding under FASB ASC Topic 825, Financial Instruments - Fair Value Option.825. The Glick JV Notes are valued based on the total assets less the liabilities senior to the Glick JV Notes in an amount not exceeding par under the EV technique.

During the three months ended December 31, 2022 and 2021, the Company did not sell any debt investments to the Glick JV.
Note 4. Fee Income
For the three months ended December 31, 20212022 and 2020,2021, the Company recorded total fee income of $0.9$2.0 million and $3.4$0.9 million, respectively, of which $0.2 million and $0.1$0.2 million, respectively, was recurring in nature. Recurring fee income primarily consisted of servicing fees and certain exit fees.


60

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Note 5. Share Data and Net Assets
The share and per share information disclosed in Note 5 have been retrospectively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
Earnings per Share
The following table sets forth the computation of basic and diluted earnings per share, pursuant to ASC Topic 260-10, Earnings per Share, for the three months ended December 31, 20212022 and 2020:2021:
(Share amounts in thousands)(Share amounts in thousands)Three months ended
December 31, 2021
Three months ended
December 31, 2020
(Share amounts in thousands)Three months ended
December 31, 2022
Three months ended
December 31, 2021
Earnings (loss) per common share — basic and diluted:Earnings (loss) per common share — basic and diluted:Earnings (loss) per common share — basic and diluted:
Net increase (decrease) in net assets resulting from operationsNet increase (decrease) in net assets resulting from operations$39,408 $65,544 Net increase (decrease) in net assets resulting from operations$13,172 $39,408 
Weighted average common shares outstanding — basic and dilutedWeighted average common shares outstanding — basic and diluted180,381 140,961 Weighted average common shares outstanding — basic and diluted61,142 60,127 
Earnings (loss) per common share — basic and dilutedEarnings (loss) per common share — basic and diluted$0.22 $0.46 Earnings (loss) per common share — basic and diluted$0.22 $0.66 


Changes in Net Assets


The following table presents the changes in net assets for the three months ended December 31, 2022:
Common Stock
(Share amounts in thousands)SharesPar ValueAdditional paid-in-capitalAccumulated Overdistributed EarningsTotal Net Assets
Balance as of September 30, 202261,125 $611 $1,827,721 $(582,769)$1,245,563 
Net investment income— 38,80838,808
Net unrealized appreciation (depreciation)(22,982)(22,982)
Net realized gains (losses)(3,203)(3,203)
(Provision) benefit for taxes on realized and unrealized gains (losses)549549
Distributions to stockholders(58,679)(58,679)
Issuance of common stock under dividend reinvestment plan9511,9321,933
Balance as of December 31, 202261,220 $612 $1,829,653 $(628,276)$1,201,989 
63

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)





The following table presents the changes in net assets for the three months ended December 31, 2021:
Common StockCommon Stock
SharesPar ValueAdditional paid-in-capitalAccumulated Overdistributed EarningsTotal Net AssetsSharesPar ValueAdditional paid-in-capitalAccumulated Overdistributed EarningsTotal Net Assets
Balance as of September 30, 2021Balance as of September 30, 2021180,361 $1,804 $1,804,354 $(493,335)$1,312,823 Balance as of September 30, 202160,120 $601 $1,805,557 $(493,335)$1,312,823 
Net investment incomeNet investment income32,29532,295Net investment income32,29532,295
Net unrealized appreciation (depreciation)Net unrealized appreciation (depreciation)(4,586)(4,586)Net unrealized appreciation (depreciation)(4,586)(4,586)
Net realized gains (losses)Net realized gains (losses)9,3219,321Net realized gains (losses)9,3219,321
(Provision) benefit for taxes on realized and unrealized gains (losses)(Provision) benefit for taxes on realized and unrealized gains (losses)2,3782,378(Provision) benefit for taxes on realized and unrealized gains (losses)2,3782,378
Distributions to stockholdersDistributions to stockholders(27,956)(27,956)Distributions to stockholders(27,956)(27,956)
Issuance of common stock under dividend reinvestment planIssuance of common stock under dividend reinvestment plan1081785786Issuance of common stock under dividend reinvestment plan361785786
Balance as of December 31, 2021Balance as of December 31, 2021180,469 $1,805 $1,805,139 $(481,883)$1,325,061 Balance as of December 31, 202160,156 $602 $1,806,342 $(481,883)$1,325,061 


The following table presents the changes in net assets for the three months ended December 31, 2020:
Common Stock
SharesPar ValueAdditional paid-in-capitalAccumulated Overdistributed EarningsTotal Net Assets
Balance as of September 30, 2020140,961 $1,409 $1,487,774 $(574,304)$914,879 
Net investment income10,01810,018
Net unrealized appreciation (depreciation)47,55647,556
Net realized gains (losses)8,2158,215
(Provision) benefit for taxes on realized and unrealized gains (losses)(245)(245)
Distributions to stockholders(15,506)(15,506)
Issuance of common stock under dividend reinvestment plan941527528
Repurchases of common stock under dividend reinvestment plan(94)(1)(527)(528)
Balance as of December 31, 2020140,961 $1,409 $1,487,774 $(524,266)$964,917 


Distributions
Distributions to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the Board of Directors and is based on management’s estimate of the Company’s annual taxable income. Net realized capital gains, if any, may be distributed to stockholders or retained for reinvestment.
The Company has adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of any distributions the Company declares in cash on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, if the Company’s Board of Directors declares a cash distribution, then the Company’s stockholders who have not “opted out” of the Company’s DRIP will have their cash distribution automatically reinvested in additional shares of the Company’s common stock, rather than receiving the cash distribution. If the Company’s shares are trading at a premium to net asset value, the Company typically issues new shares to implement the DRIP with such shares issued at the greater of the most recently computed net asset value per share of common stock or 95% of the current market price per share of common stock on the
61

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




payment date for such distribution. If the Company’s shares are trading at a discount to net asset value, the Company typically purchases shares in the open market in connection with the Company’s obligations under the DRIP.

For U.S. federal income tax purposes, the Company estimatesestimated its distributions for the 20212022 calendar year will be composed primarily of ordinary income. The character of such distributions will be appropriately reported to the Internal Revenue Service and stockholders for the 20212022 calendar year. To the extent the Company’s taxable earnings for a fiscal and taxable year fall below the amount of distributions paid for the fiscal and taxable year, a portion of the total amount of the Company’s distributions for the fiscal and taxable year is deemed a return of capital for U.S. federal income tax purposes to the Company’s stockholders.
The following table reflects the distributions per share that the Company has paid, including shares issued under the DRIP, on its common stock during the three months ended December 31, 20212022 and 2020:2021:
Date DeclaredRecord DatePayment DateAmount
per Share
Cash
Distribution
DRIP Shares
Issued (1)
DRIP Shares
Value
October 13, 2021December 15, 2021December 31, 2021$0.155 $ 27.2 million107,971 $ 0.8 million
Total for the three months ended December 31, 2021$0.155 $ 27.2 million107,971 $ 0.8 million
Date DeclaredRecord DatePayment DateAmount
per Share
Cash
Distribution
DRIP Shares
Issued (2)
DRIP Shares
Value
November 13, 2020December 15, 2020December 31, 2020$0.11 $ 15.0 million93,964 $ 0.5 million
Total for the three months ended December 31, 2020$0.11 $ 15.0 million93,964 $ 0.5 million
DistributionDate DeclaredRecord DatePayment DateAmount
per Share
Cash
Distribution
DRIP Shares
Issued
DRIP Shares
Value
QuarterlyNovember 10, 2022December 15, 2022December 30, 2022$0.54 $32.0 million53,369 (1)$1.1 million
SpecialNovember 10, 2022December 15, 2022December 30, 2022$0.42 $24.8 million41,510 (1)$0.8 million
Total for the three months ended December 31, 2022$0.96 $56.8 million94,879 $1.9 million
DistributionDate DeclaredRecord DatePayment DateAmount
per Share
Cash
Distribution
DRIP Shares
Issued
DRIP Shares
Value
QuarterlyOctober 13, 2021December 15, 2021December 31, 2021$0.465 $27.2 million35,990 (1)$0.8 million
Total for the three months ended December 31, 2021$0.465 $27.2 million35,990 $0.8 million
 __________
(1) New shares were issued and distributed.
(2) Shares were purchased on the open market and distributed.

Common Stock Issuances
During the three months ended December 31, 2022 and 2021, the Company issued an aggregate of 107,97194,879 and 35,990, respectively, of shares of common stock as part of the DRIP. There were no other
On February 7, 2022, the Company entered into an equity distribution agreement by and among the Company, Oaktree, Oaktree Administrator and Keefe, Bruyette & Woods, Inc., JMP Securities LLC, Raymond James & Associates, Inc. and
64

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




SMBC Nikko Securities America, Inc., as placement agents, in connection with the issuance and sale by the Company of shares of common stock, issuanceshaving an aggregate offering price of up to $125.0 million. Sales of the common stock may be made in negotiated transactions or transactions that are deemed to be “at the market,” as defined in Rule 415 under the Securities Act of 1933, as amended, including sales made directly on the Nasdaq Global Select Market or similar securities exchanges or sales made to or through a market maker other than on an exchange, at prices related to the prevailing market prices or at negotiated prices.
In connection with the "at the market" offering, the Company did not issue or sell any shares of common stock during the three months ended December 31, 2021 and 2020.

2022.
Note 6. Borrowings
Syndicated Facility


On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans, mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank.


On December 10, 2021, the Company entered into an incremental commitment and assumption agreement pursuant to which a new lender provided additional commitments of $50 million under the Syndicated Facility. As of December 31, 2021,2022, the size of the Syndicated Facility was $1.0 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances.


As of December 31, 2021,2022, (i) the period during which the Company may make drawings will expire on May 4, 2025 and the maturity date is May 4, 2026 and (ii) the interest rate margin for (a) LIBOR loans (which may be 1-, 2-, 3- or 6-month, at the Company’s option) was 2.00% and (b) alternate base rate loans was 1.00%.


The Syndicated Facility is secured by substantially all of the Company’s assets (excluding, among other things, investments held in and by certain subsidiaries of the Company (including OCSL Senior Funding II LLC) or investments in certain portfolio companies of the Company) and guaranteed by certain subsidiaries of the Company. As of December 31, 2021,
62

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




2022, except for assets that were held by OCSL Senior Funding II LLC and certain immaterial subsidiaries, substantially all of the Company's assets are pledged as collateral under the Syndicated Facility.


The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of December 31, 2021,2022, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions.


As of each of December 31, 20212022 and September 30, 2021,2022, the Company had $495.0$695.0 million and $540.0 million of borrowings outstanding under the Syndicated Facility, respectively, which had a fair value of $495.0 million.$695.0 million and $540.0 million, respectively. The Company's borrowings under the Syndicated Facility bore interest at a weighted average interest rate of 2.174%5.849% and 2.323%2.174% for the three months ended December 31, 20212022 and 2020,2021, respectively. For the three months ended
65

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




December 31, 20212022 and 2020,2021, the Company recorded interest expense (inclusive of fees) of $3.8$10.0 million and $3.2$3.8 million, respectively, related to the Syndicated Facility.
Citibank Facility
On March 19, 2021, as a result of the consummation of the Mergers, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC (formerly OCSI Senior Funding II LLC), the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian.
On November 18, 2021, the Company entered into an amendment to the Citibank Facility that, among other things, increased the size of the facility by $50 million and extended the reinvestment period and final maturity date. As of December 31, 2021,2022, the Company was able to borrow up to $200 million under the Citibank Facility (subject to borrowing base and other limitations). As of December 31, 2021,2022, the reinvestment period under the Citibank Facility was scheduled to expire on November 18, 2023 and the maturity date for the Citibank Facility was November 18, 2024.
As of December 31, 2021,2022, borrowings under the Citibank Facility are subject to certain customary advance rates and accrue interest at a rate equal to LIBOR plus between 1.25% and 2.20% per annum on broadly syndicated loans, subject to observable market depth and pricing, and LIBOR plus 2.25% per annum on all other eligible loans during the reinvestment period. In addition, as of December 31, 2021,2022, for the duration of the reinvestment period there is a non-usage fee payable of 0.50% per annum on the undrawn amount under the Citibank Facility. The minimum asset coverage ratio applicable to the Company under the Citibank Facility is 150% as determined in accordance with the requirements of the Investment Company Act. Borrowings under the Citibank Facility are secured by all of the assets of OCSL Senior Funding II LLC and all of the Company’s equity interests in OCSL Senior Funding II LLC. The Company may use the Citibank Facility to fund a portion of its loan origination activities and for general corporate purposes. Each loan origination under the Citibank Facility is subject to the satisfaction of certain conditions.
As of December 31, 20212022 and September 30, 2021,2022, the Company had $155.0$165.0 million and $135.0$160.0 million outstanding under the Citibank Facility, respectively, which had a fair value of $155.0$165.0 million and $135.0$160.0 million, respectively. The Company's borrowings under the Citibank Facility bore interest at a weighted average interest rate of 6.508% and 1.830% for the three months ended December 31, 2021.2022 and 2021, respectively. For the three months ended December 31, 2022 and 2021, the Company recorded interest expense (inclusive of fees) of $2.7 million and $0.8 million, respectively, related to the Citibank Facility.
63

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




2025 Notes
On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes.
The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.
Interest on the 2025 Notes is paid semi-annually on February 25 and August 25 at a rate of 3.500% per annum. The 2025 Notes mature on February 25, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2025 Notes can require the Company to repurchase the 2025 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2025 Notes Indenture. The 2025 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2021,2022, the Company did not repurchase any of the 2025 Notes in the open market.
The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to
66

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture.
2027 Notes
On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes.
The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.
Interest on the 2027 Notes is paid semi-annually on January 15 and July 15, beginning on January 15, 2022, at a rate of 2.700% per annum. The 2027 Notes mature on January 15, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2027 Notes can require the Company to repurchase the 2027 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2027 Notes Indenture. The 2027 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2021,2022, the Company did not repurchase any of the 2027 Notes in the open market.
The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as
64

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture.
In connection with the 2027 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 2.700% and pays a floating interest rate of the three-month LIBOR plus 1.658% on a notional amount of $350 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swaps.swap.
67

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




The below table presents the components of the carrying value of the 2025 Notes and the 2027 Notes as of December 31, 20212022 and September 30, 2021:2022:
As of December 31, 2021As of September 30, 2021 As of December 31, 2022As of September 30, 2022
($ in millions)($ in millions)2025 Notes2027 Notes2025 Notes2027 Notes($ in millions)2025 Notes2027 Notes2025 Notes2027 Notes
PrincipalPrincipal$300.0 $350.0 $300.0 $350.0 Principal$300.0 $350.0 $300.0 $350.0 
Unamortized financing costs Unamortized financing costs(2.3)(3.8)(2.6)(4.0) Unamortized financing costs(1.6)(3.1)(1.8)(3.2)
Unaccreted discount Unaccreted discount(1.6)(0.9)(1.7)(0.9) Unaccreted discount(1.1)(0.7)(1.2)(0.7)
Interest rate swap fair value adjustment Interest rate swap fair value adjustment— (5.9)— (2.1) Interest rate swap fair value adjustment— (39.9)— (42.0)
Net carrying valueNet carrying value$296.1 $339.4 $295.7 $343.0 Net carrying value$297.3 $306.3 $297.0 $304.1 
Fair ValueFair Value$312.8 $347.4 $314.5 $351.1 Fair Value$286.7 $296.8 $283.1 $294.0 
The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three months ended December 31, 2022:
($ in millions)2025 Notes2027 Notes
Coupon interest$2.6 $2.4 
Amortization of financing costs and discount0.3 0.2 
Effect of interest rate swap— 2.5 
 Total interest expense$2.9 $5.1 
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)3.500 %5.586 %
The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three months ended December 31, 2021:
($ in millions)2025 Notes2027 Notes
Coupon interest$2.6 $2.4 
Amortization of financing costs and discount0.3 0.2 
Effect of interest rate swap— (0.7)
 Total interest expense$2.9 $1.9 
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)3.500 %1.782 %
The below table presents the components of interest and other debt expenses related to the 2025 Notes for the three months ended December 31, 2020:
($ in millions)2025 Notes
Coupon interest$2.6 
Amortization of financing costs and discount0.3 
 Total interest expense$2.9
Coupon interest rate3.500 %


Note 7. Taxable/Distributable Income and Dividend Distributions
Taxable income differs from net increase (decrease) in net assets resulting from operations primarily due to: (1) unrealized appreciation (depreciation) on investments and foreign currency, as gains and losses are not included in taxable income until they are realized; (2) origination and exit fees received in connection with investments in portfolio companies; (3) organizational costs; (4) income or loss recognition on exited investments; and (5) recognition of interest income on certain loans.
As of September 30, 2021,2022, the Company had net capital loss carryforwards of $547.9$523.7 million to offset net capital gains that will not expire, to the extent available and permitted by U.S. federal income tax law, of which $69.1$64.5 million are available to offset future short-term capital gains and $478.8$459.2 million are available to offset future long-term capital gains. A portion of such net capital loss carryfowards represented a realized loss under sections 382 and 383 of the Code, which is carried forward to future years to offset future gains subject to certain limitations.
6568

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








Listed below is a reconciliation of "net increase (decrease) in net assets resulting from operations" to taxable income for the three months ended December 31, 20212022 and 2020.2021.
Three months ended
December 31, 2021
Three months ended
December 31, 2020
Three months ended
December 31, 2022
Three months ended
December 31, 2021
Net increase (decrease) in net assets resulting from operationsNet increase (decrease) in net assets resulting from operations$39,408 $65,544 Net increase (decrease) in net assets resulting from operations$13,172 $39,408 
Net unrealized (appreciation) depreciationNet unrealized (appreciation) depreciation4,586 (47,556)Net unrealized (appreciation) depreciation22,982 4,586 
Book/tax difference due to organizational costsBook/tax difference due to organizational costs(22)(22)Book/tax difference due to organizational costs— (22)
Book/tax difference due to interest income on certain loans— 130 
Book/tax difference due to capital losses utilizedBook/tax difference due to capital losses utilized(10,531)(9,943)Book/tax difference due to capital losses utilized8,013 (10,531)
Other book/tax differencesOther book/tax differences(11,171)5,614 Other book/tax differences(12,910)(11,171)
Taxable/Distributable Income (1)Taxable/Distributable Income (1)$22,270 $13,767 Taxable/Distributable Income (1)$31,257 $22,270 
 __________
(1) The Company's taxable income for the three months ended December 31, 20212022 is an estimate and will not be finally determined until the Company files its tax return for the fiscal year ending September 30, 2022.2023. Therefore, the final taxable income may be different than the estimate.
The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences.
When assessing the realizability of deferred tax assets, the Company considers whether it is probable that some or all of the deferred tax assets will not be realized. In determining whether the deferred tax assets are realizable, the Company considers the period of expiration of the tax asset, historical and projected taxable income and tax liabilities for the tax jurisdiction in which the tax asset is located. The deferred tax asset recognized by the Company, as it relates to the higher tax basis in the carrying value of certain assets compared to the book basis of those assets, will be recognized in future years by these taxable entities. Deferred tax assets are based on the amount of the tax benefit that the Company’s management has determined is more likely than not to be realized in future periods. In determining the realizability of this tax benefit, management considered numerous factors that will give rise to pre-tax income in future periods. Among these are the historical and expected future book and tax basis pre-tax income of the Company and unrealized gains in the Company’s assets at the determination date. Based on these and other factors, the Company determined that, as of December 31, 2021, $1.52022, $11.4 million of the $3.2$13.1 million deferred tax assets would not more likely than not be realized in future periods. As of December 31, 2021,2022, the Company recorded a net deferred tax asset of $1.7 million on the Consolidated Statements of Assets and Liabilities.
For the three months ended December 31, 2022, the Company recognized a total benefit for income tax related to realized and unrealized losses of $0.5 million, which was primarily all current income tax benefit.
For the three months ended December 31, 2021, the Company recognized a total benefit for income tax related to realized and unrealized losses of $2.4 million, which was composed of (i) a current income tax benefit of approximately $1.4 million, and (ii) a deferred income tax benefit of approximately $1.0 million, which resulted from unrealized depreciation on investments held by the Company’s wholly-owned taxable subsidiaries. For the three months ended December 31, 2021, the Company recognized a provision for income tax related to net investment income of $3.3 million, which was all current income tax expense.
For the three months ended December 31, 2020, the Company recognized a total provision for income tax expense of $0.2 million, which was comprised of (i) a current income tax expense of approximately $0.5 million, and (ii) a deferred income tax benefit of approximately $0.3 million, which resulted from unrealized depreciation on investments held by the Company’s wholly-owned taxable subsidiaries.
As of September 30, 2021,2022, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows:
Undistributed ordinary income, net$(20,260)(43,624)
Net realized capital losses497,255 473,274 
Unrealized losses, net16,340 153,119 
Accumulated overdistributed earnings$493,335582,769
The aggregate cost of investments for U.S. federal income tax purposes was $2,654.3 million as of September 30, 2022. As of September 30, 2022, the aggregate gross unrealized appreciation for all investments in which there was an excess of value over cost for U.S. federal income tax purposes was $466.9 million. As of September 30, 2022, the aggregate gross unrealized depreciation for all investments in which there was an excess of cost for U.S. federal income tax purposes over value was
66
69

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








The aggregate cost of investments for U.S. federal income tax purposes was $2.6 billion as of September 30, 2021. As of September 30, 2021, the aggregate gross unrealized appreciation for all investments in which there was an excess of value over cost for U.S. federal income tax purposes was $409.5 million. As of September 30, 2021, the aggregate gross unrealized depreciation for all investments in which there was an excess of cost for U.S. federal income tax purposes over value was $425.8$620.0 million. Net unrealized depreciation based on the aggregate cost of investments for U.S. federal income tax purposes was $16.3$153.1 million.


Note 8. Realized Gains or Losses and Net Unrealized Appreciation or Depreciation
Realized Gains or Losses
Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption and the cost basis of the investment without regard to unrealized appreciation or depreciation previously recognized, and include investments written-off during the period, net of recoveries. Realized losses may also be recorded in connection with the Company's determination that certain investments are considered worthless securities and/or meet the conditions for loss recognition per the applicable tax rules.
During the three months ended December 31, 2022, the Company recorded an aggregate net realized loss of $3.2 million, which consisted of the following:
($ in millions)
Portfolio CompanyNet Realized Gain (Loss)
Foreign currency forward contracts$4.4 
Carvana Co.(2.8)
ASP Unifrax Holdings Inc.(2.1)
Global Medical Response Inc.(1.0)
Other, net(1.7)
Total, net$(3.2)
During the three months ended December 31, 2021, the Company recorded an aggregate net realized gain of $9.3 million, which consisted of the following:
($ in millions)
Portfolio CompanyNet Realized Gain (Loss)
Foreign currency forward contracts$3.0 
OmniSYS Acquisition Corporation2.0 
First Star Speir Aviation Limited1.9 
Other, net2.4 
Total, net$9.3
During the three months ended December 31, 2020, the Company recorded an aggregate net realized gain of $8.2 million, which consisted of the following:
($ in millions)
Portfolio CompanyNet Realized Gain (Loss)
PLATO Learning Inc.$7.8 
L Squared Capital1.4 
BX Commercial Mortgage Trust 2020-VIVA1.2 
ExamSoft Worldwide Inc.0.9 
California Pizza Kitchen Inc.(2.1)
99 Cents Only Stores(0.9)
Other, net(0.1)
Total, net$8.2


Net Unrealized Appreciation or Depreciation
Net unrealized appreciation or depreciation reflects the net change in the valuation of the portfolio pursuant to the Company's valuation guidelines and the reclassification of any prior period unrealized appreciation or depreciation.
During the three months ended December 31, 20212022 and 2020,2021, the Company recorded net unrealized appreciation (depreciation)depreciation of $(4.6)$23.0 million and $47.6$4.6 million, respectively. For the three months ended December 31, 2022, this consisted of $18.7 million of net unrealized depreciation on debt investments and $11.0 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $3.9 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $2.8 million of net unrealized appreciation on equity investments. For the three months ended December 31, 2021, this consisted of $4.7 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains), $1.8 million of net unrealized depreciation on debt investments and $0.8 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $2.8 million of net unrealized appreciation on equity investments. For the three months ended December 31, 2020, this consisted of $27.2 million of net unrealized appreciation on debt investments, $12.8 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $9.9 million of net unrealized appreciation on equity investments, partially offset by $2.4 million of net unrealized depreciation of foreign currency forward contracts.

6770

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)









Note 9. Concentration of Credit Risks
The Company deposits its cash with financial institutions and at times such balances may be in excess of the FDIC insurance limit. The Company limits its exposure to credit loss by depositing its cash with high credit quality financial institutions and monitoring their financial stability.

Note 10. Related Party Transactions


As of December 31, 20212022 and September 30, 2021,2022, the Company had a liability on its Consolidated Statements of Assets and Liabilities in the amount of $26.2$16.9 million and $32.6$15.9 million, respectively, reflecting the unpaid portion of the base management fees and incentive fees payable to Oaktree.
Investment Advisory Agreement
The Company is party to the Investment Advisory Agreement. Under the Investment Advisory Agreement, the Company pays Oaktree a fee for its services under the Investment Advisory Agreement consisting of two components: a base management fee and an incentive fee. The cost of both the base management fee payable to Oaktree and any incentive fees earned by Oaktree is ultimately borne by common stockholders of the Company.
From October 17, 2017 through May 3, 2020, the Company was externally managed by OCM pursuant to an investment advisory agreement. On May 4, 2020, OCM effected the novation of such investment advisory agreement to Oaktree. Immediately following such novation, the Company and Oaktree entered into a new investment advisory agreement with the same terms, including fee structure, as the investment advisory agreement with OCM. The investment advisory agreement with Oaktree was subsequently amended and restated on March 19, 2021 in connection with the closing of the Mergers.OCSI Merger and on January 23, 2023 in connection with the OSI2 Merger. The term “Investment Advisory Agreement” refers collectively to the agreements with Oaktree and, prior to its novation, with OCM.
Unless earlier terminated as described below, the Investment Advisory Agreement will remain in effect from year-to-year if approved annually by the Board of Directors of the Company or by the affirmative vote of the holders of a majority of the Company’s outstanding voting securities, including, in either case, approval by a majority of the directors of the Company who are not interested persons. The Investment Advisory Agreement will automatically terminate in the event of its assignment. The Investment Advisory Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Investment Advisory Agreement may also be terminated, without penalty, upon the vote of a majority of the outstanding voting securities of the Company.
Base Management Fee


Under the Investment Advisory Agreement, the base management fee is calculated at an annual rate of 1.50% of total gross assets, including any investment made with borrowings, but excluding cash and cash equivalents. The base management fee is payable quarterly in arrears and the fee for any partial month or quarter is appropriately prorated. Effective May 3, 2019, the base management fee on the Company’s gross assets, including any investments made with borrowings, but excluding any cash and cash equivalents, that exceed the product of (A) 200% and (B) the Company’s net asset value will be 1.00%. For the avoidance of doubt, the 200% will be calculated in accordance with the Investment Company Act and will give effect to exemptive relief the Company received from the SEC with respect to debentures issued by a small business investment company subsidiary. In connection with the Mergers, the Company andOCSI Merger, Oaktree entered into an amended and restated investment advisory agreement, which among other items, waived an aggregate of $6 million of base management fees otherwise payable to Oaktree in the two years following the closing of the MergersOCSI Merger on March 19, 2021 at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter). In connection with the OSI2 Merger, Oaktree waived an aggregate of $9.0 million of base management fees payable to Oaktree as follows: $6.0 million at a rate of $1.5 million per quarter (with such amount appropriately prorated for any partial quarter) in the first year following closing of the OSI2 Merger on January 23, 2023 and $3.0 million at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter) in the second year following closing of the OSI2 Merger.
For the three months ended December 31, 20212022 and 2020,2021, the base management fee incurred under the Investment Advisory Agreement was $9.2 million (net of waiver) and $6.5$9.2 million (net of waiver), respectively.
68

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Incentive Fee
The incentive fee consists of two parts. Under the Investment Advisory Agreement, the first part of the incentive fee (the “incentive fee on income” or "Part I incentive fee") is calculated and payable quarterly in arrears based upon the “pre-incentive fee net investment income” of the Company for the immediately preceding quarter. The payment of the incentive fee on income
71

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




is subject to payment of a preferred return to investors each quarter (i.e., a “hurdle rate”), expressed as a rate of return on the value of the Company’s net assets at the end of the most recently completed quarter, of 1.50%, subject to a “catch up” feature.
For this purpose, “pre-incentive fee net investment income” means interest income, dividend income and any other income (including any other fees such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies, other than fees for providing managerial assistance) accrued during the fiscal quarter, minus the Company’s operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement and any interest expense and dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as OID debt, instruments with PIK interest and zero coupon securities), accrued income that the Company has not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. In addition, pre-incentive fee net investment income does not include any amortization or accretion of any purchase premium or purchase discount to interest income resulting solely from merger-related accounting adjustments in connection with the assets acquired in the Mergers,OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in pre-incentive fee net investment income.


Under the Investment Advisory Agreement, the calculation of the incentive fee on income for each quarter is as follows:


No incentive fee is payable to Oaktree in any quarter in which the Company’s pre-incentive fee net investment income does not exceed the preferred return rate of 1.50% (the “preferred return”) on net assets;
100% of the Company’s pre-incentive fee net investment income, if any, that exceeds the preferred return but is less than or equal to 1.8182% in any fiscal quarter is payable to Oaktree. This portion of the incentive fee on income is referred to as the “catch-up” provision, and it is intended to provide Oaktree with an incentive fee of 17.5% on all of the Company’s pre-incentive fee net investment income when the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets in any fiscal quarter; and
For any quarter in which the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets, the incentive fee on income is equal to 17.5% of the amount of the Company’s pre-incentive fee net investment income, as the preferred return and catch-up will have been achieved.


There is no accumulation of amounts on the hurdle rate from quarter to quarter and accordingly there is no clawback of amounts previously paid if subsequent quarters are below the quarterly hurdle.


For the three months ended December 31, 20212022 and 2020,2021, the first part of the incentive fee (incentive fee on income) incurred under the Investment Advisory Agreement was $6.5$7.7 million and $4.1$6.5 million, respectively.
Under the Investment Advisory Agreement, the second part of the incentive fee (the "capital gains incentive fee") is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Investment Advisory Agreement, as of the termination date) commencing with the fiscal year ended September 30, 2019 and equals 17.5% of the Company’s realized capital gains, if any, on a cumulative basis from the beginning of the fiscal year ended September 30, 2019 through the end of each subsequent fiscal year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees under the Investment Advisory Agreement. Any realized capital gains, realized capital losses, unrealized capital appreciation and unrealized capital depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the calculations of the second part of the incentive fee. In addition, the calculation of realized capital gains, realized capital losses and unrealized capital depreciation does (1) not include any such amounts resulting solely from merger-related accounting adjustments in connection with the assets acquired in the Mergers,OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in the capital gains incentive fee, and (2) include any such amounts associated with the investments acquired in the MergersOCSI Merger for the period from October 1, 2018 to the date of closing of the Mergers,OCSI Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee and (3) include any such amounts associated with the investments acquired in the OSI2 Merger for the period from August 6, 2018 to the date of closing of the OSI2 Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee. As of December 31, 2021,2022, the Company paid $9.6 million of capital gains incentive fees cumulatively under the Investment Advisory Agreement (net of waivers). ForPart II incentive fees are contractually calculated and paid at the three months endedend of the fiscal year in accordance with the Investment Advisory Agreement, which, as described above, differs from Part II incentive fees accrued under GAAP. Hypothetically, if Part II incentive fees were calculated as of December 31, 2021, the Company did not incur any capital gains incentive fees2022 under the Investment Advisory Agreement.Agreement, no Part II incentive fees would be payable.
6972

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)










GAAP requires that the capital gains incentive fee accrual consider the cumulative aggregate unrealized capital appreciation in the calculation, as a capital gains incentive fee would be payable if such unrealized capital appreciation were realized on a theoretical "liquidation basis." A fee so calculated and accrued would not be payable under applicable law and may never be paid based upon the computation of capital gains incentive fees in subsequent periods. Amounts ultimately paid under the Investment Advisory Agreement will be consistent with the formula reflected in the Investment Advisory Agreement. This GAAP accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital depreciation included in the calculation of the capital gains incentive fee plus the aggregate cumulative unrealized capital appreciation. Any realized capital gains and losses and cumulative unrealized capital appreciation and depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the GAAP accrual. If such amount is positive at the end of a period, then GAAP requires the Company to record a capital gains incentive fee equal to 17.5% of such cumulative amount, less the aggregate amount of actual capital gains incentive fees payable or capital gains incentive fees accrued under GAAP in all prior periods. The resulting accrual for any capital gains incentive fee under GAAP in a given period may result in an additional expense if such cumulative amount is greater than in the prior period or a reversal of previously recorded expense if such cumulative amount is less than in the prior period. If such cumulative amount is negative, then there is no accrual. There can be no assurance that such unrealized capital appreciation will be realized in the future or any accrued capital gains incentive fee will become payable under the Investment Advisory Agreement. For the three months ended December 31, 2022, there were no accrued capital gains incentive fees. For the three months ended December 31, 2021, and 2020, $1.8 million and $9.5 million of accrued capital gains incentive fees were expensed, respectively.expensed. As of December 31, 2021,2022, the total accrued capital gains incentive fee liability was $10.5 million. Part II incentive fees are contractually calculated and paid at the end of the fiscal year in accordance with the Investment Advisory Agreement, which, as described above, differs from Part II incentive fees accrued under GAAP. Hypothetically, if Part II incentive fees were calculated as of December 31, 2021 under the Investment Advisory Agreement, the amount payable would have been $2.8 million.zero.
Indemnification


The Investment Advisory Agreement provides that, absent willful misfeasance, bad faith or gross negligence in the performance of their respective duties or by reason of the reckless disregard of their respective duties and obligations, Oaktree and its officers, managers, partners, members (and their members, including the owners of their members), agents, employees, controlling persons and any other person or entity affiliated with it, are entitled to indemnification from the Company for any damages, liabilities, costs and expenses (including reasonable attorneys' fees and amounts reasonably paid in settlement) arising from the rendering of Oaktree's services under the Investment Advisory Agreement or otherwise as investment adviser.
Administrative Services
The Company is party to the Administration Agreement with Oaktree Administrator. Pursuant to the Administration Agreement, Oaktree Administrator provides administrative services to the Company necessary for the operations of the Company, which include providing office facilities, equipment, clerical, bookkeeping and record keeping services at such facilities and such other services as Oaktree Administrator, subject to review by the Company’s Board of Directors, shall from time to time deem to be necessary or useful to perform its obligations under the Administration Agreement. Oaktree Administrator may, on behalf of the Company, conduct relations and negotiate agreements with custodians, trustees, depositories, attorneys, underwriters, brokers and dealers, corporate fiduciaries, insurers, banks and such other persons in any such other capacity deemed to be necessary or desirable. Oaktree Administrator makes reports to the Company’s Board of Directors of its performance of obligations under the Administration Agreement and furnishes advice and recommendations with respect to such other aspects of the Company’s business and affairs, in each case, as it shall determine to be desirable or as reasonably required by the Company’s Board of Directors; provided that Oaktree Administrator shall not provide any investment advice or recommendation.
Oaktree Administrator also provides portfolio collection functions for interest income, fees and warrants and is responsible for the financial and other records that the Company is required to maintain and prepares, prints and disseminates reports to the Company’s stockholders and all other materials filed with the SEC. In addition, Oaktree Administrator assists the Company in determining and publishing the Company’s net asset value, overseeing the preparation and filing of the Company’s tax returns, and generally overseeing the payment of the Company’s expenses and the performance of administrative and professional services rendered to the Company by others. Oaktree Administrator may also offer to provide, on the Company’s behalf, managerial assistance to the Company’s portfolio companies.
For providing these services, facilities and personnel, the Company reimburses Oaktree Administrator the allocable portion of overhead and other expenses incurred by Oaktree Administrator in performing its obligations under the Administration
70

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Agreement, including the Company’s allocable portion of the rent of the Company’s principal executive offices (which are located in a building owned by a Brookfield affiliate) at market rates and the Company’s allocable portion of the costs of compensation and related expenses of its Chief Financial Officer, Chief Compliance Officer, their staffs and other non-investmentnon-
73

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




investment professionals at Oaktree that perform duties for the Company. Such reimbursement is at cost, with no profit to, or markup by, Oaktree Administrator. The Administration Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Administration Agreement may also be terminated, without penalty, upon the vote of a majority of the Company’s outstanding voting securities.
For the three months ended December 31, 20212022 and 2020,2021, the Company accrued administrative expenses of $0.5$0.4 million and $0.4$0.5 million, respectively, including $0.1 million and $0.1 million of general and administrative expenses, respectively.
As of December 31, 20212022 and September 30, 2021, $3.52022, $3.3 million and $4.4$3.2 million, respectively, was included in “Due to affiliate” in the Consolidated Statements of Assets and Liabilities, reflecting the unpaid portion of administrative expenses and other reimbursable expenses payable to Oaktree Administrator.

7174

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








Note 11. Financial Highlights
(Share amounts in thousands)(Share amounts in thousands)Three months ended
December 31, 2021
Three months ended
December 31, 2020
(Share amounts in thousands)Three months ended
December 31, 2022 (8)
Three months ended
December 31, 2021 (8)
Net asset value per share at beginning of periodNet asset value per share at beginning of period$7.28$6.49Net asset value per share at beginning of period$20.38$21.84
Net investment income (1)Net investment income (1)0.180.07Net investment income (1)0.630.54
Net unrealized appreciation (depreciation) (1)Net unrealized appreciation (depreciation) (1)(0.02)0.34Net unrealized appreciation (depreciation) (1)(0.38)(0.08)
Net realized gains (losses) (1)Net realized gains (losses) (1)0.050.06Net realized gains (losses) (1)(0.05)0.16
(Provision) benefit for taxes on realized and unrealized gains (losses) (1)(Provision) benefit for taxes on realized and unrealized gains (losses) (1)0.01(Provision) benefit for taxes on realized and unrealized gains (losses) (1)0.010.04
Distributions of net investment income to stockholdersDistributions of net investment income to stockholders(0.16)(0.11)Distributions of net investment income to stockholders(0.96)(0.47)
Net asset value per share at end of periodNet asset value per share at end of period7.346.85Net asset value per share at end of period$19.63$22.03
Per share market value at beginning of period(7)Per share market value at beginning of period(7)$7.06$4.84Per share market value at beginning of period(7)$18.00$21.18
Per share market value at end of period(7)Per share market value at end of period(7)7.465.57Per share market value at end of period(7)$20.61$22.38
Total return (2)Total return (2)7.92%17.34%Total return (2)19.90%7.92%
Common shares outstanding at beginning of periodCommon shares outstanding at beginning of period180,361140,961Common shares outstanding at beginning of period61,12560,120
Common shares outstanding at end of periodCommon shares outstanding at end of period180,469140,961Common shares outstanding at end of period61,22060,156
Net assets at beginning of periodNet assets at beginning of period$1,312,823$914,879Net assets at beginning of period$1,245,563$1,312,823
Net assets at end of periodNet assets at end of period$1,325,061$964,917Net assets at end of period$1,201,989$1,325,061
Average net assets (3)Average net assets (3)$1,327,934$944,955Average net assets (3)$1,241,806$1,327,934
Ratio of net investment income to average net assets (4)Ratio of net investment income to average net assets (4)9.65%4.21%Ratio of net investment income to average net assets (4)12.40%9.65%
Ratio of total expenses to average net assets (4)Ratio of total expenses to average net assets (4)8.99%11.83%Ratio of total expenses to average net assets (4)13.11%8.99%
Ratio of net expenses to average net assets (4)Ratio of net expenses to average net assets (4)8.77%11.83%Ratio of net expenses to average net assets (4)12.87%8.77%
Ratio of portfolio turnover to average investments at fair valueRatio of portfolio turnover to average investments at fair value9.14%10.34%Ratio of portfolio turnover to average investments at fair value4.24%9.14%
Weighted average outstanding debt (5)Weighted average outstanding debt (5)$1,331,141$703,403Weighted average outstanding debt (5)$1,441,326$1,331,141
Average debt per share (1)Average debt per share (1)$7.38$4.99Average debt per share (1)$23.57$22.14
Asset coverage ratio at end of period (6)Asset coverage ratio at end of period (6)200.81%236.67%Asset coverage ratio at end of period (6)176.31%200.81%
 __________
(1)Calculated based upon weighted average shares outstanding for the period.
(2)Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load.
(3)Calculated based upon the weighted average net assets for the period.
(4)Interim periods are annualized.
(5)Calculated based upon the weighted average of principal debt outstanding for the period.
(6)Based on outstanding senior securities of $1,300.0$1,514.4 million and $702.2$1,300.0 million as of December 31, 2022 and 2021, respectively.
(7)Per share market values are adjusted to reflect the 1-for-3 reverse stock split of the Company's common stock completed on January 20, 2023 and 2020, respectively.effective as of the commencement of trading on January 23, 2023.
(8)The share and per share information disclosed in this table has been retrospectively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.



7275

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)










Note 12. Derivative Instruments
The Company enters into foreign currency forward contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company’s investments denominated in foreign currencies. In order to better define its contractual rights and to secure rights that will help the Company mitigate its counterparty risk, the Company entered into an International Swaps and Derivatives Association, Inc. Master Agreement (the "ISDA Master Agreement") with its derivative counterparty, JPMorgan Chase Bank, N.A. The ISDA Master Agreement permits a single net payment in the event of a default or similar event. As of December 31, 2021,2022, no cash collateral has been pledged to cover obligations and no cash collateral has been received from the counterparty with respect to the Company's forward currency contracts.
In connection with the issuance of the 2027 Notes, the Company entered into an interest rate swap agreement with the Royal Bank of Canada pursuant to an ISDA Master Agreement. As of December 31, 2021,2022, the Company paid $3.5$39.8 million to the Royal Bank of Canada to cover collateral obligations under the terms of the interest swap agreement, which is included in due from broker on the Consolidated Statement of Assets and Liabilities.
Certain information related to the Company’s foreign currency forward contracts is presented below as of December 31, 2021.2022.
DescriptionDescriptionNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net AmountsDescriptionNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net Amounts
Foreign currency forward contractForeign currency forward contract$49,542 42.652 2/10/2022$999 $— Derivative assetForeign currency forward contract$44,825 44,224 2/9/2023$— $(2,499)Derivative liability
Foreign currency forward contractForeign currency forward contract$54,395 £40,109 2/10/2022$76 $— Derivative assetForeign currency forward contract$46,412 £39,965 2/9/2023$— $(1,712)Derivative liability
$1,075 $ $ $(4,211)
Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2021.2022.
DescriptionDescriptionNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net AmountsDescriptionNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net Amounts
Foreign currency forward contractForeign currency forward contract$52,186 £37,709 11/12/2021$1,339 $— Derivative assetForeign currency forward contract$43,179 41,444 11/10/2022$2,466 $— Derivative asset
Foreign currency forward contractForeign currency forward contract$46,663 39,736 11/12/2021$573 $— Derivative assetForeign currency forward contract$45,692 £37,033 11/10/2022$4,323 $— Derivative asset
$1,912 $ $6,789 $ 
Certain information related to the Company’s interest rate swap is presented below as of December 31, 2021.2022.
DescriptionDescriptionNotional AmountMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net AmountsDescriptionNotional AmountMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net Amounts
Interest rate swapInterest rate swap$350,000 1/15/2027$— $5,931 Derivative liabilityInterest rate swap$350,000 1/15/2027$— $39,928 Derivative liability
$ $5,931 $ $39,928 
Certain information related to the Company’s interest rate swap is presented below as of September 30, 2021.2022.
DescriptionDescriptionNotional AmountMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net AmountsDescriptionNotional AmountMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net Amounts
Interest rate swapInterest rate swap$350,000 1/15/2027$— $2,108 Derivative liabilityInterest rate swap$350,000 1/15/2027$— $41,969 Derivative liability
$ $2,108 $ $41,969 





76

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Note 13. Commitments and Contingencies
Off-Balance Sheet Arrangements
The Company may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of its portfolio companies. As of December 31, 2021,2022, the Company's only off-balance sheet arrangements
73

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




consisted of $295.3$198.9 million of unfunded commitments, which was comprised of $242.8$171.8 million to provide debt and equity financing to certain of its portfolio companies $49.0and $27.1 million to provide financing to the JVs and $3.5 million related to unfunded limited partnership interests.JVs. As of September 30, 2021,2022, the Company's only off-balance sheet arrangements consisted of $264.9$224.2 million of unfunded commitments, which was comprised of $212.4$175.2 million to provide debt and equity financing to certain of its portfolio companies and $49.0 million to provide financing to the JVs and $3.5 million related to unfunded limited partnership interests.JVs. Such commitments are subject to the portfolio companies' satisfaction of certain financial and nonfinancial covenants and may involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company's Consolidated Statements of Assets and Liabilities.
7477

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








A list of unfunded commitments by investment (consisting of revolvers, term loans with delayed draw components, subordinated notes and LLC equity interests in the JVs, preferred stock and limited partnership interests) as of December 31, 20212022 and September 30, 20212022 is shown in the table below:
December 31, 2021September 30, 2021December 31, 2022September 30, 2022
Realfi Strategic Capital Funding LLC$50,000 $— 
Delta Leasing SPV II LLCDelta Leasing SPV II LLC$23,004 $27,187 
Fairbridge Strategic Capital Funding LLCFairbridge Strategic Capital Funding LLC15,995 22,150 
OCSI Glick JV LLCOCSI Glick JV LLC13,998 13,998 
Senior Loan Fund JV I, LLCSenior Loan Fund JV I, LLC35,000 35,000 Senior Loan Fund JV I, LLC13,125 35,000 
Athenex, Inc.21,072 21,072 
BioXcel Therapeutics, Inc.BioXcel Therapeutics, Inc.11,785 11,785 
Dominion Diagnostics, LLCDominion Diagnostics, LLC11,148 11,148 
BAART Programs, Inc.BAART Programs, Inc.7,675 8,645 
iCIMs, Inc.iCIMs, Inc.6,930 6,930 
Marinus Pharmaceuticals, Inc.Marinus Pharmaceuticals, Inc.18,349 18,349 Marinus Pharmaceuticals, Inc.5,734 5,734 
scPharmaceuticals Inc.scPharmaceuticals Inc.5,212 — 
Assembled Brands Capital LLCAssembled Brands Capital LLC5,035 2,008 
RumbleOn, Inc.RumbleOn, Inc.16,301 16,301 RumbleOn, Inc.4,822 4,822 
BAART Programs, Inc.14,237 3,583 
Latam Airlines Group S.A.14,210 7,267 
OCSI Glick JV LLC13,998 13,998 
Dominion Diagnostics, LLC11,148 11,148 
Coty Inc.9,886 9,886 
Assembled Brands Capital LLC7,561 24,868 
Sunland Asphalt & Construction, LLC6,695 6,492 
NeuAG, LLC5,441 5,441 
Olaplex, Inc.4,806 4,806 
Ardonagh Midco 3 PLC4,372 14,892 
MRI Software LLCMRI Software LLC4,427 5,196 
107 Fair Street LLC107 Fair Street LLC4,322 — 
Grove Hotel Parcel Owner, LLCGrove Hotel Parcel Owner, LLC4,293 4,293 
Accupac, Inc.Accupac, Inc.4,197 4,605 
Innocoll Pharmaceuticals LimitedInnocoll Pharmaceuticals Limited4,195 4,195 
Avalara, Inc.Avalara, Inc.4,147 — 
Mindbody, Inc.Mindbody, Inc.4,000 4,000 Mindbody, Inc.4,000 4,000 
OTG Management, LLCOTG Management, LLC3,789 3,789 OTG Management, LLC3,789 3,789 
PFNY Holdings, LLC3,755 — 
Accupac, Inc.3,573 3,267 
Mesoblast, Inc.Mesoblast, Inc.3,553 — Mesoblast, Inc.3,553 3,553 
Establishment Labs Holdings Inc.Establishment Labs Holdings Inc.3,384 5,075 
112-126 Van Houten Real22 LLC112-126 Van Houten Real22 LLC3,174 — 
ADC Therapeutics SAADC Therapeutics SA3,020 3,020 
Spanx, LLCSpanx, LLC2,762 2,226 
PRGX Global, Inc.PRGX Global, Inc.2,518 2,518 
SCP Eye Care Services, LLCSCP Eye Care Services, LLC2,356 — 
Relativity ODA LLCRelativity ODA LLC2,218 2,218 
Berner Food & Beverage, LLCBerner Food & Beverage, LLC2,197 1,392 
Salus Workers' Compensation, LLCSalus Workers' Compensation, LLC2,171 — 
Pluralsight, LLCPluralsight, LLC3,532 3,532 Pluralsight, LLC1,766 3,532 
Pingora MSR Opportunity Fund I-A, LP3,500 3,500 
Dialyze Holdings, LLC3,431 3,431 
Tahoe Bidco B.V.Tahoe Bidco B.V.1,741 1,741 
CorEvitas, LLCCorEvitas, LLC3,235 3,235 CorEvitas, LLC1,526 915 
Spanx, LLC3,092 — 
Thrasio, LLC2,578 2,578 
Coyote Buyer, LLCCoyote Buyer, LLC1,333 1,333 
MHE Intermediate Holdings, LLCMHE Intermediate Holdings, LLC2,334 3,466 MHE Intermediate Holdings, LLC1,229 1,429 
Kings Buyer, LLCKings Buyer, LLC1,208 1,537 
Liquid Environmental Solutions CorporationLiquid Environmental Solutions Corporation2,324 — Liquid Environmental Solutions Corporation1,115 1,115 
Acquia Inc.Acquia Inc.2,240 2,061 Acquia Inc.923 1,326 
Relativity ODA LLC2,218 2,218 
MRI Software LLC1,800 2,699 
Berner Food & Beverage, LLC1,794 2,475 
Tahoe Bidco B.V.1,741 — 
PRGX Global, Inc.1,679 2,518 
Apptio, Inc.Apptio, Inc.1,338 1,338 Apptio, Inc.892 1,338 
Coyote Buyer, LLC1,333 1,333 
Community Brands Parentco, LLC1,100 1,100 
Digital.AI Software Holdings, Inc.Digital.AI Software Holdings, Inc.826 826 
Telestream Holdings CorporationTelestream Holdings Corporation1,055 1,266 Telestream Holdings Corporation528 528 
GKD Index Partners, LLCGKD Index Partners, LLC320 320 
PFNY Holdings, LLCPFNY Holdings, LLC275 1,527 
Ardonagh Midco 3 PLCArdonagh Midco 3 PLC— 4,372 
Dialyze Holdings, LLCDialyze Holdings, LLC— 3,431 
Thrasio, LLCThrasio, LLC— 2,578 
109 Montgomery Owner LLC109 Montgomery Owner LLC825 937 109 Montgomery Owner LLC— 477 
The Avery800 1,850 
Digital.AI Software Holdings, Inc.718 898 
Thermacell Repellents, Inc.583 833 
GKD Index Partners, LLC320 320 
CircusTrix Holdings, LLC30 37 
Gulf Operating, LLC— 10,064 
SIO2 Medical Products, Inc.— 3,406 
SumUp Holdings Luxembourg S.À.R.L.— 3,350 
4 Over International, LLC— 2,300 
LSL Holdco, LLCLSL Holdco, LLC— 427 
TotalTotal$295,346 $264,904 Total$198,868 $224,239 


7578

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)










Note 14. Subsequent Events
The Company’s management evaluated subsequent events through the date of issuance of the Consolidated Financial Statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in the Consolidated Financial Statements as of and for the three months ended December 31, 2021,2022, except as discussed below.
Distribution Declaration
On January 28, 2022,27, 2023, the Company’s Board of Directors declared a quarterly distribution of $0.16$0.55 per share, payable in cash on March 31, 20222023 to stockholders of record on March 15, 2022.2023.

Investment Advisory Agreement


On January 23, 2023, in connection with the consummation of the OSI2 Merger, the Company entered into an amended and restated investment advisory agreement with Oaktree to amend and restate the prior investment advisory agreement, dated as of March 19, 2021, by and between the Company and Oaktree to (1) waive an aggregate of $9.0 million of base management fees otherwise payable to the Oaktree in the two years following the closing of the OSI2 Merger and (2) revise the calculation of the incentive fees to eliminate certain unintended consequences of the accounting treatment of the OSI2 Merger on the incentive fees payable to Oaktree. None of the other terms were changed, and the services to be provided by Oaktree and the term of the Investment Advisory Agreement remain the same.
OSI2 Merger

On January 23, 2023, the Company completed the OSI2 Merger. In accordance with the terms of the OSI2 Merger Agreement, at the effective time of the OSI2 Merger, each outstanding share of OSI2 common stock was converted into the right to receive 0.9115 shares of the Company’s common stock (with OSI2’s stockholders receiving cash in lieu of fractional shares of the Company’s common stock). As a result of the OSI2 Merger, the Company issued an aggregate of 15,860,200 shares of its common stock to former OSI2 stockholders. Following completion of the OSI2 Merger, the Company had 77,079,805 shares of common stock outstanding.
OSI2 Citibank Facility

On January 23, 2023, as a result of the consummation of the OSI2 Merger, the Company became party to the OSI2 Citibank Facility (as described below).

OSI 2 Senior Lending SPV, LLC (“OSI 2 SPV”), the Company’s wholly-owned and consolidated subsidiary, is party to a loan and security agreement dated as of July 26, 2019, which was subsequently amended on September 20, 2019, July 2, 2020, December 31, 2020, March 31, 2021 and December 2, 2022 (as amended, the “OSI2 Citibank Loan Agreement”), with the lenders from time to time party thereto and the other parties referenced below. Under the terms of the OSI2 Citibank Loan Agreement, the Company serves as the collateral manager and seller and OSI 2 SPV serves as borrower with Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent.

The OSI2 Citibank Loan Agreement provides for a senior secured revolving credit facility (the “OSI2 Citibank Facility”) of up to $250 million (the “Citibank Maximum Commitment”) in aggregate principal amount, subject to the lesser of (i) the borrowing base, which is an amount based on advance rates that vary depending on the class of assets and the value assigned to such assets under the OSI2 Citibank Loan Agreement and (ii) the Citibank Maximum Commitment. The OSI2 Citibank Facility has a reinvestment period through May 26, 2023, during which advances may be made, and matures on January 26, 2025. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender under the OSI2 Citibank Loan Agreement, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) LIBOR for a three month maturity and (b) for all other lenders under the OSI2 Citibank Facility, LIBOR, plus, in each case, an applicable spread. During the reinvestment period, the applicable spread is the greater of (i) a weighted average rate of (x) 1.65% per year for broadly syndicated loans and (y) 2.25% per year for all other eligible loans and (ii) 1.85%. After the reinvestment period, the applicable spread is 3.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility.
7679

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)





The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets.

As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility.

Under the OSI2 Citibank Facility, the Company and OSI 2 SPV, as applicable, have made customary representations and warranties, and are required to comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar credit facilities.

OSI 2 SPV’s borrowings are non-recourse to the Company but are considered borrowings of the Company for purposes of complying with the asset coverage requirements under the Investment Company Act.

As of January 23, 2023, the Company had $225.0 million outstanding under the OSI2 Citibank Facility.
Reverse Stock Split

On January 20, 2023, the Company amended its restated certificate of incorporation, as amended and corrected, to effect a 1-for-3 reverse stock split. Immediately following completion of the reverse stock split, the Company had 61,219,605 shares of common stock outstanding.

80



Schedule 12-14
Oaktree Specialty Lending Corporation
Schedule of Investments in and Advances to Affiliates
(in thousands, except share and per share amounts, percentages and as otherwise indicated)
Three months ended December 31, 20212022
(unaudited)
Portfolio Company/Type of Investment (1)Portfolio Company/Type of Investment (1) Cash Interest RateIndustryPrincipalNet Realized Gain (Loss)Amount of
Interest,
Fees or
Dividends
Credited in
Income (2)
Fair Value
as of October 1,
2021
Gross
Additions (3)
Gross
Reductions (4)
Fair Value
as of December 31, 2021
% of Total Net AssetsPortfolio Company/Type of Investment (1) Cash Interest RateIndustryPrincipalNet Realized Gain (Loss)Amount of
Interest,
Fees or
Dividends
Credited in
Income (2)
Fair Value
as of October 1,
2022
Gross
Additions (3)
Gross
Reductions (4)
Fair Value
as of December 31, 2022
% of Total Net Assets
Control InvestmentsControl InvestmentsControl Investments
C5 Technology Holdings, LLCC5 Technology Holdings, LLCData Processing & Outsourced ServicesC5 Technology Holdings, LLCData Processing & Outsourced Services
829 Common Units829 Common Units$— $— $— $— $— $— — %829 Common Units$— $— $— $— $— $— — %
34,984,460.37 Preferred Units34,984,460.37 Preferred Units— — 27,638 — — 27,638 2.1 %34,984,460.37 Preferred Units— — 27,638 — — 27,638 2.3 %
Dominion Diagnostics, LLCDominion Diagnostics, LLCHealth Care ServicesDominion Diagnostics, LLCHealth Care Services
First Lien Term Loan, LIBOR+5.00% cash due 2/28/2024First Lien Term Loan, LIBOR+5.00% cash due 2/28/20246.00 %$23,201 — 430 27,381 — (4,180)23,201 1.8 %First Lien Term Loan, LIBOR+5.00% cash due 2/28/20249.73 %$14,297 — 331 14,333 — (36)14,297 1.2 %
First Lien Revolver, LIBOR+5.00% cash due 2/28/2024First Lien Revolver, LIBOR+5.00% cash due 2/28/2024— — 14 — — — — — %First Lien Revolver, LIBOR+5.00% cash due 2/28/2024— — 14 — — — — — %
30,030.8 Common Units in DD Healthcare Services Holdings, LLC30,030.8 Common Units in DD Healthcare Services Holdings, LLC— 3,308 18,065 — — 18,065 1.4 %30,030.8 Common Units in DD Healthcare Services Holdings, LLC— — 4,946 — (719)4,227 0.4 %
First Star Speir Aviation Limited (5)Airlines
First Lien Term Loan, 9.00% cash due 12/15/2025— 7,500 — 7,500 — (7,500)— — %
100% equity interest(5,632)158 698 — (698)— — %
OCSI Glick JV LLC (6)Multi-Sector Holdings
OCSI Glick JV LLC (5)OCSI Glick JV LLC (5)Multi-Sector Holdings
Subordinated Debt, LIBOR+4.50% cash due 10/20/2028Subordinated Debt, LIBOR+4.50% cash due 10/20/20284.58 %61,237 — 1,081 55,582 745 (473)55,854 4.2 %Subordinated Debt, LIBOR+4.50% cash due 10/20/20287.67 %59,049 — 1,624 50,283 380 (1,127)49,536 4.1 %
87.5% equity interest87.5% equity interest— — — — — — — %87.5% equity interest— — — — — — — %
Senior Loan Fund JV I, LLC (7)Multi-Sector Holdings
Senior Loan Fund JV I, LLC (6)Senior Loan Fund JV I, LLC (6)Multi-Sector Holdings
Subordinated Debt, LIBOR+7.00% cash due 12/29/2028Subordinated Debt, LIBOR+7.00% cash due 12/29/20288.00 %96,250 — 1,967 96,250 — — 96,250 7.3 %Subordinated Debt, LIBOR+7.00% cash due 12/29/202810.17 %112,656 — 2,611 96,250 16,406 — 112,656 9.4 %
87.5% LLC equity interest87.5% LLC equity interest— 451 37,651 810 — 38,461 2.9 %87.5% LLC equity interest— 1,050 20,715 5,469 (2,076)24,108 2.0 %
Total Control InvestmentsTotal Control Investments$180,688 $1,868 $7,409 $270,765 $1,555 $(12,851)$259,469 19.6 %Total Control Investments$186,002 $ $5,630 $214,165 $22,255 $(3,958)$232,462 19.3 %
Affiliate InvestmentsAffiliate InvestmentsAffiliate Investments
Assembled Brands Capital LLCAssembled Brands Capital LLCSpecialized FinanceAssembled Brands Capital LLCSpecialized Finance
First Lien Revolver, LIBOR+6.75% cash due 10/17/2023First Lien Revolver, LIBOR+6.75% cash due 10/17/20237.75 %$15,982 $— $339 $15,712 $3,499 $(3,487)$15,724 1.2 %First Lien Revolver, LIBOR+6.75% cash due 10/17/202311.48 %$21,464 $— $646 $24,225 $55 $(3,028)$21,252 1.8 %
1,609,201 Class A Units1,609,201 Class A Units— — 587 — (201)386 — %1,609,201 Class A Units— — 370 — (16)354 — %
1,019,168.80 Preferred Units, 6%1,019,168.80 Preferred Units, 6%— — 1,152 20 — 1,172 0.1 %1,019,168.80 Preferred Units, 6%— — 1,223 20 — 1,243 0.1 %
70,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/202970,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029— — — — — — — %70,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029— — — — — — — %
Caregiver Services, Inc.Caregiver Services, Inc.Health Care ServicesCaregiver Services, Inc.Health Care Services
1,080,399 shares of Series A Preferred Stock, 10%1,080,399 shares of Series A Preferred Stock, 10%— — — 838 — — 838 0.1 %1,080,399 shares of Series A Preferred Stock, 10%— — — 378 — (54)324 — %
Total Affiliate InvestmentsTotal Affiliate Investments$15,982 $ $339 $18,289 $3,519 $(3,688)$18,120 1.4 %Total Affiliate Investments$21,464 $ $646 $26,196 $75 $(3,098)$23,173 1.9 %
Total Control & Affiliate InvestmentsTotal Control & Affiliate Investments$196,670 $1,868 $7,748 $289,054 $5,074 $(16,539)$277,589 21.0 %Total Control & Affiliate Investments$207,466 $ $6,276 $240,361 $22,330 $(7,056)$255,635 21.2 %


This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements.
______________________
(1)The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments .Investments.
(2)Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories.
(3)Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category.
77


(4)Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category.
81


(5)Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required).
(6)Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required).



82


Schedule 12-14
Oaktree Specialty Lending Corporation
Schedule of Investments in and Advances to Affiliates
(in thousands, except share and per share amounts, percentages and as otherwise indicated)
Three months ended December 31, 2021
(unaudited)
Portfolio Company/Type of Investment (1) Cash Interest RateIndustryPrincipalNet Realized Gain (Loss)Amount of
Interest,
Fees or
Dividends
Credited in
Income (2)
Fair Value
as of October 1,
2021
Gross
Additions (3)
Gross
Reductions (4)
Fair Value
as of December 31, 2021
% of Total Net Assets
Control Investments
C5 Technology Holdings, LLCData Processing & Outsourced Services
829 Common Units$— $— $— $— $— $— — %
34,984,460.37 Preferred Units— — 27,638 — — 27,638 2.1 %
Dominion Diagnostics, LLCHealth Care Services
First Lien Term Loan, LIBOR+5.00% cash due 2/28/20246.00 %$23,201 — 430 27,381 — (4,180)23,201 1.8 %
First Lien Revolver, LIBOR+5.00% cash due 2/28/2024— — 14 — — — — — %
30,030.8 Common Units in DD Healthcare Services Holdings, LLC— 3,308 18,065 — — 18,065 1.4 %
First Star Speir Aviation Limited (5)Airlines
First Lien Term Loan, 9.00% cash due 12/15/2025— 7,500 — 7,500 — (7,500)— — %
100% equity interest(5,632)158 698 — (698)— — %
OCSI Glick JV LLC (6)Multi-Sector Holdings
Subordinated Debt, LIBOR+4.50% cash due 10/20/20284.58 %61,237 — 1,081 55,582 745 (473)55,854 4.2 %
87.5% equity interest— — — — — — — %
Senior Loan Fund JV I, LLC (7)Multi-Sector Holdings
Subordinated Debt, LIBOR+7.00% cash due 12/29/20288.00 %96,250 — 1,967 96,250 — — 96,250 7.3 %
87.5% LLC equity interest— 451 37,651 810 — 38,461 2.9 %
Total Control Investments$180,688 $1,868 $7,409 $270,765 $1,555 $(12,851)$259,469 19.6 %
Affiliate Investments
Assembled Brands Capital LLCSpecialized Finance
First Lien Revolver, LIBOR+6.75% cash due 10/17/20237.75 %$15,982 $— $339 $15,712 $3,499 $(3,487)$15,724 1.2 %
1,609,201 Class A Units— — 587 — (201)386 — %
1,019,168.80 Preferred Units, 6%— — 1,152 20 — 1,172 0.1 %
70,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029— — — — — — — %
Caregiver Services, Inc.Health Care Services
1,080,399 shares of Series A Preferred Stock, 10%— — — 838 — — 838 0.1 %
Total Affiliate Investments$15,982 $ $339 $18,289 $3,519 $(3,688)$18,120 1.4 %
Total Control & Affiliate Investments$196,670 $1,868 $7,748 $289,054 $5,074 $(16,539)$277,589 21.0 %

This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements.
______________________
(1)The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments included in the Company's quarterly report on Form 10-Q for the quarter ended December 31, 2021.
(2)Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories.
(3)Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category.
83


(4)Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category.
(5)First Star Speir Aviation Limited is a wholly-owned holding company formed by the Company in order to facilitate its investment strategy. In accordance with ASU 2013-08, the Company has deemed the holding company to be an investment company under GAAP and therefore deemed it appropriate to consolidate the financial results and financial position of the holding company and to recognize dividend income versus a combination of interest income and dividend income. Accordingly, the debt and equity investments in the wholly-owned holding company are disregarded for accounting purposes since the economic substance of these instruments are equity investments in the operating entities.
(6)Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required).
(7)Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required).







78


Schedule 12-14
Oaktree Specialty Lending Corporation
Schedule of Investments in and Advances to Affiliates
(in thousands, except share and per share amounts, percentages and as otherwise indicated)
Three months ended December 31, 2020
(unaudited)
Portfolio Company/Type of Investment (1) Cash Interest RateIndustryPrincipalNet Realized Gain (Loss)Amount of
Interest,
Fees or
Dividends
Credited in
Income (2)
Fair Value
as of October 1,
2020
Gross
Additions (3)
Gross
Reductions (4)
Fair Value
as of December 31, 2020
% of Total Net Assets
Control Investments
C5 Technology Holdings, LLCData Processing & Outsourced Services
829 Common Units$— $— $— $— $— $— — %
34,984,460.37 Preferred Units— — 27,638 — — 27,638 2.9 %
Dominion Diagnostics, LLCHealth Care Services
First Lien Term Loan, LIBOR+5.00% cash due 2/28/20246.00 %$27,590 — 437 27,660 — (70)27,590 2.9 %
First Lien Revolver, LIBOR+5.00% cash due 2/28/20246.00 %7,699 — 111 5,260 2,439 — 7,699 0.8 %
30,030.8 Common Units in DD Healthcare Services Holdings, LLC— — 7,667 — — 7,667 0.8 %
 First Star Speir Aviation Limited (5)Airlines
First Lien Term Loan, 9.00% cash due 12/15/20257,500 — 130 11,510 — (4,010)7,500 0.8 %
100% equity interest— — 1,622 2,204 (2,145)1,681 0.2 %
New IPT, Inc.Oil & Gas Equipment & Services
First Lien Term Loan, LIBOR+5.00% cash due 3/17/20216.00 %2,154 — 37 1,800 33 (150)1,683 0.2 %
First Lien Revolver, LIBOR+5.00% cash due 3/17/20216.00 %1,009 — 17 788 — — 788 0.1 %
50.087 Class A Common Units in New IPT Holdings, LLC— — — — — — — %
 Senior Loan Fund JV I, LLC (6)Multi-Sector Holdings
Subordinated Debt, LIBOR+7.00% cash due 12/29/20287.14 %96,250 — 1,756 96,250 — — 96,250 10.0 %
87.5% LLC equity interest— — 21,190 8,074 — 29,264 3.0 %
Total Control Investments$142,202 $ $2,488 $201,385 $12,750 $(6,375)$207,760 21.5 %
Affiliate Investments
 Assembled Brands Capital LLCSpecialized Finance
First Lien Revolver, LIBOR+6.00% cash due 10/17/20237.00 %$7,440 $— $110 $4,194 $2,755 $— $6,949 0.7 %
1,609,201 Class A Units— — 483 — (65)418 — %
1,019,168.80 Preferred Units, 6%— — 1,091 10 — 1,101 0.1 %
70,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029— — — — — — — %
Caregiver Services, Inc.Health Care Services
1,080,399 shares of Series A Preferred Stock, 10%— — — 741 — (238)503 0.1 %
Total Affiliate Investments$7,440 $ $110 $6,509 $2,765 $(303)$8,971 0.9 %
Total Control & Affiliate Investments$149,642 $ $2,598 $207,894 $15,515 $(6,678)$216,731 22.5 %


This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements.
______________________
(1)The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments included in the Company's quarterly report on Form 10-Q for the quarter ended December 31, 2020.
79


(2)Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories.
(3)Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category.
(4)Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category.
(5)First Star Speir Aviation Limited is a wholly-owned holding company formed by the Company in order to facilitate its investment strategy. In accordance with ASU 2013-08, the Company has deemed the holding company to be an investment company under GAAP and therefore deemed it appropriate to consolidate the financial results and financial position of the holding company and to recognize dividend income versus a combination of interest income and dividend income. Accordingly, the debt and equity investments in the wholly-owned holding company are disregarded for accounting purposes since the economic substance of these instruments are equity investments in the operating entities.
(6)Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required).




8084



Item 2.     Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion should be read in connection with our Consolidated Financial Statements and the notes thereto included elsewhere in this quarterly report on Form 10-Q.
Some of the statements in this quarterly report on Form 10-Q constitute forward-looking statements because they relate to future events or our future performance or financial condition. The forward-looking statements contained in this quarterly report on Form 10-Q may include statements as to:


our future operating results and distribution projections;
the ability of Oaktree Fund Advisors, LLC, or Oaktree, to reposition our portfolio and to implement Oaktree's future plans with respect to our business;
the ability of Oaktree and its affiliates to attract and retain highly talented professionals;
our business prospects and the prospects of our portfolio companies;
the impact of the investments that we expect to make;
the ability of our portfolio companies to achieve their objectives;
our expected financings and investments and additional leverage we may seek to incur in the future;
the adequacy of our cash resources and working capital;
the timing of cash flows, if any, from the operations of our portfolio companies; and
the cost or potential outcome of any litigation to which we may be a party.
In addition, words such as “anticipate,” “believe,” “expect,” “seek,” “plan,” “should,” “estimate,” “project” and “intend” indicate forward-looking statements, although not all forward-looking statements include these words. The forward-looking statements contained in this quarterly report on Form 10-Q involve risks and uncertainties. Our actual results could differ materially from those implied or expressed in the forward-looking statements for any reason, including the factors set forth in “Item 1A. Risk Factors” in our annual report on Form 10-K for the year ended September 30, 20212022 and elsewhere in this quarterly report on Form 10-Q.
Other factors that could cause actual results to differ materially include:
changes or potential disruptions in our operations, the economy, financial markets or political environment;environment, including the impacts of inflation and rising interest rates;
risks associated with possible disruption in our operations or the economy generally due to terrorism, war or other geopolitical conflict (including the current conflict between Russia and Ukraine), natural disasters or the COVID-19 pandemic;pandemics;
future changes in laws or regulations (including the interpretation of these laws and regulations by regulatory authorities) and conditions in our operating areas, particularly with respect to Business Development Companies or, regulated investment companies, or RICs;
general considerations associated with the COVID-19 pandemic;
the ability to realize the anticipated benefits of the MergersOSI2 Merger (as defined below); and
other considerations that may be disclosed from time to time in our publicly disseminated documents and filings.
We have based the forward-looking statements included in this quarterly report on Form 10-Q on information available to us on the date of this quarterly report, and we assume no obligation to update any such forward-looking statements. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the Securities and Exchange Commission, or the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.
All dollar amounts in tables are in thousands, except share and per share amounts and as otherwise indicated.
Business Overview
We are a specialty finance company dedicated to providing customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. We are a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a Business Development Company under the Investment Company Act of 1940, as amended, or the Investment Company Act. In addition, we have qualified and elected to be treated as a RIC under the Internal Revenue Code of 1986, as amended, or the Code, for U.S. federal income tax purposes.
We are externally managed by Oaktree pursuant to an investment advisory agreement, as amended from time to time, or the Investment Advisory Agreement. Oaktree Fund Administration, LLC, or Oaktree Administrator, an affiliate of Oaktree, provides certain administrative and other services necessary for us to operate pursuant to an administration agreement, as amended from time to time, or the Administration Agreement.
8185



Our investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. We may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. Our portfolio may also include certain structured finance and other non-traditional structures. We invest in companies that typically possess resilient business models with strong underlying fundamentals. We intend to deploy capital across credit and economic cycles with a focus on long-term results, which we believe will enable us to build lasting partnerships with financial sponsors and management teams, and we may seek to opportunistically take advantage of dislocations in the financial markets and other situations that may benefit from Oaktree’s credit and structuring expertise, including during the COVID-19 pandemic.expertise. Sponsors may include financial sponsors, such as an institutional investor or a private equity firm, or a strategic entity seeking to invest in a portfolio company. Oaktree is generally focused on middle-market companies, which we define as companies with enterprise values of between $100 million and $750 million. We generally invest in securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Below investment grade securities, which are often referred to as “high yield” and “junk,” have predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal.
In the current market environment, Oaktree intends to focus on the following areas,area, in which Oaktree believes there is less competition and thus potential for greater returns, for our new investment opportunities: (1) situational lending, which we define to include directly originated loans to non-sponsor companies that are hard to understand and value using traditional underwriting techniques, (2) select sponsor lending, which we define to include financing to support leveraged buyouts of companies with specialized sponsors that have expertise in certain industries, and (3) stressed sector and rescue lending, which we define to include opportunistic private loans in industries experiencing stress or limited access to capital.
Oaktree intends to continue to rotate our portfolio into investments that are better aligned with Oaktree's overall approach to credit investing and that it believes have the potential to generate attractive returns across market cycles (which we call "core investments"). Oaktree has performed a comprehensive review of our portfolio and categorized our portfolio into core investments, non-core performing investments and underperforming investments. Certain additional information on such categorization and our portfolio composition is included in investor presentations that we file with the SEC. Since an Oaktree affiliate became our investment adviser in October 2017, Oaktree and its affiliates have reduced the investments identified as non-core by approximately $800 million at fair value. Over time, Oaktree intends to rotate us out of the remaining non-core investments, which were approximately $95$71 million at fair value as of December 31, 2021.2022. Oaktree periodically reviews designations of investments as core and non-core and may change such designations over time.


On March 19, 2021, we acquired Oaktree Strategic Income Corporation, or OCSI, pursuant to an agreement and plan or merger, or the OCSI Merger Agreement, dated as of October 28, 2020, by and among OCSI, us, Lion Merger Sub, Inc., our wholly-owned subsidiary, or Merger Sub, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OCSI Merger Agreement, Merger SubOCSI was first merged with and into OCSI, with OCSI as the surviving corporation, or the Merger, and, immediately following the Merger, OCSI was then merged with and into us in a two-step transaction with us as the surviving company, or together with the OCSI Merger.

On January 23, 2023, we acquired Oaktree Strategic Income II, Inc., or OSI2, pursuant to that certain Agreement and Plan of Merger, or the Mergers. In accordance with the terms of theOSI2 Merger Agreement, atdated as of September 14, 2022, by and among OSI2, us, Project Superior Merger Sub, Inc., a wholly-owned subsidiary of us, and, solely for the effective time oflimited purposes set forth therein, Oaktree. Pursuant to the OSI2 Merger each outstanding share of OCSI’s common stockAgreement, OSI2 was convertedmerged with and into us in a two-step transaction with us as the right to receive 1.3371 shares of our common stock (with OCSI’s stockholders receiving cash in lieu of fractional shares of our common stock). As a result ofsurviving company, or the Mergers, we issued an aggregate of 39,400,011 shares of our common stock to former OCSI stockholders.OSI2 Merger.
Business Environment and Developments
The rapid spread of COVID-19
Global financial markets have experienced an increase in early 2020 led to disruptions involatility as concerns about the U.S. and global financial markets. While several countries, including the U.S., have eased certain travel restrictions, business closures and social distancing measures, the U.S. and global economies continue to rapidly evolve and experience uncertainty, particularly due to recurring COVID-19 outbreaks (including the Omicron variant), vaccine hesitancy and potential re-imposition of or changes to certain restrictions. The general uncertainty surrounding the dangers and long-term impact of COVID-19higher inflation, rising interest rates, a potential recession and the current conflict in Ukraine have weighed on market participants. These factors have created significant disruptiondisruptions in supply chains and economic activity and have had a particularly adverse impact on certain companies in the energy, raw materials and transportation oil-related, hospitality, tourism, entertainment and other industries.sectors, among others. These uncertainties can ultimately impact the overall supply and demand of the market through changing spreads, deal terms and structures and equity purchase price multiples.

We are unable to predict the full effects of the COVID-19 pandemicthese macroeconomic events or how long any further outbreaks, market disruptions or volatility might last. We continue to closely monitor the impact that this has hadthese events have on our business, industry and portfolio companies which has helped us identify vulnerabilities and allowed us to address potential problems early andwill provide constructive solutions where necessary.
Despite the ongoing uncertainty surrounding the COVID-19 pandemic,
Against this uncertain macroeconomic backdrop, we believe attractive risk-adjusted returns can be achieved by making loans to middle market companies in the middle market.that typically possess resilient business models with strong underlying fundamentals. Given the breadth of the investment platform and decades of
82


credit investing experience of Oaktree and its affiliates, we believe that we have the resources and experience to source, diligence and structure investments in these companies and are well placed to generate attractive returns for investors.
86


As of December 31, 2021, 91.6%2022, 87.3% of our debt investment portfolio (at fair value) and 91.6%87.2% of our debt investment portfolio (at cost) bore interest at floating ratesrates. Most of our floating rate loans are indexed to the London Interbank Offered Rate, or LIBOR, and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly or monthly at the borrower’s option. As a result of the COVID-19 pandemic and the related decision of the U.S. Federal Reserve to reduce certain interest rates, LIBOR decreased beginning in March 2020. A prolonged reduction in interest rates will result in a decrease in our total investment income and could result in a decrease in our net investment incomeCertain loans may also be indexed to the extent the decreases are not offset by an increase in the spread on our floating rate investments, a decrease in our interest expenseSecured Overnight Financing Rate, or a reduction of our incentive fee on income. In July 2017, the head of the United Kingdom Financial Conduct Authority,SOFR, or the FCA, announced the desire to phase out the use of LIBOR by the end of 2021. However, in March 2021 the FCA announced that mostSterling Overnight Index Average, or SONIA. Most U.S. dollar LIBOR wouldrates will continue to be published through June 30, 2023 effectively extending the LIBOR transition period to June 30, 2023. However, theThe FCA no longer compels panel banks to continue to contribute to LIBOR and the Federal Reserve Board, the Office of the Comptroller of the Currency, and the Federal Deposit Insurance Corporation have encouraged banks to cease entering into new contracts that use U.S. dollar LIBOR as a reference rate no later than December 31, 2021.rate. The U.S. Federal Reserve, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions, supports replacing U.S.-dollar LIBOR with the Secured Overnight Financing Rate, or SOFR, a new index calculated by short-term repurchase agreements, backed by Treasury securities.SOFR. Although there have beenare an increasing number of issuances utilizing SOFR or the Sterling Over Night Index Average, an alternative reference rate that is based on transactions, it is unknown whetherSONIA, these alternative reference rates willmay not attain market acceptance as replacements for LIBOR. In anticipation of the cessation of LIBOR, we may need to renegotiate any credit agreements extending beyond the applicable phase out date with our prospective portfolio companies that utilize LIBOR as a factor in determining the interest rate. Certain of the loan agreements with our portfolio companies have included fallback language in the event that LIBOR becomes unavailable. This language generally provides that the administrative agent may identify a replacement reference rate, typically with the consent of (or prior consultation with) the borrower. In certain cases, the administrative agent will be required to obtain the consent of either a majority of the lenders under the facility, or the consent of each lender, prior to identifying a replacement reference rate. Certain of the loan agreements with our portfolio companies do not include any fallback language providing a mechanism for the parties to negotiate a new reference interest rate and will instead revert to the base rate in the event LIBOR ceases to exist.


Critical Accounting Estimates
Investment Valuation
We value our investments in accordance with Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 820, Fair Value Measurements and Disclosures, or ASC 820, which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability’s fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments’ complexity.
Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows:
 
Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date.
Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities.
Level 3 — Unobservable inputs that reflect management’sOaktree’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.
If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. OurOaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative
83


in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions.
Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of our investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations.
We seekOaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If we areOaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within our set threshold, we seekOaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the
87


quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, we doOaktree does not adjust any of the prices received from these sources.
If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, we valueOaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value, or EV, of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that we are deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company’s assets and (vii) offers from third parties to buy the portfolio company. WeOaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. Under the EV technique, the significant unobservable input used in the fair value measurement of our investments in debt or equity securities is the EBITDA, revenue or asset multiple, as applicable. Increases or decreases in the valuation multiples in isolation may result in a higher or lower fair value measurement, respectively. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and we consider the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by us are substantially illiquid with no active transaction market, we dependOaktree depends on primary market data, including newly funded transactions and industry-specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. Under the market yield technique, the significant unobservable input used in the fair value measurement of the Company'sour investments in debt securities is the market yield. Increases or decreases in the market yield may result in a lower or higher fair value measurement, respectively.
In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable.
We estimateOaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk-free rate. Changes in the subjective input assumptions can materially affect the fair value estimates.
The fair value of our investments as of December 31, 20212022 and September 30, 20212022 was determined in good faith by Oaktree, as our Board of Directors. Our Board of Directors hasvaluation designee. We have and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of our portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter, and the Board of Directors may reasonably rely on that assistance.quarter. As of December 31, 2021, 90.0%2022, 92.1% of our portfolio at fair value was valued
84


either based on market quotations, the transactions precedent approach or corroborated by independent valuation firms. However, our Board of Directors is responsible for the ultimate valuation of the portfolio investments at fair value as determined in good faith pursuant to our valuation policy and a consistently applied valuation process.
Certain factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s earnings and its ability to make payments on its indebtedness, the markets in which the portfolio company does business, comparison to comparable publicly-traded companies, discounted cash flow and other relevant factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, may fluctuate over short periods of time and may be based on estimates, our determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed. Due to these uncertainties, ourOaktree's fair value determinations may cause our net asset value on a given date to materially understate or overstate the value that we may ultimately realize upon the sale of one or more of our investments.
88


As of December 31, 2021,2022, we held $2,588.6$2,642.9 million of investments at fair value, up from $2,556.6$2,494.1 million held at September 30, 2021,2022, primarily driven by new originations.originations outpacing the rate of repayments. As of December 31, 20212022 and September 30, 2021,2022, approximately 95.9%95.5% and 97.0%94.2%, respectively, of our total assets represented investments at fair value.
Revenue Recognition
Interest Income
Interest income, adjusted for accretion of original issue discount, or OID, is recorded on an accrual basis to the extent that such amounts are expected to be collected. We stop accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash, and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of each of December 31, 20212022 and September 30, 2021,2022, there were no investments on non-accrual status.
In connection with our investment in a portfolio company, we sometimes receive nominal cost equity that is valued as part of the negotiation process with the portfolio company. When we receive nominal cost equity, we allocate our cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan.
PIK Interest Income
Our investments in debt securities may contain payment-in-kind, or PIK, interest provisions. PIK interest, which typically represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We generally cease accruing PIK interest if there is insufficient value to support the accrual or if we do not expect the portfolio company to be able to pay all principal and interest due. Our decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; our assessment of the portfolio company's business development success; information obtained by us in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. Our determination to cease accruing PIK interest is generally made well before our full write-down of a loan or debt security. In addition, if it is subsequently determined that we will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on our debt investments increases the recorded cost bases of these investments in our Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by us to Oaktree. To maintain our status as a RIC, certain income from PIK interest may be required to be distributed to our stockholders, even though we have not yet collected the cash and may never do so.
85


Portfolio Composition
Our investments principally consist of loans, common and preferred equity and warrants in privately-held companies, Senior Loan Fund JV I, LLC, or SLF JV I, a joint venture through which we and Trinity Universal Insurance Company, a subsidiary of Kemper Corporation, or Kemper, co-invest in senior secured loans of middle-market companies and other corporate debt securities, and OCSI Glick JV LLC, or the Glick JV, a joint venture through which we and GF Equity Funding 2014 LLC, or GF Equity Funding, co-invest primarily in senior secured loans of middle-market companies. We refer to SLF JV I and the Glick JV collectively as the JVs. Our loans are typically secured by a first, second or subordinated lien on the assets of the portfolio company and generally have terms of up to ten years (but an expected average life of between three and four years).
During the three months ended December 31, 2021,2022, we originated $299.9$250.3 million of investment commitments in 1218 new and nineseven existing portfolio companies and funded $240.8$274.4 million of investments.
During the three months ended December 31, 2021,2022, we received $235.0$104.4 million of proceeds from prepayments, exits, other paydowns and sales and exited 1011 portfolio companies.
89


A summary of the composition of our investment portfolio at cost and fair value as a percentage of total investments is shown in the following tables:
December 31, 2021September 30, 2021December 31, 2022September 30, 2022
Cost:Cost:Cost:
Senior secured debtSenior secured debt86.94 %85.85 %Senior secured debt84.94 %85.08 %
Debt investments in the JVsDebt investments in the JVs5.70 5.79 Debt investments in the JVs5.85 5.59 
Preferred equityPreferred equity2.60 2.60 Preferred equity3.16 3.26 
Subordinated debtSubordinated debt2.48 2.57 
LLC equity interests of the JVsLLC equity interests of the JVs1.92 1.94 LLC equity interests of the JVs1.97 1.88 
Common equity and warrantsCommon equity and warrants1.82 2.15 Common equity and warrants1.60 1.62 
Subordinated debt1.02 1.67 
TotalTotal100.00 %100.00 %Total100.00 %100.00 %
 
December 31, 2021September 30, 2021December 31, 2022September 30, 2022
Fair value:Fair value:Fair value:
Senior secured debtSenior secured debt87.43 %86.72 %Senior secured debt86.32 %86.86 %
Debt investments in the JVsDebt investments in the JVs5.88 5.94 Debt investments in the JVs6.14 5.88 
Preferred equityPreferred equity2.53 2.49 Preferred equity3.05 3.19 
Subordinated debtSubordinated debt2.35 2.28 
Common equity and warrantsCommon equity and warrants1.63 1.71 Common equity and warrants1.23 0.96 
LLC equity interests of the JVsLLC equity interests of the JVs1.49 1.47 LLC equity interests of the JVs0.91 0.83 
Subordinated debt1.04 1.67 
TotalTotal100.00 %100.00 %Total100.00 %100.00 %


8690



The industry composition of our portfolio at cost and fair value as a percentage of total investments was as follows:
December 31, 2021September 30, 2021December 31, 2022September 30, 2022
Cost:Cost:Cost:
Application SoftwareApplication Software16.04 %14.49 %Application Software15.66 %14.98 %
Multi-Sector Holdings (1)Multi-Sector Holdings (1)7.62 7.73 Multi-Sector Holdings (1)8.27 7.48 
PharmaceuticalsPharmaceuticals5.37 5.44 Pharmaceuticals4.73 4.83 
Data Processing & Outsourced ServicesData Processing & Outsourced Services4.68 4.74 Data Processing & Outsourced Services4.25 4.60 
BiotechnologyBiotechnology4.49 4.41 Biotechnology4.02 4.20 
Personal Products4.00 4.08 
Health Care TechnologyHealth Care Technology3.97 3.82 
Specialized FinanceSpecialized Finance3.15 3.09 
Industrial MachineryIndustrial Machinery3.39 3.47 Industrial Machinery2.93 3.12 
Health Care ServicesHealth Care Services3.05 3.34 Health Care Services2.37 2.24 
Specialized Finance2.66 2.70 
Internet & Direct Marketing RetailInternet & Direct Marketing Retail2.36 2.59 
Aerospace & DefenseAerospace & Defense2.64 2.66 Aerospace & Defense2.23 2.37 
Construction & EngineeringConstruction & Engineering2.19 2.33 
Health Care DistributorsHealth Care Distributors2.10 2.18 
Other Diversified Financial ServicesOther Diversified Financial Services2.06 1.12 
Personal ProductsPersonal Products1.91 2.03 
Automotive RetailAutomotive Retail1.86 2.26 
Auto Parts & EquipmentAuto Parts & Equipment1.84 0.48 
Real Estate Operating CompaniesReal Estate Operating Companies1.80 1.82 
Fertilizers & Agricultural ChemicalsFertilizers & Agricultural Chemicals2.60 2.63 Fertilizers & Agricultural Chemicals1.77 1.88 
Internet & Direct Marketing Retail2.45 2.45 
Construction & Engineering2.39 2.44 
Internet Services & InfrastructureInternet Services & Infrastructure2.07 1.85 Internet Services & Infrastructure1.77 2.07 
Metal & Glass ContainersMetal & Glass Containers1.70 1.82 
Home Improvement RetailHome Improvement Retail1.80 1.83 Home Improvement Retail1.63 1.75 
Soft DrinksSoft Drinks1.58 1.31 
Airport ServicesAirport Services1.63 1.64 Airport Services1.57 1.65 
Automotive Retail1.63 1.65 
Leisure FacilitiesLeisure Facilities1.61 0.99 Leisure Facilities1.48 1.52 
Insurance BrokersInsurance Brokers1.41 1.36 
Diversified Support ServicesDiversified Support Services1.37 1.45 
Specialty ChemicalsSpecialty Chemicals1.34 1.43 
Health Care SuppliesHealth Care Supplies1.32 1.39 
Real Estate ServicesReal Estate Services1.57 1.59 Real Estate Services1.30 1.54 
Specialty Chemicals1.55 1.84 
Diversified Support Services1.51 1.60 
Oil & Gas Storage & Transportation1.44 1.44 
Health Care Supplies1.39 1.17 
Insurance Brokers1.39 1.00 
Soft Drinks1.32 1.32 
Integrated Telecommunication ServicesIntegrated Telecommunication Services1.25 1.32 
Electrical Components & EquipmentElectrical Components & Equipment1.25 1.27 Electrical Components & Equipment1.22 1.29 
AdvertisingAdvertising1.09 1.13 Advertising0.99 1.08 
Oil & Gas Refining & Marketing1.08 1.42 
Integrated Telecommunication Services1.04 1.85 
Movies & EntertainmentMovies & Entertainment1.01 1.02 Movies & Entertainment0.94 1.00 
DistributorsDistributors0.99 — Distributors0.91 0.97 
Real Estate Operating Companies0.97 1.08 
Health Care Technology0.96 0.55 
AirlinesAirlines0.87 — 
Health Care EquipmentHealth Care Equipment0.93 0.93 Health Care Equipment0.79 0.93 
Airlines0.83 0.88 
Metal & Glass Containers0.82 0.69 
Health Care Distributors0.76 0.78 
Environmental & Facilities ServicesEnvironmental & Facilities Services0.76 0.80 
Oil & Gas Storage & TransportationOil & Gas Storage & Transportation0.72 0.85 
Home FurnishingsHome Furnishings0.76 0.77 Home Furnishings0.70 0.75 
Other Diversified Financial Services0.76 0.63 
Independent Power Producers & Energy Traders0.76 0.92 
Systems SoftwareSystems Software0.54 0.57 
Consumer FinanceConsumer Finance0.52 0.55 
Hotels, Resorts & Cruise LinesHotels, Resorts & Cruise Lines0.50 0.53 
IT Consulting & Other ServicesIT Consulting & Other Services0.42 0.45 
RestaurantsRestaurants0.34 0.36 
Education ServicesEducation Services0.33 0.35 
Cable & SatelliteCable & Satellite0.71 1.05 Cable & Satellite0.29 0.79 
Thrifts & Mortgage Finance0.62 0.63 
Auto Parts & Equipment0.48 0.49 
Research & Consulting ServicesResearch & Consulting Services0.28 0.35 
Apparel, Accessories & Luxury GoodsApparel, Accessories & Luxury Goods0.19 0.20 
Air Freight & LogisticsAir Freight & Logistics0.38 0.19 Air Freight & Logistics0.18 0.28 
Restaurants0.36 0.37 
IT Consulting & Other Services0.29 0.30 
Research & Consulting Services0.29 0.29 
Property & Casualty Insurance0.27 0.39 
Leisure Products0.27 0.26 
Systems Software0.26 0.26 
Environmental & Facilities Services0.21 — 
Apparel, Accessories & Luxury Goods0.20 0.20 
Integrated Oil & GasIntegrated Oil & Gas0.19 0.19 Integrated Oil & Gas0.18 0.19 
Alternative Carriers0.18 0.26 
Apparel RetailApparel Retail0.17 0.20 
Food DistributorsFood Distributors0.18 0.18 Food Distributors0.17 0.18 
Apparel Retail0.17 — 
Specialized REITsSpecialized REITs0.16 0.16 
Real Estate DevelopmentReal Estate Development0.15 — 
Diversified BanksDiversified Banks0.14 0.14 Diversified Banks0.13 0.13 
Technology DistributorsTechnology Distributors0.12 0.12 Technology Distributors0.11 0.12 
Food Retail0.10 0.15 
Construction MaterialsConstruction Materials0.09 0.09 Construction Materials0.08 0.09 
Housewares & SpecialtiesHousewares & Specialties0.08 0.09 
Electronic ComponentsElectronic Components0.08 0.40 Electronic Components0.08 0.08 
Housewares & Specialties0.07 0.07 
Education Services0.04 0.04 
Commercial Printing— 0.78 
Managed Health Care— 0.73 
Alternative CarriersAlternative Carriers0.01 0.01 
Oil & Gas Refining & MarketingOil & Gas Refining & Marketing— 0.33 
Trading Companies & DistributorsTrading Companies & Distributors— 0.29 
TotalTotal100.00 %100.00 %Total100.00 %100.00 %
8791



December 31, 2021September 30, 2021December 31, 2022September 30, 2022
Fair value:Fair value:Fair value:
Application SoftwareApplication Software16.20 %14.58 %Application Software15.95 %15.43 %
Multi-Sector Holdings (1)Multi-Sector Holdings (1)7.36 7.41 Multi-Sector Holdings (1)7.53 6.71 
PharmaceuticalsPharmaceuticals5.43 5.56 Pharmaceuticals4.82 4.79 
BiotechnologyBiotechnology4.53 4.44 Biotechnology4.37 4.35 
Data Processing & Outsourced ServicesData Processing & Outsourced Services4.39 4.46 Data Processing & Outsourced Services4.02 4.46 
Personal Products4.07 4.13 
Health Care TechnologyHealth Care Technology3.92 3.90 
Industrial MachineryIndustrial Machinery3.42 3.53 Industrial Machinery3.02 3.25 
Health Care Services3.10 3.31 
Specialized FinanceSpecialized Finance3.02 2.93 
Internet & Direct Marketing RetailInternet & Direct Marketing Retail2.71 2.68 Internet & Direct Marketing Retail2.50 2.82 
Aerospace & DefenseAerospace & Defense2.70 2.72 Aerospace & Defense2.33 2.48 
Specialized Finance2.64 2.69 
Construction & EngineeringConstruction & Engineering2.31 2.45 
Health Care DistributorsHealth Care Distributors2.08 2.19 
Other Diversified Financial ServicesOther Diversified Financial Services2.05 0.98 
Fertilizers & Agricultural ChemicalsFertilizers & Agricultural Chemicals2.62 2.64 Fertilizers & Agricultural Chemicals1.98 2.08 
Construction & Engineering2.42 2.47 
Health Care ServicesHealth Care Services1.94 1.84 
Automotive RetailAutomotive Retail1.92 2.31 
Real Estate Operating CompaniesReal Estate Operating Companies1.90 1.93 
Auto Parts & EquipmentAuto Parts & Equipment1.89 0.46 
Internet Services & InfrastructureInternet Services & Infrastructure2.10 1.87 Internet Services & Infrastructure1.85 2.16 
Personal ProductsPersonal Products1.85 2.01 
Home Improvement RetailHome Improvement Retail1.78 1.82 Home Improvement Retail1.71 1.82 
Automotive Retail1.71 1.65 
Metal & Glass ContainersMetal & Glass Containers1.69 1.91 
Soft DrinksSoft Drinks1.68 1.35 
Airport ServicesAirport Services1.59 1.59 Airport Services1.64 1.72 
Real Estate Services1.58 1.61 
Diversified Support Services1.51 1.60 
Leisure FacilitiesLeisure Facilities1.50 0.90 Leisure Facilities1.54 1.57 
Specialty Chemicals1.50 1.82 
Insurance BrokersInsurance Brokers1.47 1.08 Insurance Brokers1.48 1.33 
Health Care SuppliesHealth Care Supplies1.40 1.18 Health Care Supplies1.43 1.47 
Soft Drinks1.31 1.31 
Diversified Support ServicesDiversified Support Services1.35 1.47 
Real Estate ServicesReal Estate Services1.35 1.59 
Electrical Components & EquipmentElectrical Components & Equipment1.25 1.32 
Integrated Telecommunication ServicesIntegrated Telecommunication Services1.21 1.29 
Specialty ChemicalsSpecialty Chemicals1.19 1.36 
Movies & EntertainmentMovies & Entertainment1.00 1.07 
AdvertisingAdvertising0.98 1.08 
AirlinesAirlines0.98 — 
DistributorsDistributors0.93 0.98 
Health Care EquipmentHealth Care Equipment0.86 0.97 
Environmental & Facilities ServicesEnvironmental & Facilities Services0.78 0.83 
Oil & Gas Storage & TransportationOil & Gas Storage & Transportation1.31 1.35 Oil & Gas Storage & Transportation0.69 0.84 
Electrical Components & Equipment1.24 1.26 
Advertising1.15 1.19 
Integrated Telecommunication Services1.10 1.94 
Oil & Gas Refining & Marketing1.08 1.43 
Movies & Entertainment1.04 1.06 
Real Estate Operating Companies1.00 1.11 
Distributors0.99 — 
Health Care Technology0.97 0.55 
Health Care Equipment0.92 0.93 
Airlines0.83 0.96 
Metal & Glass Containers0.82 0.68 
Home FurnishingsHome Furnishings0.76 0.77 Home Furnishings0.68 0.73 
Independent Power Producers & Energy Traders0.76 0.92 
Health Care Distributors0.76 0.77 
Other Diversified Financial Services0.73 0.62 
Hotels, Resorts & Cruise LinesHotels, Resorts & Cruise Lines0.53 0.56 
Systems SoftwareSystems Software0.46 0.51 
Consumer FinanceConsumer Finance0.43 0.53 
Education ServicesEducation Services0.34 0.34 
RestaurantsRestaurants0.33 0.35 
Cable & SatelliteCable & Satellite0.72 1.06 Cable & Satellite0.30 0.78 
Thrifts & Mortgage Finance0.61 0.62 
Auto Parts & Equipment0.48 0.48 
Air Freight & Logistics0.38 0.19 
Restaurants0.36 0.37 
Research & Consulting ServicesResearch & Consulting Services0.29 0.30 Research & Consulting Services0.27 0.34 
IT Consulting & Other ServicesIT Consulting & Other Services0.28 0.29 IT Consulting & Other Services0.26 0.34 
Property & Casualty Insurance0.27 0.39 
Leisure Products0.26 0.26 
Systems Software0.26 0.26 
Environmental & Facilities Services0.21 — 
Alternative Carriers0.19 0.27 
Integrated Oil & GasIntegrated Oil & Gas0.19 0.19 Integrated Oil & Gas0.18 0.20 
Apparel RetailApparel Retail0.18 0.21 
Real Estate DevelopmentReal Estate Development0.16 — 
Air Freight & LogisticsAir Freight & Logistics0.16 0.26 
Food DistributorsFood Distributors0.18 0.18 Food Distributors0.14 0.13 
Apparel Retail0.17 — 
Diversified BanksDiversified Banks0.14 0.14 Diversified Banks0.13 0.14 
Specialized REITsSpecialized REITs0.12 0.13 
Technology DistributorsTechnology Distributors0.12 0.12 Technology Distributors0.11 0.12 
Food Retail0.10 0.15 
Housewares & SpecialtiesHousewares & Specialties0.09 0.10 
Construction MaterialsConstruction Materials0.09 0.09 Construction Materials0.07 0.08 
Electronic ComponentsElectronic Components0.08 0.40 Electronic Components0.06 0.08 
Housewares & Specialties0.08 0.08 
Education Services0.04 0.04 
Commercial Printing— 0.79 
Managed Health Care— 0.74 
Alternative CarriersAlternative Carriers0.01 0.01 
Oil & Gas Refining & MarketingOil & Gas Refining & Marketing— 0.34 
Trading Companies & DistributorsTrading Companies & Distributors— 0.22 
TotalTotal100.00 %100.00 %Total100.00 %100.00 %
___________________
(1)This industry includes our investments in the JVs and certain limited partnership interests.JVs.


8892





The Joint Ventures


Senior Loan Fund JV I, LLC


In May 2014, we entered into a limited liability company, or LLC, agreement with Kemper to form SLF JV I. We co-invest in senior secured loans of middle-market companies and other corporate debt securities with Kemper through our investment in SLF JV I. SLF JV I is managed by a four person Board of Directors, two of whom are selected by us and two of whom are selected by Kemper. All portfolio decisions and investment decisions in respect of SLF JV I must be approved by the SLF JV I investment committee, which consists of one representative selected by us and one representative selected by Kemper (with approval from a representative of each required). Since we do not have a controlling financial interest in SLF JV I, we do not consolidate SLF JV I. SLF JV I is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act. SLF JV I is capitalized pro rata with LLC equity interests as transactions are completed and may be capitalized with additional subordinated notes issued to us and Kemper by SLF JV I. The subordinated notes issued by SLF JV I are referred to as the SLF JV I Notes. The SLF JV I Notes are senior in right of payment to SLF JV I LLC equity interests and subordinated in right of payment to SLF JV I’s secured debt.
As of December 31, 20212022 and September 30, 2021,2022, we and Kemper owned, in the aggregate, 87.5% and 12.5%, respectively, of the LLC equity interests of SLF JV I and the outstanding SLF JV I Notes. As of each of December 31, 20212022, we and Kemper had funded approximately $190.5 million to SLF JV I, of which $166.7 million was from us. As of September 30, 2021,2022, we and Kemper had funded approximately $165.5 million to SLF JV I, of which $144.8 million was from us. As of each of December 31, 20212022, we had aggregate commitments to fund SLF JV I of $13.1 million, of which approximately $9.8 million was to fund additional SLF JV I Notes and approximately $3.3 million was to fund LLC equity interests in SLF JV I. During the three months ended December 31, 2022, we contributed $16.4 million to fund additional SLF JV I Notes and approximately $5.5 million to fund additional LLC equity interests in SLF JV I. As of September 30, 2021,2022, we had aggregate commitments to fund SLF JV I of $35.0 million, of which approximately $26.2 million was to fund additional SLF JV I Notes and approximately $8.8 million was to fund LLC equity interests in SLF JV I.
Both the cost and fair value of our SLF JV I Notes were $112.7 million as of December 31, 2022. Both the cost and fair value of our SLF JV I Notes were $96.3 million as of each of December 31, 2021 and September 30, 2021.2022. We earned interest income of $2.6 million and $2.0 million and $1.8 million on our investment in the SLF JV I Notes for the three months ended December 31, 20212022 and 2020,2021, respectively. As of December 31, 2021,2022, the SLF JV I Notes bore interest at a rate of one-month LIBOR plus 7.00% per annum with a LIBOR floor of 1.00% and will mature on December 29, 2028.
The cost and fair value of the LLC equity interests in SLF JV I held by us was $49.3$54.8 million and $38.5$24.1 million, respectively, as of December 31, 2021,2022, and $49.3 million and $37.7$20.7 million, respectively, as of September 30, 2021.2022. We earned $1.1 million and $0.5 million in dividend income for the three months ended December 31, 2022 and December 31, 2021, respectively, with respect to our investment in the LLC equity interests of SLF JV I. We did not earn dividend income for the three months ended December 31, 2020 with respect to our investment in the LLC equity interests of SLF JV I. The LLC equity interests of SLF JV I are dividend producing to the extent SLF JV I has residual cash to be distributed on a quarterly basis.
Below is a summary of SLF JV I's portfolio as of December 31, 20212022 and September 30, 2021:2022:
December 31, 2021September 30, 2021December 31, 2022September 30, 2022
Senior secured loans (1)Senior secured loans (1)$362,106$344,196Senior secured loans (1)$382,148$383,194
Weighted average interest rate on senior secured loans (2)Weighted average interest rate on senior secured loans (2)5.76%5.60%Weighted average interest rate on senior secured loans (2)9.55%8.33%
Number of borrowers in SLF JV INumber of borrowers in SLF JV I6155Number of borrowers in SLF JV I5960
Largest exposure to a single borrower (1)Largest exposure to a single borrower (1)$9,813$9,875Largest exposure to a single borrower (1)$11,337$10,093
Total of five largest loan exposures to borrowers (1)Total of five largest loan exposures to borrowers (1)$47,882$46,984Total of five largest loan exposures to borrowers (1)$51,990$48,139
__________________
(1) At principal amount.
(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.


See "Note 3. Portfolio Investments" in the notes to the accompanying financial statements for more information on SLF JV I and its portfolio.
8993



OCSI Glick JV LLC
On March 19, 2021, as a result of the consummation of the Mergers, we became party to the LLC agreement of the Glick JV. The Glick JV invests primarily in senior secured loans of middle-market companies. We co-invest in these securities with GF Equity Funding through the Glick JV. The Glick JV is managed by a four person Board of Directors, two of whom are selected by us and two of whom are selected by GF Equity Funding. All portfolio decisions and investment decisions in respect of the Glick JV must be approved by the Glick JV investment committee, consisting of one representative selected by us and one representative selected by GF Equity Funding (with approval from a representative of each required). Since we do not have a controlling financial interest in the Glick JV, we do not consolidate the Glick JV. The Glick JV is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act. The Glick JV is capitalized as transactions are completed. The members provide capital to the Glick JV in exchange for LLC equity interests, and we and GF Debt Funding, 2014 LLC, or GF Debt Funding, an entity advised by affiliates of GF Equity Funding, provide capital to the Glick JV in exchange for subordinated notes issued by the Glick JV, or the Glick JV Notes. The Glick JV Notes are junior in right of payment to the repayment of temporary contributions made by us to fund investments of the Glick JV that are repaid when GF Equity Funding and GF Debt Funding make their capital contributions and fund their Glick JV Notes, respectively.
As of December 31, 20212022 and September 30, 2021,2022, we and GF Equity Funding owned 87.5% and 12.5%, respectively, of the outstanding LLC equity interests, and we and GF Debt Funding owned 87.5% and 12.5%, respectively, of the Glick JV Notes. Approximately $84.0 million in aggregate commitments was funded as of each of December 31, 20212022 and September 30, 2021,2022, of which $73.5 million was from us. As of December 31, 20212022 and September 30, 2021,2022, we had commitments to fund Glick JV Notes of $78.8 million, of which $12.4 million was unfunded. As of each of December 31, 20212022 and September 30, 2021,2022, we had commitments to fund LLC equity interests in the Glick JV of $8.7 million, of which $1.6 million was unfunded.

The cost and fair value of our aggregate investment in the Glick JV was $50.6$50.0 million and $55.9$49.5 million, respectively, as of December 31, 20212022. The cost and fair value of our aggregate investment in the Glick JV was $50.7$50.2 million and $55.6$50.3 million, respectively, as of September 30, 20212022. For the three months ended December 31, 2022 and December 31, 2021, our investment in the Glick JV Notes earned interest income of $1.6 million and $1.1 million.million, respectively. We did not earn any dividend income for the three months ended December 31, 2022 and December 31, 2021 with respect to our investment in the LLC equity interests of the Glick JV. The LLC equity interests of the Glick JV are income producing to the extent there is residual cash to be distributed on a quarterly basis.
Below is a summary of the Glick JV's portfolio as of December 31, 20212022 and September 30, 2021:2022:
December 31, 2021September 30, 2021December 31, 2022September 30, 2022
Senior secured loans (1)Senior secured loans (1)$140,078$126,512Senior secured loans (1)$134,080$143,225
Weighted average current interest rate on senior secured loans (2)Weighted average current interest rate on senior secured loans (2)6.05%5.86%Weighted average current interest rate on senior secured loans (2)9.86%8.52%
Number of borrowers in the Glick JVNumber of borrowers in the Glick JV4437Number of borrowers in the Glick JV4043
Largest loan exposure to a single borrower (1)Largest loan exposure to a single borrower (1)$6,820$6,907Largest loan exposure to a single borrower (1)$7,476$6,562
Total of five largest loan exposures to borrowers (1)Total of five largest loan exposures to borrowers (1)$28,283$28,324Total of five largest loan exposures to borrowers (1)$29,830$28,973
__________
(1) At principal amount.
(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.
See "Note 3. Portfolio Investments" in the notes to the accompanying financial statements for more information on the Glick JV and its portfolio.
9094



Discussion and Analysis of Results and Operations
Results of Operations
Net increase (decrease) in net assets resulting from operations includes net investment income, net realized gains (losses) and net unrealized appreciation (depreciation). Net investment income is the difference between our income from interest, dividends and fees and net expenses. Net realized gains (losses) is the difference between the proceeds received from dispositions of investment related assets and liabilities and their stated costs. Net unrealized appreciation (depreciation) is the net change in the fair value of our investment related assets and liabilities carried at fair value during the reporting period, including the reversal of previously recorded unrealized appreciation (depreciation) when gains or losses are realized.
Comparison of three months ended December 31, 20212022 and December 31, 20202021
Total Investment Income
Total investment income includes interest on our investments, fee income and dividend income.
Total investment income for the three months ended December 31, 2022 and 2021 was $79.2 million and 2020 was $64.9 million, respectively. For the three months ended December 31, 2022, this amount consisted of $76.1 million of interest income from portfolio investments (which included $6.1 million of PIK interest), $2.0 million of fee income and $38.2$1.1 million respectively.of dividend income. For the three months ended December 31, 2021, this amount consisted of $60.1 million of interest income from portfolio investments (which included $4.7 million of PIK interest), $0.9 million of fee income and $3.9 million of dividend income. For the three months ended December 31, 2020, this amount consisted of $34.7 million of interest income from portfolio investments (which included $3.1 million of PIK interest), $3.4 million of fee income and $0.1 million of dividend income. The increase of $26.7$14.2 million, or 70.0%21.9%, in our total investment income for the three months ended December 31, 2021,2022, as compared to the three months ended December 31, 2020,2021, was due primarily to (1) a $25.4$16.0 million increase in interest income, which was primarily driven by a larger investment portfolio primarily due to the increase in assets resulting from the Mergers and new originations, OID accretion that resulted from merger-related accounting adjustments and higher OID acceleration resulting from exitsimpact of investmentsrising reference rates on interest income and (2) a $3.8$1.1 million increase in dividend income mainly driven by dividends received from two investments that did not pay dividends in the prior year, partially offset by a $2.4 million decrease in fee income primarily due to lower prepaymenthigher exit and amendment fees. This was partially offset by a $2.9 million decrease in dividend income.
Expenses
Net expenses (expenses net of fee waivers) for the three months ended December 31, 2022 and 2021 and 2020 were $29.3$40.3 million and $28.2$29.3 million, respectively. Net expenses increased for the three months ended December 31, 2021,2022, as compared to the three months ended December 31, 2020,2021, by $1.2$11.0 million, or 4.1%37.3%, primarily due to (1) a $3.3$11.3 million increase in interest expense due to higher borrowings outstanding and the impact of rising reference rates and (2) $2.7 million of higher base management fees (net of management fee waivers) primarily as a result of a larger investment portfolio, (3) a $2.3$1.2 million increase in Part I incentive fees mainly due to increasedhigher total investment income and (4) a $0.5 million increase in professional fees,income. These were partially offset by $7.8$1.8 million of lower accrued Part II incentive fees (net of waivers) as a result of lower capital gains earned during the current quarter.fees.
Net Investment Income
Primarily as a result of the $26.7$14.2 million increase in total investment income, the $1.2$11.0 million increase in net expenses and a $3.3 million increasedecrease in the provision for taxes on net investment income, net investment income for the three months ended December 31, 20212022 increased by $22.3$6.5 million compared to the three months ended December 31, 2020.2021.
Realized Gain (Loss)
Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption of investments and foreign currency and the cost basis without regard to unrealized appreciation or depreciation previously recognized, and includes investments written-off during the period, net of recoveries. Realized losses may also be recorded in connection with our determination that certain investments are considered worthless securities and/or meet the conditions for loss recognition per the applicable tax rules.
During the three months ended December 31, 20212022 and 2020,2021, we recorded aggregate net realized gains (losses) of $9.3$(3.2) million and $8.2$9.3 million, respectively, in connection with the exits or restructurings of various investments.investments and foreign currency forward contracts. See “Note 8. Realized Gains or Losses and Net Unrealized Appreciation or Depreciation” in the notes to the accompanying Consolidated Financial Statements for more details regarding investment realization events for the three months ended December 31, 20212022 and 2020.
91


2021.
Net Unrealized Appreciation (Depreciation)
Net unrealized appreciation or depreciation is the net change in the fair value of our investments and foreign currency during the reporting period, including the reversal of previously recorded unrealized appreciation or depreciation when gains or losses are realized.
95


During the three months ended December 31, 20212022 and 2020,2021, we recorded net unrealized appreciation (depreciation)depreciation of $(4.6)$23.0 million and $47.6$4.6 million, respectively. For the three months ended December 31, 2022, this consisted of $18.7 million of net unrealized depreciation on debt investments and $11.0 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $3.9 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $2.8 million of net unrealized appreciation on equity investments. For the three months ended December 31, 2021, this consisted of $4.7 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains), $1.8 million of net unrealized depreciation on debt investments and $0.8 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $2.8 million of net unrealized appreciation on equity investments. For the three months ended December 31, 2020, this consisted of $27.2 million of net unrealized appreciation on debt investments, $12.8 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $9.9 million of net unrealized appreciation on equity investments, partially offset by $2.4 million of net unrealized depreciation of foreign currency forward contracts.
Financial Condition, Liquidity and Capital Resources
We have a number of alternatives available to fund our investment portfolio and our operations, including raising equity, increasing or refinancing debt and funding from operational cash flow. We generally expect to fund the growth of our investment portfolio through additional debt and equity capital, which may include securitizing a portion of our investments. We cannot assure you, however, that our efforts to grow our portfolio will be successful. For example, our common stock has generally traded at prices below net asset value for the past several years, and we are currently limited in our abilitymay not be able to raise additional equity at prices below the then-current net asset value per share. We intend to continue to generate cash primarily from cash flows from operations, including interest earned, and future borrowings.borrowings or equity offerings. We intend to fund our future distribution obligations through operating cash flow or with funds obtained through future equity and debt offerings or credit facilities, as we deem appropriate.
Our primary uses of funds are investments in our targeted asset classes and cash distributions to holders of our common stock. We may also from time to time repurchase or redeem some or all of our outstanding notes. At a special meeting of our stockholders held on June 28, 2019, our stockholders approved the application of the reduced asset coverage requirements in Section 61(a)(2) of the Investment Company Act to us effective as of June 29, 2019. As a result of the reduced asset coverage requirement, we can incur $2 of debt for each $1 of equity as compared to $1 of debt for each $1 of equity. As of December 31, 2021,2022, we had $1,300.0$1,514.4 million in senior securities and our asset coverage ratio was 200.8%176.3%. As of December 31, 2021,During the year ended September 30, 2022, we increased our debt to equity ratio was 0.98x. Our target debt to equity ratio isfrom 0.85x to 1.0x to 0.90x to 1.25x (i.e., one dollar of equity for each $0.85$0.90 to $1.00$1.25 of debt outstanding) as we plan to continueprovide us with increased capacity to opportunistically deploy capital into the markets. As of December 31, 2022, our net debt to equity ratio was 1.24x.
For the three months ended December 31, 2022, we experienced a net decrease in cash and cash equivalents (including restricted cash) of $7.1 million. During that period, net cash used in operating activities was $109.9 million, primarily from funding $261.4 million of investments and $10.0 million of net decrease in payables from unsettled transactions, partially offset by $108.8 million of principal payments and sale proceeds received, the cash activities related to $38.8 million of net investment income and a $16.3 million increase in due from portfolio companies. During the same period, net cash provided by financing activities was $103.3 million, primarily consisting of $160.0 million of net borrowings under the credit facilities, partially offset by $56.7 million of cash distributions paid to our stockholders.
For the three months ended December 31, 2021, we experienced a net increase in cash and cash equivalents (including restricted cash) of $14.4 million. During that period, we received $23.2 million of net cash from operating activities, primarily from $235.0 million of principal payments and sale proceeds received, $15.0 million of net increases in payables from unsettled transactions and the cash activities related to $32.3 million of net investment income, partially offset by funding $246.6 million of investments. During the same period, net cash used by financing activities was $7.5 million, primarily consisting of $27.2 million of cash distributions paid to our stockholders and $0.3 million of deferred financing costs paid, partially offset by $20.0 million of net borrowings under the credit facilities.
For the three months ended December 31, 2020, we experienced a net decrease in cash and cash equivalents of $14.9 million. During that period, we received $16.1 million of net cash from operating activities, primarily from $169.8 million of principal payments and sale proceeds received, $100.3 million of net increase in payables from unsettled transactions and the cash activities related to $10.0 million of net investment income, partially offset by funding $243.7 million of investments and $26.3 million of net increase in other assets. During the same period, net cash used by financing activities was $30.6 million, primarily consisting of $15.0 million of cash distributions paid to our stockholders, $14.8 million of net repayments under the Syndicated Facility (as defined below), $0.5 million of repurchases of common stock under our dividend reinvestment plan, or DRIP, and $0.3 million of deferred financing costs paid.
As of December 31, 2021,2022, we had $46.1$19.2 million in cash and cash equivalents (including $2.3$1.9 million of restricted cash), portfolio investments (at fair value) of $2.6 billion, $18.5$37.8 million of interest, dividends and fees receivable, $550.0$6.2 million of due from portfolio companies, $340.0 million of undrawn capacity on our credit facilities (subject to borrowing base and other limitations), $15.0$12.3 million of net payables from unsettled transactions, $650.0$860.0 million of borrowings outstanding under our credit facilities and $635.5$603.6 million of unsecured notes payable (net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment).
As of September 30, 2021,2022, we had $31.6$26.4 million in cash and cash equivalents (including $2.3$2.8 million of restricted cash), portfolio investments (at fair value) of $2.6$2.5 billion, $22.1$35.6 million of interest, dividends and fees receivable, $470.0$22.5 million of due from portfolio companies, $500.0 million of undrawn capacity on our credit facilities (subject to borrowing base and other limitations), $0.1$22.3 million of net receivablespayables from
92


unsettled transactions, $630.0$700.0 million of borrowings outstanding under our credit facilities and $638.7$601.0 million of unsecured notes payable (net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment).
96


We may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of our portfolio companies. As of December 31, 2021,2022, our only off-balance sheet arrangements consisted of $295.3$198.9 million of unfunded commitments, which was comprised of $242.8$171.8 million to provide debt and equity financing to certain of our portfolio companies $49.0and $27.1 million to provide financing to the JVs and $3.5 million related to unfunded limited partnership interests.JVs. As of September 30, 2021,2022, our only off-balance sheet arrangements consisted of $264.9$224.2 million of unfunded commitments, which was comprised of $212.4$175.2 million to provide debt and equity financing to certain of our portfolio companies and $49.0 million to provide financing to the JVs and $3.5 million related to unfunded limited partnership interests. Such commitments are subject to our portfolio companies' satisfaction of certain financial and nonfinancial covenants and may involve, to varying degrees, elements of credit risk in excess of the amount recognized in our Consolidated Statements of Assets and Liabilities.JVs.
As of December 31, 2021,2022, we have analyzed cash and cash equivalents, availability under our credit facilities, the ability to rotate out of certain assets and amounts of unfunded commitments that could be drawn and believe our liquidity and capital resources are sufficient to take advantage of market opportunities in the current economic climate.
Contractual ObligationsSyndicated Facility

On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans, mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank.

As of December 31, 2022, the size of the Syndicated Facility was $1.0 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances.

As of December 31, 2022, (i) the period during which the Company may make drawings will expire on May 4, 2025 and the maturity date is May 4, 2026 and (ii) the interest rate margin for (a) LIBOR loans (which may be 1-, 2-, 3- or 6-month, at the Company’s option) was 2.00% and (b) alternate base rate loans was 1.00%.

The following table reflects information pertainingSyndicated Facility is secured by substantially all of the Company’s assets (excluding, among other things, investments held in and by certain subsidiaries of the Company (including OCSL Senior Funding II LLC) or investments in certain portfolio companies of the Company) and guaranteed by certain subsidiaries of the Company. As of December 31, 2022, except for assets that were held by OCSL Senior Funding II LLC and certain immaterial subsidiaries, substantially all of the Company's assets are pledged as collateral under the Syndicated Facility.

The Syndicated Facility requires the Company to, our principal debtamong other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of December 31, 2022, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions.

As of December 31, 2022 and September 30, 2022, the Company had $695.0 million and $540.0 million of borrowings outstanding under the Syndicated Facility, respectively, which had a fair value of $695.0 million and $540.0 million, respectively. The Company's borrowings under the Syndicated Facility bore interest at a weighted average interest rate of 5.849% and 2.174% for the three months ended December 31, 2022 and 2021, respectively. For the three months ended
65

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




December 31, 2022 and 2021, the Company recorded interest expense (inclusive of fees) of $10.0 million and $3.8 million, respectively, related to the Syndicated Facility.
Citibank Facility
On March 19, 2021, the Company became party to a revolving credit facility (as defined below)amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC (formerly OCSI Senior Funding II LLC), the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian.
As of December 31, 2022, the Company was able to borrow up to $200 million under the Citibank Facility (as defined below)(subject to borrowing base and other limitations). As of December 31, 2022, the reinvestment period under the Citibank Facility was scheduled to expire on November 18, 2023 and the maturity date for the Citibank Facility was November 18, 2024.
As of December 31, 2022, borrowings under the Citibank Facility are subject to certain customary advance rates and accrue interest at a rate equal to LIBOR plus between 1.25% and 2.20% per annum on broadly syndicated loans, subject to observable market depth and pricing, and LIBOR plus 2.25% per annum on all other eligible loans during the reinvestment period. In addition, as of December 31, 2022, for the duration of the reinvestment period there is a non-usage fee payable of 0.50% per annum on the undrawn amount under the Citibank Facility. The minimum asset coverage ratio applicable to the Company under the Citibank Facility is 150% as determined in accordance with the requirements of the Investment Company Act. Borrowings under the Citibank Facility are secured by all of the assets of OCSL Senior Funding II LLC and all of the Company’s equity interests in OCSL Senior Funding II LLC. The Company may use the Citibank Facility to fund a portion of its loan origination activities and for general corporate purposes. Each loan origination under the Citibank Facility is subject to the satisfaction of certain conditions.
As of December 31, 2022 and September 30, 2022, the Company had $165.0 million and $160.0 million outstanding under the Citibank Facility, respectively, which had a fair value of $165.0 million and $160.0 million, respectively. The Company's borrowings under the Citibank Facility bore interest at a weighted average interest rate of 6.508% and 1.830% for the three months ended December 31, 2022 and 2021, respectively. For the three months ended December 31, 2022 and 2021, the Company recorded interest expense (inclusive of fees) of $2.7 million and $0.8 million, respectively, related to the Citibank Facility.
2025 Notes
On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes.
The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), ourbetween the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.
Interest on the 2025 Notes is paid semi-annually on February 25 and August 25 at a rate of 3.500% notes dueper annum. The 2025 Notes mature on February 25, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2025 Notes can require the Company to repurchase the 2025 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2025 Notes Indenture. The 2025 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2022, the Company did not repurchase any of the 2025 Notes in the open market.
The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to
66

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




the holders of the 2025 Notes and our 2.700% notes due the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture.
2027 orNotes
On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes:
Debt Outstanding
as of September 30, 2021
Debt Outstanding
as of December 31, 2021
Weighted average debt
outstanding for the
three months ended
December 31, 2021
Maximum debt
outstanding for the three months ended
December 31, 2021
Syndicated Facility$495,000 $495,000 $526,793 $535,000 
Citibank Facility135,000 155,000 154,348 165,000 
2025 Notes300,000 300,000 300,000 300,000 
2027 Notes350,000 350,000 350,000 350,000 
Total debt$1,280,000 $1,300,000 $1,331,141 
Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The following table reflects our contractual obligations arising from the Syndicated Facility, Citibank Facility, 2025 Notes and 2027 Notes:
 Payments due by period as of December 31, 2021
Contractual ObligationsTotalLess than 1 year1-3 years3-5 yearsMore than 5 years
Syndicated Facility$495,000 $— $— $495,000 $— 
Interest due on Syndicated Facility45,677 10,519 21,038 14,120 — 
Citibank Facility155,000 — 155,000 — — 
Interest due on Citibank Facility8,530 2,957 5,573 — — 
2025 Notes300,000 — — 300,000 — 
Interest due on 2025 Notes33,140 10,500 21,000 1,640 — 
2027 Notes350,000 — — — 350,000 
Interest due on 2027 Notes (a)31,454 6,236 12,472 12,472 274 
Total$1,418,801 $30,212 $215,083 $823,232 $350,274 
__________ 
(a) The interest dueOID on the 2027 Notes was calculated netis amortized based on the effective interest method over the term of the 2027 Notes.
The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.
Interest on the 2027 Notes is paid semi-annually on January 15 and July 15, beginning on January 15, 2022, at a rate of 2.700% per annum. The 2027 Notes mature on January 15, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2027 Notes can require the Company to repurchase the 2027 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2027 Notes Indenture. The 2027 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2022, the Company did not repurchase any of the 2027 Notes in the open market.
The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture.
In connection with the 2027 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 2.700% and pays a floating interest rate of the three-month LIBOR plus 1.658% on a notional amount of $350 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap.
Equity Issuances
67

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




The below table presents the components of the carrying value of the 2025 Notes and the 2027 Notes as of December 31, 2022 and September 30, 2022:
 As of December 31, 2022As of September 30, 2022
($ in millions)2025 Notes2027 Notes2025 Notes2027 Notes
Principal$300.0 $350.0 $300.0 $350.0 
  Unamortized financing costs(1.6)(3.1)(1.8)(3.2)
  Unaccreted discount(1.1)(0.7)(1.2)(0.7)
  Interest rate swap fair value adjustment— (39.9)— (42.0)
Net carrying value$297.3 $306.3 $297.0 $304.1 
Fair Value$286.7 $296.8 $283.1 $294.0 
The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three months ended December 31, 2022:
($ in millions)2025 Notes2027 Notes
Coupon interest$2.6 $2.4 
Amortization of financing costs and discount0.3 0.2 
Effect of interest rate swap— 2.5 
 Total interest expense$2.9 $5.1 
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)3.500 %5.586 %
The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three months ended December 31, 2021:
($ in millions)2025 Notes2027 Notes
Coupon interest$2.6 $2.4 
Amortization of financing costs and discount0.3 0.2 
Effect of interest rate swap— (0.7)
 Total interest expense$2.9 $1.9 
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)3.500 %1.782 %

Note 7. Taxable/Distributable Income and Dividend Distributions
Taxable income differs from net increase (decrease) in net assets resulting from operations primarily due to: (1) unrealized appreciation (depreciation) on investments and foreign currency, as gains and losses are not included in taxable income until they are realized; (2) origination and exit fees received in connection with investments in portfolio companies; (3) organizational costs; (4) income or loss recognition on exited investments; and (5) recognition of interest income on certain loans.
As of September 30, 2022, the Company had net capital loss carryforwards of $523.7 million to offset net capital gains that will not expire, to the extent available and permitted by U.S. federal income tax law, of which $64.5 million are available to offset future short-term capital gains and $459.2 million are available to offset future long-term capital gains. A portion of such net capital loss carryfowards represented a realized loss under sections 382 and 383 of the Code, which is carried forward to future years to offset future gains subject to certain limitations.
68

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Listed below is a reconciliation of "net increase (decrease) in net assets resulting from operations" to taxable income for the three months ended December 31, 2022 and 2021.
Three months ended
December 31, 2022
Three months ended
December 31, 2021
Net increase (decrease) in net assets resulting from operations$13,172 $39,408 
Net unrealized (appreciation) depreciation22,982 4,586 
Book/tax difference due to organizational costs— (22)
Book/tax difference due to capital losses utilized8,013 (10,531)
Other book/tax differences(12,910)(11,171)
Taxable/Distributable Income (1)$31,257 $22,270 
 __________
(1) The Company's taxable income for the three months ended December 31, 2022 is an estimate and will not be finally determined until the Company files its tax return for the fiscal year ending September 30, 2023. Therefore, the final taxable income may be different than the estimate.
The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences.
When assessing the realizability of deferred tax assets, the Company considers whether it is probable that some or all of the deferred tax assets will not be realized. In determining whether the deferred tax assets are realizable, the Company considers the period of expiration of the tax asset, historical and projected taxable income and tax liabilities for the tax jurisdiction in which the tax asset is located. The deferred tax asset recognized by the Company, as it relates to the higher tax basis in the carrying value of certain assets compared to the book basis of those assets, will be recognized in future years by these taxable entities. Deferred tax assets are based on the amount of the tax benefit that the Company’s management has determined is more likely than not to be realized in future periods. In determining the realizability of this tax benefit, management considered numerous factors that will give rise to pre-tax income in future periods. Among these are the historical and expected future book and tax basis pre-tax income of the Company and unrealized gains in the Company’s assets at the determination date. Based on these and other factors, the Company determined that, as of December 31, 2022, $11.4 million of the $13.1 million deferred tax assets would not more likely than not be realized in future periods. As of December 31, 2022, the Company recorded a net deferred tax asset of $1.7 million on the Consolidated Statements of Assets and Liabilities.
For the three months ended December 31, 2022, the Company recognized a total benefit for income tax related to realized and unrealized losses of $0.5 million, which was primarily all current income tax benefit.
For the three months ended December 31, 2021, the Company recognized a total benefit for income tax related to realized and unrealized losses of $2.4 million, which was composed of (i) a current income tax benefit of approximately $1.4 million, and (ii) a deferred income tax benefit of approximately $1.0 million, which resulted from unrealized depreciation on investments held by the Company’s wholly-owned taxable subsidiaries. For the three months ended December 31, 2021, the Company recognized a provision for income tax related to net investment income of $3.3 million, which was all current income tax expense.
As of September 30, 2022, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows:
Undistributed ordinary income, net$(43,624)
Net realized capital losses473,274 
Unrealized losses, net153,119 
Accumulated overdistributed earnings$582,769
The aggregate cost of investments for U.S. federal income tax purposes was $2,654.3 million as of September 30, 2022. As of September 30, 2022, the aggregate gross unrealized appreciation for all investments in which there was an excess of value over cost for U.S. federal income tax purposes was $466.9 million. As of September 30, 2022, the aggregate gross unrealized depreciation for all investments in which there was an excess of cost for U.S. federal income tax purposes over value was
69

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




$620.0 million. Net unrealized depreciation based on the aggregate cost of investments for U.S. federal income tax purposes was $153.1 million.

Note 8. Realized Gains or Losses and Net Unrealized Appreciation or Depreciation
Realized Gains or Losses
Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption and the cost basis of the investment without regard to unrealized appreciation or depreciation previously recognized, and include investments written-off during the period, net of recoveries. Realized losses may also be recorded in connection with the Company's determination that certain investments are considered worthless securities and/or meet the conditions for loss recognition per the applicable tax rules.
During the three months ended December 31, 2022, the Company recorded an aggregate net realized loss of $3.2 million, which consisted of the following:
($ in millions)
Portfolio CompanyNet Realized Gain (Loss)
Foreign currency forward contracts$4.4 
Carvana Co.(2.8)
ASP Unifrax Holdings Inc.(2.1)
Global Medical Response Inc.(1.0)
Other, net(1.7)
Total, net$(3.2)
During the three months ended December 31, 2021, we issuedthe Company recorded an aggregate net realized gain of 107,971 shares of common stock as part$9.3 million, which consisted of the DRIP. There were no other common stock issuances duringfollowing:
($ in millions)
Portfolio CompanyNet Realized Gain (Loss)
Foreign currency forward contracts$3.0 
OmniSYS Acquisition Corporation2.0 
First Star Speir Aviation Limited1.9 
Other, net2.4 
Total, net$9.3

Net Unrealized Appreciation or Depreciation
Net unrealized appreciation or depreciation reflects the net change in the valuation of the portfolio pursuant to the Company's valuation guidelines and the reclassification of any prior period unrealized appreciation or depreciation.
During the three months ended December 31, 2022 and 2021, the Company recorded net unrealized depreciation of $23.0 million and $4.6 million, respectively. For the three months ended December 31, 2022, this consisted of $18.7 million of net unrealized depreciation on debt investments and $11.0 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $3.9 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $2.8 million of net unrealized appreciation on equity investments. For the three months ended December 31, 2021, this consisted of $4.7 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains), $1.8 million of net unrealized depreciation on debt investments and 2020.$0.8 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $2.8 million of net unrealized appreciation on equity investments.


9370


OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Significant Capital TransactionsNote 9. Concentration of Credit Risks
The Company deposits its cash with financial institutions and at times such balances may be in excess of the FDIC insurance limit. The Company limits its exposure to credit loss by depositing its cash with high credit quality financial institutions and monitoring their financial stability.
Note 10. Related Party Transactions

As of December 31, 2022 and September 30, 2022, the Company had a liability on its Consolidated Statements of Assets and Liabilities in the amount of $16.9 million and $15.9 million, respectively, reflecting the unpaid portion of the base management fees and incentive fees payable to Oaktree.
Investment Advisory Agreement
The Company is party to the Investment Advisory Agreement. Under the Investment Advisory Agreement, the Company pays Oaktree a fee for its services under the Investment Advisory Agreement consisting of two components: a base management fee and an incentive fee. The cost of both the base management fee payable to Oaktree and any incentive fees earned by Oaktree is ultimately borne by common stockholders of the Company.
From October 17, 2017 through May 3, 2020, the Company was externally managed by OCM pursuant to an investment advisory agreement. On May 4, 2020, OCM effected the novation of such investment advisory agreement to Oaktree. Immediately following table reflectssuch novation, the distributions per share that we have paid,Company and Oaktree entered into a new investment advisory agreement with the same terms, including shares issued under our DRIP,fee structure, as the investment advisory agreement with OCM. The investment advisory agreement with Oaktree was subsequently amended and restated on our common stock since October 1, 2019:March 19, 2021 in connection with the closing of the OCSI Merger and on January 23, 2023 in connection with the OSI2 Merger. The term “Investment Advisory Agreement” refers collectively to the agreements with Oaktree and, prior to its novation, with OCM.
Date DeclaredRecord DatePayment DateAmount
per Share
Cash
Distribution
DRIP Shares
Issued (1)
DRIP Shares
Value
November 12, 2019December 13, 2019December 31, 2019$0.095 $ 12.9 million87,747 $ 0.5 million
January 31, 2020March 13, 2020March 31, 20200.095 12.9 million157,523 0.5 million
April 30, 2020June 15, 2020June 30, 20200.095 13.0 million87,351 0.4 million
July 31, 2020September 15, 2020September 30, 20200.105 14.3 million102,404 0.5 million
November 13, 2020December 15, 2020December 31, 20200.11 15.0 million93,964 0.5 million
January 29, 2021March 15, 2021March 31, 20210.12 16.4 million81,702 0.5 million
April 30, 2021June 15, 2021June 30, 20210.13 22.9 million76,979 0.5 million
July 30, 2021September 15, 2021September 30, 20210.145 25.5 million85,075 0.6 million
October 13, 2021December 15, 2021December 31, 20210.155 27.2 million107,971 0.8 million
Unless earlier terminated as described below, the Investment Advisory Agreement will remain in effect from year-to-year if approved annually by the Board of Directors of the Company or by the affirmative vote of the holders of a majority of the Company’s outstanding voting securities, including, in either case, approval by a majority of the directors of the Company who are not interested persons. The Investment Advisory Agreement will automatically terminate in the event of its assignment. The Investment Advisory Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Investment Advisory Agreement may also be terminated, without penalty, upon the vote of a majority of the outstanding voting securities of the Company.
 ______________Base Management Fee
(1)Shares were purchased
Under the Investment Advisory Agreement, the base management fee is calculated at an annual rate of 1.50% of total gross assets, including any investment made with borrowings, but excluding cash and cash equivalents. The base management fee is payable quarterly in arrears and the fee for any partial month or quarter is appropriately prorated. Effective May 3, 2019, the base management fee on the open marketCompany’s gross assets, including any investments made with borrowings, but excluding any cash and distributed other thancash equivalents, that exceed the product of (A) 200% and (B) the Company’s net asset value will be 1.00%. For the avoidance of doubt, the 200% will be calculated in accordance with the Investment Company Act and will give effect to exemptive relief the Company received from the SEC with respect to debentures issued by a small business investment company subsidiary. In connection with the distribution paidOCSI Merger, Oaktree waived an aggregate of $6 million of base management fees otherwise payable to Oaktree in the two years following the closing of the OCSI Merger on December 31, 2021. New shares were issuedMarch 19, 2021 at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter). In connection with the OSI2 Merger, Oaktree waived an aggregate of $9.0 million of base management fees payable to Oaktree as follows: $6.0 million at a rate of $1.5 million per quarter (with such amount appropriately prorated for any partial quarter) in the first year following closing of the OSI2 Merger on January 23, 2023 and distributed during$3.0 million at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter) in the second year following closing of the OSI2 Merger.
For the three months ended December 31, 2021.2022 and 2021, the base management fee incurred under the Investment Advisory Agreement was $9.2 million (net of waiver) and $9.2 million (net of waiver), respectively.

Incentive Fee

The incentive fee consists of two parts. Under the Investment Advisory Agreement, the first part of the incentive fee (the “incentive fee on income” or "Part I incentive fee") is calculated and payable quarterly in arrears based upon the “pre-incentive fee net investment income” of the Company for the immediately preceding quarter. The payment of the incentive fee on income
Indebtedness
71

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




is subject to payment of a preferred return to investors each quarter (i.e., a “hurdle rate”), expressed as a rate of return on the value of the Company’s net assets at the end of the most recently completed quarter, of 1.50%, subject to a “catch up” feature.
For this purpose, “pre-incentive fee net investment income” means interest income, dividend income and any other income (including any other fees such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies, other than fees for providing managerial assistance) accrued during the fiscal quarter, minus the Company’s operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement and any interest expense and dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as OID debt, instruments with PIK interest and zero coupon securities), accrued income that the Company has not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. In addition, pre-incentive fee net investment income does not include any amortization or accretion of any purchase premium or purchase discount to interest income resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in pre-incentive fee net investment income.

Under the Investment Advisory Agreement, the calculation of the incentive fee on income for each quarter is as follows:

No incentive fee is payable to Oaktree in any quarter in which the Company’s pre-incentive fee net investment income does not exceed the preferred return rate of 1.50% (the “preferred return”) on net assets;
100% of the Company’s pre-incentive fee net investment income, if any, that exceeds the preferred return but is less than or equal to 1.8182% in any fiscal quarter is payable to Oaktree. This portion of the incentive fee on income is referred to as the “catch-up” provision, and it is intended to provide Oaktree with an incentive fee of 17.5% on all of the Company’s pre-incentive fee net investment income when the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets in any fiscal quarter; and
For any quarter in which the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets, the incentive fee on income is equal to 17.5% of the amount of the Company’s pre-incentive fee net investment income, as the preferred return and catch-up will have been achieved.

There is no accumulation of amounts on the hurdle rate from quarter to quarter and accordingly there is no clawback of amounts previously paid if subsequent quarters are below the quarterly hurdle.

For the three months ended December 31, 2022 and 2021, the first part of the incentive fee (incentive fee on income) incurred under the Investment Advisory Agreement was $7.7 million and $6.5 million, respectively.
Under the Investment Advisory Agreement, the second part of the incentive fee (the "capital gains incentive fee") is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Investment Advisory Agreement, as of the termination date) commencing with the fiscal year ended September 30, 2019 and equals 17.5% of the Company’s realized capital gains, if any, on a cumulative basis from the beginning of the fiscal year ended September 30, 2019 through the end of each subsequent fiscal year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees under the Investment Advisory Agreement. Any realized capital gains, realized capital losses, unrealized capital appreciation and unrealized capital depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the calculations of the second part of the incentive fee. In addition, the calculation of realized capital gains, realized capital losses and unrealized capital depreciation does (1) not include any such amounts resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in the capital gains incentive fee, (2) include any such amounts associated with the investments acquired in the OCSI Merger for the period from October 1, 2018 to the date of closing of the OCSI Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee and (3) include any such amounts associated with the investments acquired in the OSI2 Merger for the period from August 6, 2018 to the date of closing of the OSI2 Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee. As of December 31, 2022, the Company paid $9.6 million of capital gains incentive fees cumulatively under the Investment Advisory Agreement (net of waivers). Part II incentive fees are contractually calculated and paid at the end of the fiscal year in accordance with the Investment Advisory Agreement, which, as described above, differs from Part II incentive fees accrued under GAAP. Hypothetically, if Part II incentive fees were calculated as of December 31, 2022 under the Investment Advisory Agreement, no Part II incentive fees would be payable.
72

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)





GAAP requires that the capital gains incentive fee accrual consider the cumulative aggregate unrealized capital appreciation in the calculation, as a capital gains incentive fee would be payable if such unrealized capital appreciation were realized on a theoretical "liquidation basis." A fee so calculated and accrued would not be payable under applicable law and may never be paid based upon the computation of capital gains incentive fees in subsequent periods. Amounts ultimately paid under the Investment Advisory Agreement will be consistent with the formula reflected in the Investment Advisory Agreement. This GAAP accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital depreciation included in the calculation of the capital gains incentive fee plus the aggregate cumulative unrealized capital appreciation. Any realized capital gains and losses and cumulative unrealized capital appreciation and depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the GAAP accrual. If such amount is positive at the end of a period, then GAAP requires the Company to record a capital gains incentive fee equal to 17.5% of such cumulative amount, less the aggregate amount of actual capital gains incentive fees payable or capital gains incentive fees accrued under GAAP in all prior periods. The resulting accrual for any capital gains incentive fee under GAAP in a given period may result in an additional expense if such cumulative amount is greater than in the prior period or a reversal of previously recorded expense if such cumulative amount is less than in the prior period. If such cumulative amount is negative, then there is no accrual. There can be no assurance that such unrealized capital appreciation will be realized in the future or any accrued capital gains incentive fee will become payable under the Investment Advisory Agreement. For the three months ended December 31, 2022, there were no accrued capital gains incentive fees. For the three months ended December 31, 2021, $1.8 million of accrued capital gains incentive fees were expensed. As of December 31, 2022, the total accrued capital gains incentive fee liability was zero.
Indemnification

The Investment Advisory Agreement provides that, absent willful misfeasance, bad faith or gross negligence in the performance of their respective duties or by reason of the reckless disregard of their respective duties and obligations, Oaktree and its officers, managers, partners, members (and their members, including the owners of their members), agents, employees, controlling persons and any other person or entity affiliated with it, are entitled to indemnification from the Company for any damages, liabilities, costs and expenses (including reasonable attorneys' fees and amounts reasonably paid in settlement) arising from the rendering of Oaktree's services under the Investment Advisory Agreement or otherwise as investment adviser.
Administrative Services
The Company is party to the Administration Agreement with Oaktree Administrator. Pursuant to the Administration Agreement, Oaktree Administrator provides administrative services to the Company necessary for the operations of the Company, which include providing office facilities, equipment, clerical, bookkeeping and record keeping services at such facilities and such other services as Oaktree Administrator, subject to review by the Company’s Board of Directors, shall from time to time deem to be necessary or useful to perform its obligations under the Administration Agreement. Oaktree Administrator may, on behalf of the Company, conduct relations and negotiate agreements with custodians, trustees, depositories, attorneys, underwriters, brokers and dealers, corporate fiduciaries, insurers, banks and such other persons in any such other capacity deemed to be necessary or desirable. Oaktree Administrator makes reports to the Company’s Board of Directors of its performance of obligations under the Administration Agreement and furnishes advice and recommendations with respect to such other aspects of the Company’s business and affairs, in each case, as it shall determine to be desirable or as reasonably required by the Company’s Board of Directors; provided that Oaktree Administrator shall not provide any investment advice or recommendation.
Oaktree Administrator also provides portfolio collection functions for interest income, fees and warrants and is responsible for the financial and other records that the Company is required to maintain and prepares, prints and disseminates reports to the Company’s stockholders and all other materials filed with the SEC. In addition, Oaktree Administrator assists the Company in determining and publishing the Company’s net asset value, overseeing the preparation and filing of the Company’s tax returns, and generally overseeing the payment of the Company’s expenses and the performance of administrative and professional services rendered to the Company by others. Oaktree Administrator may also offer to provide, on the Company’s behalf, managerial assistance to the Company’s portfolio companies.
For providing these services, facilities and personnel, the Company reimburses Oaktree Administrator the allocable portion of overhead and other expenses incurred by Oaktree Administrator in performing its obligations under the Administration Agreement, including the Company’s allocable portion of the rent of the Company’s principal executive offices (which are located in a building owned by a Brookfield affiliate) at market rates and the Company’s allocable portion of the costs of compensation and related expenses of its Chief Financial Officer, Chief Compliance Officer, their staffs and other non-
73

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




investment professionals at Oaktree that perform duties for the Company. Such reimbursement is at cost, with no profit to, or markup by, Oaktree Administrator. The Administration Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Administration Agreement may also be terminated, without penalty, upon the vote of a majority of the Company’s outstanding voting securities.
For the three months ended December 31, 2022 and 2021, the Company accrued administrative expenses of $0.4 million and $0.5 million, respectively, including $0.1 million and $0.1 million of general and administrative expenses, respectively.
As of December 31, 2022 and September 30, 2022, $3.3 million and $3.2 million, respectively, was included in “Due to affiliate” in the Consolidated Statements of Assets and Liabilities, reflecting the unpaid portion of administrative expenses and other reimbursable expenses payable to Oaktree Administrator.
74

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Note 11. Financial Highlights
(Share amounts in thousands)Three months ended
December 31, 2022 (8)
Three months ended
December 31, 2021 (8)
Net asset value per share at beginning of period$20.38$21.84
Net investment income (1)0.630.54
Net unrealized appreciation (depreciation) (1)(0.38)(0.08)
Net realized gains (losses) (1)(0.05)0.16
(Provision) benefit for taxes on realized and unrealized gains (losses) (1)0.010.04
Distributions of net investment income to stockholders(0.96)(0.47)
Net asset value per share at end of period$19.63$22.03
Per share market value at beginning of period (7)$18.00$21.18
Per share market value at end of period (7)$20.61$22.38
Total return (2)19.90%7.92%
Common shares outstanding at beginning of period61,12560,120
Common shares outstanding at end of period61,22060,156
Net assets at beginning of period$1,245,563$1,312,823
Net assets at end of period$1,201,989$1,325,061
Average net assets (3)$1,241,806$1,327,934
Ratio of net investment income to average net assets (4)12.40%9.65%
Ratio of total expenses to average net assets (4)13.11%8.99%
Ratio of net expenses to average net assets (4)12.87%8.77%
Ratio of portfolio turnover to average investments at fair value4.24%9.14%
Weighted average outstanding debt (5)$1,441,326$1,331,141
Average debt per share (1)$23.57$22.14
Asset coverage ratio at end of period (6)176.31%200.81%
 __________
(1)Calculated based upon weighted average shares outstanding for the period.
(2)Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load.
(3)Calculated based upon the weighted average net assets for the period.
(4)Interim periods are annualized.
(5)Calculated based upon the weighted average of principal debt outstanding for the period.
(6)Based on outstanding senior securities of $1,514.4 million and $1,300.0 million as of December 31, 2022 and 2021, respectively.
(7)Per share market values are adjusted to reflect the 1-for-3 reverse stock split of the Company's common stock completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
(8)The share and per share information disclosed in this table has been retrospectively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.

75

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)





Note 12. Derivative Instruments
The Company enters into foreign currency forward contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company’s investments denominated in foreign currencies. In order to better define its contractual rights and to secure rights that will help the Company mitigate its counterparty risk, the Company entered into an International Swaps and Derivatives Association, Inc. Master Agreement (the "ISDA Master Agreement") with its derivative counterparty, JPMorgan Chase Bank, N.A. The ISDA Master Agreement permits a single net payment in the event of a default or similar event. As of December 31, 2022, no cash collateral has been pledged to cover obligations and no cash collateral has been received from the counterparty with respect to the Company's forward currency contracts.
In connection with the issuance of the 2027 Notes, the Company entered into an interest rate swap agreement with the Royal Bank of Canada pursuant to an ISDA Master Agreement. As of December 31, 2022, the Company paid $39.8 million to the Royal Bank of Canada to cover collateral obligations under the terms of the interest swap agreement, which is included in due from broker on the Consolidated Statement of Assets and Liabilities.
Certain information related to the Company’s foreign currency forward contracts is presented below as of December 31, 2022.
DescriptionNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net Amounts
Foreign currency forward contract$44,825 44,224 2/9/2023$— $(2,499)Derivative liability
Foreign currency forward contract$46,412 £39,965 2/9/2023$— $(1,712)Derivative liability
$ $(4,211)
Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2022.
DescriptionNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net Amounts
Foreign currency forward contract$43,179 41,444 11/10/2022$2,466 $— Derivative asset
Foreign currency forward contract$45,692 £37,033 11/10/2022$4,323 $— Derivative asset
$6,789 $ 
Certain information related to the Company’s interest rate swap is presented below as of December 31, 2022.
DescriptionNotional AmountMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net Amounts
Interest rate swap$350,000 1/15/2027$— $39,928 Derivative liability
$ $39,928 
Certain information related to the Company’s interest rate swap is presented below as of September 30, 2022.
DescriptionNotional AmountMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net Amounts
Interest rate swap$350,000 1/15/2027$— $41,969 Derivative liability
$ $41,969 



76

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Note 13. Commitments and Contingencies
Off-Balance Sheet Arrangements
The Company may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of its portfolio companies. As of December 31, 2022, the Company's only off-balance sheet arrangements consisted of $198.9 million of unfunded commitments, which was comprised of $171.8 million to provide debt and equity financing to certain of its portfolio companies and $27.1 million to provide financing to the JVs. As of September 30, 2022, the Company's only off-balance sheet arrangements consisted of $224.2 million of unfunded commitments, which was comprised of $175.2 million to provide debt and equity financing to certain of its portfolio companies and $49.0 million to provide financing to the JVs. Such commitments are subject to the portfolio companies' satisfaction of certain financial and nonfinancial covenants and may involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Consolidated Statements of Assets and Liabilities.
77

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




A list of unfunded commitments by investment (consisting of revolvers, term loans with delayed draw components, subordinated notes and LLC equity interests in the JVs, preferred stock and limited partnership interests) as of December 31, 2022 and September 30, 2022 is shown in the table below:
December 31, 2022September 30, 2022
Delta Leasing SPV II LLC$23,004 $27,187 
Fairbridge Strategic Capital Funding LLC15,995 22,150 
OCSI Glick JV LLC13,998 13,998 
Senior Loan Fund JV I, LLC13,125 35,000 
BioXcel Therapeutics, Inc.11,785 11,785 
Dominion Diagnostics, LLC11,148 11,148 
BAART Programs, Inc.7,675 8,645 
iCIMs, Inc.6,930 6,930 
Marinus Pharmaceuticals, Inc.5,734 5,734 
scPharmaceuticals Inc.5,212 — 
Assembled Brands Capital LLC5,035 2,008 
RumbleOn, Inc.4,822 4,822 
MRI Software LLC4,427 5,196 
107 Fair Street LLC4,322 — 
Grove Hotel Parcel Owner, LLC4,293 4,293 
Accupac, Inc.4,197 4,605 
Innocoll Pharmaceuticals Limited4,195 4,195 
Avalara, Inc.4,147 — 
Mindbody, Inc.4,000 4,000 
OTG Management, LLC3,789 3,789 
Mesoblast, Inc.3,553 3,553 
Establishment Labs Holdings Inc.3,384 5,075 
112-126 Van Houten Real22 LLC3,174 — 
ADC Therapeutics SA3,020 3,020 
Spanx, LLC2,762 2,226 
PRGX Global, Inc.2,518 2,518 
SCP Eye Care Services, LLC2,356 — 
Relativity ODA LLC2,218 2,218 
Berner Food & Beverage, LLC2,197 1,392 
Salus Workers' Compensation, LLC2,171 — 
Pluralsight, LLC1,766 3,532 
Tahoe Bidco B.V.1,741 1,741 
CorEvitas, LLC1,526 915 
Coyote Buyer, LLC1,333 1,333 
MHE Intermediate Holdings, LLC1,229 1,429 
Kings Buyer, LLC1,208 1,537 
Liquid Environmental Solutions Corporation1,115 1,115 
Acquia Inc.923 1,326 
Apptio, Inc.892 1,338 
Digital.AI Software Holdings, Inc.826 826 
Telestream Holdings Corporation528 528 
GKD Index Partners, LLC320 320 
PFNY Holdings, LLC275 1,527 
Ardonagh Midco 3 PLC— 4,372 
Dialyze Holdings, LLC— 3,431 
Thrasio, LLC— 2,578 
109 Montgomery Owner LLC— 477 
LSL Holdco, LLC— 427 
Total$198,868 $224,239 

78

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)





Note 14. Subsequent Events
The Company’s management evaluated subsequent events through the date of issuance of the Consolidated Financial Statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in the Consolidated Financial Statements as of and for the three months ended December 31, 2022, except as discussed below.
Distribution Declaration
On January 27, 2023, the Company’s Board of Directors declared a quarterly distribution of $0.55 per share, payable in cash on March 31, 2023 to stockholders of record on March 15, 2023.
Investment Advisory Agreement

On January 23, 2023, in connection with the consummation of the OSI2 Merger, the Company entered into an amended and restated investment advisory agreement with Oaktree to amend and restate the prior investment advisory agreement, dated as of March 19, 2021, by and between the Company and Oaktree to (1) waive an aggregate of $9.0 million of base management fees otherwise payable to the Oaktree in the two years following the closing of the OSI2 Merger and (2) revise the calculation of the incentive fees to eliminate certain unintended consequences of the accounting treatment of the OSI2 Merger on the incentive fees payable to Oaktree. None of the other terms were changed, and the services to be provided by Oaktree and the term of the Investment Advisory Agreement remain the same.
OSI2 Merger

On January 23, 2023, the Company completed the OSI2 Merger. In accordance with the terms of the OSI2 Merger Agreement, at the effective time of the OSI2 Merger, each outstanding share of OSI2 common stock was converted into the right to receive 0.9115 shares of the Company’s common stock (with OSI2’s stockholders receiving cash in lieu of fractional shares of the Company’s common stock). As a result of the OSI2 Merger, the Company issued an aggregate of 15,860,200 shares of its common stock to former OSI2 stockholders. Following completion of the OSI2 Merger, the Company had 77,079,805 shares of common stock outstanding.
OSI2 Citibank Facility

On January 23, 2023, as a result of the consummation of the OSI2 Merger, the Company became party to the OSI2 Citibank Facility (as described below).

OSI 2 Senior Lending SPV, LLC (“OSI 2 SPV”), the Company’s wholly-owned and consolidated subsidiary, is party to a loan and security agreement dated as of July 26, 2019, which was subsequently amended on September 20, 2019, July 2, 2020, December 31, 2020, March 31, 2021 and December 2, 2022 (as amended, the “OSI2 Citibank Loan Agreement”), with the lenders from time to time party thereto and the other parties referenced below. Under the terms of the OSI2 Citibank Loan Agreement, the Company serves as the collateral manager and seller and OSI 2 SPV serves as borrower with Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent.

The OSI2 Citibank Loan Agreement provides for a senior secured revolving credit facility (the “OSI2 Citibank Facility”) of up to $250 million (the “Citibank Maximum Commitment”) in aggregate principal amount, subject to the lesser of (i) the borrowing base, which is an amount based on advance rates that vary depending on the class of assets and the value assigned to such assets under the OSI2 Citibank Loan Agreement and (ii) the Citibank Maximum Commitment. The OSI2 Citibank Facility has a reinvestment period through May 26, 2023, during which advances may be made, and matures on January 26, 2025. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender under the OSI2 Citibank Loan Agreement, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) LIBOR for a three month maturity and (b) for all other lenders under the OSI2 Citibank Facility, LIBOR, plus, in each case, an applicable spread. During the reinvestment period, the applicable spread is the greater of (i) a weighted average rate of (x) 1.65% per year for broadly syndicated loans and (y) 2.25% per year for all other eligible loans and (ii) 1.85%. After the reinvestment period, the applicable spread is 3.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility.
79

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)





The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets.

As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility.

Under the OSI2 Citibank Facility, the Company and OSI 2 SPV, as applicable, have made customary representations and warranties, and are required to comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar credit facilities.

OSI 2 SPV’s borrowings are non-recourse to the Company but are considered borrowings of the Company for purposes of complying with the asset coverage requirements under the Investment Company Act.

As of January 23, 2023, the Company had $225.0 million outstanding under the OSI2 Citibank Facility.
Reverse Stock Split

On January 20, 2023, the Company amended its restated certificate of incorporation, as amended and corrected, to effect a 1-for-3 reverse stock split. Immediately following completion of the reverse stock split, the Company had 61,219,605 shares of common stock outstanding.

80


Schedule 12-14
Oaktree Specialty Lending Corporation
Schedule of Investments in and Advances to Affiliates
(in thousands, except share and per share amounts, percentages and as otherwise indicated)
Three months ended December 31, 2022
(unaudited)
Portfolio Company/Type of Investment (1) Cash Interest RateIndustryPrincipalNet Realized Gain (Loss)Amount of
Interest,
Fees or
Dividends
Credited in
Income (2)
Fair Value
as of October 1,
2022
Gross
Additions (3)
Gross
Reductions (4)
Fair Value
as of December 31, 2022
% of Total Net Assets
Control Investments
C5 Technology Holdings, LLCData Processing & Outsourced Services
829 Common Units$— $— $— $— $— $— — %
34,984,460.37 Preferred Units— — 27,638 — — 27,638 2.3 %
Dominion Diagnostics, LLCHealth Care Services
First Lien Term Loan, LIBOR+5.00% cash due 2/28/20249.73 %$14,297 — 331 14,333 — (36)14,297 1.2 %
First Lien Revolver, LIBOR+5.00% cash due 2/28/2024— — 14 — — — — — %
30,030.8 Common Units in DD Healthcare Services Holdings, LLC— — 4,946 — (719)4,227 0.4 %
OCSI Glick JV LLC (5)Multi-Sector Holdings
Subordinated Debt, LIBOR+4.50% cash due 10/20/20287.67 %59,049 — 1,624 50,283 380 (1,127)49,536 4.1 %
87.5% equity interest— — — — — — — %
Senior Loan Fund JV I, LLC (6)Multi-Sector Holdings
Subordinated Debt, LIBOR+7.00% cash due 12/29/202810.17 %112,656 — 2,611 96,250 16,406 — 112,656 9.4 %
87.5% LLC equity interest— 1,050 20,715 5,469 (2,076)24,108 2.0 %
Total Control Investments$186,002 $ $5,630 $214,165 $22,255 $(3,958)$232,462 19.3 %
Affiliate Investments
Assembled Brands Capital LLCSpecialized Finance
First Lien Revolver, LIBOR+6.75% cash due 10/17/202311.48 %$21,464 $— $646 $24,225 $55 $(3,028)$21,252 1.8 %
1,609,201 Class A Units— — 370 — (16)354 — %
1,019,168.80 Preferred Units, 6%— — 1,223 20 — 1,243 0.1 %
70,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029— — — — — — — %
Caregiver Services, Inc.Health Care Services
1,080,399 shares of Series A Preferred Stock, 10%— — — 378 — (54)324 — %
Total Affiliate Investments$21,464 $ $646 $26,196 $75 $(3,098)$23,173 1.9 %
Total Control & Affiliate Investments$207,466 $ $6,276 $240,361 $22,330 $(7,056)$255,635 21.2 %

This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements.
______________________
(1)The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments.
(2)Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories.
(3)Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category.
(4)Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category.
81


(5)Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required).
(6)Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required).



82


Schedule 12-14
Oaktree Specialty Lending Corporation
Schedule of Investments in and Advances to Affiliates
(in thousands, except share and per share amounts, percentages and as otherwise indicated)
Three months ended December 31, 2021
(unaudited)
Portfolio Company/Type of Investment (1) Cash Interest RateIndustryPrincipalNet Realized Gain (Loss)Amount of
Interest,
Fees or
Dividends
Credited in
Income (2)
Fair Value
as of October 1,
2021
Gross
Additions (3)
Gross
Reductions (4)
Fair Value
as of December 31, 2021
% of Total Net Assets
Control Investments
C5 Technology Holdings, LLCData Processing & Outsourced Services
829 Common Units$— $— $— $— $— $— — %
34,984,460.37 Preferred Units— — 27,638 — — 27,638 2.1 %
Dominion Diagnostics, LLCHealth Care Services
First Lien Term Loan, LIBOR+5.00% cash due 2/28/20246.00 %$23,201 — 430 27,381 — (4,180)23,201 1.8 %
First Lien Revolver, LIBOR+5.00% cash due 2/28/2024— — 14 — — — — — %
30,030.8 Common Units in DD Healthcare Services Holdings, LLC— 3,308 18,065 — — 18,065 1.4 %
First Star Speir Aviation Limited (5)Airlines
First Lien Term Loan, 9.00% cash due 12/15/2025— 7,500 — 7,500 — (7,500)— — %
100% equity interest(5,632)158 698 — (698)— — %
OCSI Glick JV LLC (6)Multi-Sector Holdings
Subordinated Debt, LIBOR+4.50% cash due 10/20/20284.58 %61,237 — 1,081 55,582 745 (473)55,854 4.2 %
87.5% equity interest— — — — — — — %
Senior Loan Fund JV I, LLC (7)Multi-Sector Holdings
Subordinated Debt, LIBOR+7.00% cash due 12/29/20288.00 %96,250 — 1,967 96,250 — — 96,250 7.3 %
87.5% LLC equity interest— 451 37,651 810 — 38,461 2.9 %
Total Control Investments$180,688 $1,868 $7,409 $270,765 $1,555 $(12,851)$259,469 19.6 %
Affiliate Investments
Assembled Brands Capital LLCSpecialized Finance
First Lien Revolver, LIBOR+6.75% cash due 10/17/20237.75 %$15,982 $— $339 $15,712 $3,499 $(3,487)$15,724 1.2 %
1,609,201 Class A Units— — 587 — (201)386 — %
1,019,168.80 Preferred Units, 6%— — 1,152 20 — 1,172 0.1 %
70,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029— — — — — — — %
Caregiver Services, Inc.Health Care Services
1,080,399 shares of Series A Preferred Stock, 10%— — — 838 — — 838 0.1 %
Total Affiliate Investments$15,982 $ $339 $18,289 $3,519 $(3,688)$18,120 1.4 %
Total Control & Affiliate Investments$196,670 $1,868 $7,748 $289,054 $5,074 $(16,539)$277,589 21.0 %

This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements.
______________________
(1)The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments included in the Company's quarterly report on Form 10-Q for the quarter ended December 31, 2021.
(2)Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories.
(3)Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category.
83


(4)Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category.
(5)First Star Speir Aviation Limited is a wholly-owned holding company formed by the Company in order to facilitate its investment strategy. In accordance with ASU 2013-08, the Company has deemed the holding company to be an investment company under GAAP and therefore deemed it appropriate to consolidate the financial results and financial position of the holding company and to recognize dividend income versus a combination of interest income and dividend income. Accordingly, the debt and equity investments in the wholly-owned holding company are disregarded for accounting purposes since the economic substance of these instruments are equity investments in the operating entities.
(6)Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required).
(7)Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required).




84


Item 2.     Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion should be read in connection with our Consolidated Financial Statements and the notes thereto included elsewhere in this quarterly report on Form 10-Q.
Some of the statements in this quarterly report on Form 10-Q constitute forward-looking statements because they relate to future events or our future performance or financial condition. The forward-looking statements contained in this quarterly report on Form 10-Q may include statements as to:

our future operating results and distribution projections;
the ability of Oaktree Fund Advisors, LLC, or Oaktree, to reposition our portfolio and to implement Oaktree's future plans with respect to our business;
the ability of Oaktree and its affiliates to attract and retain highly talented professionals;
our business prospects and the prospects of our portfolio companies;
the impact of the investments that we expect to make;
the ability of our portfolio companies to achieve their objectives;
our expected financings and investments and additional leverage we may seek to incur in the future;
the adequacy of our cash resources and working capital;
the timing of cash flows, if any, from the operations of our portfolio companies; and
the cost or potential outcome of any litigation to which we may be a party.
In addition, words such as “anticipate,” “believe,” “expect,” “seek,” “plan,” “should,” “estimate,” “project” and “intend” indicate forward-looking statements, although not all forward-looking statements include these words. The forward-looking statements contained in this quarterly report on Form 10-Q involve risks and uncertainties. Our actual results could differ materially from those implied or expressed in the forward-looking statements for any reason, including the factors set forth in “Item 1A. Risk Factors” in our annual report on Form 10-K for the year ended September 30, 2022 and elsewhere in this quarterly report on Form 10-Q.
Other factors that could cause actual results to differ materially include:
changes or potential disruptions in our operations, the economy, financial markets or political environment, including the impacts of inflation and rising interest rates;
risks associated with possible disruption in our operations or the economy generally due to terrorism, war or other geopolitical conflict (including the current conflict between Russia and Ukraine), natural disasters or pandemics;
future changes in laws or regulations (including the interpretation of these laws and regulations by regulatory authorities) and conditions in our operating areas, particularly with respect to Business Development Companies or, regulated investment companies, or RICs;
the ability to realize the benefits of the OSI2 Merger (as defined below); and
other considerations that may be disclosed from time to time in our publicly disseminated documents and filings.
We have based the forward-looking statements included in this quarterly report on Form 10-Q on information available to us on the date of this quarterly report, and we assume no obligation to update any such forward-looking statements. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the Securities and Exchange Commission, or the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.
All dollar amounts in tables are in thousands, except share and per share amounts and as otherwise indicated.
Business Overview
We are a specialty finance company dedicated to providing customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. We are a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a Business Development Company under the Investment Company Act of 1940, as amended, or the Investment Company Act. In addition, we have qualified and elected to be treated as a RIC under the Internal Revenue Code of 1986, as amended, or the Code, for U.S. federal income tax purposes.
We are externally managed by Oaktree pursuant to an investment advisory agreement, as amended from time to time, or the Investment Advisory Agreement. Oaktree Fund Administration, LLC, or Oaktree Administrator, an affiliate of Oaktree, provides certain administrative and other services necessary for us to operate pursuant to an administration agreement, as amended from time to time, or the Administration Agreement.
85


Our investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. We may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. Our portfolio may also include certain structured finance and other non-traditional structures. We invest in companies that typically possess resilient business models with strong underlying fundamentals. We intend to deploy capital across credit and economic cycles with a focus on long-term results, which we believe will enable us to build lasting partnerships with financial sponsors and management teams, and we may seek to opportunistically take advantage of dislocations in the financial markets and other situations that may benefit from Oaktree’s credit and structuring expertise. Sponsors may include financial sponsors, such as an institutional investor or a private equity firm, or a strategic entity seeking to invest in a portfolio company. Oaktree is generally focused on middle-market companies, which we define as companies with enterprise values of between $100 million and $750 million. We generally invest in securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Below investment grade securities, which are often referred to as “high yield” and “junk,” have predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal.
In the current market environment, Oaktree intends to focus on the following area, in which Oaktree believes there is less competition and thus potential for greater returns, for our new investment opportunities: (1) situational lending, which we define to include directly originated loans to non-sponsor companies that are hard to understand and value using traditional underwriting techniques, (2) select sponsor lending, which we define to include financing to support leveraged buyouts of companies with specialized sponsors that have expertise in certain industries, and (3) stressed sector and rescue lending, which we define to include opportunistic private loans in industries experiencing stress or limited access to capital.
Oaktree intends to continue to rotate our portfolio into investments that are better aligned with Oaktree's overall approach to credit investing and that it believes have the potential to generate attractive returns across market cycles (which we call "core investments"). Oaktree has performed a comprehensive review of our portfolio and categorized our portfolio into core investments, non-core performing investments and underperforming investments. Certain additional information on such categorization and our portfolio composition is included in investor presentations that we file with the SEC. Since an Oaktree affiliate became our investment adviser in October 2017, Oaktree and its affiliates have reduced the investments identified as non-core by approximately $800 million at fair value. Over time, Oaktree intends to rotate us out of the remaining non-core investments, which were approximately $71 million at fair value as of December 31, 2022. Oaktree periodically reviews designations of investments as core and non-core and may change such designations over time.

On March 19, 2021, we acquired Oaktree Strategic Income Corporation, or OCSI, pursuant to an agreement and plan or merger, or the OCSI Merger Agreement, dated as of October 28, 2020, by and among OCSI, us, Lion Merger Sub, Inc., our wholly-owned subsidiary, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OCSI Merger Agreement, OCSI was merged with and into us in a two-step transaction with us as the surviving company, or the OCSI Merger.

On January 23, 2023, we acquired Oaktree Strategic Income II, Inc., or OSI2, pursuant to that certain Agreement and Plan of Merger, or the OSI2 Merger Agreement, dated as of September 14, 2022, by and among OSI2, us, Project Superior Merger Sub, Inc., a wholly-owned subsidiary of us, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OSI2 Merger Agreement, OSI2 was merged with and into us in a two-step transaction with us as the surviving company, or the OSI2 Merger.
Business Environment and Developments

Global financial markets have experienced an increase in volatility as concerns about the impact of higher inflation, rising interest rates, a potential recession and the current conflict in Ukraine have weighed on market participants. These factors have created disruptions in supply chains and economic activity and have had a particularly adverse impact on certain companies in the energy, raw materials and transportation sectors, among others. These uncertainties can ultimately impact the overall supply and demand of the market through changing spreads, deal terms and structures and equity purchase price multiples.

We are unable to predict the full effects of these macroeconomic events or how long any further market disruptions or volatility might last. We continue to closely monitor the impact these events have on our business, industry and portfolio companies and will provide constructive solutions where necessary.

Against this uncertain macroeconomic backdrop, we believe attractive risk-adjusted returns can be achieved by making loans to middle market companies that typically possess resilient business models with strong underlying fundamentals. Given the breadth of the investment platform and decades of credit investing experience of Oaktree and its affiliates, we believe that we have the resources and experience to source, diligence and structure investments in these companies and are well placed to generate attractive returns for investors.
86


As of December 31, 2022, 87.3% of our debt investment portfolio (at fair value) and 87.2% of our debt investment portfolio (at cost) bore interest at floating rates. Most of our floating rate loans are indexed to the London Interbank Offered Rate, or LIBOR, and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly or monthly at the borrower’s option. Certain loans may also be indexed to the Secured Overnight Financing Rate, or SOFR, or the Sterling Overnight Index Average, or SONIA. Most U.S. dollar LIBOR rates will continue to be published through June 30, 2023. The FCA no longer compels panel banks to continue to contribute to LIBOR and the Federal Reserve Board, the Office of the Comptroller of the Currency, and the Federal Deposit Insurance Corporation have encouraged banks to cease entering into new contracts that use U.S. dollar LIBOR as a reference rate. The U.S. Federal Reserve, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions, supports replacing U.S.-dollar LIBOR with SOFR. Although there are an increasing number of issuances utilizing SOFR or SONIA, these alternative reference rates may not attain market acceptance as replacements for LIBOR. In anticipation of the cessation of LIBOR, we may need to renegotiate any credit agreements extending beyond the applicable phase out date with our prospective portfolio companies that utilize LIBOR as a factor in determining the interest rate. Certain of the loan agreements with our portfolio companies have included fallback language in the event that LIBOR becomes unavailable. This language generally provides that the administrative agent may identify a replacement reference rate, typically with the consent of (or prior consultation with) the borrower. In certain cases, the administrative agent will be required to obtain the consent of either a majority of the lenders under the facility, or the consent of each lender, prior to identifying a replacement reference rate. Certain of the loan agreements with our portfolio companies do not include any fallback language providing a mechanism for the parties to negotiate a new reference interest rate and will instead revert to the base rate in the event LIBOR ceases to exist.

Critical Accounting Estimates
Investment Valuation
We value our investments in accordance with Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 820, Fair Value Measurements and Disclosures, or ASC 820, which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability’s fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments’ complexity.
Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows:
Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date.
Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities.
Level 3 — Unobservable inputs that reflect Oaktree’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.
If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. Oaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions.
Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of our investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations.
Oaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If Oaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within our set threshold, Oaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the
87


quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, Oaktree does not adjust any of the prices received from these sources.
If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, Oaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value, or EV, of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that we are deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company’s assets and (vii) offers from third parties to buy the portfolio company. Oaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. Under the EV technique, the significant unobservable input used in the fair value measurement of our investments in debt or equity securities is the EBITDA, revenue or asset multiple, as applicable. Increases or decreases in the valuation multiples in isolation may result in a higher or lower fair value measurement, respectively. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and we consider the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by us are substantially illiquid with no active transaction market, Oaktree depends on primary market data, including newly funded transactions and industry-specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. Under the market yield technique, the significant unobservable input used in the fair value measurement of our investments in debt securities is the market yield. Increases or decreases in the market yield may result in a lower or higher fair value measurement, respectively.
In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable.
Oaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk-free rate. Changes in the subjective input assumptions can materially affect the fair value estimates.
The fair value of our investments as of December 31, 2022 and September 30, 2022 was determined by Oaktree, as our valuation designee. We have and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of our portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter. As of December 31, 2022, 92.1% of our portfolio at fair value was valued either based on market quotations, the transactions precedent approach or corroborated by independent valuation firms.
Certain factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s earnings and its ability to make payments on its indebtedness, the markets in which the portfolio company does business, comparison to comparable publicly-traded companies, discounted cash flow and other relevant factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, may fluctuate over short periods of time and may be based on estimates, our determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed. Due to these uncertainties, Oaktree's fair value determinations may cause our net asset value on a given date to materially understate or overstate the value that we may ultimately realize upon the sale of one or more of our investments.
88


As of December 31, 2022, we held $2,642.9 million of investments at fair value, up from $2,494.1 million held at September 30, 2022, primarily driven by new originations outpacing the rate of repayments. As of December 31, 2022 and September 30, 2022, approximately 95.5% and 94.2%, respectively, of our total assets represented investments at fair value.
Revenue Recognition
Interest Income
Interest income, adjusted for accretion of original issue discount, or OID, is recorded on an accrual basis to the extent that such amounts are expected to be collected. We stop accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash, and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of each of December 31, 2022 and September 30, 2022, there were no investments on non-accrual status.
In connection with our investment in a portfolio company, we sometimes receive nominal cost equity that is valued as part of the negotiation process with the portfolio company. When we receive nominal cost equity, we allocate our cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan.
PIK Interest Income
Our investments in debt securities may contain payment-in-kind, or PIK, interest provisions. PIK interest, which typically represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We generally cease accruing PIK interest if there is insufficient value to support the accrual or if we do not expect the portfolio company to be able to pay all principal and interest due. Our decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; our assessment of the portfolio company's business development success; information obtained by us in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. Our determination to cease accruing PIK interest is generally made well before our full write-down of a loan or debt security. In addition, if it is subsequently determined that we will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on our debt investments increases the recorded cost bases of these investments in our Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by us to Oaktree. To maintain our status as a RIC, certain income from PIK interest may be required to be distributed to our stockholders, even though we have not yet collected the cash and may never do so.
Portfolio Composition
Our investments principally consist of loans, common and preferred equity and warrants in privately-held companies, Senior Loan Fund JV I, LLC, or SLF JV I, a joint venture through which we and Trinity Universal Insurance Company, a subsidiary of Kemper Corporation, or Kemper, co-invest in senior secured loans of middle-market companies and other corporate debt securities, and OCSI Glick JV LLC, or the Glick JV, a joint venture through which we and GF Equity Funding 2014 LLC, or GF Equity Funding, co-invest primarily in senior secured loans of middle-market companies. We refer to SLF JV I and the Glick JV collectively as the JVs. Our loans are typically secured by a first, second or subordinated lien on the assets of the portfolio company and generally have terms of up to ten years (but an expected average life of between three and four years).
During the three months ended December 31, 2022, we originated $250.3 million of investment commitments in 18 new and seven existing portfolio companies and funded $274.4 million of investments.
During the three months ended December 31, 2022, we received $104.4 million of proceeds from prepayments, exits, other paydowns and sales and exited 11 portfolio companies.
89


A summary of the composition of our investment portfolio at cost and fair value as a percentage of total investments is shown in the following tables:
December 31, 2022September 30, 2022
Cost:
Senior secured debt84.94 %85.08 %
Debt investments in the JVs5.85 5.59 
Preferred equity3.16 3.26 
Subordinated debt2.48 2.57 
LLC equity interests of the JVs1.97 1.88 
Common equity and warrants1.60 1.62 
Total100.00 %100.00 %
December 31, 2022September 30, 2022
Fair value:
Senior secured debt86.32 %86.86 %
Debt investments in the JVs6.14 5.88 
Preferred equity3.05 3.19 
Subordinated debt2.35 2.28 
Common equity and warrants1.23 0.96 
LLC equity interests of the JVs0.91 0.83 
Total100.00 %100.00 %

90


The industry composition of our portfolio at cost and fair value as a percentage of total investments was as follows:
December 31, 2022September 30, 2022
Cost:
Application Software15.66 %14.98 %
Multi-Sector Holdings (1)8.27 7.48 
Pharmaceuticals4.73 4.83 
Data Processing & Outsourced Services4.25 4.60 
Biotechnology4.02 4.20 
Health Care Technology3.97 3.82 
Specialized Finance3.15 3.09 
Industrial Machinery2.93 3.12 
Health Care Services2.37 2.24 
Internet & Direct Marketing Retail2.36 2.59 
Aerospace & Defense2.23 2.37 
Construction & Engineering2.19 2.33 
Health Care Distributors2.10 2.18 
Other Diversified Financial Services2.06 1.12 
Personal Products1.91 2.03 
Automotive Retail1.86 2.26 
Auto Parts & Equipment1.84 0.48 
Real Estate Operating Companies1.80 1.82 
Fertilizers & Agricultural Chemicals1.77 1.88 
Internet Services & Infrastructure1.77 2.07 
Metal & Glass Containers1.70 1.82 
Home Improvement Retail1.63 1.75 
Soft Drinks1.58 1.31 
Airport Services1.57 1.65 
Leisure Facilities1.48 1.52 
Insurance Brokers1.41 1.36 
Diversified Support Services1.37 1.45 
Specialty Chemicals1.34 1.43 
Health Care Supplies1.32 1.39 
Real Estate Services1.30 1.54 
Integrated Telecommunication Services1.25 1.32 
Electrical Components & Equipment1.22 1.29 
Advertising0.99 1.08 
Movies & Entertainment0.94 1.00 
Distributors0.91 0.97 
Airlines0.87 — 
Health Care Equipment0.79 0.93 
Environmental & Facilities Services0.76 0.80 
Oil & Gas Storage & Transportation0.72 0.85 
Home Furnishings0.70 0.75 
Systems Software0.54 0.57 
Consumer Finance0.52 0.55 
Hotels, Resorts & Cruise Lines0.50 0.53 
IT Consulting & Other Services0.42 0.45 
Restaurants0.34 0.36 
Education Services0.33 0.35 
Cable & Satellite0.29 0.79 
Research & Consulting Services0.28 0.35 
Apparel, Accessories & Luxury Goods0.19 0.20 
Air Freight & Logistics0.18 0.28 
Integrated Oil & Gas0.18 0.19 
Apparel Retail0.17 0.20 
Food Distributors0.17 0.18 
Specialized REITs0.16 0.16 
Real Estate Development0.15 — 
Diversified Banks0.13 0.13 
Technology Distributors0.11 0.12 
Construction Materials0.08 0.09 
Housewares & Specialties0.08 0.09 
Electronic Components0.08 0.08 
Alternative Carriers0.01 0.01 
Oil & Gas Refining & Marketing— 0.33 
Trading Companies & Distributors— 0.29 
Total100.00 %100.00 %
91


December 31, 2022September 30, 2022
Fair value:
Application Software15.95 %15.43 %
Multi-Sector Holdings (1)7.53 6.71 
Pharmaceuticals4.82 4.79 
Biotechnology4.37 4.35 
Data Processing & Outsourced Services4.02 4.46 
Health Care Technology3.92 3.90 
Industrial Machinery3.02 3.25 
Specialized Finance3.02 2.93 
Internet & Direct Marketing Retail2.50 2.82 
Aerospace & Defense2.33 2.48 
Construction & Engineering2.31 2.45 
Health Care Distributors2.08 2.19 
Other Diversified Financial Services2.05 0.98 
Fertilizers & Agricultural Chemicals1.98 2.08 
Health Care Services1.94 1.84 
Automotive Retail1.92 2.31 
Real Estate Operating Companies1.90 1.93 
Auto Parts & Equipment1.89 0.46 
Internet Services & Infrastructure1.85 2.16 
Personal Products1.85 2.01 
Home Improvement Retail1.71 1.82 
Metal & Glass Containers1.69 1.91 
Soft Drinks1.68 1.35 
Airport Services1.64 1.72 
Leisure Facilities1.54 1.57 
Insurance Brokers1.48 1.33 
Health Care Supplies1.43 1.47 
Diversified Support Services1.35 1.47 
Real Estate Services1.35 1.59 
Electrical Components & Equipment1.25 1.32 
Integrated Telecommunication Services1.21 1.29 
Specialty Chemicals1.19 1.36 
Movies & Entertainment1.00 1.07 
Advertising0.98 1.08 
Airlines0.98 — 
Distributors0.93 0.98 
Health Care Equipment0.86 0.97 
Environmental & Facilities Services0.78 0.83 
Oil & Gas Storage & Transportation0.69 0.84 
Home Furnishings0.68 0.73 
Hotels, Resorts & Cruise Lines0.53 0.56 
Systems Software0.46 0.51 
Consumer Finance0.43 0.53 
Education Services0.34 0.34 
Restaurants0.33 0.35 
Cable & Satellite0.30 0.78 
Research & Consulting Services0.27 0.34 
IT Consulting & Other Services0.26 0.34 
Integrated Oil & Gas0.18 0.20 
Apparel Retail0.18 0.21 
Real Estate Development0.16 — 
Air Freight & Logistics0.16 0.26 
Food Distributors0.14 0.13 
Diversified Banks0.13 0.14 
Specialized REITs0.12 0.13 
Technology Distributors0.11 0.12 
Housewares & Specialties0.09 0.10 
Construction Materials0.07 0.08 
Electronic Components0.06 0.08 
Alternative Carriers0.01 0.01 
Oil & Gas Refining & Marketing— 0.34 
Trading Companies & Distributors— 0.22 
Total100.00 %100.00 %
___________________
(1)This industry includes our investments in the JVs.

92



The Joint Ventures

Senior Loan Fund JV I, LLC

In May 2014, we entered into a limited liability company, or LLC, agreement with Kemper to form SLF JV I. We co-invest in senior secured loans of middle-market companies and other corporate debt securities with Kemper through our investment in SLF JV I. SLF JV I is managed by a four person Board of Directors, two of whom are selected by us and two of whom are selected by Kemper. All portfolio decisions and investment decisions in respect of SLF JV I must be approved by the SLF JV I investment committee, which consists of one representative selected by us and one representative selected by Kemper (with approval from a representative of each required). Since we do not have a controlling financial interest in SLF JV I, we do not consolidate SLF JV I. SLF JV I is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act. SLF JV I is capitalized pro rata with LLC equity interests as transactions are completed and may be capitalized with additional subordinated notes issued to us and Kemper by SLF JV I. The subordinated notes issued by SLF JV I are referred to as the SLF JV I Notes. The SLF JV I Notes are senior in right of payment to SLF JV I LLC equity interests and subordinated in right of payment to SLF JV I’s secured debt.
As of December 31, 2022 and September 30, 2022, we and Kemper owned, in the aggregate, 87.5% and 12.5%, respectively, of the LLC equity interests of SLF JV I and the outstanding SLF JV I Notes. As of December 31, 2022, we and Kemper had funded approximately $190.5 million to SLF JV I, of which $166.7 million was from us. As of September 30, 2022, we and Kemper had funded approximately $165.5 million to SLF JV I, of which $144.8 million was from us. As of December 31, 2022, we had aggregate commitments to fund SLF JV I of $13.1 million, of which approximately $9.8 million was to fund additional SLF JV I Notes and approximately $3.3 million was to fund LLC equity interests in SLF JV I. During the three months ended December 31, 2022, we contributed $16.4 million to fund additional SLF JV I Notes and approximately $5.5 million to fund additional LLC equity interests in SLF JV I. As of September 30, 2022, we had aggregate commitments to fund SLF JV I of $35.0 million, of which approximately $26.2 million was to fund additional SLF JV I Notes and approximately $8.8 million was to fund LLC equity interests in SLF JV I.
Both the cost and fair value of our SLF JV I Notes were $112.7 million as of December 31, 2022. Both the cost and fair value of our SLF JV I Notes were $96.3 million as of September 30, 2022. We earned interest income of $2.6 million and $2.0 million on the SLF JV I Notes for the three months ended December 31, 2022 and 2021, respectively. As of December 31, 2022, the SLF JV I Notes bore interest at a rate of one-month LIBOR plus 7.00% per annum with a LIBOR floor of 1.00% and will mature on December 29, 2028.
The cost and fair value of the LLC equity interests in SLF JV I held by us was $54.8 million and $24.1 million, respectively, as of December 31, 2022, and $49.3 million and $20.7 million, respectively, as of September 30, 2022. We earned $1.1 million and $0.5 million in dividend income for the three months ended December 31, 2022 and December 31, 2021, respectively, with respect to our investment in the LLC equity interests of SLF JV I.
Below is a summary of SLF JV I's portfolio as of December 31, 2022 and September 30, 2022:
December 31, 2022September 30, 2022
Senior secured loans (1)$382,148$383,194
Weighted average interest rate on senior secured loans (2)9.55%8.33%
Number of borrowers in SLF JV I5960
Largest exposure to a single borrower (1)$11,337$10,093
Total of five largest loan exposures to borrowers (1)$51,990$48,139
__________________
(1) At principal amount.
(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.

See "Note 3. Portfolio Investments" in the notes to the accompanying financial statements for more information on SLF JV I and its portfolio.
93


OCSI Glick JV LLC
On March 19, 2021, we became party to the LLC agreement of the Glick JV. The Glick JV invests primarily in senior secured loans of middle-market companies. We co-invest in these securities with GF Equity Funding through the Glick JV. The Glick JV is managed by a four person Board of Directors, two of whom are selected by us and two of whom are selected by GF Equity Funding. All portfolio decisions and investment decisions in respect of the Glick JV must be approved by the Glick JV investment committee, consisting of one representative selected by us and one representative selected by GF Equity Funding (with approval from a representative of each required). Since we do not have a controlling financial interest in the Glick JV, we do not consolidate the Glick JV. The Glick JV is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act. The Glick JV is capitalized as transactions are completed. The members provide capital to the Glick JV in exchange for LLC equity interests, and we and GF Debt Funding, an entity advised by affiliates of GF Equity Funding, provide capital to the Glick JV in exchange for subordinated notes issued by the Glick JV, or the Glick JV Notes. The Glick JV Notes are junior in right of payment to the repayment of temporary contributions made by us to fund investments of the Glick JV that are repaid when GF Equity Funding and GF Debt Funding make their capital contributions and fund their Glick JV Notes, respectively.
As of December 31, 2022 and September 30, 2022, we and GF Equity Funding owned 87.5% and 12.5%, respectively, of the outstanding LLC equity interests, and we and GF Debt Funding owned 87.5% and 12.5%, respectively, of the Glick JV Notes. Approximately $84.0 million in aggregate commitments was funded as of each of December 31, 2022 and September 30, 2022, of which $73.5 million was from us. As of December 31, 2022 and September 30, 2022, we had commitments to fund Glick JV Notes of $78.8 million, of which $12.4 million was unfunded. As of each of December 31, 2022 and September 30, 2022, we had commitments to fund LLC equity interests in the Glick JV of $8.7 million, of which $1.6 million was unfunded.

The cost and fair value of our aggregate investment in the Glick JV was $50.0 million and $49.5 million, respectively, as of December 31, 2022. The cost and fair value of our aggregate investment in the Glick JV was $50.2 million and $50.3 million, respectively, as of September 30, 2022. For the three months ended December 31, 2022 and December 31, 2021, our investment in the Glick JV Notes earned interest income of $1.6 million and $1.1 million, respectively. We did not earn any dividend income for the three months ended December 31, 2022 and December 31, 2021 with respect to our investment in the LLC equity interests of the Glick JV.
Below is a summary of the Glick JV's portfolio as of December 31, 2022 and September 30, 2022:
December 31, 2022September 30, 2022
Senior secured loans (1)$134,080$143,225
Weighted average current interest rate on senior secured loans (2)9.86%8.52%
Number of borrowers in the Glick JV4043
Largest loan exposure to a single borrower (1)$7,476$6,562
Total of five largest loan exposures to borrowers (1)$29,830$28,973
__________
(1) At principal amount.
(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.
See "Note 3. Portfolio Investments" in the notes to the accompanying financial statements for more information on the Glick JV and its portfolio.
94


Discussion and Analysis of Results and Operations
Results of Operations
Net increase (decrease) in net assets resulting from operations includes net investment income, net realized gains (losses) and net unrealized appreciation (depreciation). Net investment income is the difference between our income from interest, dividends and fees and net expenses. Net realized gains (losses) is the difference between the proceeds received from dispositions of investment related assets and liabilities and their stated costs. Net unrealized appreciation (depreciation) is the net change in the fair value of our investment related assets and liabilities carried at fair value during the reporting period, including the reversal of previously recorded unrealized appreciation (depreciation) when gains or losses are realized.
Comparison of three months ended December 31, 2022 and December 31, 2021
Total Investment Income
Total investment income includes interest on our investments, fee income and dividend income.
Total investment income for the three months ended December 31, 2022 and 2021 was $79.2 million and $64.9 million, respectively. For the three months ended December 31, 2022, this amount consisted of $76.1 million of interest income from portfolio investments (which included $6.1 million of PIK interest), $2.0 million of fee income and $1.1 million of dividend income. For the three months ended December 31, 2021, this amount consisted of $60.1 million of interest income from portfolio investments (which included $4.7 million of PIK interest), $0.9 million of fee income and $3.9 million of dividend income. The increase of $14.2 million, or 21.9%, in our total investment income for the three months ended December 31, 2022, as compared to the three months ended December 31, 2021, was due primarily to (1) a $16.0 million increase in interest income, which was primarily driven by the impact of rising reference rates on interest income and (2) a $1.1 million increase in fee income primarily due to higher exit and amendment fees. This was partially offset by a $2.9 million decrease in dividend income.
Expenses
Net expenses (expenses net of fee waivers) for the three months ended December 31, 2022 and 2021 were $40.3 million and $29.3 million, respectively. Net expenses increased for the three months ended December 31, 2022, as compared to the three months ended December 31, 2021, by $11.0 million, or 37.3%, primarily due to (1) a $11.3 million increase in interest expense due to higher borrowings outstanding and the impact of rising reference rates and (2) a $1.2 million increase in Part I incentive fees mainly due to higher total investment income. These were partially offset by $1.8 million of lower accrued Part II incentive fees.
Net Investment Income
Primarily as a result of the $14.2 million increase in total investment income, the $11.0 million increase in net expenses and a $3.3 million decrease in the provision for taxes on net investment income, net investment income for the three months ended December 31, 2022 increased by $6.5 million compared to the three months ended December 31, 2021.
Realized Gain (Loss)
Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption of investments and foreign currency and the cost basis without regard to unrealized appreciation or depreciation previously recognized, and includes investments written-off during the period, net of recoveries. Realized losses may also be recorded in connection with our determination that certain investments are considered worthless securities and/or meet the conditions for loss recognition per the applicable tax rules.
During the three months ended December 31, 2022 and 2021, we recorded aggregate net realized gains (losses) of $(3.2) million and $9.3 million, respectively, in connection with the exits of various investments and foreign currency forward contracts. See “Note 6. Borrowings8. Realized Gains or Losses and Net Unrealized Appreciation or Depreciation” in the notes to the accompanying Consolidated Financial Statements for more details regarding investment realization events for the three months ended December 31, 2022 and 2021.
Net Unrealized Appreciation (Depreciation)
Net unrealized appreciation or depreciation is the net change in the fair value of our indebtedness.investments and foreign currency during the reporting period, including the reversal of previously recorded unrealized appreciation or depreciation when gains or losses are realized.
95


During the three months ended December 31, 2022 and 2021, we recorded net unrealized depreciation of $23.0 million and $4.6 million, respectively. For the three months ended December 31, 2022, this consisted of $18.7 million of net unrealized depreciation on debt investments and $11.0 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $3.9 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $2.8 million of net unrealized appreciation on equity investments. For the three months ended December 31, 2021, this consisted of $4.7 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains), $1.8 million of net unrealized depreciation on debt investments and $0.8 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $2.8 million of net unrealized appreciation on equity investments.
Financial Condition, Liquidity and Capital Resources
We have a number of alternatives available to fund our investment portfolio and our operations, including raising equity, increasing or refinancing debt and funding from operational cash flow. We generally expect to fund the growth of our investment portfolio through additional debt and equity capital, which may include securitizing a portion of our investments. We cannot assure you, however, that our efforts to grow our portfolio will be successful. For example, our common stock has generally traded at prices below net asset value for the past several years, and we may not be able to raise additional equity at prices below the then-current net asset value per share. We intend to continue to generate cash primarily from cash flows from operations, including interest earned, and future borrowings or equity offerings. We intend to fund our future distribution obligations through operating cash flow or with funds obtained through future equity and debt offerings or credit facilities, as we deem appropriate.
Our primary uses of funds are investments in our targeted asset classes and cash distributions to holders of our common stock. We may also from time to time repurchase or redeem some or all of our outstanding notes. At a special meeting of our stockholders held on June 28, 2019, our stockholders approved the application of the reduced asset coverage requirements in Section 61(a)(2) of the Investment Company Act to us effective as of June 29, 2019. As a result of the reduced asset coverage requirement, we can incur $2 of debt for each $1 of equity as compared to $1 of debt for each $1 of equity. As of December 31, 2022, we had $1,514.4 million in senior securities and our asset coverage ratio was 176.3%. During the year ended September 30, 2022, we increased our target debt to equity ratio from 0.85x to 1.0x to 0.90x to 1.25x (i.e., one dollar of equity for each $0.90 to $1.25 of debt outstanding) to provide us with increased capacity to opportunistically deploy capital into the markets. As of December 31, 2022, our net debt to equity ratio was 1.24x.
For the three months ended December 31, 2022, we experienced a net decrease in cash and cash equivalents (including restricted cash) of $7.1 million. During that period, net cash used in operating activities was $109.9 million, primarily from funding $261.4 million of investments and $10.0 million of net decrease in payables from unsettled transactions, partially offset by $108.8 million of principal payments and sale proceeds received, the cash activities related to $38.8 million of net investment income and a $16.3 million increase in due from portfolio companies. During the same period, net cash provided by financing activities was $103.3 million, primarily consisting of $160.0 million of net borrowings under the credit facilities, partially offset by $56.7 million of cash distributions paid to our stockholders.
For the three months ended December 31, 2021, we experienced a net increase in cash and cash equivalents (including restricted cash) of $14.4 million. During that period, we received $23.2 million of net cash from operating activities, primarily from $235.0 million of principal payments and sale proceeds received, $15.0 million of net increases in payables from unsettled transactions and the cash activities related to $32.3 million of net investment income, partially offset by funding $246.6 million of investments. During the same period, net cash used by financing activities was $7.5 million, primarily consisting of $27.2 million of cash distributions paid to our stockholders and $0.3 million of deferred financing costs paid, partially offset by $20.0 million of net borrowings under the credit facilities.
As of December 31, 2022, we had $19.2 million in cash and cash equivalents (including $1.9 million of restricted cash), portfolio investments (at fair value) of $2.6 billion, $37.8 million of interest, dividends and fees receivable, $6.2 million of due from portfolio companies, $340.0 million of undrawn capacity on our credit facilities (subject to borrowing base and other limitations), $12.3 million of net payables from unsettled transactions, $860.0 million of borrowings outstanding under our credit facilities and $603.6 million of unsecured notes payable (net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment).
As of September 30, 2022, we had $26.4 million in cash and cash equivalents (including $2.8 million of restricted cash), portfolio investments (at fair value) of $2.5 billion, $35.6 million of interest, dividends and fees receivable, $22.5 million of due from portfolio companies, $500.0 million of undrawn capacity on our credit facilities (subject to borrowing base and other limitations), $22.3 million of net payables from unsettled transactions, $700.0 million of borrowings outstanding under our credit facilities and $601.0 million of unsecured notes payable (net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment).
96


We may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of our portfolio companies. As of December 31, 2022, our only off-balance sheet arrangements consisted of $198.9 million of unfunded commitments, which was comprised of $171.8 million to provide debt and equity financing to certain of our portfolio companies and $27.1 million to provide financing to the JVs. As of September 30, 2022, our only off-balance sheet arrangements consisted of $224.2 million of unfunded commitments, which was comprised of $175.2 million to provide debt and equity financing to certain of our portfolio companies and $49.0 million to provide financing to the JVs.
As of December 31, 2022, we have analyzed cash and cash equivalents, availability under our credit facilities, the ability to rotate out of certain assets and amounts of unfunded commitments that could be drawn and believe our liquidity and capital resources are sufficient to take advantage of market opportunities in the current economic climate.
Syndicated Facility


On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans, mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank.

As of December 31, 2022, the size of the Syndicated Facility was $1.0 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances.

As of December 31, 2022, (i) the period during which the Company may make drawings will expire on May 4, 2025 and the maturity date is May 4, 2026 and (ii) the interest rate margin for (a) LIBOR loans (which may be 1-, 2-, 3- or 6-month, at the Company’s option) was 2.00% and (b) alternate base rate loans was 1.00%.

The Syndicated Facility is secured by substantially all of the Company’s assets (excluding, among other things, investments held in and by certain subsidiaries of the Company (including OCSL Senior Funding II LLC) or investments in certain portfolio companies of the Company) and guaranteed by certain subsidiaries of the Company. As of December 31, 2022, except for assets that were held by OCSL Senior Funding II LLC and certain immaterial subsidiaries, substantially all of the Company's assets are pledged as collateral under the Syndicated Facility.

The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of December 31, 2022, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions.

As of December 31, 2022 and September 30, 2022, the Company had $695.0 million and $540.0 million of borrowings outstanding under the Syndicated Facility, respectively, which had a fair value of $695.0 million and $540.0 million, respectively. The Company's borrowings under the Syndicated Facility bore interest at a weighted average interest rate of 5.849% and 2.174% for the three months ended December 31, 2022 and 2021, respectively. For the three months ended
65

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




December 31, 2022 and 2021, the Company recorded interest expense (inclusive of fees) of $10.0 million and $3.8 million, respectively, related to the Syndicated Facility.
Citibank Facility
On March 19, 2021, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC (formerly OCSI Senior Funding II LLC), the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian.
As of December 31, 2022, the Company was able to borrow up to $200 million under the Citibank Facility (subject to borrowing base and other limitations). As of December 31, 2022, the reinvestment period under the Citibank Facility was scheduled to expire on November 18, 2023 and the maturity date for the Citibank Facility was November 18, 2024.
As of December 31, 2022, borrowings under the Citibank Facility are subject to certain customary advance rates and accrue interest at a rate equal to LIBOR plus between 1.25% and 2.20% per annum on broadly syndicated loans, subject to observable market depth and pricing, and LIBOR plus 2.25% per annum on all other eligible loans during the reinvestment period. In addition, as of December 31, 2022, for the duration of the reinvestment period there is a non-usage fee payable of 0.50% per annum on the undrawn amount under the Citibank Facility. The minimum asset coverage ratio applicable to the Company under the Citibank Facility is 150% as determined in accordance with the requirements of the Investment Company Act. Borrowings under the Citibank Facility are secured by all of the assets of OCSL Senior Funding II LLC and all of the Company’s equity interests in OCSL Senior Funding II LLC. The Company may use the Citibank Facility to fund a portion of its loan origination activities and for general corporate purposes. Each loan origination under the Citibank Facility is subject to the satisfaction of certain conditions.
As of December 31, 2022 and September 30, 2022, the Company had $165.0 million and $160.0 million outstanding under the Citibank Facility, respectively, which had a fair value of $165.0 million and $160.0 million, respectively. The Company's borrowings under the Citibank Facility bore interest at a weighted average interest rate of 6.508% and 1.830% for the three months ended December 31, 2022 and 2021, respectively. For the three months ended December 31, 2022 and 2021, the Company recorded interest expense (inclusive of fees) of $2.7 million and $0.8 million, respectively, related to the Citibank Facility.
2025 Notes
On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes.
The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.
Interest on the 2025 Notes is paid semi-annually on February 25 and August 25 at a rate of 3.500% per annum. The 2025 Notes mature on February 25, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2025 Notes can require the Company to repurchase the 2025 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2025 Notes Indenture. The 2025 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2022, the Company did not repurchase any of the 2025 Notes in the open market.
The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to
66

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture.
2027 Notes
On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes.
The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.
Interest on the 2027 Notes is paid semi-annually on January 15 and July 15, beginning on January 15, 2022, at a rate of 2.700% per annum. The 2027 Notes mature on January 15, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2027 Notes can require the Company to repurchase the 2027 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2027 Notes Indenture. The 2027 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the three months ended December 31, 2022, the Company did not repurchase any of the 2027 Notes in the open market.
The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture.
In connection with the 2027 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 2.700% and pays a floating interest rate of the three-month LIBOR plus 1.658% on a notional amount of $350 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap.
67

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




The below table presents the components of the carrying value of the 2025 Notes and the 2027 Notes as of December 31, 2022 and September 30, 2022:
 As of December 31, 2022As of September 30, 2022
($ in millions)2025 Notes2027 Notes2025 Notes2027 Notes
Principal$300.0 $350.0 $300.0 $350.0 
  Unamortized financing costs(1.6)(3.1)(1.8)(3.2)
  Unaccreted discount(1.1)(0.7)(1.2)(0.7)
  Interest rate swap fair value adjustment— (39.9)— (42.0)
Net carrying value$297.3 $306.3 $297.0 $304.1 
Fair Value$286.7 $296.8 $283.1 $294.0 
The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three months ended December 31, 2022:
($ in millions)2025 Notes2027 Notes
Coupon interest$2.6 $2.4 
Amortization of financing costs and discount0.3 0.2 
Effect of interest rate swap— 2.5 
 Total interest expense$2.9 $5.1 
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)3.500 %5.586 %
The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three months ended December 31, 2021:
($ in millions)2025 Notes2027 Notes
Coupon interest$2.6 $2.4 
Amortization of financing costs and discount0.3 0.2 
Effect of interest rate swap— (0.7)
 Total interest expense$2.9 $1.9 
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)3.500 %1.782 %

Note 7. Taxable/Distributable Income and Dividend Distributions
Taxable income differs from net increase (decrease) in net assets resulting from operations primarily due to: (1) unrealized appreciation (depreciation) on investments and foreign currency, as gains and losses are not included in taxable income until they are realized; (2) origination and exit fees received in connection with investments in portfolio companies; (3) organizational costs; (4) income or loss recognition on exited investments; and (5) recognition of interest income on certain loans.
As of September 30, 2022, the Company had net capital loss carryforwards of $523.7 million to offset net capital gains that will not expire, to the extent available and permitted by U.S. federal income tax law, of which $64.5 million are available to offset future short-term capital gains and $459.2 million are available to offset future long-term capital gains. A portion of such net capital loss carryfowards represented a realized loss under sections 382 and 383 of the Code, which is carried forward to future years to offset future gains subject to certain limitations.
68

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Listed below is a reconciliation of "net increase (decrease) in net assets resulting from operations" to taxable income for the three months ended December 31, 2022 and 2021.
Three months ended
December 31, 2022
Three months ended
December 31, 2021
Net increase (decrease) in net assets resulting from operations$13,172 $39,408 
Net unrealized (appreciation) depreciation22,982 4,586 
Book/tax difference due to organizational costs— (22)
Book/tax difference due to capital losses utilized8,013 (10,531)
Other book/tax differences(12,910)(11,171)
Taxable/Distributable Income (1)$31,257 $22,270 
 __________
(1) The Company's taxable income for the three months ended December 31, 2022 is an estimate and will not be finally determined until the Company files its tax return for the fiscal year ending September 30, 2023. Therefore, the final taxable income may be different than the estimate.
The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences.
When assessing the realizability of deferred tax assets, the Company considers whether it is probable that some or all of the deferred tax assets will not be realized. In determining whether the deferred tax assets are realizable, the Company considers the period of expiration of the tax asset, historical and projected taxable income and tax liabilities for the tax jurisdiction in which the tax asset is located. The deferred tax asset recognized by the Company, as it relates to the higher tax basis in the carrying value of certain assets compared to the book basis of those assets, will be recognized in future years by these taxable entities. Deferred tax assets are based on the amount of the tax benefit that the Company’s management has determined is more likely than not to be realized in future periods. In determining the realizability of this tax benefit, management considered numerous factors that will give rise to pre-tax income in future periods. Among these are the historical and expected future book and tax basis pre-tax income of the Company and unrealized gains in the Company’s assets at the determination date. Based on these and other factors, the Company determined that, as of December 31, 2022, $11.4 million of the $13.1 million deferred tax assets would not more likely than not be realized in future periods. As of December 31, 2022, the Company recorded a net deferred tax asset of $1.7 million on the Consolidated Statements of Assets and Liabilities.
For the three months ended December 31, 2022, the Company recognized a total benefit for income tax related to realized and unrealized losses of $0.5 million, which was primarily all current income tax benefit.
For the three months ended December 31, 2021, the Company recognized a total benefit for income tax related to realized and unrealized losses of $2.4 million, which was composed of (i) a current income tax benefit of approximately $1.4 million, and (ii) a deferred income tax benefit of approximately $1.0 million, which resulted from unrealized depreciation on investments held by the Company’s wholly-owned taxable subsidiaries. For the three months ended December 31, 2021, the Company recognized a provision for income tax related to net investment income of $3.3 million, which was all current income tax expense.
As of September 30, 2022, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows:
Undistributed ordinary income, net$(43,624)
Net realized capital losses473,274 
Unrealized losses, net153,119 
Accumulated overdistributed earnings$582,769
The aggregate cost of investments for U.S. federal income tax purposes was $2,654.3 million as of September 30, 2022. As of September 30, 2022, the aggregate gross unrealized appreciation for all investments in which there was an excess of value over cost for U.S. federal income tax purposes was $466.9 million. As of September 30, 2022, the aggregate gross unrealized depreciation for all investments in which there was an excess of cost for U.S. federal income tax purposes over value was
69

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




$620.0 million. Net unrealized depreciation based on the aggregate cost of investments for U.S. federal income tax purposes was $153.1 million.

Note 8. Realized Gains or Losses and Net Unrealized Appreciation or Depreciation
Realized Gains or Losses
Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption and the cost basis of the investment without regard to unrealized appreciation or depreciation previously recognized, and include investments written-off during the period, net of recoveries. Realized losses may also be recorded in connection with the Company's determination that certain investments are considered worthless securities and/or meet the conditions for loss recognition per the applicable tax rules.
During the three months ended December 31, 2022, the Company recorded an aggregate net realized loss of $3.2 million, which consisted of the following:
($ in millions)
Portfolio CompanyNet Realized Gain (Loss)
Foreign currency forward contracts$4.4 
Carvana Co.(2.8)
ASP Unifrax Holdings Inc.(2.1)
Global Medical Response Inc.(1.0)
Other, net(1.7)
Total, net$(3.2)
During the three months ended December 31, 2021, the Company recorded an aggregate net realized gain of $9.3 million, which consisted of the following:
($ in millions)
Portfolio CompanyNet Realized Gain (Loss)
Foreign currency forward contracts$3.0 
OmniSYS Acquisition Corporation2.0 
First Star Speir Aviation Limited1.9 
Other, net2.4 
Total, net$9.3

Net Unrealized Appreciation or Depreciation
Net unrealized appreciation or depreciation reflects the net change in the valuation of the portfolio pursuant to the Company's valuation guidelines and the reclassification of any prior period unrealized appreciation or depreciation.
During the three months ended December 31, 2022 and 2021, the Company recorded net unrealized depreciation of $23.0 million and $4.6 million, respectively. For the three months ended December 31, 2022, this consisted of $18.7 million of net unrealized depreciation on debt investments and $11.0 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $3.9 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $2.8 million of net unrealized appreciation on equity investments. For the three months ended December 31, 2021, this consisted of $4.7 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains), $1.8 million of net unrealized depreciation on debt investments and $0.8 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $2.8 million of net unrealized appreciation on equity investments.

70

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Note 9. Concentration of Credit Risks
The Company deposits its cash with financial institutions and at times such balances may be in excess of the FDIC insurance limit. The Company limits its exposure to credit loss by depositing its cash with high credit quality financial institutions and monitoring their financial stability.
Note 10. Related Party Transactions

As of December 31, 2022 and September 30, 2022, the Company had a liability on its Consolidated Statements of Assets and Liabilities in the amount of $16.9 million and $15.9 million, respectively, reflecting the unpaid portion of the base management fees and incentive fees payable to Oaktree.
Investment Advisory Agreement
The Company is party to the Investment Advisory Agreement. Under the Investment Advisory Agreement, the Company pays Oaktree a fee for its services under the Investment Advisory Agreement consisting of two components: a base management fee and an incentive fee. The cost of both the base management fee payable to Oaktree and any incentive fees earned by Oaktree is ultimately borne by common stockholders of the Company.
From October 17, 2017 through May 3, 2020, the Company was externally managed by OCM pursuant to an investment advisory agreement. On May 4, 2020, OCM effected the novation of such investment advisory agreement to Oaktree. Immediately following such novation, the Company and Oaktree entered into a new investment advisory agreement with the same terms, including fee structure, as the investment advisory agreement with OCM. The investment advisory agreement with Oaktree was subsequently amended and restated on March 19, 2021 in connection with the closing of the OCSI Merger and on January 23, 2023 in connection with the OSI2 Merger. The term “Investment Advisory Agreement” refers collectively to the agreements with Oaktree and, prior to its novation, with OCM.
Unless earlier terminated as described below, the Investment Advisory Agreement will remain in effect from year-to-year if approved annually by the Board of Directors of the Company or by the affirmative vote of the holders of a majority of the Company’s outstanding voting securities, including, in either case, approval by a majority of the directors of the Company who are not interested persons. The Investment Advisory Agreement will automatically terminate in the event of its assignment. The Investment Advisory Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Investment Advisory Agreement may also be terminated, without penalty, upon the vote of a majority of the outstanding voting securities of the Company.
Base Management Fee

Under the Investment Advisory Agreement, the base management fee is calculated at an annual rate of 1.50% of total gross assets, including any investment made with borrowings, but excluding cash and cash equivalents. The base management fee is payable quarterly in arrears and the fee for any partial month or quarter is appropriately prorated. Effective May 3, 2019, the base management fee on the Company’s gross assets, including any investments made with borrowings, but excluding any cash and cash equivalents, that exceed the product of (A) 200% and (B) the Company’s net asset value will be 1.00%. For the avoidance of doubt, the 200% will be calculated in accordance with the Investment Company Act and will give effect to exemptive relief the Company received from the SEC with respect to debentures issued by a small business investment company subsidiary. In connection with the OCSI Merger, Oaktree waived an aggregate of $6 million of base management fees otherwise payable to Oaktree in the two years following the closing of the OCSI Merger on March 19, 2021 at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter). In connection with the OSI2 Merger, Oaktree waived an aggregate of $9.0 million of base management fees payable to Oaktree as follows: $6.0 million at a rate of $1.5 million per quarter (with such amount appropriately prorated for any partial quarter) in the first year following closing of the OSI2 Merger on January 23, 2023 and $3.0 million at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter) in the second year following closing of the OSI2 Merger.
For the three months ended December 31, 2022 and 2021, the base management fee incurred under the Investment Advisory Agreement was $9.2 million (net of waiver) and $9.2 million (net of waiver), respectively.
Incentive Fee
The incentive fee consists of two parts. Under the Investment Advisory Agreement, the first part of the incentive fee (the “incentive fee on income” or "Part I incentive fee") is calculated and payable quarterly in arrears based upon the “pre-incentive fee net investment income” of the Company for the immediately preceding quarter. The payment of the incentive fee on income
71

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




is subject to payment of a preferred return to investors each quarter (i.e., a “hurdle rate”), expressed as a rate of return on the value of the Company’s net assets at the end of the most recently completed quarter, of 1.50%, subject to a “catch up” feature.
For this purpose, “pre-incentive fee net investment income” means interest income, dividend income and any other income (including any other fees such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies, other than fees for providing managerial assistance) accrued during the fiscal quarter, minus the Company’s operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement and any interest expense and dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as OID debt, instruments with PIK interest and zero coupon securities), accrued income that the Company has not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. In addition, pre-incentive fee net investment income does not include any amortization or accretion of any purchase premium or purchase discount to interest income resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in pre-incentive fee net investment income.

Under the Investment Advisory Agreement, the calculation of the incentive fee on income for each quarter is as follows:

No incentive fee is payable to Oaktree in any quarter in which the Company’s pre-incentive fee net investment income does not exceed the preferred return rate of 1.50% (the “preferred return”) on net assets;
100% of the Company’s pre-incentive fee net investment income, if any, that exceeds the preferred return but is less than or equal to 1.8182% in any fiscal quarter is payable to Oaktree. This portion of the incentive fee on income is referred to as the “catch-up” provision, and it is intended to provide Oaktree with an incentive fee of 17.5% on all of the Company’s pre-incentive fee net investment income when the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets in any fiscal quarter; and
For any quarter in which the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets, the incentive fee on income is equal to 17.5% of the amount of the Company’s pre-incentive fee net investment income, as the preferred return and catch-up will have been achieved.

There is no accumulation of amounts on the hurdle rate from quarter to quarter and accordingly there is no clawback of amounts previously paid if subsequent quarters are below the quarterly hurdle.

For the three months ended December 31, 2022 and 2021, the first part of the incentive fee (incentive fee on income) incurred under the Investment Advisory Agreement was $7.7 million and $6.5 million, respectively.
Under the Investment Advisory Agreement, the second part of the incentive fee (the "capital gains incentive fee") is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Investment Advisory Agreement, as of the termination date) commencing with the fiscal year ended September 30, 2019 and equals 17.5% of the Company’s realized capital gains, if any, on a cumulative basis from the beginning of the fiscal year ended September 30, 2019 through the end of each subsequent fiscal year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees under the Investment Advisory Agreement. Any realized capital gains, realized capital losses, unrealized capital appreciation and unrealized capital depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the calculations of the second part of the incentive fee. In addition, the calculation of realized capital gains, realized capital losses and unrealized capital depreciation does (1) not include any such amounts resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in the capital gains incentive fee, (2) include any such amounts associated with the investments acquired in the OCSI Merger for the period from October 1, 2018 to the date of closing of the OCSI Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee and (3) include any such amounts associated with the investments acquired in the OSI2 Merger for the period from August 6, 2018 to the date of closing of the OSI2 Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee. As of December 31, 2022, the Company paid $9.6 million of capital gains incentive fees cumulatively under the Investment Advisory Agreement (net of waivers). Part II incentive fees are contractually calculated and paid at the end of the fiscal year in accordance with the Investment Advisory Agreement, which, as described above, differs from Part II incentive fees accrued under GAAP. Hypothetically, if Part II incentive fees were calculated as of December 31, 2022 under the Investment Advisory Agreement, no Part II incentive fees would be payable.
72

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)





GAAP requires that the capital gains incentive fee accrual consider the cumulative aggregate unrealized capital appreciation in the calculation, as a capital gains incentive fee would be payable if such unrealized capital appreciation were realized on a theoretical "liquidation basis." A fee so calculated and accrued would not be payable under applicable law and may never be paid based upon the computation of capital gains incentive fees in subsequent periods. Amounts ultimately paid under the Investment Advisory Agreement will be consistent with the formula reflected in the Investment Advisory Agreement. This GAAP accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital depreciation included in the calculation of the capital gains incentive fee plus the aggregate cumulative unrealized capital appreciation. Any realized capital gains and losses and cumulative unrealized capital appreciation and depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the GAAP accrual. If such amount is positive at the end of a period, then GAAP requires the Company to record a capital gains incentive fee equal to 17.5% of such cumulative amount, less the aggregate amount of actual capital gains incentive fees payable or capital gains incentive fees accrued under GAAP in all prior periods. The resulting accrual for any capital gains incentive fee under GAAP in a given period may result in an additional expense if such cumulative amount is greater than in the prior period or a reversal of previously recorded expense if such cumulative amount is less than in the prior period. If such cumulative amount is negative, then there is no accrual. There can be no assurance that such unrealized capital appreciation will be realized in the future or any accrued capital gains incentive fee will become payable under the Investment Advisory Agreement. For the three months ended December 31, 2022, there were no accrued capital gains incentive fees. For the three months ended December 31, 2021, $1.8 million of accrued capital gains incentive fees were expensed. As of December 31, 2022, the total accrued capital gains incentive fee liability was zero.
Indemnification

The Investment Advisory Agreement provides that, absent willful misfeasance, bad faith or gross negligence in the performance of their respective duties or by reason of the reckless disregard of their respective duties and obligations, Oaktree and its officers, managers, partners, members (and their members, including the owners of their members), agents, employees, controlling persons and any other person or entity affiliated with it, are entitled to indemnification from the Company for any damages, liabilities, costs and expenses (including reasonable attorneys' fees and amounts reasonably paid in settlement) arising from the rendering of Oaktree's services under the Investment Advisory Agreement or otherwise as investment adviser.
Administrative Services
The Company is party to the Administration Agreement with Oaktree Administrator. Pursuant to the Administration Agreement, Oaktree Administrator provides administrative services to the Company necessary for the operations of the Company, which include providing office facilities, equipment, clerical, bookkeeping and record keeping services at such facilities and such other services as Oaktree Administrator, subject to review by the Company’s Board of Directors, shall from time to time deem to be necessary or useful to perform its obligations under the Administration Agreement. Oaktree Administrator may, on behalf of the Company, conduct relations and negotiate agreements with custodians, trustees, depositories, attorneys, underwriters, brokers and dealers, corporate fiduciaries, insurers, banks and such other persons in any such other capacity deemed to be necessary or desirable. Oaktree Administrator makes reports to the Company’s Board of Directors of its performance of obligations under the Administration Agreement and furnishes advice and recommendations with respect to such other aspects of the Company’s business and affairs, in each case, as it shall determine to be desirable or as reasonably required by the Company’s Board of Directors; provided that Oaktree Administrator shall not provide any investment advice or recommendation.
Oaktree Administrator also provides portfolio collection functions for interest income, fees and warrants and is responsible for the financial and other records that the Company is required to maintain and prepares, prints and disseminates reports to the Company’s stockholders and all other materials filed with the SEC. In addition, Oaktree Administrator assists the Company in determining and publishing the Company’s net asset value, overseeing the preparation and filing of the Company’s tax returns, and generally overseeing the payment of the Company’s expenses and the performance of administrative and professional services rendered to the Company by others. Oaktree Administrator may also offer to provide, on the Company’s behalf, managerial assistance to the Company’s portfolio companies.
For providing these services, facilities and personnel, the Company reimburses Oaktree Administrator the allocable portion of overhead and other expenses incurred by Oaktree Administrator in performing its obligations under the Administration Agreement, including the Company’s allocable portion of the rent of the Company’s principal executive offices (which are located in a building owned by a Brookfield affiliate) at market rates and the Company’s allocable portion of the costs of compensation and related expenses of its Chief Financial Officer, Chief Compliance Officer, their staffs and other non-
73

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




investment professionals at Oaktree that perform duties for the Company. Such reimbursement is at cost, with no profit to, or markup by, Oaktree Administrator. The Administration Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Administration Agreement may also be terminated, without penalty, upon the vote of a majority of the Company’s outstanding voting securities.
For the three months ended December 31, 2022 and 2021, the Company accrued administrative expenses of $0.4 million and $0.5 million, respectively, including $0.1 million and $0.1 million of general and administrative expenses, respectively.
As of December 31, 2022 and September 30, 2022, $3.3 million and $3.2 million, respectively, was included in “Due to affiliate” in the Consolidated Statements of Assets and Liabilities, reflecting the unpaid portion of administrative expenses and other reimbursable expenses payable to Oaktree Administrator.
74

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Note 11. Financial Highlights
(Share amounts in thousands)Three months ended
December 31, 2022 (8)
Three months ended
December 31, 2021 (8)
Net asset value per share at beginning of period$20.38$21.84
Net investment income (1)0.630.54
Net unrealized appreciation (depreciation) (1)(0.38)(0.08)
Net realized gains (losses) (1)(0.05)0.16
(Provision) benefit for taxes on realized and unrealized gains (losses) (1)0.010.04
Distributions of net investment income to stockholders(0.96)(0.47)
Net asset value per share at end of period$19.63$22.03
Per share market value at beginning of period (7)$18.00$21.18
Per share market value at end of period (7)$20.61$22.38
Total return (2)19.90%7.92%
Common shares outstanding at beginning of period61,12560,120
Common shares outstanding at end of period61,22060,156
Net assets at beginning of period$1,245,563$1,312,823
Net assets at end of period$1,201,989$1,325,061
Average net assets (3)$1,241,806$1,327,934
Ratio of net investment income to average net assets (4)12.40%9.65%
Ratio of total expenses to average net assets (4)13.11%8.99%
Ratio of net expenses to average net assets (4)12.87%8.77%
Ratio of portfolio turnover to average investments at fair value4.24%9.14%
Weighted average outstanding debt (5)$1,441,326$1,331,141
Average debt per share (1)$23.57$22.14
Asset coverage ratio at end of period (6)176.31%200.81%
 __________
(1)Calculated based upon weighted average shares outstanding for the period.
(2)Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load.
(3)Calculated based upon the weighted average net assets for the period.
(4)Interim periods are annualized.
(5)Calculated based upon the weighted average of principal debt outstanding for the period.
(6)Based on outstanding senior securities of $1,514.4 million and $1,300.0 million as of December 31, 2022 and 2021, respectively.
(7)Per share market values are adjusted to reflect the 1-for-3 reverse stock split of the Company's common stock completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
(8)The share and per share information disclosed in this table has been retrospectively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.

75

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)





Note 12. Derivative Instruments
The Company enters into foreign currency forward contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company’s investments denominated in foreign currencies. In order to better define its contractual rights and to secure rights that will help the Company mitigate its counterparty risk, the Company entered into an International Swaps and Derivatives Association, Inc. Master Agreement (the "ISDA Master Agreement") with its derivative counterparty, JPMorgan Chase Bank, N.A. The ISDA Master Agreement permits a single net payment in the event of a default or similar event. As of December 31, 2022, no cash collateral has been pledged to cover obligations and no cash collateral has been received from the counterparty with respect to the Company's forward currency contracts.
In connection with the issuance of the 2027 Notes, the Company entered into an interest rate swap agreement with the Royal Bank of Canada pursuant to an ISDA Master Agreement. As of December 31, 2022, the Company paid $39.8 million to the Royal Bank of Canada to cover collateral obligations under the terms of the interest swap agreement, which is included in due from broker on the Consolidated Statement of Assets and Liabilities.
Certain information related to the Company’s foreign currency forward contracts is presented below as of December 31, 2022.
DescriptionNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net Amounts
Foreign currency forward contract$44,825 44,224 2/9/2023$— $(2,499)Derivative liability
Foreign currency forward contract$46,412 £39,965 2/9/2023$— $(1,712)Derivative liability
$ $(4,211)
Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2022.
DescriptionNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net Amounts
Foreign currency forward contract$43,179 41,444 11/10/2022$2,466 $— Derivative asset
Foreign currency forward contract$45,692 £37,033 11/10/2022$4,323 $— Derivative asset
$6,789 $ 
Certain information related to the Company’s interest rate swap is presented below as of December 31, 2022.
DescriptionNotional AmountMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net Amounts
Interest rate swap$350,000 1/15/2027$— $39,928 Derivative liability
$ $39,928 
Certain information related to the Company’s interest rate swap is presented below as of September 30, 2022.
DescriptionNotional AmountMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net Amounts
Interest rate swap$350,000 1/15/2027$— $41,969 Derivative liability
$ $41,969 



76

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Note 13. Commitments and Contingencies
Off-Balance Sheet Arrangements
The Company may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of its portfolio companies. As of December 31, 2022, the Company's only off-balance sheet arrangements consisted of $198.9 million of unfunded commitments, which was comprised of $171.8 million to provide debt and equity financing to certain of its portfolio companies and $27.1 million to provide financing to the JVs. As of September 30, 2022, the Company's only off-balance sheet arrangements consisted of $224.2 million of unfunded commitments, which was comprised of $175.2 million to provide debt and equity financing to certain of its portfolio companies and $49.0 million to provide financing to the JVs. Such commitments are subject to the portfolio companies' satisfaction of certain financial and nonfinancial covenants and may involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Consolidated Statements of Assets and Liabilities.
77

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




A list of unfunded commitments by investment (consisting of revolvers, term loans with delayed draw components, subordinated notes and LLC equity interests in the JVs, preferred stock and limited partnership interests) as of December 31, 2022 and September 30, 2022 is shown in the table below:
December 31, 2022September 30, 2022
Delta Leasing SPV II LLC$23,004 $27,187 
Fairbridge Strategic Capital Funding LLC15,995 22,150 
OCSI Glick JV LLC13,998 13,998 
Senior Loan Fund JV I, LLC13,125 35,000 
BioXcel Therapeutics, Inc.11,785 11,785 
Dominion Diagnostics, LLC11,148 11,148 
BAART Programs, Inc.7,675 8,645 
iCIMs, Inc.6,930 6,930 
Marinus Pharmaceuticals, Inc.5,734 5,734 
scPharmaceuticals Inc.5,212 — 
Assembled Brands Capital LLC5,035 2,008 
RumbleOn, Inc.4,822 4,822 
MRI Software LLC4,427 5,196 
107 Fair Street LLC4,322 — 
Grove Hotel Parcel Owner, LLC4,293 4,293 
Accupac, Inc.4,197 4,605 
Innocoll Pharmaceuticals Limited4,195 4,195 
Avalara, Inc.4,147 — 
Mindbody, Inc.4,000 4,000 
OTG Management, LLC3,789 3,789 
Mesoblast, Inc.3,553 3,553 
Establishment Labs Holdings Inc.3,384 5,075 
112-126 Van Houten Real22 LLC3,174 — 
ADC Therapeutics SA3,020 3,020 
Spanx, LLC2,762 2,226 
PRGX Global, Inc.2,518 2,518 
SCP Eye Care Services, LLC2,356 — 
Relativity ODA LLC2,218 2,218 
Berner Food & Beverage, LLC2,197 1,392 
Salus Workers' Compensation, LLC2,171 — 
Pluralsight, LLC1,766 3,532 
Tahoe Bidco B.V.1,741 1,741 
CorEvitas, LLC1,526 915 
Coyote Buyer, LLC1,333 1,333 
MHE Intermediate Holdings, LLC1,229 1,429 
Kings Buyer, LLC1,208 1,537 
Liquid Environmental Solutions Corporation1,115 1,115 
Acquia Inc.923 1,326 
Apptio, Inc.892 1,338 
Digital.AI Software Holdings, Inc.826 826 
Telestream Holdings Corporation528 528 
GKD Index Partners, LLC320 320 
PFNY Holdings, LLC275 1,527 
Ardonagh Midco 3 PLC— 4,372 
Dialyze Holdings, LLC— 3,431 
Thrasio, LLC— 2,578 
109 Montgomery Owner LLC— 477 
LSL Holdco, LLC— 427 
Total$198,868 $224,239 

78

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)





Note 14. Subsequent Events
The Company’s management evaluated subsequent events through the date of issuance of the Consolidated Financial Statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in the Consolidated Financial Statements as of and for the three months ended December 31, 2022, except as discussed below.
Distribution Declaration
On January 27, 2023, the Company’s Board of Directors declared a quarterly distribution of $0.55 per share, payable in cash on March 31, 2023 to stockholders of record on March 15, 2023.
Investment Advisory Agreement

On January 23, 2023, in connection with the consummation of the OSI2 Merger, the Company entered into an amended and restated investment advisory agreement with Oaktree to amend and restate the prior investment advisory agreement, dated as of March 19, 2021, by and between the Company and Oaktree to (1) waive an aggregate of $9.0 million of base management fees otherwise payable to the Oaktree in the two years following the closing of the OSI2 Merger and (2) revise the calculation of the incentive fees to eliminate certain unintended consequences of the accounting treatment of the OSI2 Merger on the incentive fees payable to Oaktree. None of the other terms were changed, and the services to be provided by Oaktree and the term of the Investment Advisory Agreement remain the same.
OSI2 Merger

On January 23, 2023, the Company completed the OSI2 Merger. In accordance with the terms of the OSI2 Merger Agreement, at the effective time of the OSI2 Merger, each outstanding share of OSI2 common stock was converted into the right to receive 0.9115 shares of the Company’s common stock (with OSI2’s stockholders receiving cash in lieu of fractional shares of the Company’s common stock). As a result of the OSI2 Merger, the Company issued an aggregate of 15,860,200 shares of its common stock to former OSI2 stockholders. Following completion of the OSI2 Merger, the Company had 77,079,805 shares of common stock outstanding.
OSI2 Citibank Facility

On January 23, 2023, as a result of the consummation of the OSI2 Merger, the Company became party to the OSI2 Citibank Facility (as described below).

OSI 2 Senior Lending SPV, LLC (“OSI 2 SPV”), the Company’s wholly-owned and consolidated subsidiary, is party to a loan and security agreement dated as of July 26, 2019, which was subsequently amended on September 20, 2019, July 2, 2020, December 31, 2020, March 31, 2021 and December 2, 2022 (as amended, the “OSI2 Citibank Loan Agreement”), with the lenders from time to time party thereto and the other parties referenced below. Under the terms of the OSI2 Citibank Loan Agreement, the Company serves as the collateral manager and seller and OSI 2 SPV serves as borrower with Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent.

The OSI2 Citibank Loan Agreement provides for a senior secured revolving credit facility (the “OSI2 Citibank Facility”) of up to $250 million (the “Citibank Maximum Commitment”) in aggregate principal amount, subject to the lesser of (i) the borrowing base, which is an amount based on advance rates that vary depending on the class of assets and the value assigned to such assets under the OSI2 Citibank Loan Agreement and (ii) the Citibank Maximum Commitment. The OSI2 Citibank Facility has a reinvestment period through May 26, 2023, during which advances may be made, and matures on January 26, 2025. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender under the OSI2 Citibank Loan Agreement, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) LIBOR for a three month maturity and (b) for all other lenders under the OSI2 Citibank Facility, LIBOR, plus, in each case, an applicable spread. During the reinvestment period, the applicable spread is the greater of (i) a weighted average rate of (x) 1.65% per year for broadly syndicated loans and (y) 2.25% per year for all other eligible loans and (ii) 1.85%. After the reinvestment period, the applicable spread is 3.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility.
79

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)





The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets.

As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility.

Under the OSI2 Citibank Facility, the Company and OSI 2 SPV, as applicable, have made customary representations and warranties, and are required to comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar credit facilities.

OSI 2 SPV’s borrowings are non-recourse to the Company but are considered borrowings of the Company for purposes of complying with the asset coverage requirements under the Investment Company Act.

As of January 23, 2023, the Company had $225.0 million outstanding under the OSI2 Citibank Facility.
Reverse Stock Split

On January 20, 2023, the Company amended its restated certificate of incorporation, as amended and corrected, to effect a 1-for-3 reverse stock split. Immediately following completion of the reverse stock split, the Company had 61,219,605 shares of common stock outstanding.

80


Schedule 12-14
Oaktree Specialty Lending Corporation
Schedule of Investments in and Advances to Affiliates
(in thousands, except share and per share amounts, percentages and as otherwise indicated)
Three months ended December 31, 2022
(unaudited)
Portfolio Company/Type of Investment (1) Cash Interest RateIndustryPrincipalNet Realized Gain (Loss)Amount of
Interest,
Fees or
Dividends
Credited in
Income (2)
Fair Value
as of October 1,
2022
Gross
Additions (3)
Gross
Reductions (4)
Fair Value
as of December 31, 2022
% of Total Net Assets
Control Investments
C5 Technology Holdings, LLCData Processing & Outsourced Services
829 Common Units$— $— $— $— $— $— — %
34,984,460.37 Preferred Units— — 27,638 — — 27,638 2.3 %
Dominion Diagnostics, LLCHealth Care Services
First Lien Term Loan, LIBOR+5.00% cash due 2/28/20249.73 %$14,297 — 331 14,333 — (36)14,297 1.2 %
First Lien Revolver, LIBOR+5.00% cash due 2/28/2024— — 14 — — — — — %
30,030.8 Common Units in DD Healthcare Services Holdings, LLC— — 4,946 — (719)4,227 0.4 %
OCSI Glick JV LLC (5)Multi-Sector Holdings
Subordinated Debt, LIBOR+4.50% cash due 10/20/20287.67 %59,049 — 1,624 50,283 380 (1,127)49,536 4.1 %
87.5% equity interest— — — — — — — %
Senior Loan Fund JV I, LLC (6)Multi-Sector Holdings
Subordinated Debt, LIBOR+7.00% cash due 12/29/202810.17 %112,656 — 2,611 96,250 16,406 — 112,656 9.4 %
87.5% LLC equity interest— 1,050 20,715 5,469 (2,076)24,108 2.0 %
Total Control Investments$186,002 $ $5,630 $214,165 $22,255 $(3,958)$232,462 19.3 %
Affiliate Investments
Assembled Brands Capital LLCSpecialized Finance
First Lien Revolver, LIBOR+6.75% cash due 10/17/202311.48 %$21,464 $— $646 $24,225 $55 $(3,028)$21,252 1.8 %
1,609,201 Class A Units— — 370 — (16)354 — %
1,019,168.80 Preferred Units, 6%— — 1,223 20 — 1,243 0.1 %
70,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029— — — — — — — %
Caregiver Services, Inc.Health Care Services
1,080,399 shares of Series A Preferred Stock, 10%— — — 378 — (54)324 — %
Total Affiliate Investments$21,464 $ $646 $26,196 $75 $(3,098)$23,173 1.9 %
Total Control & Affiliate Investments$207,466 $ $6,276 $240,361 $22,330 $(7,056)$255,635 21.2 %

This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements.
______________________
(1)The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments.
(2)Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories.
(3)Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category.
(4)Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category.
81


(5)Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required).
(6)Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required).



82


Schedule 12-14
Oaktree Specialty Lending Corporation
Schedule of Investments in and Advances to Affiliates
(in thousands, except share and per share amounts, percentages and as otherwise indicated)
Three months ended December 31, 2021
(unaudited)
Portfolio Company/Type of Investment (1) Cash Interest RateIndustryPrincipalNet Realized Gain (Loss)Amount of
Interest,
Fees or
Dividends
Credited in
Income (2)
Fair Value
as of October 1,
2021
Gross
Additions (3)
Gross
Reductions (4)
Fair Value
as of December 31, 2021
% of Total Net Assets
Control Investments
C5 Technology Holdings, LLCData Processing & Outsourced Services
829 Common Units$— $— $— $— $— $— — %
34,984,460.37 Preferred Units— — 27,638 — — 27,638 2.1 %
Dominion Diagnostics, LLCHealth Care Services
First Lien Term Loan, LIBOR+5.00% cash due 2/28/20246.00 %$23,201 — 430 27,381 — (4,180)23,201 1.8 %
First Lien Revolver, LIBOR+5.00% cash due 2/28/2024— — 14 — — — — — %
30,030.8 Common Units in DD Healthcare Services Holdings, LLC— 3,308 18,065 — — 18,065 1.4 %
First Star Speir Aviation Limited (5)Airlines
First Lien Term Loan, 9.00% cash due 12/15/2025— 7,500 — 7,500 — (7,500)— — %
100% equity interest(5,632)158 698 — (698)— — %
OCSI Glick JV LLC (6)Multi-Sector Holdings
Subordinated Debt, LIBOR+4.50% cash due 10/20/20284.58 %61,237 — 1,081 55,582 745 (473)55,854 4.2 %
87.5% equity interest— — — — — — — %
Senior Loan Fund JV I, LLC (7)Multi-Sector Holdings
Subordinated Debt, LIBOR+7.00% cash due 12/29/20288.00 %96,250 — 1,967 96,250 — — 96,250 7.3 %
87.5% LLC equity interest— 451 37,651 810 — 38,461 2.9 %
Total Control Investments$180,688 $1,868 $7,409 $270,765 $1,555 $(12,851)$259,469 19.6 %
Affiliate Investments
Assembled Brands Capital LLCSpecialized Finance
First Lien Revolver, LIBOR+6.75% cash due 10/17/20237.75 %$15,982 $— $339 $15,712 $3,499 $(3,487)$15,724 1.2 %
1,609,201 Class A Units— — 587 — (201)386 — %
1,019,168.80 Preferred Units, 6%— — 1,152 20 — 1,172 0.1 %
70,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029— — — — — — — %
Caregiver Services, Inc.Health Care Services
1,080,399 shares of Series A Preferred Stock, 10%— — — 838 — — 838 0.1 %
Total Affiliate Investments$15,982 $ $339 $18,289 $3,519 $(3,688)$18,120 1.4 %
Total Control & Affiliate Investments$196,670 $1,868 $7,748 $289,054 $5,074 $(16,539)$277,589 21.0 %

This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements.
______________________
(1)The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments included in the Company's quarterly report on Form 10-Q for the quarter ended December 31, 2021.
(2)Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories.
(3)Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category.
83


(4)Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category.
(5)First Star Speir Aviation Limited is a wholly-owned holding company formed by the Company in order to facilitate its investment strategy. In accordance with ASU 2013-08, the Company has deemed the holding company to be an investment company under GAAP and therefore deemed it appropriate to consolidate the financial results and financial position of the holding company and to recognize dividend income versus a combination of interest income and dividend income. Accordingly, the debt and equity investments in the wholly-owned holding company are disregarded for accounting purposes since the economic substance of these instruments are equity investments in the operating entities.
(6)Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required).
(7)Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required).




84


Item 2.     Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion should be read in connection with our Consolidated Financial Statements and the notes thereto included elsewhere in this quarterly report on Form 10-Q.
Some of the statements in this quarterly report on Form 10-Q constitute forward-looking statements because they relate to future events or our future performance or financial condition. The forward-looking statements contained in this quarterly report on Form 10-Q may include statements as to:

our future operating results and distribution projections;
the ability of Oaktree Fund Advisors, LLC, or Oaktree, to reposition our portfolio and to implement Oaktree's future plans with respect to our business;
the ability of Oaktree and its affiliates to attract and retain highly talented professionals;
our business prospects and the prospects of our portfolio companies;
the impact of the investments that we expect to make;
the ability of our portfolio companies to achieve their objectives;
our expected financings and investments and additional leverage we may seek to incur in the future;
the adequacy of our cash resources and working capital;
the timing of cash flows, if any, from the operations of our portfolio companies; and
the cost or potential outcome of any litigation to which we may be a party.
In addition, words such as “anticipate,” “believe,” “expect,” “seek,” “plan,” “should,” “estimate,” “project” and “intend” indicate forward-looking statements, although not all forward-looking statements include these words. The forward-looking statements contained in this quarterly report on Form 10-Q involve risks and uncertainties. Our actual results could differ materially from those implied or expressed in the forward-looking statements for any reason, including the factors set forth in “Item 1A. Risk Factors” in our annual report on Form 10-K for the year ended September 30, 2022 and elsewhere in this quarterly report on Form 10-Q.
Other factors that could cause actual results to differ materially include:
changes or potential disruptions in our operations, the economy, financial markets or political environment, including the impacts of inflation and rising interest rates;
risks associated with possible disruption in our operations or the economy generally due to terrorism, war or other geopolitical conflict (including the current conflict between Russia and Ukraine), natural disasters or pandemics;
future changes in laws or regulations (including the interpretation of these laws and regulations by regulatory authorities) and conditions in our operating areas, particularly with respect to Business Development Companies or, regulated investment companies, or RICs;
the ability to realize the benefits of the OSI2 Merger (as defined below); and
other considerations that may be disclosed from time to time in our publicly disseminated documents and filings.
We have based the forward-looking statements included in this quarterly report on Form 10-Q on information available to us on the date of this quarterly report, and we assume no obligation to update any such forward-looking statements. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the Securities and Exchange Commission, or the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.
All dollar amounts in tables are in thousands, except share and per share amounts and as otherwise indicated.
Business Overview
We are a specialty finance company dedicated to providing customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. We are a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a Business Development Company under the Investment Company Act of 1940, as amended, or the Investment Company Act. In addition, we have qualified and elected to be treated as a RIC under the Internal Revenue Code of 1986, as amended, or the Code, for U.S. federal income tax purposes.
We are externally managed by Oaktree pursuant to an investment advisory agreement, as amended from time to time, or the Investment Advisory Agreement. Oaktree Fund Administration, LLC, or Oaktree Administrator, an affiliate of Oaktree, provides certain administrative and other services necessary for us to operate pursuant to an administration agreement, as amended from time to time, or the Administration Agreement.
85


Our investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. We may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. Our portfolio may also include certain structured finance and other non-traditional structures. We invest in companies that typically possess resilient business models with strong underlying fundamentals. We intend to deploy capital across credit and economic cycles with a focus on long-term results, which we believe will enable us to build lasting partnerships with financial sponsors and management teams, and we may seek to opportunistically take advantage of dislocations in the financial markets and other situations that may benefit from Oaktree’s credit and structuring expertise. Sponsors may include financial sponsors, such as an institutional investor or a private equity firm, or a strategic entity seeking to invest in a portfolio company. Oaktree is generally focused on middle-market companies, which we define as companies with enterprise values of between $100 million and $750 million. We generally invest in securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Below investment grade securities, which are often referred to as “high yield” and “junk,” have predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal.
In the current market environment, Oaktree intends to focus on the following area, in which Oaktree believes there is less competition and thus potential for greater returns, for our new investment opportunities: (1) situational lending, which we define to include directly originated loans to non-sponsor companies that are hard to understand and value using traditional underwriting techniques, (2) select sponsor lending, which we define to include financing to support leveraged buyouts of companies with specialized sponsors that have expertise in certain industries, and (3) stressed sector and rescue lending, which we define to include opportunistic private loans in industries experiencing stress or limited access to capital.
Oaktree intends to continue to rotate our portfolio into investments that are better aligned with Oaktree's overall approach to credit investing and that it believes have the potential to generate attractive returns across market cycles (which we call "core investments"). Oaktree has performed a comprehensive review of our portfolio and categorized our portfolio into core investments, non-core performing investments and underperforming investments. Certain additional information on such categorization and our portfolio composition is included in investor presentations that we file with the SEC. Since an Oaktree affiliate became our investment adviser in October 2017, Oaktree and its affiliates have reduced the investments identified as non-core by approximately $800 million at fair value. Over time, Oaktree intends to rotate us out of the remaining non-core investments, which were approximately $71 million at fair value as of December 31, 2022. Oaktree periodically reviews designations of investments as core and non-core and may change such designations over time.

On March 19, 2021, we acquired Oaktree Strategic Income Corporation, or OCSI, pursuant to an agreement and plan or merger, or the OCSI Merger Agreement, dated as of October 28, 2020, by and among OCSI, us, Lion Merger Sub, Inc., our wholly-owned subsidiary, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OCSI Merger Agreement, OCSI was merged with and into us in a two-step transaction with us as the surviving company, or the OCSI Merger.

On January 23, 2023, we acquired Oaktree Strategic Income II, Inc., or OSI2, pursuant to that certain Agreement and Plan of Merger, or the OSI2 Merger Agreement, dated as of September 14, 2022, by and among OSI2, us, Project Superior Merger Sub, Inc., a wholly-owned subsidiary of us, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OSI2 Merger Agreement, OSI2 was merged with and into us in a two-step transaction with us as the surviving company, or the OSI2 Merger.
Business Environment and Developments

Global financial markets have experienced an increase in volatility as concerns about the impact of higher inflation, rising interest rates, a potential recession and the current conflict in Ukraine have weighed on market participants. These factors have created disruptions in supply chains and economic activity and have had a particularly adverse impact on certain companies in the energy, raw materials and transportation sectors, among others. These uncertainties can ultimately impact the overall supply and demand of the market through changing spreads, deal terms and structures and equity purchase price multiples.

We are unable to predict the full effects of these macroeconomic events or how long any further market disruptions or volatility might last. We continue to closely monitor the impact these events have on our business, industry and portfolio companies and will provide constructive solutions where necessary.

Against this uncertain macroeconomic backdrop, we believe attractive risk-adjusted returns can be achieved by making loans to middle market companies that typically possess resilient business models with strong underlying fundamentals. Given the breadth of the investment platform and decades of credit investing experience of Oaktree and its affiliates, we believe that we have the resources and experience to source, diligence and structure investments in these companies and are well placed to generate attractive returns for investors.
86


As of December 31, 2022, 87.3% of our debt investment portfolio (at fair value) and 87.2% of our debt investment portfolio (at cost) bore interest at floating rates. Most of our floating rate loans are indexed to the London Interbank Offered Rate, or LIBOR, and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly or monthly at the borrower’s option. Certain loans may also be indexed to the Secured Overnight Financing Rate, or SOFR, or the Sterling Overnight Index Average, or SONIA. Most U.S. dollar LIBOR rates will continue to be published through June 30, 2023. The FCA no longer compels panel banks to continue to contribute to LIBOR and the Federal Reserve Board, the Office of the Comptroller of the Currency, and the Federal Deposit Insurance Corporation have encouraged banks to cease entering into new contracts that use U.S. dollar LIBOR as a reference rate. The U.S. Federal Reserve, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions, supports replacing U.S.-dollar LIBOR with SOFR. Although there are an increasing number of issuances utilizing SOFR or SONIA, these alternative reference rates may not attain market acceptance as replacements for LIBOR. In anticipation of the cessation of LIBOR, we may need to renegotiate any credit agreements extending beyond the applicable phase out date with our prospective portfolio companies that utilize LIBOR as a factor in determining the interest rate. Certain of the loan agreements with our portfolio companies have included fallback language in the event that LIBOR becomes unavailable. This language generally provides that the administrative agent may identify a replacement reference rate, typically with the consent of (or prior consultation with) the borrower. In certain cases, the administrative agent will be required to obtain the consent of either a majority of the lenders under the facility, or the consent of each lender, prior to identifying a replacement reference rate. Certain of the loan agreements with our portfolio companies do not include any fallback language providing a mechanism for the parties to negotiate a new reference interest rate and will instead revert to the base rate in the event LIBOR ceases to exist.

Critical Accounting Estimates
Investment Valuation
We value our investments in accordance with Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 820, Fair Value Measurements and Disclosures, or ASC 820, which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability’s fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments’ complexity.
Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows:
Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date.
Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities.
Level 3 — Unobservable inputs that reflect Oaktree’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.
If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. Oaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions.
Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of our investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations.
Oaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If Oaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within our set threshold, Oaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the
87


quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, Oaktree does not adjust any of the prices received from these sources.
If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, Oaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value, or EV, of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that we are deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company’s assets and (vii) offers from third parties to buy the portfolio company. Oaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. Under the EV technique, the significant unobservable input used in the fair value measurement of our investments in debt or equity securities is the EBITDA, revenue or asset multiple, as applicable. Increases or decreases in the valuation multiples in isolation may result in a higher or lower fair value measurement, respectively. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and we consider the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by us are substantially illiquid with no active transaction market, Oaktree depends on primary market data, including newly funded transactions and industry-specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. Under the market yield technique, the significant unobservable input used in the fair value measurement of our investments in debt securities is the market yield. Increases or decreases in the market yield may result in a lower or higher fair value measurement, respectively.
In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable.
Oaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk-free rate. Changes in the subjective input assumptions can materially affect the fair value estimates.
The fair value of our investments as of December 31, 2022 and September 30, 2022 was determined by Oaktree, as our valuation designee. We have and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of our portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter. As of December 31, 2022, 92.1% of our portfolio at fair value was valued either based on market quotations, the transactions precedent approach or corroborated by independent valuation firms.
Certain factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s earnings and its ability to make payments on its indebtedness, the markets in which the portfolio company does business, comparison to comparable publicly-traded companies, discounted cash flow and other relevant factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, may fluctuate over short periods of time and may be based on estimates, our determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed. Due to these uncertainties, Oaktree's fair value determinations may cause our net asset value on a given date to materially understate or overstate the value that we may ultimately realize upon the sale of one or more of our investments.
88


As of December 31, 2022, we held $2,642.9 million of investments at fair value, up from $2,494.1 million held at September 30, 2022, primarily driven by new originations outpacing the rate of repayments. As of December 31, 2022 and September 30, 2022, approximately 95.5% and 94.2%, respectively, of our total assets represented investments at fair value.
Revenue Recognition
Interest Income
Interest income, adjusted for accretion of original issue discount, or OID, is recorded on an accrual basis to the extent that such amounts are expected to be collected. We stop accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash, and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of each of December 31, 2022 and September 30, 2022, there were no investments on non-accrual status.
In connection with our investment in a portfolio company, we sometimes receive nominal cost equity that is valued as part of the negotiation process with the portfolio company. When we receive nominal cost equity, we allocate our cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan.
PIK Interest Income
Our investments in debt securities may contain payment-in-kind, or PIK, interest provisions. PIK interest, which typically represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We generally cease accruing PIK interest if there is insufficient value to support the accrual or if we do not expect the portfolio company to be able to pay all principal and interest due. Our decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; our assessment of the portfolio company's business development success; information obtained by us in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. Our determination to cease accruing PIK interest is generally made well before our full write-down of a loan or debt security. In addition, if it is subsequently determined that we will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on our debt investments increases the recorded cost bases of these investments in our Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by us to Oaktree. To maintain our status as a RIC, certain income from PIK interest may be required to be distributed to our stockholders, even though we have not yet collected the cash and may never do so.
Portfolio Composition
Our investments principally consist of loans, common and preferred equity and warrants in privately-held companies, Senior Loan Fund JV I, LLC, or SLF JV I, a joint venture through which we and Trinity Universal Insurance Company, a subsidiary of Kemper Corporation, or Kemper, co-invest in senior secured loans of middle-market companies and other corporate debt securities, and OCSI Glick JV LLC, or the Glick JV, a joint venture through which we and GF Equity Funding 2014 LLC, or GF Equity Funding, co-invest primarily in senior secured loans of middle-market companies. We refer to SLF JV I and the Glick JV collectively as the JVs. Our loans are typically secured by a first, second or subordinated lien on the assets of the portfolio company and generally have terms of up to ten years (but an expected average life of between three and four years).
During the three months ended December 31, 2022, we originated $250.3 million of investment commitments in 18 new and seven existing portfolio companies and funded $274.4 million of investments.
During the three months ended December 31, 2022, we received $104.4 million of proceeds from prepayments, exits, other paydowns and sales and exited 11 portfolio companies.
89


A summary of the composition of our investment portfolio at cost and fair value as a percentage of total investments is shown in the following tables:
December 31, 2022September 30, 2022
Cost:
Senior secured debt84.94 %85.08 %
Debt investments in the JVs5.85 5.59 
Preferred equity3.16 3.26 
Subordinated debt2.48 2.57 
LLC equity interests of the JVs1.97 1.88 
Common equity and warrants1.60 1.62 
Total100.00 %100.00 %
December 31, 2022September 30, 2022
Fair value:
Senior secured debt86.32 %86.86 %
Debt investments in the JVs6.14 5.88 
Preferred equity3.05 3.19 
Subordinated debt2.35 2.28 
Common equity and warrants1.23 0.96 
LLC equity interests of the JVs0.91 0.83 
Total100.00 %100.00 %

90


The industry composition of our portfolio at cost and fair value as a percentage of total investments was as follows:
December 31, 2022September 30, 2022
Cost:
Application Software15.66 %14.98 %
Multi-Sector Holdings (1)8.27 7.48 
Pharmaceuticals4.73 4.83 
Data Processing & Outsourced Services4.25 4.60 
Biotechnology4.02 4.20 
Health Care Technology3.97 3.82 
Specialized Finance3.15 3.09 
Industrial Machinery2.93 3.12 
Health Care Services2.37 2.24 
Internet & Direct Marketing Retail2.36 2.59 
Aerospace & Defense2.23 2.37 
Construction & Engineering2.19 2.33 
Health Care Distributors2.10 2.18 
Other Diversified Financial Services2.06 1.12 
Personal Products1.91 2.03 
Automotive Retail1.86 2.26 
Auto Parts & Equipment1.84 0.48 
Real Estate Operating Companies1.80 1.82 
Fertilizers & Agricultural Chemicals1.77 1.88 
Internet Services & Infrastructure1.77 2.07 
Metal & Glass Containers1.70 1.82 
Home Improvement Retail1.63 1.75 
Soft Drinks1.58 1.31 
Airport Services1.57 1.65 
Leisure Facilities1.48 1.52 
Insurance Brokers1.41 1.36 
Diversified Support Services1.37 1.45 
Specialty Chemicals1.34 1.43 
Health Care Supplies1.32 1.39 
Real Estate Services1.30 1.54 
Integrated Telecommunication Services1.25 1.32 
Electrical Components & Equipment1.22 1.29 
Advertising0.99 1.08 
Movies & Entertainment0.94 1.00 
Distributors0.91 0.97 
Airlines0.87 — 
Health Care Equipment0.79 0.93 
Environmental & Facilities Services0.76 0.80 
Oil & Gas Storage & Transportation0.72 0.85 
Home Furnishings0.70 0.75 
Systems Software0.54 0.57 
Consumer Finance0.52 0.55 
Hotels, Resorts & Cruise Lines0.50 0.53 
IT Consulting & Other Services0.42 0.45 
Restaurants0.34 0.36 
Education Services0.33 0.35 
Cable & Satellite0.29 0.79 
Research & Consulting Services0.28 0.35 
Apparel, Accessories & Luxury Goods0.19 0.20 
Air Freight & Logistics0.18 0.28 
Integrated Oil & Gas0.18 0.19 
Apparel Retail0.17 0.20 
Food Distributors0.17 0.18 
Specialized REITs0.16 0.16 
Real Estate Development0.15 — 
Diversified Banks0.13 0.13 
Technology Distributors0.11 0.12 
Construction Materials0.08 0.09 
Housewares & Specialties0.08 0.09 
Electronic Components0.08 0.08 
Alternative Carriers0.01 0.01 
Oil & Gas Refining & Marketing— 0.33 
Trading Companies & Distributors— 0.29 
Total100.00 %100.00 %
91


December 31, 2022September 30, 2022
Fair value:
Application Software15.95 %15.43 %
Multi-Sector Holdings (1)7.53 6.71 
Pharmaceuticals4.82 4.79 
Biotechnology4.37 4.35 
Data Processing & Outsourced Services4.02 4.46 
Health Care Technology3.92 3.90 
Industrial Machinery3.02 3.25 
Specialized Finance3.02 2.93 
Internet & Direct Marketing Retail2.50 2.82 
Aerospace & Defense2.33 2.48 
Construction & Engineering2.31 2.45 
Health Care Distributors2.08 2.19 
Other Diversified Financial Services2.05 0.98 
Fertilizers & Agricultural Chemicals1.98 2.08 
Health Care Services1.94 1.84 
Automotive Retail1.92 2.31 
Real Estate Operating Companies1.90 1.93 
Auto Parts & Equipment1.89 0.46 
Internet Services & Infrastructure1.85 2.16 
Personal Products1.85 2.01 
Home Improvement Retail1.71 1.82 
Metal & Glass Containers1.69 1.91 
Soft Drinks1.68 1.35 
Airport Services1.64 1.72 
Leisure Facilities1.54 1.57 
Insurance Brokers1.48 1.33 
Health Care Supplies1.43 1.47 
Diversified Support Services1.35 1.47 
Real Estate Services1.35 1.59 
Electrical Components & Equipment1.25 1.32 
Integrated Telecommunication Services1.21 1.29 
Specialty Chemicals1.19 1.36 
Movies & Entertainment1.00 1.07 
Advertising0.98 1.08 
Airlines0.98 — 
Distributors0.93 0.98 
Health Care Equipment0.86 0.97 
Environmental & Facilities Services0.78 0.83 
Oil & Gas Storage & Transportation0.69 0.84 
Home Furnishings0.68 0.73 
Hotels, Resorts & Cruise Lines0.53 0.56 
Systems Software0.46 0.51 
Consumer Finance0.43 0.53 
Education Services0.34 0.34 
Restaurants0.33 0.35 
Cable & Satellite0.30 0.78 
Research & Consulting Services0.27 0.34 
IT Consulting & Other Services0.26 0.34 
Integrated Oil & Gas0.18 0.20 
Apparel Retail0.18 0.21 
Real Estate Development0.16 — 
Air Freight & Logistics0.16 0.26 
Food Distributors0.14 0.13 
Diversified Banks0.13 0.14 
Specialized REITs0.12 0.13 
Technology Distributors0.11 0.12 
Housewares & Specialties0.09 0.10 
Construction Materials0.07 0.08 
Electronic Components0.06 0.08 
Alternative Carriers0.01 0.01 
Oil & Gas Refining & Marketing— 0.34 
Trading Companies & Distributors— 0.22 
Total100.00 %100.00 %
___________________
(1)This industry includes our investments in the JVs.

92



The Joint Ventures

Senior Loan Fund JV I, LLC

In May 2014, we entered into a limited liability company, or LLC, agreement with Kemper to form SLF JV I. We co-invest in senior secured loans of middle-market companies and other corporate debt securities with Kemper through our investment in SLF JV I. SLF JV I is managed by a four person Board of Directors, two of whom are selected by us and two of whom are selected by Kemper. All portfolio decisions and investment decisions in respect of SLF JV I must be approved by the SLF JV I investment committee, which consists of one representative selected by us and one representative selected by Kemper (with approval from a representative of each required). Since we do not have a controlling financial interest in SLF JV I, we do not consolidate SLF JV I. SLF JV I is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act. SLF JV I is capitalized pro rata with LLC equity interests as transactions are completed and may be capitalized with additional subordinated notes issued to us and Kemper by SLF JV I. The subordinated notes issued by SLF JV I are referred to as the SLF JV I Notes. The SLF JV I Notes are senior in right of payment to SLF JV I LLC equity interests and subordinated in right of payment to SLF JV I’s secured debt.
As of December 31, 2022 and September 30, 2022, we and Kemper owned, in the aggregate, 87.5% and 12.5%, respectively, of the LLC equity interests of SLF JV I and the outstanding SLF JV I Notes. As of December 31, 2022, we and Kemper had funded approximately $190.5 million to SLF JV I, of which $166.7 million was from us. As of September 30, 2022, we and Kemper had funded approximately $165.5 million to SLF JV I, of which $144.8 million was from us. As of December 31, 2022, we had aggregate commitments to fund SLF JV I of $13.1 million, of which approximately $9.8 million was to fund additional SLF JV I Notes and approximately $3.3 million was to fund LLC equity interests in SLF JV I. During the three months ended December 31, 2022, we contributed $16.4 million to fund additional SLF JV I Notes and approximately $5.5 million to fund additional LLC equity interests in SLF JV I. As of September 30, 2022, we had aggregate commitments to fund SLF JV I of $35.0 million, of which approximately $26.2 million was to fund additional SLF JV I Notes and approximately $8.8 million was to fund LLC equity interests in SLF JV I.
Both the cost and fair value of our SLF JV I Notes were $112.7 million as of December 31, 2022. Both the cost and fair value of our SLF JV I Notes were $96.3 million as of September 30, 2022. We earned interest income of $2.6 million and $2.0 million on the SLF JV I Notes for the three months ended December 31, 2022 and 2021, respectively. As of December 31, 2022, the SLF JV I Notes bore interest at a rate of one-month LIBOR plus 7.00% per annum with a LIBOR floor of 1.00% and will mature on December 29, 2028.
The cost and fair value of the LLC equity interests in SLF JV I held by us was $54.8 million and $24.1 million, respectively, as of December 31, 2022, and $49.3 million and $20.7 million, respectively, as of September 30, 2022. We earned $1.1 million and $0.5 million in dividend income for the three months ended December 31, 2022 and December 31, 2021, respectively, with respect to our investment in the LLC equity interests of SLF JV I.
Below is a summary of SLF JV I's portfolio as of December 31, 2022 and September 30, 2022:
December 31, 2022September 30, 2022
Senior secured loans (1)$382,148$383,194
Weighted average interest rate on senior secured loans (2)9.55%8.33%
Number of borrowers in SLF JV I5960
Largest exposure to a single borrower (1)$11,337$10,093
Total of five largest loan exposures to borrowers (1)$51,990$48,139
__________________
(1) At principal amount.
(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.

See "Note 3. Portfolio Investments" in the notes to the accompanying financial statements for more information on SLF JV I and its portfolio.
93


OCSI Glick JV LLC
On March 19, 2021, we became party to the LLC agreement of the Glick JV. The Glick JV invests primarily in senior secured loans of middle-market companies. We co-invest in these securities with GF Equity Funding through the Glick JV. The Glick JV is managed by a four person Board of Directors, two of whom are selected by us and two of whom are selected by GF Equity Funding. All portfolio decisions and investment decisions in respect of the Glick JV must be approved by the Glick JV investment committee, consisting of one representative selected by us and one representative selected by GF Equity Funding (with approval from a representative of each required). Since we do not have a controlling financial interest in the Glick JV, we do not consolidate the Glick JV. The Glick JV is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act. The Glick JV is capitalized as transactions are completed. The members provide capital to the Glick JV in exchange for LLC equity interests, and we and GF Debt Funding, an entity advised by affiliates of GF Equity Funding, provide capital to the Glick JV in exchange for subordinated notes issued by the Glick JV, or the Glick JV Notes. The Glick JV Notes are junior in right of payment to the repayment of temporary contributions made by us to fund investments of the Glick JV that are repaid when GF Equity Funding and GF Debt Funding make their capital contributions and fund their Glick JV Notes, respectively.
As of December 31, 2022 and September 30, 2022, we and GF Equity Funding owned 87.5% and 12.5%, respectively, of the outstanding LLC equity interests, and we and GF Debt Funding owned 87.5% and 12.5%, respectively, of the Glick JV Notes. Approximately $84.0 million in aggregate commitments was funded as of each of December 31, 2022 and September 30, 2022, of which $73.5 million was from us. As of December 31, 2022 and September 30, 2022, we had commitments to fund Glick JV Notes of $78.8 million, of which $12.4 million was unfunded. As of each of December 31, 2022 and September 30, 2022, we had commitments to fund LLC equity interests in the Glick JV of $8.7 million, of which $1.6 million was unfunded.

The cost and fair value of our aggregate investment in the Glick JV was $50.0 million and $49.5 million, respectively, as of December 31, 2022. The cost and fair value of our aggregate investment in the Glick JV was $50.2 million and $50.3 million, respectively, as of September 30, 2022. For the three months ended December 31, 2022 and December 31, 2021, our investment in the Glick JV Notes earned interest income of $1.6 million and $1.1 million, respectively. We did not earn any dividend income for the three months ended December 31, 2022 and December 31, 2021 with respect to our investment in the LLC equity interests of the Glick JV.
Below is a summary of the Glick JV's portfolio as of December 31, 2022 and September 30, 2022:
December 31, 2022September 30, 2022
Senior secured loans (1)$134,080$143,225
Weighted average current interest rate on senior secured loans (2)9.86%8.52%
Number of borrowers in the Glick JV4043
Largest loan exposure to a single borrower (1)$7,476$6,562
Total of five largest loan exposures to borrowers (1)$29,830$28,973
__________
(1) At principal amount.
(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.
See "Note 3. Portfolio Investments" in the notes to the accompanying financial statements for more information on the Glick JV and its portfolio.
94


Discussion and Analysis of Results and Operations
Results of Operations
Net increase (decrease) in net assets resulting from operations includes net investment income, net realized gains (losses) and net unrealized appreciation (depreciation). Net investment income is the difference between our income from interest, dividends and fees and net expenses. Net realized gains (losses) is the difference between the proceeds received from dispositions of investment related assets and liabilities and their stated costs. Net unrealized appreciation (depreciation) is the net change in the fair value of our investment related assets and liabilities carried at fair value during the reporting period, including the reversal of previously recorded unrealized appreciation (depreciation) when gains or losses are realized.
Comparison of three months ended December 31, 2022 and December 31, 2021
Total Investment Income
Total investment income includes interest on our investments, fee income and dividend income.
Total investment income for the three months ended December 31, 2022 and 2021 was $79.2 million and $64.9 million, respectively. For the three months ended December 31, 2022, this amount consisted of $76.1 million of interest income from portfolio investments (which included $6.1 million of PIK interest), $2.0 million of fee income and $1.1 million of dividend income. For the three months ended December 31, 2021, this amount consisted of $60.1 million of interest income from portfolio investments (which included $4.7 million of PIK interest), $0.9 million of fee income and $3.9 million of dividend income. The increase of $14.2 million, or 21.9%, in our total investment income for the three months ended December 31, 2022, as compared to the three months ended December 31, 2021, was due primarily to (1) a $16.0 million increase in interest income, which was primarily driven by the impact of rising reference rates on interest income and (2) a $1.1 million increase in fee income primarily due to higher exit and amendment fees. This was partially offset by a $2.9 million decrease in dividend income.
Expenses
Net expenses (expenses net of fee waivers) for the three months ended December 31, 2022 and 2021 were $40.3 million and $29.3 million, respectively. Net expenses increased for the three months ended December 31, 2022, as compared to the three months ended December 31, 2021, by $11.0 million, or 37.3%, primarily due to (1) a $11.3 million increase in interest expense due to higher borrowings outstanding and the impact of rising reference rates and (2) a $1.2 million increase in Part I incentive fees mainly due to higher total investment income. These were partially offset by $1.8 million of lower accrued Part II incentive fees.
Net Investment Income
Primarily as a result of the $14.2 million increase in total investment income, the $11.0 million increase in net expenses and a $3.3 million decrease in the provision for taxes on net investment income, net investment income for the three months ended December 31, 2022 increased by $6.5 million compared to the three months ended December 31, 2021.
Realized Gain (Loss)
Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption of investments and foreign currency and the cost basis without regard to unrealized appreciation or depreciation previously recognized, and includes investments written-off during the period, net of recoveries. Realized losses may also be recorded in connection with our determination that certain investments are considered worthless securities and/or meet the conditions for loss recognition per the applicable tax rules.
During the three months ended December 31, 2022 and 2021, we recorded aggregate net realized gains (losses) of $(3.2) million and $9.3 million, respectively, in connection with the exits of various investments and foreign currency forward contracts. See “Note 8. Realized Gains or Losses and Net Unrealized Appreciation or Depreciation” in the notes to the accompanying Consolidated Financial Statements for more details regarding investment realization events for the three months ended December 31, 2022 and 2021.
Net Unrealized Appreciation (Depreciation)
Net unrealized appreciation or depreciation is the net change in the fair value of our investments and foreign currency during the reporting period, including the reversal of previously recorded unrealized appreciation or depreciation when gains or losses are realized.
95


During the three months ended December 31, 2022 and 2021, we recorded net unrealized depreciation of $23.0 million and $4.6 million, respectively. For the three months ended December 31, 2022, this consisted of $18.7 million of net unrealized depreciation on debt investments and $11.0 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $3.9 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $2.8 million of net unrealized appreciation on equity investments. For the three months ended December 31, 2021, this consisted of $4.7 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains), $1.8 million of net unrealized depreciation on debt investments and $0.8 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $2.8 million of net unrealized appreciation on equity investments.
Financial Condition, Liquidity and Capital Resources
We have a number of alternatives available to fund our investment portfolio and our operations, including raising equity, increasing or refinancing debt and funding from operational cash flow. We generally expect to fund the growth of our investment portfolio through additional debt and equity capital, which may include securitizing a portion of our investments. We cannot assure you, however, that our efforts to grow our portfolio will be successful. For example, our common stock has generally traded at prices below net asset value for the past several years, and we may not be able to raise additional equity at prices below the then-current net asset value per share. We intend to continue to generate cash primarily from cash flows from operations, including interest earned, and future borrowings or equity offerings. We intend to fund our future distribution obligations through operating cash flow or with funds obtained through future equity and debt offerings or credit facilities, as we deem appropriate.
Our primary uses of funds are investments in our targeted asset classes and cash distributions to holders of our common stock. We may also from time to time repurchase or redeem some or all of our outstanding notes. At a special meeting of our stockholders held on June 28, 2019, our stockholders approved the application of the reduced asset coverage requirements in Section 61(a)(2) of the Investment Company Act to us effective as of June 29, 2019. As a result of the reduced asset coverage requirement, we can incur $2 of debt for each $1 of equity as compared to $1 of debt for each $1 of equity. As of December 31, 2022, we had $1,514.4 million in senior securities and our asset coverage ratio was 176.3%. During the year ended September 30, 2022, we increased our target debt to equity ratio from 0.85x to 1.0x to 0.90x to 1.25x (i.e., one dollar of equity for each $0.90 to $1.25 of debt outstanding) to provide us with increased capacity to opportunistically deploy capital into the markets. As of December 31, 2022, our net debt to equity ratio was 1.24x.
For the three months ended December 31, 2022, we experienced a net decrease in cash and cash equivalents (including restricted cash) of $7.1 million. During that period, net cash used in operating activities was $109.9 million, primarily from funding $261.4 million of investments and $10.0 million of net decrease in payables from unsettled transactions, partially offset by $108.8 million of principal payments and sale proceeds received, the cash activities related to $38.8 million of net investment income and a $16.3 million increase in due from portfolio companies. During the same period, net cash provided by financing activities was $103.3 million, primarily consisting of $160.0 million of net borrowings under the credit facilities, partially offset by $56.7 million of cash distributions paid to our stockholders.
For the three months ended December 31, 2021, we experienced a net increase in cash and cash equivalents (including restricted cash) of $14.4 million. During that period, we received $23.2 million of net cash from operating activities, primarily from $235.0 million of principal payments and sale proceeds received, $15.0 million of net increases in payables from unsettled transactions and the cash activities related to $32.3 million of net investment income, partially offset by funding $246.6 million of investments. During the same period, net cash used by financing activities was $7.5 million, primarily consisting of $27.2 million of cash distributions paid to our stockholders and $0.3 million of deferred financing costs paid, partially offset by $20.0 million of net borrowings under the credit facilities.
As of December 31, 2022, we had $19.2 million in cash and cash equivalents (including $1.9 million of restricted cash), portfolio investments (at fair value) of $2.6 billion, $37.8 million of interest, dividends and fees receivable, $6.2 million of due from portfolio companies, $340.0 million of undrawn capacity on our credit facilities (subject to borrowing base and other limitations), $12.3 million of net payables from unsettled transactions, $860.0 million of borrowings outstanding under our credit facilities and $603.6 million of unsecured notes payable (net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment).
As of September 30, 2022, we had $26.4 million in cash and cash equivalents (including $2.8 million of restricted cash), portfolio investments (at fair value) of $2.5 billion, $35.6 million of interest, dividends and fees receivable, $22.5 million of due from portfolio companies, $500.0 million of undrawn capacity on our credit facilities (subject to borrowing base and other limitations), $22.3 million of net payables from unsettled transactions, $700.0 million of borrowings outstanding under our credit facilities and $601.0 million of unsecured notes payable (net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment).
96


We may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of our portfolio companies. As of December 31, 2022, our only off-balance sheet arrangements consisted of $198.9 million of unfunded commitments, which was comprised of $171.8 million to provide debt and equity financing to certain of our portfolio companies and $27.1 million to provide financing to the JVs. As of September 30, 2022, our only off-balance sheet arrangements consisted of $224.2 million of unfunded commitments, which was comprised of $175.2 million to provide debt and equity financing to certain of our portfolio companies and $49.0 million to provide financing to the JVs.
As of December 31, 2022, we have analyzed cash and cash equivalents, availability under our credit facilities, the ability to rotate out of certain assets and amounts of unfunded commitments that could be drawn and believe our liquidity and capital resources are sufficient to take advantage of market opportunities in the current economic climate.
Contractual Obligations
The following table reflects information pertaining to our principal debt outstanding under the Syndicated Facility (as defined below), Citibank Facility (as defined below), our 3.500% notes due 2025, or the 2025 Notes, and our 2.700% notes due 2027, or the 2027 Notes:
Debt Outstanding
as of September 30, 2022
Debt Outstanding
as of December 31, 2022
Weighted average debt
outstanding for the
three months ended
December 31, 2022
Maximum debt
outstanding for the three months ended
December 31, 2022
Syndicated Facility$540,000 $695,000 $627,826 $710,000 
Citibank Facility160,000 165,000 163,500 175,000 
2025 Notes300,000 300,000 300,000 300,000 
2027 Notes350,000 350,000 350,000 350,000 
Total debt$1,350,000 $1,510,000 $1,441,326 
The following table reflects our contractual obligations arising from the Syndicated Facility, Citibank Facility, 2025 Notes and 2027 Notes:
 Payments due by period as of December 31, 2022
Contractual ObligationsTotalLess than 1 year1-3 years3-5 years
Syndicated Facility$695,000 $— $— $695,000 
Interest due on Syndicated Facility145,376 43,494 86,988 14,894 
Citibank Facility165,000 — 165,000 — 
Interest due on Citibank Facility20,573 10,915 9,658 — 
2025 Notes300,000 — 300,000 — 
Interest due on 2025 Notes22,640 10,500 12,140 — 
2027 Notes350,000 — — 350,000 
Interest due on 2027 Notes (a)81,200 20,080 40,160 20,960 
Total$1,779,789 $84,989 $613,946 $1,080,854 
__________ 
(a) The interest due on the 2027 Notes was calculated net of the interest rate swap.
Equity Issuances
During the three months ended December 31, 2022 and 2021, we issued an aggregate of 94,879 and 35,990, respectively, shares of common stock as part of the DRIP.
On February 7, 2022, we entered into an equity distribution agreement by and among us, Oaktree, Oaktree Administrator and Keefe, Bruyette & Woods, Inc., JMP Securities LLC, Raymond James & Associates, Inc. and SMBC Nikko Securities America, Inc., as placement agents, in connection with the issuance and sale by us of shares of common stock, having an aggregate offering price of up to $125.0 million. Sales of the common stock, if any, may be made in negotiated transactions or transactions that are deemed to be “at the market,” as defined in Rule 415 under the Securities Act of 1933, as amended, including sales made directly on the Nasdaq Global Select Market or similar securities exchanges or sales made to or through a market maker other than on an exchange, at prices related to the prevailing market prices or at negotiated prices.
97


In connection with the "at the market" offering, we did not issue or sell any shares of common stock during the three months ended December 31, 2022.
Distributions
The following table reflects the distributions per share that we have paid, including shares issued under our DRIP, on our common stock since October 1, 2020. The distributions per share and shares issued under our DRIP information disclosed in this table has been retrospectively adjusted to reflect our 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
DistributionDate DeclaredRecord DatePayment DateAmount
per Share
Cash
Distribution
DRIP Shares
Issued (1)
DRIP Shares
Value
QuarterlyNovember 13, 2020December 15, 2020December 31, 2020$0.33 $ 15.0 million31,321 $ 0.5 million
QuarterlyJanuary 29, 2021March 15, 2021March 31, 20210.36 16.4 million27,234 0.5 million
QuarterlyApril 30, 2021June 15, 2021June 30, 20210.39 22.9 million25,660 0.5 million
QuarterlyJuly 30, 2021September 15, 2021September 30, 20210.435 25.5 million28,358 0.6 million
QuarterlyOctober 13, 2021December 15, 2021December 31, 20210.465 27.2 million35,990 0.8 million
QuarterlyJanuary 28, 2022March 15, 2022March 31, 20220.48 28.5 million34,804 0.8 million
QuarterlyApril 29, 2022June 15, 2022June 30, 20220.495 29.4 million43,676 0.9 million
QuarterlyJuly 29, 2022September 15, 2022September 30, 20220.51 30.2 million51,181 1.0 million
QuarterlyNovember 10, 2022December 15, 2022December 30, 20220.54 32.0 million53,369 1.1 million
SpecialNovember 10, 2022December 15, 2022December 30, 20220.42 24.8 million41,510 0.8 million
 ______________
(1)Shares were purchased on the open market and distributed other than with respect to the distributions paid on December 31, 2021, March 31, 2022 and December 30, 2022. New shares were issued and distributed during the quarters ended December 31, 2021, March 31, 2022 and December 31, 2022.


Indebtedness
See “Note 6. Borrowings” in the Consolidated Financial Statements for more details regarding our indebtedness.
Syndicated Facility

As of December 31, 2022, (i) the size of our senior secured revolving credit facility, or, as amended and/or restated from time to time, the Syndicated Facility, pursuant to a senior secured revolving credit agreement, with the lenders, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A. as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents, was $1.0 billion (with an “accordion” feature that permits us, under certain circumstances, to increase the size of the facility to up to the greater of $1.25 billion and our net worth (as defined in the Syndicated Facility) on the date of such increase), (ii) the period during which we may make drawings will expire on May 4, 2025 and the maturity date was May 4, 2026 and (iii) the interest rate margin for (a) LIBOR loans (which may be 1-, 2-, 3- or 6-month, at our option) was 2.00% and (b) alternate base rate loans was 1.00%.


Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions. Borrowings under the Syndicated Facility are subject to the facility’s various covenants and the leverage restrictions contained in the Investment Company Act. We cannot assure you that we will be able to borrow funds under the Syndicated Facility at any particular time or at all.
98


The following table describes significant financial covenants, as of December 31, 2021,2022, with which we must comply under the Syndicated Facility on a quarterly basis:
Financial CovenantDescriptionTarget ValueSeptember 30, 20212022 Reported Value (1)
Minimum shareholders' equityNet assets shall not be less than the sum of (x) $600 million, plus (y) 50% of the aggregate net proceeds of all sales of equity interests after May 6, 2020

$600610 million$1,3131,246 million
Asset coverage ratioAsset coverage ratio shall not be less than the greater of 1.50:1 and the statutory test applicable to us1.50:12.02:1.89:1
Interest coverage ratioInterest coverage ratio shall not be less than 2.25:12.25:14.13:4.01:1
Minimum net worthNet worth shall not be less than $550 million$550 million$1,1521,034 million
 ___________ 
(1) As contractually required, we report financial covenants based on the last filed quarterly or annual report, in this case our Annual Report on Form 10-K for the year ended September 30, 2021.2022. We were in compliance with all financial covenants under the Syndicated Facility based on the financial information contained in this Quarterly Report on Form 10-Q.

As of each of December 31, 20212022 and September 30, 2021,2022, we had $495.0$695.0 million and $540.0 million of borrowings outstanding under the Syndicated Facility, respectively, which had a fair value of $495.0 million.$695.0 million and $540.0 million, respectively. Our borrowings under the Syndicated Facility bore interest at a
94


weighted average interest rate of 2.174%5.849% and 2.323%2.174% for the three months ended December 31, 20212022 and 2020,2021, respectively. For the three months ended December 31, 20212022 and 2020,2021, we recorded interest expense (inclusive of fees) of $3.8$10.0 million and $3.2$3.8 million, respectively, related to the Syndicated Facility.
Citibank Facility
On March 19, 2021, as a result of the consummation of the Mergers, we became party to a revolving credit facility, or, as amended and/or restated from time to time, the Citibank Facility, with OCSL Senior Funding II LLC, our wholly-owned, special purpose financing subsidiary, as the borrower, us, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. As of December 31, 2021,2022, we were able to borrow up to $200 million under the Citibank Facility (subject to borrowing base and other limitations). As of December 31, 2021,2022, the reinvestment period under the Citibank Facility was scheduled to expire on November 18, 2023 and the maturity date for the Citibank Facility was November 18, 2024.
As of December 31, 2021,2022, borrowings under the Citibank Facility are subject to certain customary advance rates and accrue interest at a rate equal to LIBOR plus between 1.25% and 2.20% per annum on broadly syndicated loans, subject to observable market depth and pricing, and LIBOR plus 2.25% per annum on all other eligible loans during the reinvestment period. In addition, as of December 31, 2021,2022, for the duration of the reinvestment period there is a non-usage fee payable of 0.50% per annum on the undrawn amount under the Citibank Facility. The minimum asset coverage ratio applicable to us under the Citibank Facility is 150% as determined in accordance with the requirements of the Investment Company Act. Borrowings under the Citibank Facility are secured by all of the assets of OCSL Senior Funding II LLC and all of our equity interests in OCSL Senior Funding II LLC. We may use the Citibank Facility to fund a portion of our loan origination activities and for general corporate purposes. Each loan origination under the Citibank Facility is subject to the satisfaction of certain conditions.
As of December 31, 20212022 and September 30, 2021,2022, we had $155.0$165.0 million and $135.0$160.0 million outstanding under the Citibank Facility, respectively, which had a fair value of $155.0$165.0 million and $135.0$160.0 million, respectively. Our borrowings under the Citibank Facility bore interest at a weighted average interest rate of 6.508% and 1.830% for the three months ended December 31, 2021.2022 and December 31, 2021, respectively. For the three months ended December 31, 2022 and  December 31, 2021, we recorded interest expense (inclusive of fees) of $2.7 million and $0.8 million, respectively, related to the Citibank Facility.
2025 Notes
On February 25, 2020, we issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the notes.
2027 Notes
On May 18, 2021, we issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the notes.
In connection with the 2027 Notes, we entered into an interest rate swap to more closely align the interest rates of our liabilities with our investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap
99


agreement, we receive a fixed interest rate of 2.7%2.700% and pay a floating interest rate of the three-month LIBOR plus 1.658% on a notional amount of $350 million. We designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship.
The below table presents the components of the carrying value of the 2025 Notes and the 2027 Notes as of December 31, 20212022 and September 30, 2021:2022:
As of December 31, 2021As of September 30, 2021 As of December 31, 2022As of September 30, 2022
($ in millions)($ in millions)2025 Notes2027 Notes2025 Notes2027 Notes($ in millions)2025 Notes2027 Notes2025 Notes2027 Notes
PrincipalPrincipal$300.0 $350.0 $300.0 $350.0 Principal$300.0 $350.0 $300.0 $350.0 
Unamortized financing costs Unamortized financing costs(2.3)(3.8)(2.6)(4.0) Unamortized financing costs(1.6)(3.1)(1.8)(3.2)
Unaccreted discount Unaccreted discount(1.6)(0.9)(1.7)(0.9) Unaccreted discount(1.1)(0.7)(1.2)(0.7)
Interest rate swap fair value adjustment Interest rate swap fair value adjustment— (5.9)— (2.1) Interest rate swap fair value adjustment— (39.9)— (42.0)
Net carrying valueNet carrying value$296.1 $339.4 $295.7 $343.0 Net carrying value$297.3 $306.3 $297.0 $304.1 
Fair ValueFair Value$312.8 $347.4 $314.5 $351.1 Fair Value$286.7 $296.8 $283.1 $294.0 
95


The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three months ended December 31, 2022:

($ in millions)2025 Notes2027 Notes
Coupon interest$2.6 $2.4 
Amortization of financing costs and discount0.3 0.2 
Effect of interest rate swap— 2.5 
 Total interest expense$2.9 $5.1 
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)3.500 %5.586 %
The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three months ended December 31, 2021:
($ in millions)2025 Notes2027 Notes
Coupon interest$2.6 $2.4 
Amortization of financing costs and discount0.3 0.2 
Effect of interest rate swap— (0.7)
 Total interest expense$2.9 $1.9 
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)3.500 %1.782 %
The below table presents the components of interest and other debt expenses related to the 2025 Notes for the three months ended December 31, 2020:
($ in millions)2025 Notes
Coupon interest$2.6 
Amortization of financing costs and discount0.3 
 Total interest expense$2.9
Coupon interest rate3.500 %


Regulated Investment Company Status and Distributions


We have qualified and elected to be treated as a RIC under Subchapter M of the Code for U.S. federal income tax purposes. As long as we continue to qualify as a RIC, we will not be subject to tax on our investment company taxable income (determined without regard to any deduction for dividends paid) or realized net capital gains, to the extent that such taxable income or gains is distributed, or deemed to be distributed as dividends, to stockholders on a timely basis.
Taxable income generally differs from net income for financial reporting purposes due to temporary and permanent differences in the recognition of income and expenses, and generally excludes net unrealized appreciation or depreciation. Distributions declared and paid by us in a taxable year may differ from taxable income for that taxable year as such distributions may include the distribution of taxable income derived from the current taxable year or the distribution of taxable income derived from the prior taxable year carried forward into and distributed in the current taxable year. Distributions also may include returns of capital.
To maintain RIC tax treatment, we must, among other things, distribute dividends, with respect to each taxable year, of an amount at least equal to 90% of our investment company taxable income (i.e., our net ordinary income and our realized net short-term capital gains in excess of realized net long-term capital losses, if any), determined without regard to any deduction for dividends paid. As a RIC, we are also subject to a federal excise tax, based on distribution requirements of our taxable income on a calendar year basis. We anticipate timely distribution of our taxable income in accordance with tax rules. We did
100


not incur a U.S. federal excise tax for calendar years 2020 and 2021 andyear 2021. For the calendar year 2022, we incurred $0.1 million of excise tax. We do not expect to incur a U.S. federal excise tax for calendar year 2022. We may incur a federal excise tax in future years.2023.
We intend to distribute at least 90% of our annual taxable income (which includes our taxable interest and fee income) to our stockholders. The covenants contained in our credit facilities may prohibit us from making distributions to our stockholders, and, as a result, could hinder our ability to satisfy the distribution requirement associated with our ability to be subject to tax as a RIC. In addition, we may retain for investment some or all of our net capital gains (i.e., realized net long-term capital gains in excess of realized net short-term capital losses) and treat such amounts as deemed distributions to our stockholders. If we do this, our stockholders will be treated as if they received actual distributions of the capital gains we retained and then reinvested the net after-tax proceeds in our common stock. Our stockholders also may be eligible to claim tax credits (or, in certain circumstances, tax refunds) equal to their allocable share of the tax we paid on the capital gains deemed distributed to them. To the extent our taxable earnings for a fiscal and taxable year fall below the total amount of our dividend distributions for that fiscal and taxable year, a portion of those distributions may be deemed a return of capital to our stockholders.
We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of these distributions from time to time. In addition, we may be limited in our ability to make distributions due to the asset coverage test for borrowings applicable to us as a Business Development Company under the Investment Company Act and due to provisions in our credit facilities and debt instruments. If we do not distribute a certain percentage of our taxable
96


income annually, we will suffer adverse tax consequences, including possible loss of our ability to be subject to tax as a RIC. We cannot assure stockholders that they will receive any distributions or distributions at a particular level.
A RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder elects to receive his or her entire distribution in either cash or stock of the RIC, subject to certain limitations regarding the aggregate amount of cash to be distributed to all stockholders. If these and certain other requirements are met, for U.S federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.
We may generate qualified net interest income or qualified net short-term capital gains that may be exempt from U.S. withholding tax when distributed to foreign stockholders. A RIC is permitted to designate distributions of qualified net interest income and qualified short-term capital gains as exempt from U.S. withholding tax when paid to non-U.S. shareholders with proper documentation. The following table, which may be subject to change as we finalize our annual tax filings, lists the percentage of qualified net interest income and qualified short-term capital gains for the year ended September 30, 2021.2022.
Year EndedQualified Net Interest IncomeQualified Short-Term Capital Gains
September 30, 2021202289.8 80.8 %— 
We have adopted a DRIP that provides for the reinvestment of any distributions that we declare in cash on behalf of our stockholders, unless a stockholder elects to receive cash. As a result, if our Board of Directors declares a cash distribution, then our stockholders who have not “opted out” of the DRIP will have their cash distributions automatically reinvested in additional shares of our common stock, rather than receiving a cash distribution. If our shares are trading at a premium to net asset value, we typically issue new shares to implement the DRIP, with such shares issued at the greater of the most recently computed net asset value per share of our common stock or 95% of the current market value per share of our common stock on the payment date for such distribution. If our shares are trading at a discount to net asset value, we typically purchase shares in the open market in connection with our obligations under the DRIP.
Related Party Transactions
We have entered into the Investment Advisory Agreement with Oaktree and the Administration Agreement with Oaktree Administrator, an affiliate of Oaktree. Mr. John B. Frank, an interested member of our Board of Directors, has an indirect pecuniary interest in Oaktree. Oaktree is a registered investment adviser under the Investment Advisers Act of 1940, as amended, that is partially and indirectly owned by Oaktree Capital Group, LLC. See “Note 10. Related Party Transactions – Investment Advisory Agreement” and “– Administrative Services” in the notes to the accompanying Consolidated Financial Statements.
101


Recent Developments
Distribution Declaration
On January 28, 2022,27, 2023, our Board of Directors declared a quarterly distribution of $0.16$0.55 per share, payable in cash on March 31, 20222023 to stockholders of record on March 15, 2022.2023.

Election of Chief Operating Officer

Investment Advisory Agreement
On January 28,23, 2023, in connection with the consummation of the OSI2 Merger, we entered into an amended and restated investment advisory agreement with Oaktree to amend and restate the prior investment advisory agreement, dated as of March 19, 2021, by and between us and Oaktree to (1) waive an aggregate of $9.0 million of base management fees otherwise payable to the Oaktree in the two years following the closing of the OSI2 Merger and (2) revise the calculation of the incentive fees to eliminate certain unintended consequences of the accounting treatment of the OSI2 Merger on the incentive fees payable to Oaktree. None of the other terms were changed, and the services to be provided by Oaktree and the term of the Investment Advisory Agreement remain the same.
OSI2 Merger
On January 23, 2023, we completed the OSI2 Merger. In accordance with the terms of the OSI2 Merger Agreement, at the effective time of the OSI2 Merger, each outstanding share of OSI2 common stock was converted into the right to receive 0.9115 shares of our common stock (with OSI2’s stockholders receiving cash in lieu of fractional shares of our common stock). As a result of the OSI2 Merger, we issued an aggregate of 15,860,200 shares of its common stock to former OSI2 stockholders. Following completion of the OSI2 Merger, we had 77,079,805 shares of common stock outstanding.
OSI2 Citibank Facility
On January 23, 2023, as a result of the consummation of the OSI2 Merger, we became party to the OSI2 Citibank Facility (as described below).
OSI 2 Senior Lending SPV, LLC, or OSI 2 SPV, our wholly-owned and consolidated subsidiary, is party to a loan and security agreement dated as of July 26, 2019, which was subsequently amended on September 20, 2019, July 2, 2020, December 31, 2020, March 31, 2021 and December 2, 2022, our boardor, as amended, the OSI2 Citibank Loan Agreement, with the lenders from time to time party thereto and the other parties referenced below. Under the terms of directors appointed Matthew Stewartthe OSI2 Citibank Loan Agreement, we serve as Chief Operating Officer, effective immediately. Mathew Pendo, previously the Presidentcollateral manager and Chief Operating Officer, will continue in his role as President.

Mr. Stewart joined Oaktree Capital Management, L.P., or OCM, in 2017seller and currentlyOSI 2 SPV serves as borrower with Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent.
The OSI2 Citibank Loan Agreement provides for a senior vice presidentsecured revolving credit facility, or the OSI2 Citibank Facility of up to $250 million, or the Citibank Maximum Commitment, in aggregate principal amount, subject to the lesser of (i) the borrowing base, which is an amount based on advance rates that vary depending on the class of assets and investment professionalthe value assigned to such assets under the OSI2 Citibank Loan Agreement and (ii) the Citibank Maximum Commitment. The OSI2 Citibank Facility has a reinvestment period through May 26, 2023, during which advances may be made, and matures on OCM’s Strategic Credit team. PriorJanuary 26, 2025. Following the reinvestment period, OSI 2 SPV will be required to joining OCM, Mr. Stewart wasmake certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a vice president at Fifth Street Management. Prior thereto, he was a director at Stifel Nicolaus where he workedrate per year equal to (a) in the Leveraged Finance group. Mr. Stewart began his careercase of a lender that is identified as a senior associate at BDO Consultingconduit lender under the OSI2 Citibank Loan Agreement, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) LIBOR for a three month maturity and (b) for all other lenders under the OSI2 Citibank Facility, LIBOR, plus, in each case, an applicable spread. During the reinvestment period, the applicable spread is the greater of (i) a weighted average rate of (x) 1.65% per year for broadly syndicated loans and (y) 2.25% per year for all other eligible loans and (ii) 1.85%. After the reinvestment period, the applicable spread is 3.00% per year. There is also a non-usage fee of 0.50% per year thereafter on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility.
The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets.
As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the Business Restructuring group before moving on to serving as a vice president inacceleration of the institutional fixed income business at Knight Capital Group. He received a B.B.A. in finance and a B.S. in accountancy from Villanova University. Mr. Stewart is a Certified Public Accountant (inactive) and CFA charterholder.

amounts due under the OSI2 Citibank Facility.
97102


Under the OSI2 Citibank Facility, we and OSI 2 SPV, as applicable, have made customary representations and warranties, and are required to comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar credit facilities.
OSI 2 SPV’s borrowings are non-recourse to us but are considered our borrowings for purposes of complying with the asset coverage requirements under the Investment Company Act.
As of January 23, 2023, we had $225.0 million outstanding under the OSI2 Citibank Facility.
Reverse Stock Split
On January 20, 2023, we amended our restated certificate of incorporation, as amended and corrected, to effect a 1-for-3 reverse stock split. Following completion of the reverse stock split, we had 61,219,605 shares of common stock outstanding.




103





Item 3. Quantitative and Qualitative Disclosures about Market Risk


We are subject to financial market risks, including changes in the valuations of our investment portfolio and interest rates.
Valuation Risk
Our investments may not have a readily available market price, and we value these investments at fair value as determined in good faith by Oaktree, as our Board of Directors, with the assistance of the Audit Committee and Oaktree.valuation designee. There is no single standard for determining fair value in good faith and valuation methodologies involve a significant degree of management judgment. In addition, our valuation methodology utilizes discount rates in part in valuing our investments, and changes in those discount rates may have an impact on the valuation of our investments. Accordingly, valuations by usOaktree do not necessarily represent the amounts which may eventually be realized from sales or other dispositions of investments. Estimated fair values may differ from the values that would have been used had a ready market for the investment existed, and the differences could be material to the financial statements.
Interest Rate Risk
We are subject to financial market risks, including changes in interest rates. Changes in interest rates may affect both our cost of funding and our interest income from portfolio investments, cash and cash equivalents and idle fund investments. Our risk management procedures are designed to identify and analyze our risk, to set appropriate policies and to continually monitor these risks. Our investment income will be affected by changes in various interest rates, including LIBOR, SOFR, SONIA and prime rates, to the extent our debt investments include floating interest rates.
As of December 31, 2021, 91.6%2022, 87.3% of our debt investment portfolio (at fair value) and 91.6%87.2% of our debt investment portfolio (at cost) bore interest at floating rates. As of September 30, 2021, 91.5%2022, 86.5% of our debt investment portfolio (at fair value) and 91.8%86.3% of our debt investment portfolio (at cost) bore interest at floating rates. The composition of our floating rate debt investments by interest rate floor as of December 31, 20212022 and September 30, 2021,2022, was as follows:
December 31, 2021September 30, 2021 December 31, 2022September 30, 2022
($ in thousands)($ in thousands)Fair Value% of Floating Rate PortfolioFair Value% of Floating Rate Portfolio($ in thousands)Fair Value% of Floating Rate PortfolioFair Value% of Floating Rate Portfolio
0%0%$260,536 11.7 %$322,222 14.6 %0%$242,898 11.1 %$228,186 11.1 %
>0% and <1%>0% and <1%368,912 16.5 %283,065 12.8 %>0% and <1%431,661 19.7 %388,458 19.0 %
1%1%1,510,936 67.5 %1,507,977 68.4 %1%1,397,099 63.9 %1,364,668 66.6 %
>1%>1%96,455 4.3 %92,384 4.2 %>1%116,535 5.3 %68,332 3.3 %
Total Floating Rate InvestmentsTotal Floating Rate Investments$2,236,839 100.0 %$2,205,648 100.0 %Total Floating Rate Investments$2,188,193 100.0 %$2,049,644 100.0 %


Based on our Consolidated Statement of Assets and Liabilities as of December 31, 2021,2022, the following table shows the approximate annualized net increase (decrease) in net assets resulting from operations (excluding the impact of any potential incentive fees) of hypothetical base rate changes in interest rates, assuming no changes in our investment and capital structure. However, there can be no assurances our portfolio companies will be able to meet their contractual obligations at any or all levels on increases in interest rates.
($ in thousands)
Basis point increaseIncrease in Interest Income(Increase) in Interest ExpenseNet increase (decrease) in net assets resulting from operations
($ in thousands) Basis point increase($ in thousands) Basis point increaseIncrease in Interest Income(Increase) in Interest ExpenseNet increase in net assets resulting from operations
250250$41,219 $(25,000)$16,219 250$57,529 $(30,250)$27,279 
20020030,067 (20,000)10,067 20046,020 (24,200)21,820 
15015018,993 (15,000)3,993 15034,512 (18,150)16,362 
1001008,061 (10,000)(1,939)10023,004 (12,100)10,904 
50501,650 (5,000)(3,350)5011,498 (6,050)5,448 


The net effect of any decrease in interest rates is limited and would not be of significance due to interest rate floors on investments and borrowings outstanding.
98104



($ in thousands) Basis point decrease(Decrease) in Interest IncomeDecrease in Interest ExpenseNet (decrease) in net assets resulting from operations
50$(11,471)$6,050 $(5,421)
100(22,729)12,100 (10,629)
150(33,959)18,150 (15,809)
200(45,156)24,200 (20,956)
250(56,204)30,250 (25,954)
We regularly measure exposure to interest rate risk. We assess interest rate risk and manage our interest rate exposure on an ongoing basis by comparing our interest rate sensitive assets to our interest rate sensitive liabilities. Based on this review, we determine whether or not any hedging transactions are necessary to mitigate exposure to changes in interest rates. The following table shows a comparison of the interest rate base for our interest-bearing cash and outstanding investments, at principal, and our outstanding borrowings as of December 31, 20212022 and September 30, 2021:2022:
December 31, 2021September 30, 2021 December 31, 2022September 30, 2022
($ in thousands)($ in thousands)Interest Bearing
Cash and
Investments
BorrowingsInterest Bearing
Cash and
Investments
Borrowings($ in thousands)Interest Bearing
Cash and
Investments
BorrowingsInterest Bearing
Cash and
Investments
Borrowings
Money market rateMoney market rate$32,083 $— $23,600 $— Money market rate$3,421 $— $5,262 $— 
Prime ratePrime rate305 — 305 10,000 Prime rate305 — 2,618 — 
LIBORLIBORLIBOR
30 day30 day715,378 495,000 674,613 485,000 30 day593,798 695,000 669,273 540,000 
60 day2,500 — — — 
90 day (a)90 day (a)975,208 505,000 1,037,019 485,000 90 day (a)1,030,274 515,000 928,978 510,000 
180 day180 day377,829 — 323,869 — 180 day91,244 — 199,301 — 
360 day89,291 — 96,095 — 
EURIBOREURIBOREURIBOR
30 day30 day28,246 — 28,786 — 30 day24,838 — 24,838 — 
90 day90 day19,232 — 19,599 — 90 day30,810 — 16,911 — 
180 day180 day2,234 — 18,516 — 180 day14,304 — 1,964 — 
SOFRSOFRSOFR
30 day30 day14,414 — — — 30 day$142,913 — $50,099 — 
UK LIBOR
30 day24,380 — 28,991 — 
90 day90 day4,742 — — — 90 day285,690 — 190,799 — 
180 day180 day25,242 — 25,128 — 180 day47,323 — 18,390 — 
SONIASONIA£40,137 — £40,137 — 
Fixed rateFixed rate203,747 300,000 200,599 300,000 Fixed rate$338,548 300,000 $341,749 300,000 
Total$2,514,831 $1,300,000 $2,477,120 $1,280,000 
__________ 
(a)Borrowings include the 2027 Notes, which pay interest at a floating rate under the terms of the interest rate swap.
99105



Item 4. Controls and Procedures


(a) Evaluation of Disclosure Controls and Procedures


Management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2021.2022. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives. Based on the evaluation of our disclosure controls and procedures as of December 31, 2021,2022, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective, at the reasonable assurance level, in timely identifying, recording, processing, summarizing and reporting any material information relating to us that is required to be disclosed in the reports we file or submit under the Exchange Act.


There were no changes in our internal control over financial reporting that occurred during the three months ended December 31, 20212022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.



PART II


Item 1.     Legal Proceedings
We are currently not a party to any pending material legal proceedings.

Item 1A. Risk Factors
There have been no material changes during the three months ended December 31, 20212022 to the risk factors discussed in Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended September 30, 2021.

2022.
Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds.
None.


Item 3. Defaults Upon Senior Securities
None.
Item 4.     Mine Safety Disclosures
Not applicable.


Item 5. Other Information
None.


100106




Item 6. Exhibits

Seventh Amendment to the Amended and Restated Loan and Security Agreement by and among the Company, as collateral manager, OCSL Senior Funding II LLC, as borrower, and Citibank, N.A., as administrative agent and sole lender, dated as of November 18, 2021.
Incremental Commitment Agreement, dated asRestated Certificate of December 10, 2021, madeIncorporation of the Registrant (incorporated by Oaktree Specialty Lending Corporation, as Borrower, BNP Paribas, as assuming lender, and ING Capital LLC, as administrative agent and issuing bank relatingreference to Exhibit 3.1 filed with Registrant’s Form 8-A (File No. 001-33901) filed on January 2, 2008).
Certificate of Amendment to the Amended andRegistrant’s Restated Senior Secured Revolving Credit Agreement, dated asCertificate of February 25, 2019 among Oaktree Specialty Lending Corporation, as Borrower,Incorporation (incorporated by reference to Exhibit (a)(2) filed with Registrant’s Registration Statement on Form N-2 (File No. 333-146743) filed on June 6, 2008).
Certificate of Correction to the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A. and Merrill Lynch, Pierce, Fenner & Smith Incorporated as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and BankCertificate of America, N.A., as syndication agentsAmendment to the Registrant’s Restated Certificate of Incorporation (Incorporated by reference to Exhibit 10.1(a)(3) filed with Registrant’s Registration Statement on Form N-2 (File No. 333-146743) filed on June 6, 2008).
Certificate of Amendment to Registrant’s Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 filed with Registrant’s Quarterly Report on Form 10-Q (File No. 001-33901) filed on May 5, 2010).
Certificate of Amendment to Registrant’s Certificate of Incorporation (incorporated by reference to Exhibit (a)(5) filed with the Registrant’s Current ReportRegistration Statement on Form N-2 (File No. 333-180267) filed on April 2, 2013).
Certificate of Amendment to the Restated Certificate of Incorporation of the Registrant, dated as of October 17, 2017 (incorporated by reference to Exhibit 3.1 filed with the Registrant’s Form 8-K (File No. 814-00755) filed on December 13, 2021)October 17, 2017).
Certificate of Amendment to the Restated Certificate of Incorporation of the Registrant, dated as of January 20, 2023 (incorporated by reference to Exhibit 3.7 filed with the Registrant’s Form 8-K (File No. 814-00755) filed on January 20, 2023).

Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).
Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).
101.INS*Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH*Inline XBRL Taxonomy Extension Schema Document.
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104*Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
*Filed herewith.







107




SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
OAKTREE SPECIALTY LENDING CORPORATION
By:/s/   Armen Panossian
Armen Panossian
Chief Executive Officer
By:/s/   Christopher McKown
Christopher McKown
Chief Financial Officer and Treasurer
Date: February 2, 20226, 2023













101108